,Title,Page Type,Country Code,Author,Category Details,Full Text,Gender,Hashtags,Interest,Professions,clean_tw
0,"Federica Picarello, PhD, postdoctoral researcher and psychologist, King's College, London, spoke about fatigue mechanisms in patients with #MS based on presentations from the #ECTRIMS Congress.
https://t.co/rU3tJ9Vwz8",twitter,USA,byMattHoffman,,"federica picarello, phd, postdoctoral researcher and psychologist, king's college, london, spoke about fatigue mechanisms in patients with #ms based on presentations from the #ectrims congress. https://t.co/ru3tj9vwz8",male,"#ms, #ectrims",Books,"{profession=Journalist, jobTitle=Editor}","federica picarello, phd, postdoctoral researcher and psychologist, king's college, london, spoke about fatigue mechanisms in patients with ms based on presentations from the ec trims congress."
1,"ECTRIMS 2022: Dimethyl Fumarate Demonstrates Benefit in People With Radiologically Isolated Syndrome
https://t.co/CLh1tuDL4N #multiplesclerosis",twitter,USA,PracUpNeuro,,ectrims 2022: dimethyl fumarate demonstrates benefit in people with radiologically isolated syndrome https://t.co/clh1tudl4n #multiplesclerosis,,#multiplesclerosis,,,ectrims 2022: dimethyl fumarate demonstrates benefit in people with radiologically isolated syndrome multiple sclerosis
2,"üö®Novel risk allele identified as the first genome-wide significant genetic modifier of #MS severity

Adil Harroud (@mcgillu) shares the results of his work on genetic contributions to MS severity: https://t.co/jZjT8p7Is3

#ECTRIMS2022 #Neurology #NeuroTwitter #MultipleSclerosis",twitter,,VJNeurology,,üö®novel risk allele identified as the first genome-wide significant genetic modifier of #ms severity adil harroud (@mcgillu) shares the results of his work on genetic contributions to ms severity: https://t.co/jzjt8p7is3 #ectrims2022 #neurology #neurotwitter #multiplesclerosis,,"#ms, #ectrims2022, #neurology, #neurotwitter, #multiplesclerosis",Photo & Video,,novel risk allele identified as the first genome-wide significant genetic modifier of ms severity adil harroud () shares the results of his work on genetic contributions to ms severity: ec trims #neurology #neurotwitter multiple sclerosis
3,"üé• Reliable. Innovation. Community. Just a few words our participants used to describe ECTRIMS in this year's highlight video. A humble reminder that we will continue to aim for excellence as we serve the #MS community 

Learn more about our mission ‚ñ∂Ô∏è https://t.co/ISNDpLPNmA https://t.co/2QvVTUb6KI",twitter,CHE,ECTRIMS,,üé• reliable. innovation. community. just a few words our participants used to describe ectrims in this year's highlight video. a humble reminder that we will continue to aim for excellence as we serve the #ms community learn more about our mission ‚ñ∂Ô∏è https://t.co/isndplpnma https://t.co/2qvvtub6ki,,#ms,,,reliable. innovation. community. just a few words our participants used to describe ectrims in this year's highlight video. a humble reminder that we will continue to aim for excellence as we serve the ms community learn more about our mission
4,"#ECTRIMS2022 ‚Äì The investigational immunotherapy ATA188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of #MS, according to the data, now reaching up to four years, on patients in an ongoing clinical trial. https://t.co/EH3mEWUafY https://t.co/LtYMpNLHht",twitter,USA,MSNewsToday,,"#ectrims2022 ‚Äì the investigational immunotherapy ata188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of #ms, according to the data, now reaching up to four years, on patients in an ongoing clinical trial. https://t.co/eh3mewuafy https://t.co/ltympnlhht",female,"#ectrims2022, #ms","Beauty/Health & Fitness, Science",,"ec trims the investigational immunotherapy ata188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of ms, according to the data, now reaching up to four years, on patients in an ongoing clinical trial."
5,"#ECTRIMS2022 - Treatment with #Tecfidera significantly reduces the risk of experiencing the first multiple sclerosis symptoms in adults with radiologically isolated syndrome, according to data from a Phase 4 clinical trial. https://t.co/4xt9yQSKAi #multiplesclerosis #MSresearch https://t.co/Eo0HHPyPpk",twitter,USA,MSNewsToday,,"#ectrims2022 - treatment with #tecfidera significantly reduces the risk of experiencing the first multiple sclerosis symptoms in adults with radiologically isolated syndrome, according to data from a phase 4 clinical trial. https://t.co/4xt9yqskai #multiplesclerosis #msresearch https://t.co/eo0hhpyppk",female,"#ectrims2022, #tecfidera, #multiplesclerosis, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - treatment with #tecfidera significantly reduces the risk of experiencing the first multiple sclerosis symptoms in adults with radiologically isolated syndrome, according to data from a phase 4 clinical trial. multiple sclerosis msresearch"
6,"In our top three editorial picks from #ECTRIMS2022: One study found that an EBV infection consistently preceded biomarkers of nerve cell damage in people who went on to develop MS. https://t.co/C1DcXsgE9r

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/CMqrp9qL3p",twitter,USA,MSNewsToday,,in our top three editorial picks from #ectrims2022: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. https://t.co/c1dcxsge9r #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/cmqrp9ql3p,female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims
7,"At the 2022 @ECTRIMS Congress, October 26-28, in Amsterdam, the Netherlands, multiple analyses from the phase 3 N-MOmentum trial of inebilizumab (@HorizonNews) were presented. #ECTRIMS #MS @UCSF @UCSF 

View: https://t.co/urTgp1AsHa",twitter,USA,neurology_live,,"at the 2022 @ectrims congress, october 26-28, in amsterdam, the netherlands, multiple analyses from the phase 3 n-momentum trial of inebilizumab (@horizonnews) were presented. #ectrims #ms @ucsf @ucsf view: https://t.co/urtgp1asha",,"#ectrims, #ms",Beauty/Health & Fitness,,"at the 2022 congress, october 26-28, in amsterdam, the netherlands, multiple analyses from the phase 3 n-momentum trial of inebilizumab () were presented. ec trims ms view:"
8,"#ECTRIMS2022 - Remyelination, or regeneration of the myelin sheath that‚Äôs progressively damaged and lost in multiple sclerosis, may be less effective for those who develop MS later in life, new research suggests. https://t.co/8rnSTYuM5D  #MSresearch #multiplesclerosis #MSnews https://t.co/usAZMaGFhG",twitter,USA,MSNewsToday,,"#ectrims2022 - remyelination, or regeneration of the myelin sheath that‚Äôs progressively damaged and lost in multiple sclerosis, may be less effective for those who develop ms later in life, new research suggests. https://t.co/8rnstyum5d #msresearch #multiplesclerosis #msnews https://t.co/usazmagfhg",female,"#ectrims2022, #msresearch, #multiplesclerosis, #msnews","Beauty/Health & Fitness, Science",,"ec trims - remyelination, or regeneration of the myelin sheath thats progressively damaged and lost in multiple sclerosis, may be less effective for those who develop ms later in life, new research suggests. msresearch multiple sclerosis msnews"
9,"ECTRIMS 2022: Progression Independent of Relapse Activity Occurs Less Often in Pediatric-Onset Than Adult-Onset MS
https://t.co/BLjNiPP232 #multiplesclerosis",twitter,USA,PracUpNeuro,,ectrims 2022: progression independent of relapse activity occurs less often in pediatric-onset than adult-onset ms https://t.co/bljnipp232 #multiplesclerosis,,#multiplesclerosis,,,ectrims 2022: progression independent of relapse activity occurs less often in pediatric-onset than adult-onset ms multiple sclerosis
11,"#ECTRIMS2022 - An infection with the Epstein-Barr virus consistently preceded elevations in neurofilament light chain, an early biomarker of nerve cell damage, in people who went on to develop multiple sclerosis, new data show. https://t.co/itQt14U09Z #EBVandMS #MSnews https://t.co/YS4Snzo3BR",twitter,USA,MSNewsToday,,"#ectrims2022 - an infection with the epstein-barr virus consistently preceded elevations in neurofilament light chain, an early biomarker of nerve cell damage, in people who went on to develop multiple sclerosis, new data show. https://t.co/itqt14u09z #ebvandms #msnews https://t.co/ys4snzo3br",female,"#ectrims2022, #ebvandms, #msnews","Beauty/Health & Fitness, Science",,"ec trims - an infection with the epstein-barr virus consistently preceded elevations in neurofilament light chain, an early biomarker of nerve cell damage, in people who went on to develop multiple sclerosis, new data show. #ebvandms msnews"
12,"Via @ECTRIMS: Focusing only on processing speed during an assessment could hinder the identification and treatment of cognitive impairments in patients with #MS: https://t.co/f2NW6f9kpS
#ECTRIMS2022 #MultipleSclerosis #NeurologyToday #neurotwitter @AANMember @MSHSNeurology https://t.co/FKCVSzwUm8",twitter,USA,NeurologyToday,,via @ectrims: focusing only on processing speed during an assessment could hinder the identification and treatment of cognitive impairments in patients with #ms: https://t.co/f2nw6f9kps #ectrims2022 #multiplesclerosis #neurologytoday #neurotwitter @aanmember @mshsneurology https://t.co/fkcvszwum8,,"#ms, #ectrims2022, #multiplesclerosis, #neurologytoday, #neurotwitter",,,via : focusing only on processing speed during an assessment could hinder the identification and treatment of cognitive impairments in patients with ms: ec trims multiple sclerosis #neurologytoday #neurotwitter
13,"In an early trial, investigational treatment ATA188 stabilized or eased disability in most people with non-active, progressive forms of MS for up to four years. https://t.co/yVdX8uHHdM

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/qlAYW46e8Y",twitter,USA,MSNewsToday,,"in an early trial, investigational treatment ata188 stabilized or eased disability in most people with non-active, progressive forms of ms for up to four years. https://t.co/yvdx8uhhdm #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/qlayw46e8y",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"in an early trial, investigational treatment ata188 stabilized or eased disability in most people with non-active, progressive forms of ms for up to four years. multiple sclerosis msnews msawareness msresearch ec trims"
14,"@LivedHealth @AaronBosterMD @themsguide @ECTRIMS In the same appointment that my MS specialist diagnosed me with MS, he also asked me what my goals were.  He has referred back to those goals in his notes a few times when talking about treatments and symptom mitigation. I'm glad he thought to ask.",twitter,,joy_chronic,,"@livedhealth @aaronbostermd @themsguide @ectrims in the same appointment that my ms specialist diagnosed me with ms, he also asked me what my goals were. he has referred back to those goals in his notes a few times when talking about treatments and symptom mitigation. i'm glad he thought to ask.",unknown,,"Science, Family & Parenting",,"in the same appointment that my ms specialist diagnosed me with ms, he also asked me what my goals were. he has referred back to those goals in his notes a few times when talking about treatments and symptom mitigation. i'm glad he thought to ask."
15,"Via @ECTRIMS: Hematopoietic stem cell transplantation performed as well as or better on some disease-modifying therapies in patients with relapsing-remitting #MS: https://t.co/cdbfxQwhOW
#ECTRIMS2022 #MultipleSclerosis #NeurologyToday #neurotwitter @AANMember @UoMNeuroscience https://t.co/mjou6kqK3N",twitter,USA,NeurologyToday,,via @ectrims: hematopoietic stem cell transplantation performed as well as or better on some disease-modifying therapies in patients with relapsing-remitting #ms: https://t.co/cdbfxqwhow #ectrims2022 #multiplesclerosis #neurologytoday #neurotwitter @aanmember @uomneuroscience https://t.co/mjou6kqk3n,,"#ms, #ectrims2022, #multiplesclerosis, #neurologytoday, #neurotwitter",,,via : hematopoietic stem cell transplantation performed as well as or better on some disease-modifying therapies in patients with relapsing-remitting ms: ec trims multiple sclerosis #neurologytoday #neurotwitter
16,"üß†#MultipleSclerosis controversiesüß†

Escalation strategy vs. high-efficacy DMTs at early stages: what is preferable and for who?

Jaume Sastre-Garriga of @vallhebron discusses: https://t.co/2jEAr8jdtm

#ECTRIMS2022 @ECTRIMS #Neurology #NeuroTwitter #MS",twitter,,VJNeurology,,üß†#multiplesclerosis controversiesüß† escalation strategy vs. high-efficacy dmts at early stages: what is preferable and for who? jaume sastre-garriga of @vallhebron discusses: https://t.co/2jear8jdtm #ectrims2022 @ectrims #neurology #neurotwitter #ms,,"#multiplesclerosis, #ectrims2022, #neurology, #neurotwitter, #ms",Photo & Video,,multiple sclerosis controversies escalation strategy vs. high-efficacy dmts at early stages: what is preferable and for who? jaume sastre-garriga of discusses: ec trims #neurology #neurotwitter ms
17,"Hey that's me! Thanks for having me at #ECTRIMS2022 @LivedHealth and @themsguide üôè
#MS took a lot from me but it also gave me the #Idgaf attitude that I needed to pursue my dream of becoming an independent (copy)writer üëá",twitter,NLD,MSWarriorMJ,,hey that's me! thanks for having me at #ectrims2022 @livedhealth and @themsguide üôè #ms took a lot from me but it also gave me the #idgaf attitude that i needed to pursue my dream of becoming an independent (copy)writer üëá,female,"#ectrims2022, #ms, #idgaf",Books,,hey that's me! thanks for having me at ec trims and ms took a lot from me but it also gave me the #idgaf attitude that i needed to pursue my dream of becoming an independent (copy)writer
18,"Findings suggest that rituximab ‚Äî a cancer treatment that can be used off-label for MS ‚Äî cannot be considered as good as Ocrevus, despite their similar mechanism of action. https://t.co/cFE4grCP83

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/m7eXsgBwZH",twitter,USA,MSNewsToday,,"findings suggest that rituximab ‚Äî a cancer treatment that can be used off-label for ms ‚Äî cannot be considered as good as ocrevus, despite their similar mechanism of action. https://t.co/cfe4grcp83 #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/m7exsgbwzh",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"findings suggest that rituximab a cancer treatment that can be used off-label for ms cannot be considered as good as ocrevus, despite their similar mechanism of action. multiple sclerosis msnews msawareness msresearch ec trims"
19,"ECTRIMS 2022: Rituximab Tied to More Relapses in RRMS Than Ocrelizumab
https://t.co/l0AbnJ1CpH #multiplesclerosis",twitter,USA,PracUpNeuro,,ectrims 2022: rituximab tied to more relapses in rrms than ocrelizumab https://t.co/l0abnj1cph #multiplesclerosis,,#multiplesclerosis,,,ectrims 2022: rituximab tied to more relapses in rrms than ocrelizumab multiple sclerosis
20,"EBV is a suspect in the development of multiple sclerosis (MS), and recent research developments have strengthened that connection. #ECTRIMS2022 #PedsTwitter https://t.co/mNua8bSnPN",twitter,,MedscapePeds,,"ebv is a suspect in the development of multiple sclerosis (ms), and recent research developments have strengthened that connection. #ectrims2022 #pedstwitter https://t.co/mnua8bsnpn",,"#ectrims2022, #pedstwitter",Beauty/Health & Fitness,,"ebv is a suspect in the development of multiple sclerosis (ms), and recent research developments have strengthened that connection. ec trims #pedstwitter"
21,"How can I get my neurologist to understand what I need? Chat with @AaronBosterMD and @themsguide at @ECTRIMS üçª

Turn on notifications to watch the full video live with us on 15/11/22 at 16:30 GMT üëâ https://t.co/cVyVmNHaUF 

#WeHaveMS #MS https://t.co/z8niPgdwAp",twitter,,LivedHealth,,how can i get my neurologist to understand what i need? chat with @aaronbostermd and @themsguide at @ectrims üçª turn on notifications to watch the full video live with us on 15/11/22 at 16:30 gmt üëâ https://t.co/cvyvmnhauf #wehavems #ms https://t.co/z8nipgdwap,unknown,"#wehavems, #ms","Beauty/Health & Fitness, Photo & Video",,how can i get my neurologist to understand what i need? chat with and at turn on notifications to watch the full video live with us on 15/11/22 at 16:30 gmt #wehavems ms
22,"The associate professor of neurology at the University of California, San Francisco, discussed the key points from an oral presentation at #ECTRIMS2022 on understanding postpartum for patients with #MS and #NMOSD.
https://t.co/0WVzdzn66K",twitter,USA,byMattHoffman,,"the associate professor of neurology at the university of california, san francisco, discussed the key points from an oral presentation at #ectrims2022 on understanding postpartum for patients with #ms and #nmosd. https://t.co/0wvzdzn66k",male,"#ectrims2022, #ms, #nmosd",Books,"{profession=Journalist, jobTitle=Editor}","the associate professor of neurology at the university of california, san francisco, discussed the key points from an oral presentation at ec trims on understanding postpartum for patients with ms and #nmosd."
23,Did you know there were different types of relapses? Nada‚Äôs journey continues as she learns of the differing impact of relapses in people with neuromyelitis optica spectrum disorder and multiple sclerosis ‚è∞ #ECTRIMS2022 #NMOSD #multiplesclerosis,twitter,CHE,Roche,,did you know there were different types of relapses? nada‚Äôs journey continues as she learns of the differing impact of relapses in people with neuromyelitis optica spectrum disorder and multiple sclerosis ‚è∞ #ectrims2022 #nmosd #multiplesclerosis,,"#ectrims2022, #nmosd, #multiplesclerosis",,,did you know there were different types of relapses? nadas journey continues as she learns of the differing impact of relapses in people with neuromyelitis optica spectrum disorder and multiple sclerosis ec trims #nmosd multiple sclerosis
24,"This is one of our top three editorial picks from #ECTRIMS2022: aHSCT is better than Gilenya and Tysabri at preventing relapses in people with highly active RRMS. https://t.co/r9MZPZRRoc

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/CV5wQPR9Zh",twitter,USA,MSNewsToday,,this is one of our top three editorial picks from #ectrims2022: ahsct is better than gilenya and tysabri at preventing relapses in people with highly active rrms. https://t.co/r9mzpzrroc #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/cv5wqpr9zh,female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,this is one of our top three editorial picks from ec trims: ahsct is better than gilenya and tysabri at preventing relapses in people with highly active rrms. multiple sclerosis msnews msawareness msresearch ec trims
25,"EBV is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. #ECTRIMS2022 #MedTwitter https://t.co/8MTklH4y4y",twitter,USA,Medscape,,"ebv is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. #ectrims2022 #medtwitter https://t.co/8mtklh4y4y",unknown,"#ectrims2022, #medtwitter",Beauty/Health & Fitness,,"ebv is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. ec trims #medtwitter"
26,"An internet-based cognitive-behavioral therapy program specifically designed for patients with MS significantly reduced depressive symptoms compared to usual treatment, new research shows. #ECTRIMS2022 #MedTwitter https://t.co/encmyYjHV9",twitter,USA,Medscape,,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. #ectrims2022 #medtwitter https://t.co/encmyyjhv9",unknown,"#ectrims2022, #medtwitter",Beauty/Health & Fitness,,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter"
27,"Long-term use of the investigational BTK inhibitor evobrutinib among people with relapsing forms of MS maintained disease stability for up to three and half years. https://t.co/8d6jsYR6EI

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/EaJcqudEmc",twitter,USA,MSNewsToday,,long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. https://t.co/8d6jsyr6ei #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/eajcqudemc,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims
29,"MS/PTSD
Did the way your doctor tell u you had MS lead to you having Post Traumatic Stress Disorder (PTSD)?
@_heathermah, #ECTRIMS2022 @preventiveneur1, @shiftms,@GavinGiovannoni,@somehow_related,@drruthdobson, @gpeps 
Here is H Mah's insightful piece:
https://t.co/mkZhr2Sw4B https://t.co/S7X3lBH7Zj",twitter,GBR,RachelHorne19,,"ms/ptsd did the way your doctor tell u you had ms lead to you having post traumatic stress disorder (ptsd)? @_heathermah, #ectrims2022 @preventiveneur1, @shiftms,@gavingiovannoni,@somehow_related,@drruthdobson, @gpeps here is h mah's insightful piece: https://t.co/mkzhr2sw4b https://t.co/s7x3lbh7zj",female,#ectrims2022,,"{profession=Journalist, jobTitle=Journalist}, {profession=Scientist & Researcher, jobTitle=Research Fellow}","ms/ptsd did the way your doctor tell u you had ms lead to you having post traumatic stress disorder (ptsd)? , ec trims , ,,,, here is h mah's insightful piece:"
30,"EBV is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. #ECTRIMS2022 #NeuroTwitter https://t.co/i7EMzdqfnE",twitter,,MedscapeNeuro,,"ebv is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. #ectrims2022 #neurotwitter https://t.co/i7emzdqfne",,"#ectrims2022, #neurotwitter",Beauty/Health & Fitness,,"ebv is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. ec trims #neurotwitter"
33,"Experimental therapy ublituximab works better than Aubagio at easing disability independently of relapses and at reducing overall disease activity in adults with relapsing forms of MS. https://t.co/hMbGmn4Qoq

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/XO17gXfYBZ",twitter,USA,MSNewsToday,,experimental therapy ublituximab works better than aubagio at easing disability independently of relapses and at reducing overall disease activity in adults with relapsing forms of ms. https://t.co/hmbgmn4qoq #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/xo17gxfybz,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,experimental therapy ublituximab works better than aubagio at easing disability independently of relapses and at reducing overall disease activity in adults with relapsing forms of ms. multiple sclerosis msnews msawareness msresearch ec trims
34,"Audio news üéßPrice Wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset MS patients, which could underlie more severe disease progression. He also reads a column from Ed Tobias. https://t.co/gGjw0Y7ObA #MSnews #ECTRIMS2022 #MS https://t.co/UEtG3uOjlo",twitter,USA,MSNewsToday,,"audio news üéßprice wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. https://t.co/ggjw0y7oba #msnews #ectrims2022 #ms https://t.co/uetg3uojlo",female,"#msnews, #ectrims2022, #ms","Beauty/Health & Fitness, Science",,"audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms"
35,"Nondisabling relapses that occur early in the course of relapsing-remitting multiple sclerosis signal faster accumulation of disability relative to no early relapses, new research suggests. #ECTRIMS2022 https://t.co/biIiTpIAUs https://t.co/8PQfTyInW4",twitter,,MedscapeNeuro,,"nondisabling relapses that occur early in the course of relapsing-remitting multiple sclerosis signal faster accumulation of disability relative to no early relapses, new research suggests. #ectrims2022 https://t.co/biiitpiaus https://t.co/8pqftyinw4",,#ectrims2022,Beauty/Health & Fitness,,"nondisabling relapses that occur early in the course of relapsing-remitting multiple sclerosis signal faster accumulation of disability relative to no early relapses, new research suggests. ec trims"
36,Please join @neurognanapavan and myself tonight from 6pm GMT to discuss some highlights @ECTRIMS #ECTRIMS2022 @Iamsterdam #MS @atthelimits You will be able to speak up!,twitter,GBR,KlausSchmierer,,please join @neurognanapavan and myself tonight from 6pm gmt to discuss some highlights @ectrims #ectrims2022 @iamsterdam #ms @atthelimits you will be able to speak up!,male,"#ectrims2022, #ms",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",please join and myself tonight from 6pm gmt to discuss some highlights ec trims ms you will be able to speak up!
37,"This is one of our top three editorial picks from #ECTRIMS2022: Tecfidera can reduce the risk of experiencing the first MS symptoms in adults with radiologically isolated syndrome. https://t.co/PD1UrSPd7z

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/cKj9Mw922s",twitter,USA,MSNewsToday,,this is one of our top three editorial picks from #ectrims2022: tecfidera can reduce the risk of experiencing the first ms symptoms in adults with radiologically isolated syndrome. https://t.co/pd1urspd7z #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/ckj9mw922s,female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,this is one of our top three editorial picks from ec trims: tecfidera can reduce the risk of experiencing the first ms symptoms in adults with radiologically isolated syndrome. multiple sclerosis msnews msawareness msresearch ec trims
38,"An internet-based cognitive-behavioral therapy program specifically designed for patients with MS significantly reduced depressive symptoms compared to usual treatment, new research shows. #ECTRIMS2022 #PsychTwitter https://t.co/hzxToncEhp",twitter,,MedscapePsych,,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. #ectrims2022 #psychtwitter https://t.co/hzxtoncehp",,"#ectrims2022, #psychtwitter",Beauty/Health & Fitness,,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter"
39,"#ECTRIMS2022 ‚Äì Disability progression in the absence of relapses is less common in children and adolescents with #MultipleSclerosis than among people with adult-onset disease, according to data covering more than 5,000 patients with relapsing forms of #MS. https://t.co/pPzCszCWmq https://t.co/Cz6q3sZxco",twitter,USA,MSNewsToday,,"#ectrims2022 ‚Äì disability progression in the absence of relapses is less common in children and adolescents with #multiplesclerosis than among people with adult-onset disease, according to data covering more than 5,000 patients with relapsing forms of #ms. https://t.co/ppzcszcwmq https://t.co/cz6q3szxco",female,"#ectrims2022, #multiplesclerosis, #ms","Beauty/Health & Fitness, Science",,"ec trims disability progression in the absence of relapses is less common in children and adolescents with multiple sclerosis than among people with adult-onset disease, according to data covering more than 5,000 patients with relapsing forms of ms."
40,"One study has suggested that recently diagnosed MS patients with two forms of chronic active brain lesions on their MRI scans experience greater disability progression. https://t.co/6dyZl8xqQH

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/ppkNIUj1Am",twitter,USA,MSNewsToday,,one study has suggested that recently diagnosed ms patients with two forms of chronic active brain lesions on their mri scans experience greater disability progression. https://t.co/6dyzl8xqqh #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/ppkniuj1am,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,one study has suggested that recently diagnosed ms patients with two forms of chronic active brain lesions on their mri scans experience greater disability progression. multiple sclerosis msnews msawareness msresearch ec trims
41,"Is anyone on #Tysabri considering switching to #Ocrevus following the recent data from #ECTRIMS2022 ?

https://t.co/Bxgm2QIa2Q",twitter,GBR,italoromeno,,is anyone on #tysabri considering switching to #ocrevus following the recent data from #ectrims2022 ? https://t.co/bxgm2qia2q,male,"#tysabri, #ocrevus, #ectrims2022",Politics,,is anyone on #tysabri considering switching to #ocrevus following the recent data from ec trims ?
43,"Stem cell transplant is better than Gilenya and Tysabri at preventing relapses and reducing disability in people with highly active RRMS. It also appears to be as effective as Ocrevus. https://t.co/9fz4x20wLB

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/3b35Uw7Hyl",twitter,USA,MSNewsToday,,stem cell transplant is better than gilenya and tysabri at preventing relapses and reducing disability in people with highly active rrms. it also appears to be as effective as ocrevus. https://t.co/9fz4x20wlb #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/3b35uw7hyl,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,stem cell transplant is better than gilenya and tysabri at preventing relapses and reducing disability in people with highly active rrms. it also appears to be as effective as ocrevus. multiple sclerosis msnews msawareness msresearch ec trims
44,The future & the present for some. #MS #multidisciplinary #CenterthePatient #ICYMI #ECTRIMS2022,twitter,,IJMSCtweets,,the future & the present for some. #ms #multidisciplinary #centerthepatient #icymi #ectrims2022,,"#ms, #multidisciplinary, #centerthepatient, #icymi, #ectrims2022",,,the future & the present for some. ms #multidisciplinary #centerthepatient #icymi ec trims
46,@kellyhenwo @Brandon_Beaber No but on ECTRIMS was presented study comparing HSCT vs Natalizumab for progressive MS,twitter,CZE,Lucie_Cermanova,,@kellyhenwo @brandon_beaber no but on ectrims was presented study comparing hsct vs natalizumab for progressive ms,female,,,,no but on ectrims was presented study comparing hsct vs natalizumab for progressive ms
47,"Nasal administration of #Foralumab showed positive clinical effects for 2 patients with nonactive #SecondaryProgressiveMultipleSclerosis (#SPMS), according to findings presented at the Congress of the @ECTRIMS¬†https://t.co/PkOEuMcrmy #MSCommunity #MS #MultipleSclerosis #ECTRIMS",twitter,USA,RareDisease_Adv,,"nasal administration of #foralumab showed positive clinical effects for 2 patients with nonactive #secondaryprogressivemultiplesclerosis (#spms), according to findings presented at the congress of the @ectrims https://t.co/pkoeumcrmy #mscommunity #ms #multiplesclerosis #ectrims",,"#foralumab, #secondaryprogressivemultiplesclerosis, #spms, #mscommunity, #ms, #multiplesclerosis, #ectrims",,,"nasal administration of #foralumab showed positive clinical effects for 2 patients with nonactive #secondaryprogressivemultiplesclerosis (#spms), according to findings presented at the congress of the mscommunity ms multiple sclerosis ec trims"
48,"#ECTRIMS2022 - #Ocrevus, an anti-CD20 therapy developed by Genentech, seems to be superior to rituximab at lowering relapse rates among patients with relapsing-remitting multiple sclerosis, according to data from two large #MS registries. https://t.co/RKMY9dSQBC #msnews https://t.co/rwxhUoAiR7",twitter,USA,MSNewsToday,,"#ectrims2022 - #ocrevus, an anti-cd20 therapy developed by genentech, seems to be superior to rituximab at lowering relapse rates among patients with relapsing-remitting multiple sclerosis, according to data from two large #ms registries. https://t.co/rkmy9dsqbc #msnews https://t.co/rwxhuoair7",female,"#ectrims2022, #ocrevus, #ms, #msnews","Beauty/Health & Fitness, Science",,"ec trims - #ocrevus, an anti-cd20 therapy developed by genentech, seems to be superior to rituximab at lowering relapse rates among patients with relapsing-remitting multiple sclerosis, according to data from two large ms registries. msnews"
49,"ECTRIMS 2022: Early Nondisabling Relapses Tied to Risk for Disability Accumulation in Relapsing-Remitting MS
https://t.co/98FjpKugOg #multiplesclerosis",twitter,USA,PracUpNeuro,,ectrims 2022: early nondisabling relapses tied to risk for disability accumulation in relapsing-remitting ms https://t.co/98fjpkugog #multiplesclerosis,,#multiplesclerosis,,,ectrims 2022: early nondisabling relapses tied to risk for disability accumulation in relapsing-remitting ms multiple sclerosis
50,#ECTRIMS2022 highlights from National MS Society.,twitter,,IJMSCtweets,,#ectrims2022 highlights from national ms society.,,#ectrims2022,,,ec trims highlights from national ms society.
52,@OliviaWills20 @ECTRIMS Many thanks for your interest in becoming a #MRI in #MultipleSclerosis expert! We all hope you will enjoy this @ECTRIMS @MAGNIMS Winterschool.,twitter,,MAGNIMS,,@oliviawills20 @ectrims many thanks for your interest in becoming a #mri in #multiplesclerosis expert! we all hope you will enjoy this @ectrims @magnims winterschool.,unknown,"#mri, #multiplesclerosis",,,many thanks for your interest in becoming a #mri in multiple sclerosis expert! we all hope you will enjoy this winterschool.
53,"An internet-based cognitive-behavioral therapy program specifically designed for patients with MS significantly reduced depressive symptoms compared to usual treatment, new research shows. #ECTRIMS2022 #NeuroTwitter https://t.co/R555SB24um",twitter,,MedscapeNeuro,,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. #ectrims2022 #neurotwitter https://t.co/r555sb24um",,"#ectrims2022, #neurotwitter",Beauty/Health & Fitness,,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter"
54,"Biomarkers, diet, progressive MS, and Epstein-Barr virus were among research news shared at ECTRIMS, the world‚Äôs largest #MSResearch conference.

Check out highlights: https://t.co/fmgveIC5fx. https://t.co/Fkjo02SYjw",twitter,,mssociety,,"biomarkers, diet, progressive ms, and epstein-barr virus were among research news shared at ectrims, the world‚Äôs largest #msresearch conference. check out highlights: https://t.co/fmgveic5fx. https://t.co/fkjo02syjw",female,#msresearch,,,"biomarkers, diet, progressive ms, and epstein-barr virus were among research news shared at ectrims, the worlds largest msresearch conference. check out highlights: ."
55,"At this year's ECTRIMS Congress, Marisa McGinley of @ClevelandClinic sat down with us to discuss how telehealth and digital measures can help with monitoring the progression of patients with #MS. 

Watch here: https://t.co/DA9HG6cLjX",twitter,USA,neurology_live,,"at this year's ectrims congress, marisa mcginley of @clevelandclinic sat down with us to discuss how telehealth and digital measures can help with monitoring the progression of patients with #ms. watch here: https://t.co/da9hg6cljx",,#ms,Beauty/Health & Fitness,,"at this year's ectrims congress, marisa mcginley of sat down with us to discuss how telehealth and digital measures can help with monitoring the progression of patients with ms. watch here:"
56,#ECTRIMS2022 ‚Äì Targeting EBV Key in Progressive MS: Experts | ATA188 May Be 'Game Changing' Treatment for Non-active Forms | #MultipleSclerosis News Today https://t.co/C8kzr4gb96,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì targeting ebv key in progressive ms: experts | ata188 may be 'game changing' treatment for non-active forms | #multiplesclerosis news today https://t.co/c8kzr4gb96,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims targeting ebv key in progressive ms: experts | ata188 may be 'game changing' treatment for non-active forms | multiple sclerosis news today
57,"What are the 'do's' and 'don'ts' of having a baby when you live with multiple sclerosis? üçº You'll be surprised by the answers from neurologist, Dr Rhonda Voskuhl of @UCLA üëâ https://t.co/aVUIZ2wVDt

@themsguide @ECTRIMS #MultipleSclerosis #ECTRIMS2022",twitter,,LivedHealth,,"what are the 'do's' and 'don'ts' of having a baby when you live with multiple sclerosis? üçº you'll be surprised by the answers from neurologist, dr rhonda voskuhl of @ucla üëâ https://t.co/avuiz2wvdt @themsguide @ectrims #multiplesclerosis #ectrims2022",unknown,"#multiplesclerosis, #ectrims2022","Beauty/Health & Fitness, Photo & Video",,"what are the 'do's' and 'don'ts' of having a baby when you live with multiple sclerosis? you'll be surprised by the answers from neurologist, dr rhonda voskuhl of multiple sclerosis ec trims"
58,"Thank you for having me @ECTRIMS along with the 70 students from over 50 countries! What a privilege to learn about all things #MRI to accurately diagnose, evaluate effectiveness of treatment and monitor progression of #MS. https://t.co/HPyZ3odPlQ",twitter,,OliviaWills20,,"thank you for having me @ectrims along with the 70 students from over 50 countries! what a privilege to learn about all things #mri to accurately diagnose, evaluate effectiveness of treatment and monitor progression of #ms. https://t.co/hpyz3odplq",female,"#mri, #ms","Beauty/Health & Fitness, Science, Politics, Food & Drinks","{profession=Student, jobTitle=PhD Candidate}","thank you for having me along with the 70 students from over 50 countries! what a privilege to learn about all things #mri to accurately diagnose, evaluate effectiveness of treatment and monitor progression of ms."
59,"@MarTintore & @rocca_mara warmly welcome all participants to the 1st @ECTRIMS @MAGNIMS winterschool on #MRI in diagnosis, prognosis and treatment monitoring of #MultipleSclerosis where I have the pleasure & honor to serve as local organizer together with @alexrovirarayos https://t.co/2EexXwSugp",twitter,ESP,J_SastreGarriga,,"@martintore & @rocca_mara warmly welcome all participants to the 1st @ectrims @magnims winterschool on #mri in diagnosis, prognosis and treatment monitoring of #multiplesclerosis where i have the pleasure & honor to serve as local organizer together with @alexrovirarayos https://t.co/2eexxwsugp",male,"#mri, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}","& warmly welcome all participants to the 1st winterschool on #mri in diagnosis, prognosis and treatment monitoring of multiple sclerosis where i have the pleasure & honor to serve as local organizer together with"
61,"Is HSCT really that good?  This analysis at #ECTRIMS2022 (unrandomized) found HSCT is better than gilenya but similar in efficacy to ocrevus and tysabri (in relapses, disability progression), though improvement was more common with HSCT. https://t.co/1Ml4Rz5grW",twitter,USA,Brandon_Beaber,,"is hsct really that good? this analysis at #ectrims2022 (unrandomized) found hsct is better than gilenya but similar in efficacy to ocrevus and tysabri (in relapses, disability progression), though improvement was more common with hsct. https://t.co/1ml4rz5grw",male,#ectrims2022,"Books, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neurologist}","is hsct really that good? this analysis at ec trims (unrandomized) found hsct is better than gilenya but similar in efficacy to ocrevus and tysabri (in relapses, disability progression), though improvement was more common with hsct."
63,"Early use of DMTs among people with SPMS may lead to overall lower levels of disability. However, staying on treatment does not appear to significantly slow disability progression over time. https://t.co/uWEaimt2ty

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/6D2Jq4hF9B",twitter,USA,MSNewsToday,,"early use of dmts among people with spms may lead to overall lower levels of disability. however, staying on treatment does not appear to significantly slow disability progression over time. https://t.co/uweaimt2ty #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/6d2jq4hf9b",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"early use of dmts among people with spms may lead to overall lower levels of disability. however, staying on treatment does not appear to significantly slow disability progression over time. multiple sclerosis msnews msawareness msresearch ec trims"
65,"This year ECTRIMS is ensuring the latest MS research unveiled at our congress reaches the entire #MS community. The ECTRIMS 2022: For People with MS Event is now available for viewing in English, Dutch, French, German, Italian & Spanish. 

Watch it now ‚û°Ô∏è https://t.co/GHq9cP6aiY https://t.co/yefaiH3ERF",twitter,CHE,ECTRIMS,,"this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire #ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now ‚û°Ô∏è https://t.co/ghq9cp6aiy https://t.co/yefaih3erf",,#ms,,,"this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now"
66,"#ECTRIMS2022 - Long-term use of the investigational BTK inhibitor evobrutinib among people with relapsing forms of multiple sclerosis continues to maintain MS relapse rates, and keep MRI lesion activity low. https://t.co/Ad77VIIZwI #MSnews #MSresearch #MStreatments #RRMS #MS https://t.co/O4uwlM2KbB",twitter,USA,MSNewsToday,,"#ectrims2022 - long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of multiple sclerosis continues to maintain ms relapse rates, and keep mri lesion activity low. https://t.co/ad77viizwi #msnews #msresearch #mstreatments #rrms #ms https://t.co/o4uwlm2kbb",female,"#ectrims2022, #msnews, #msresearch, #mstreatments, #rrms, #ms","Beauty/Health & Fitness, Science",,"ec trims - long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of multiple sclerosis continues to maintain ms relapse rates, and keep mri lesion activity low. msnews msresearch mstreatments #rrms ms"
67,#ECTRIMS2022 - Long-term treatment with #Gilenya continues to be safe and lower the rate of relapses in children and adolescents with multiple sclerosis more than #Avonex (interferon beta-1a) does. https://t.co/ixVuQx3xFP #MStreatments #MSresearch #multiplesclerosis https://t.co/CckboLw4gs,twitter,USA,MSNewsToday,,#ectrims2022 - long-term treatment with #gilenya continues to be safe and lower the rate of relapses in children and adolescents with multiple sclerosis more than #avonex (interferon beta-1a) does. https://t.co/ixvuqx3xfp #mstreatments #msresearch #multiplesclerosis https://t.co/cckbolw4gs,female,"#ectrims2022, #gilenya, #avonex, #mstreatments, #msresearch, #multiplesclerosis","Beauty/Health & Fitness, Science",,ec trims - long-term treatment with #gilenya continues to be safe and lower the rate of relapses in children and adolescents with multiple sclerosis more than #avonex (interferon beta-1a) does. mstreatments msresearch multiple sclerosis
70,Fantastic to see @AminZarghami18 of our MS Research Flagship virtually present his work about employment transitions in people with #MultipleSclerosis on the world stage @ECTRIMS üôå,twitter,AUS,ResearchMenzies,,fantastic to see @aminzarghami18 of our ms research flagship virtually present his work about employment transitions in people with #multiplesclerosis on the world stage @ectrims üôå,male,#multiplesclerosis,,,fantastic to see of our ms research flagship virtually present his work about employment transitions in people with multiple sclerosis on the world stage
71,"https://t.co/7l6uq4qHEn
We were in Amsterdam last week, attending #ECTRIMS2022 -- the largest MS research conference in the world. Today, @mssociety Executive VP of Research, Dr. Bruce Bebo, shares the research and presentations that got his attention. #MultipleSclerosis",twitter,USA,RealTalkMS_jon,,"https://t.co/7l6uq4qhen we were in amsterdam last week, attending #ectrims2022 -- the largest ms research conference in the world. today, @mssociety executive vp of research, dr. bruce bebo, shares the research and presentations that got his attention. #multiplesclerosis",male,"#ectrims2022, #multiplesclerosis",Family & Parenting,,"we were in amsterdam last week, attending ec trims -- the largest ms research conference in the world. today, executive vp of research, dr. bruce bebo, shares the research and presentations that got his attention. multiple sclerosis"
73,#ECTRIMS2022 ‚Äì Smartphone Tap Speed May Help in Monitoring MS: Tap speed ‚Äî or how quickly one types on a smartphone keyboard ‚Äî may be a useful tool for monitoring #MS severity and detecting the transition to a progressive form of the disease. https://t.co/SEmnINvahg #MSnews https://t.co/DgHeMHJIc7,twitter,USA,MSNewsToday,,#ectrims2022 ‚Äì smartphone tap speed may help in monitoring ms: tap speed ‚Äî or how quickly one types on a smartphone keyboard ‚Äî may be a useful tool for monitoring #ms severity and detecting the transition to a progressive form of the disease. https://t.co/semninvahg #msnews https://t.co/dghemhjic7,female,"#ectrims2022, #ms, #msnews","Beauty/Health & Fitness, Science",,ec trims smartphone tap speed may help in monitoring ms: tap speed or how quickly one types on a smartphone keyboard may be a useful tool for monitoring ms severity and detecting the transition to a progressive form of the disease. msnews
74,"https://t.co/7l6uq4qHEn
There's been a major step forward in preventing RIS from transitioning to diagnosable MS. @mssociety Executive VP of Research, Dr. Bruce Bebo, discusses the research and presentations that got his attention last week at #ECTRIMS2022 #MultipleSclerosis",twitter,USA,RealTalkMS_jon,,"https://t.co/7l6uq4qhen there's been a major step forward in preventing ris from transitioning to diagnosable ms. @mssociety executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at #ectrims2022 #multiplesclerosis",male,"#ectrims2022, #multiplesclerosis",Family & Parenting,,"there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"
75,"ECTRIMS 2022: Behavioral Interventions May Help Alleviate Cognitive Problems in MS
https://t.co/97zqZmVqqs #multiplesclerosis",twitter,USA,PracUpNeuro,,ectrims 2022: behavioral interventions may help alleviate cognitive problems in ms https://t.co/97zqzmvqqs #multiplesclerosis,,#multiplesclerosis,,,ectrims 2022: behavioral interventions may help alleviate cognitive problems in ms multiple sclerosis
77,"#ECTRIMS2022 - Exposure to high-efficacy disease-modifying therapies is associated with an increased risk of cervical abnormalities in women with multiple sclerosis, recent data suggest. https://t.co/OfQtKLwajG  #MSresearch #msnews #multiplesclerosis #MS #MSawareness https://t.co/9VjqhFqJrp",twitter,USA,MSNewsToday,,"#ectrims2022 - exposure to high-efficacy disease-modifying therapies is associated with an increased risk of cervical abnormalities in women with multiple sclerosis, recent data suggest. https://t.co/ofqtklwajg #msresearch #msnews #multiplesclerosis #ms #msawareness https://t.co/9vjqhfqjrp",female,"#ectrims2022, #msresearch, #msnews, #multiplesclerosis, #ms, #msawareness","Beauty/Health & Fitness, Science",,"ec trims - exposure to high-efficacy disease-modifying therapies is associated with an increased risk of cervical abnormalities in women with multiple sclerosis, recent data suggest. msresearch msnews multiple sclerosis ms msawareness"
78,"Tecfidera reduces the risk of patients experiencing the first MS symptoms in adults with radiologically isolated syndrome ‚Äî when patients have MS-like lesions on MRI scans but lack symptoms. https://t.co/1iqNV0yWUM

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/5veQgRYzdn",twitter,USA,MSNewsToday,,tecfidera reduces the risk of patients experiencing the first ms symptoms in adults with radiologically isolated syndrome ‚Äî when patients have ms-like lesions on mri scans but lack symptoms. https://t.co/1iqnv0ywum #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/5veqgryzdn,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,tecfidera reduces the risk of patients experiencing the first ms symptoms in adults with radiologically isolated syndrome when patients have ms-like lesions on mri scans but lack symptoms. multiple sclerosis msnews msawareness msresearch ec trims
79,"#ECTRIMS2022 - Genetic variants in genes mostly active in the brain and spinal cord ‚Äî the central nervous system ‚Äî are associated with the severity of #MS, and linked to a faster accrual of disability and greater signs of brain tissue damage. https://t.co/wB376VhPSJ #MSnews https://t.co/YMiiOrHlFK",twitter,USA,MSNewsToday,,"#ectrims2022 - genetic variants in genes mostly active in the brain and spinal cord ‚Äî the central nervous system ‚Äî are associated with the severity of #ms, and linked to a faster accrual of disability and greater signs of brain tissue damage. https://t.co/wb376vhpsj #msnews https://t.co/ymiiorhlfk",female,"#ectrims2022, #ms, #msnews","Beauty/Health & Fitness, Science",,"ec trims - genetic variants in genes mostly active in the brain and spinal cord the central nervous system are associated with the severity of ms, and linked to a faster accrual of disability and greater signs of brain tissue damage. msnews"
80,"https://t.co/7l6uq4qHEn
Scientists have identified a genetic variant that contributes to the severity of an individual's MS. My guest, @mssociety Executive VP of Research, Dr. Bruce Bebo, discusses the research that got his attention at #ECTRIMS2022 #MultipleSclerosis",twitter,USA,RealTalkMS_jon,,"https://t.co/7l6uq4qhen scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, @mssociety executive vp of research, dr. bruce bebo, discusses the research that got his attention at #ectrims2022 #multiplesclerosis",male,"#ectrims2022, #multiplesclerosis",Family & Parenting,,"scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis"
81,"Ibudilast has a significant beneficial effect on slowly evolving lesions in patients with progressive MS, new data suggest. #ECTRIMS2022 https://t.co/fwPWgdxHaf",twitter,,MedscapeNeuro,,"ibudilast has a significant beneficial effect on slowly evolving lesions in patients with progressive ms, new data suggest. #ectrims2022 https://t.co/fwpwgdxhaf",,#ectrims2022,Beauty/Health & Fitness,,"ibudilast has a significant beneficial effect on slowly evolving lesions in patients with progressive ms, new data suggest. ec trims"
82,"At #ECTRIMS2022, Riley Bove, MD, sat down with us to discuss the safety profiles of anti-CD20 therapies for women with MS who may be pregnant. 

Listen in to her thoughts üéß https://t.co/l9MzEEH5Rp",twitter,USA,neurology_live,,"at #ectrims2022, riley bove, md, sat down with us to discuss the safety profiles of anti-cd20 therapies for women with ms who may be pregnant. listen in to her thoughts üéß https://t.co/l9mzeeh5rp",,#ectrims2022,Beauty/Health & Fitness,,"at ec trims, riley bove, md, sat down with us to discuss the safety profiles of anti-cd20 therapies for women with ms who may be pregnant. listen in to her thoughts"
84,"ECTRIMS 2022: Disease-Modifying Therapy Effects Diminish in Secondary Progressive MS
https://t.co/WVc7EziGdw #multiplesclerosis",twitter,USA,PracUpNeuro,,ectrims 2022: disease-modifying therapy effects diminish in secondary progressive ms https://t.co/wvc7ezigdw #multiplesclerosis,,#multiplesclerosis,,,ectrims 2022: disease-modifying therapy effects diminish in secondary progressive ms multiple sclerosis
85,"Columnist Ed Tobias discusses the week's top MS news, which includes a new study on Ocrevus and details about why stopping a DMT could be risky. https://t.co/HJOOovIU8S

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/UN17DQTpXj",twitter,USA,MSNewsToday,,"columnist ed tobias discusses the week's top ms news, which includes a new study on ocrevus and details about why stopping a dmt could be risky. https://t.co/hjoooviu8s #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/un17dqtpxj",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"columnist ed tobias discusses the week's top ms news, which includes a new study on ocrevus and details about why stopping a dmt could be risky. multiple sclerosis msnews msawareness msresearch ec trims"
86,"#ECTRIMS2022 - Treatment with #Ocrevus  before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications, with 79% of the pregnancies leading to live births, according to data from more than 2,000 women with #MS. https://t.co/Uz8Pbl65v3 https://t.co/PsNvW18x0p",twitter,USA,MSNewsToday,,"#ectrims2022 - treatment with #ocrevus before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications, with 79% of the pregnancies leading to live births, according to data from more than 2,000 women with #ms. https://t.co/uz8pbl65v3 https://t.co/psnvw18x0p",female,"#ectrims2022, #ocrevus, #ms","Beauty/Health & Fitness, Science",,"ec trims - treatment with #ocrevus before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications, with 79% of the pregnancies leading to live births, according to data from more than 2,000 women with ms."
87,#ECTRIMS2022 ‚Äì Vumerity Lowers RRMS Activity Over 2 Years | #MultipleSclerosis News Today https://t.co/QWsuvoTLJH,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì vumerity lowers rrms activity over 2 years | #multiplesclerosis news today https://t.co/qwsuvotljh,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims vumerity lowers rrms activity over 2 years | multiple sclerosis news today
88,"#ECTRIMS2022 ‚Äì Evobrutinib Reduces MS Relapses Over 3 Years | Long-term Use of MS Therapy Candidate Safe, Effective: Trial Data | #MultipleSclerosis News Today https://t.co/dtWApCfxvz",twitter,GBR,AbiBuddComms,,"#ectrims2022 ‚Äì evobrutinib reduces ms relapses over 3 years | long-term use of ms therapy candidate safe, effective: trial data | #multiplesclerosis news today https://t.co/dtwapcfxvz",unknown,"#ectrims2022, #multiplesclerosis",Books,,"ec trims evobrutinib reduces ms relapses over 3 years | long-term use of ms therapy candidate safe, effective: trial data | multiple sclerosis news today"
89,"üéôÔ∏è ""We thought that progression in #MS was something that happened later on in the disease. But more & more we are seeing that this is a process that in fact starts much earlier: ECTRIMS President @MarTintore from @cemcat_em 

‚ñ∂Ô∏è  https://t.co/LPPCoPYVpA

#SciencePodcast https://t.co/Q2xIBSFQ3q",twitter,CHE,ECTRIMS,,"üéôÔ∏è ""we thought that progression in #ms was something that happened later on in the disease. but more & more we are seeing that this is a process that in fact starts much earlier: ectrims president @martintore from @cemcat_em ‚ñ∂Ô∏è https://t.co/lppcopyvpa #sciencepodcast https://t.co/q2xibsfq3q",,"#ms, #sciencepodcast",,,"""we thought that progression in ms was something that happened later on in the disease. but more & more we are seeing that this is a process that in fact starts much earlier: ectrims president from #sciencepodcast"
91,"New research confirms the importance of COVID-19 mRNA booster doses for patients with MS who are receiving the anti-CD20 monoclonal antibody ocrelizumab, as currently recommended. #ECTRIMS2022 #NeuroTwitter https://t.co/yDtCed4ctz",twitter,,MedscapeNeuro,,"new research confirms the importance of covid-19 mrna booster doses for patients with ms who are receiving the anti-cd20 monoclonal antibody ocrelizumab, as currently recommended. #ectrims2022 #neurotwitter https://t.co/ydtced4ctz",,"#ectrims2022, #neurotwitter",Beauty/Health & Fitness,,"new research confirms the importance of covid-19 mrna booster doses for patients with ms who are receiving the anti-cd20 monoclonal antibody ocrelizumab, as currently recommended. ec trims #neurotwitter"
95,"#ECTRIMS2022 - Columnist Ed Tobias comments on the week's top MS news, including important reports from this year's¬†ECTRIMS conference. https://t.co/oPPlyJ5fsO  #MSresearch #MSnews #MScommunity #ECTRIMS #MStreatments #MSawareness https://t.co/W9ITJBBBY9",twitter,USA,MSNewsToday,,"#ectrims2022 - columnist ed tobias comments on the week's top ms news, including important reports from this year's ectrims conference. https://t.co/opplyj5fso #msresearch #msnews #mscommunity #ectrims #mstreatments #msawareness https://t.co/w9itjbbby9",female,"#ectrims2022, #msresearch, #msnews, #mscommunity, #ectrims, #mstreatments, #msawareness","Beauty/Health & Fitness, Science",,"ec trims - columnist ed tobias comments on the week's top ms news, including important reports from this year's ectrims conference. msresearch msnews mscommunity ec trims mstreatments msawareness"
96,"https://t.co/7l6uq4qHEn
Treatment with Vitamin D was shown to be unsuccessful in preventing CIS from developing into MS. @mssociety Executive EVP of Research, Dr. Bruce Bebo, discusses the research and presentations that got his attention at #ECTRIMS2022 #MultipleSclerosis",twitter,USA,RealTalkMS_jon,,"https://t.co/7l6uq4qhen treatment with vitamin d was shown to be unsuccessful in preventing cis from developing into ms. @mssociety executive evp of research, dr. bruce bebo, discusses the research and presentations that got his attention at #ectrims2022 #multiplesclerosis",male,"#ectrims2022, #multiplesclerosis",Family & Parenting,,"treatment with vitamin d was shown to be unsuccessful in preventing cis from developing into ms. executive evp of research, dr. bruce bebo, discusses the research and presentations that got his attention at ec trims multiple sclerosis"
97,"Have you seen our videos from @ECTRIMS yet?

We spoke to @GavinGiovannoni last week to bring you the latest on the most efficacious treatments for #multiplesclerosis üß†  üëâ https://t.co/wZ0apTCve9

#ECTRIMS2022 https://t.co/4TACa9Cri8",twitter,,LivedHealth,,have you seen our videos from @ectrims yet? we spoke to @gavingiovannoni last week to bring you the latest on the most efficacious treatments for #multiplesclerosis üß† üëâ https://t.co/wz0aptcve9 #ectrims2022 https://t.co/4taca9cri8,unknown,"#multiplesclerosis, #ectrims2022","Beauty/Health & Fitness, Photo & Video",,have you seen our videos from yet? we spoke to last week to bring you the latest on the most efficacious treatments for multiple sclerosis ec trims
98,"Bruce Cree, MD, PhD, MAS, FAAN, discussed the need for measures that track disease progression in #NMOSD, and the shift in focus similar to the #multiplesclerosis field. @UCSF  #ECTRIMS2022 #MS @ECTRIMS @genentech @HorizonNews  @AlexionPharma 

üé• Watch: https://t.co/3aX3e1MgG9 https://t.co/2DJWnwsyQG",twitter,USA,neurology_live,,"bruce cree, md, phd, mas, faan, discussed the need for measures that track disease progression in #nmosd, and the shift in focus similar to the #multiplesclerosis field. @ucsf #ectrims2022 #ms @ectrims @genentech @horizonnews @alexionpharma üé• watch: https://t.co/3ax3e1mgg9 https://t.co/2djwnwsyqg",,"#nmosd, #multiplesclerosis, #ectrims2022, #ms",Beauty/Health & Fitness,,"bruce cree, md, phd, mas, faan, discussed the need for measures that track disease progression in #nmosd, and the shift in focus similar to the multiple sclerosis field. ec trims ms watch:"
99,"Dimethyl fumarate could delay ‚Äì or even prevent ‚Äì clinical symptoms in patients with radiologically isolated syndrome, the earliest detected preclinical phase of multiple sclerosis. #ECTRIMS2022 https://t.co/BWvQVR3eVF https://t.co/hJJDaFgO7V",twitter,USA,MDEdgeTweets,,"dimethyl fumarate could delay ‚Äì or even prevent ‚Äì clinical symptoms in patients with radiologically isolated syndrome, the earliest detected preclinical phase of multiple sclerosis. #ectrims2022 https://t.co/bwvqvr3evf https://t.co/hjjdafgo7v",unknown,#ectrims2022,Beauty/Health & Fitness,,"dimethyl fumarate could delay or even prevent clinical symptoms in patients with radiologically isolated syndrome, the earliest detected preclinical phase of multiple sclerosis. ec trims"
100,"People who achieved confirmed disability improvement with investigational immunotherapy ATA188 also showed potential signs of remyelination. https://t.co/LwZVTFAusc

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/uPcU8gniJ5",twitter,USA,MSNewsToday,,people who achieved confirmed disability improvement with investigational immunotherapy ata188 also showed potential signs of remyelination. https://t.co/lwzvtfausc #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/upcu8gnij5,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,people who achieved confirmed disability improvement with investigational immunotherapy ata188 also showed potential signs of remyelination. multiple sclerosis msnews msawareness msresearch ec trims
101,"#ECTRIMS2022: Fertility treatments do not significantly increase the risk of relapse in women with #MS, even among those who undergo treatment protocols associated with greater levels of hormone exposure, according to a recent U.S.-based analysis.  https://t.co/AIcaiChg8U https://t.co/W3vC6McGEh",twitter,USA,MSNewsToday,,"#ectrims2022: fertility treatments do not significantly increase the risk of relapse in women with #ms, even among those who undergo treatment protocols associated with greater levels of hormone exposure, according to a recent u.s.-based analysis. https://t.co/aicaichg8u https://t.co/w3vc6mcgeh",female,"#ectrims2022, #ms","Beauty/Health & Fitness, Science",,"ec trims: fertility treatments do not significantly increase the risk of relapse in women with ms, even among those who undergo treatment protocols associated with greater levels of hormone exposure, according to a recent u.s.-based analysis."
102,#ECTRIMS2022 ‚Äì Ocrevus Superior to Rituximab at Reducing Relapses in Study | Lower Relapse Rate Found in Patients on Ocrevus vs. Rituximab | #MultipleSclerosis News Today https://t.co/mZbTW7OYdE,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì ocrevus superior to rituximab at reducing relapses in study | lower relapse rate found in patients on ocrevus vs. rituximab | #multiplesclerosis news today https://t.co/mzbtw7oyde,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims ocrevus superior to rituximab at reducing relapses in study | lower relapse rate found in patients on ocrevus vs. rituximab | multiple sclerosis news today
103,#ECTRIMS2022 ‚Äì Job Prospects Can Gradually Decline After CIS Diagnosis | Study: Job Prospects Lower Among CIS Patients Who Progress to MS | #MultipleSclerosis News Today https://t.co/dncgKcdi5L,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì job prospects can gradually decline after cis diagnosis | study: job prospects lower among cis patients who progress to ms | #multiplesclerosis news today https://t.co/dncgkcdi5l,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims job prospects can gradually decline after cis diagnosis | study: job prospects lower among cis patients who progress to ms | multiple sclerosis news today
104,"We had a great time @ECTRIMS last week; sharing the latest data, research üî¨ and innovations that have the potential to improve outcomes for people living with #MS. Check out our highlights video below! #ECTRIMS2022 https://t.co/Gmlc35tqQO",twitter,DEU,MerckHealthcare,,"we had a great time @ectrims last week; sharing the latest data, research üî¨ and innovations that have the potential to improve outcomes for people living with #ms. check out our highlights video below! #ectrims2022 https://t.co/gmlc35tqqo",,"#ms, #ectrims2022",,,"we had a great time last week; sharing the latest data, research and innovations that have the potential to improve outcomes for people living with ms. check out our highlights video below! ec trims"
105,"If you didn't get a chance to see us at #ECTRIMS2022 last week, you can now read our poster on remote web-based assessment of #cognition for people with multiple sclerosis: https://t.co/gJPigMDboM https://t.co/VTiwhlIJvm",twitter,GBR,CANTABconnect,,"if you didn't get a chance to see us at #ectrims2022 last week, you can now read our poster on remote web-based assessment of #cognition for people with multiple sclerosis: https://t.co/gjpigmdbom https://t.co/vtiwhlijvm",,"#ectrims2022, #cognition","Beauty/Health & Fitness, Technology, Business",,"if you didn't get a chance to see us at ec trims last week, you can now read our poster on remote web-based assessment of #cognition for people with multiple sclerosis:"
106,"Happy Friday! I‚Äôve got a brand new #MindMoments for you! This time, we‚Äôre highlighting some of the hot topics and conversations from #ECTRIMS2022, featuring a number of experts in #MultipleSclerosis.

Listen hereüëáüèº
https://t.co/uc8zTtK034",twitter,USA,byMattHoffman,,"happy friday! i‚Äôve got a brand new #mindmoments for you! this time, we‚Äôre highlighting some of the hot topics and conversations from #ectrims2022, featuring a number of experts in #multiplesclerosis. listen hereüëáüèº https://t.co/uc8zttk034",male,"#mindmoments, #ectrims2022, #multiplesclerosis",Books,"{profession=Journalist, jobTitle=Editor}","happy friday! ive got a brand new #mindmoments for you! this time, were highlighting some of the hot topics and conversations from ec trims, featuring a number of experts in multiple sclerosis. listen here"
107,"A big thank you to everyone at @ECTRIMS and the amazing speakers who made the meeting so interesting!

#ECTRIMS2022 was a brilliant opportunity to share the new developments in #MSresearch. Check out interviews from the meeting at https://t.co/FB5htuqt0q

#MS #MultipleSclerosis https://t.co/fLUvlecmIC",twitter,,VJNeurology,,a big thank you to everyone at @ectrims and the amazing speakers who made the meeting so interesting! #ectrims2022 was a brilliant opportunity to share the new developments in #msresearch. check out interviews from the meeting at https://t.co/fb5htuqt0q #ms #multiplesclerosis https://t.co/fluvlecmic,,"#ectrims2022, #msresearch, #ms, #multiplesclerosis",Photo & Video,,a big thank you to everyone at and the amazing speakers who made the meeting so interesting! ec trims was a brilliant opportunity to share the new developments in msresearch. check out interviews from the meeting at ms multiple sclerosis
108,"@BoveRiley mentioned the key advances in understanding how to navigate the postpartum period for patients with #MS and the types of data she would like to see conducted in the future in this field. @ECTRIMS @UCSF #ECTRIMS2022 #ECTRIMS

üé• Watch: https://t.co/lIArOhe2NX",twitter,USA,neurology_live,,@boveriley mentioned the key advances in understanding how to navigate the postpartum period for patients with #ms and the types of data she would like to see conducted in the future in this field. @ectrims @ucsf #ectrims2022 #ectrims üé• watch: https://t.co/liarohe2nx,,"#ms, #ectrims2022, #ectrims",Beauty/Health & Fitness,,mentioned the key advances in understanding how to navigate the postpartum period for patients with ms and the types of data she would like to see conducted in the future in this field. ec trims ec trims watch:
109,No magic cure in the sunshine vitamin then üò¢‚òÄ Early Reports from ECTRIMS Suggest Vitamin D Supplements Do Not Reduce Ongoing MS Disease Activity https://t.co/inyXdErZvD,twitter,GBR,RoseannaMcMahon,,no magic cure in the sunshine vitamin then üò¢‚òÄ early reports from ectrims suggest vitamin d supplements do not reduce ongoing ms disease activity https://t.co/inyxderzvd,female,,,,no magic cure in the sunshine vitamin then early reports from ectrims suggest vitamin d supplements do not reduce ongoing ms disease activity
112,"Laurits Taul Madsen, a PhD candidate at Aarhus University, discussed the use of lower extremity function assessments to characterize patients with MS at risk for future falls. #ECTRIMS2022 #NeuroTwitter

Exclusive interview here: https://t.co/bOtc458fJq",twitter,USA,neurology_live,,"laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. #ectrims2022 #neurotwitter exclusive interview here: https://t.co/botc458fjq",,"#ectrims2022, #neurotwitter",Beauty/Health & Fitness,,"laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:"
113,"#ECTRIMS2022 - Ocrevus safely and effectively reduces disease activity in people with early-stage relapsing-remitting multiple sclerosis, trial data show. https://t.co/0ynhT8boVe

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/RsERrKjXaw",twitter,USA,MSNewsToday,,"#ectrims2022 - ocrevus safely and effectively reduces disease activity in people with early-stage relapsing-remitting multiple sclerosis, trial data show. https://t.co/0ynht8bove #multiplesclerosis #msnews #msawareness #msresearch https://t.co/rserrkjxaw",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - ocrevus safely and effectively reduces disease activity in people with early-stage relapsing-remitting multiple sclerosis, trial data show. multiple sclerosis msnews msawareness msresearch"
114,"Bruce Cree, MD, clinical research director of the UCSF Multiple Sclerosis Center provided insight on an abstract from ECTRIMS 2022 regarding inebilizumab‚Äôs mechanism of action to prevent NMOSD attacks. 

Watch here üëâ https://t.co/L86qYLlgQO",twitter,USA,neurology_live,,"bruce cree, md, clinical research director of the ucsf multiple sclerosis center provided insight on an abstract from ectrims 2022 regarding inebilizumab‚Äôs mechanism of action to prevent nmosd attacks. watch here üëâ https://t.co/l86qyllgqo",,,Beauty/Health & Fitness,,"bruce cree, md, clinical research director of the ucsf multiple sclerosis center provided insight on an abstract from ectrims 2022 regarding inebilizumabs mechanism of action to prevent nmosd attacks. watch here"
115,"Exposure to high-efficacy DMTs has been linked to a higher risk of cervical abnormalities in women with MS, although additional studies are needed to further substantiate this relationship. https://t.co/wrgveo5NHT

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/6xSwAqy3yv",twitter,USA,MSNewsToday,,"exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. https://t.co/wrgveo5nht #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/6xswaqy3yv",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims"
116,"https://t.co/7l6uq4qHEn
There's been major progress in potentially preventing RIS from developing into diagnosable MS. @mssociety Executive VP of Research, Dr. Bruce Bebo, discusses the research and presentations that got his attention last week at #ECTRIMS2022 #MultipleSclerosis",twitter,USA,RealTalkMS_jon,,"https://t.co/7l6uq4qhen there's been major progress in potentially preventing ris from developing into diagnosable ms. @mssociety executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at #ectrims2022 #multiplesclerosis",male,"#ectrims2022, #multiplesclerosis",Family & Parenting,,"there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"
117,"#ECTRIMS2022 - For women with multiple sclerosis in the U.S., fertility treatment was not associated with an increased MS relapse risk, a study found. https://t.co/OpkSujzkGu

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/tNob6OJN5a",twitter,USA,MSNewsToday,,"#ectrims2022 - for women with multiple sclerosis in the u.s., fertility treatment was not associated with an increased ms relapse risk, a study found. https://t.co/opksujzkgu #multiplesclerosis #msnews #msawareness #msresearch https://t.co/tnob6ojn5a",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - for women with multiple sclerosis in the u.s., fertility treatment was not associated with an increased ms relapse risk, a study found. multiple sclerosis msnews msawareness msresearch"
118,"#ECTRIMS2022 - Ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with MS or their babies. https://t.co/HhnuuDkDuL

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/wh9Ulrr0mL",twitter,USA,MSNewsToday,,#ectrims2022 - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. https://t.co/hhnuudkdul #multiplesclerosis #msnews #msawareness #msresearch https://t.co/wh9ulrr0ml,female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch
119,"@genentech's Ocrevus stole the show at last month‚Äôs @ECTRIMS meeting, particularly in relapsing-remitting MS. 
#Genentech #Roche #ECTRIMS
https://t.co/3wCMigHMVx",twitter,USA,biospace,,"@genentech's ocrevus stole the show at last month‚Äôs @ectrims meeting, particularly in relapsing-remitting ms. #genentech #roche #ectrims https://t.co/3wcmighmvx",,"#genentech, #roche, #ectrims",,,"'s ocrevus stole the show at last months meeting, particularly in relapsing-remitting ms. #genentech #roche ec trims"
120,"#ECTRIMS2022 - Signs of a prior Epstein-Barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic MS patients. https://t.co/VqmdZ75B2m

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/JPpZV7atZI",twitter,USA,MSNewsToday,,#ectrims2022 - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. https://t.co/vqmdz75b2m #multiplesclerosis #msnews #msawareness #msresearch https://t.co/jppzv7atzi,female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch
121,"Is haematopoietic stem cell transplantation the most effective treatment for #multiplesclerosis? 

@themsguide hears about the latest clinical trials from Prof Richard Nicholas of @imperialcollege during @ECTRIMS üëâ https://t.co/7YIVlvuqig

#HSCT #StemCells",twitter,,LivedHealth,,is haematopoietic stem cell transplantation the most effective treatment for #multiplesclerosis? @themsguide hears about the latest clinical trials from prof richard nicholas of @imperialcollege during @ectrims üëâ https://t.co/7yivlvuqig #hsct #stemcells,unknown,"#multiplesclerosis, #hsct, #stemcells","Beauty/Health & Fitness, Photo & Video",,is haematopoietic stem cell transplantation the most effective treatment for multiple sclerosis? hears about the latest clinical trials from prof richard nicholas of during #hsct #stemcells
123,"#ECTRIMS2022 - New research suggests that remyelination, or regeneration of the myelin sheath that‚Äôs progressively damaged in MS, may be less effective for those who develop the condition later in life. https://t.co/2beyv5tffE

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/WcS6vmyHah",twitter,USA,MSNewsToday,,"#ectrims2022 - new research suggests that remyelination, or regeneration of the myelin sheath that‚Äôs progressively damaged in ms, may be less effective for those who develop the condition later in life. https://t.co/2beyv5tffe #multiplesclerosis #msnews #msawareness #msresearch https://t.co/wcs6vmyhah",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - new research suggests that remyelination, or regeneration of the myelin sheath thats progressively damaged in ms, may be less effective for those who develop the condition later in life. multiple sclerosis msnews msawareness msresearch"
124,"Genetic variants in genes mostly active in the brain and spinal cord have been linked to MS severity ‚Äî findings that will help ‚Äúprioritize‚Äù the development of MS treatments. https://t.co/DwqLRnVYnV

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/cxIpSnmTac",twitter,USA,MSNewsToday,,genetic variants in genes mostly active in the brain and spinal cord have been linked to ms severity ‚Äî findings that will help ‚Äúprioritize‚Äù the development of ms treatments. https://t.co/dwqlrnvynv #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/cxipsnmtac,female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,genetic variants in genes mostly active in the brain and spinal cord have been linked to ms severity findings that will help prioritize the development of ms treatments. multiple sclerosis msnews msawareness msresearch ec trims
125,Favorite #ECTRIMS2022 news for @tim_coetzee of @mssociety: #genetics and progressive #MS.,twitter,,IJMSCtweets,,favorite #ectrims2022 news for @tim_coetzee of @mssociety: #genetics and progressive #ms.,,"#ectrims2022, #genetics, #ms",,,favorite ec trims news for of : #genetics and progressive ms.
126,"#ECTRIMS2022 - New myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. https://t.co/XbjBVfYpdp 

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/XKbL6VF1mK",twitter,USA,MSNewsToday,,"#ectrims2022 - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. https://t.co/xbjbvfypdp #multiplesclerosis #msnews #msawareness #msresearch https://t.co/xkbl6vf1mk",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch"
127,"üéôÔ∏èÔ∏è ""The talk on the ability to connect the genetic underpinnings potentially around disease severity in progressive #MS was really a breakthrough session that left me inspired"": @Tim_Coetzee from @mssociety at #ECTRIMS2022

Listen now ‚û°Ô∏è https://t.co/OgQc2ew63x

#ECTRIMSPodcast https://t.co/ZynvQxlgVk",twitter,CHE,ECTRIMS,,"üéôÔ∏èÔ∏è ""the talk on the ability to connect the genetic underpinnings potentially around disease severity in progressive #ms was really a breakthrough session that left me inspired"": @tim_coetzee from @mssociety at #ectrims2022 listen now ‚û°Ô∏è https://t.co/ogqc2ew63x #ectrimspodcast https://t.co/zynvqxlgvk",,"#ms, #ectrims2022, #ectrimspodcast",,,"""the talk on the ability to connect the genetic underpinnings potentially around disease severity in progressive ms was really a breakthrough session that left me inspired"": from at ec trims listen now ec trimspodcast"
128,"#ECTRIMS2022 - A slower tap speed on a smartphone keyboard was linked to greater disability and worse function in people with multiple sclerosis in a study. https://t.co/LsgshvNo9G #ectrims2022 #news

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/5Hc2oGuh9a",twitter,USA,MSNewsToday,,#ectrims2022 - a slower tap speed on a smartphone keyboard was linked to greater disability and worse function in people with multiple sclerosis in a study. https://t.co/lsgshvno9g #ectrims2022 #news #multiplesclerosis #msnews #msawareness #msresearch https://t.co/5hc2oguh9a,female,"#ectrims2022, #ectrims2022, #news, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,ec trims - a slower tap speed on a smartphone keyboard was linked to greater disability and worse function in people with multiple sclerosis in a study. ec trims #news multiple sclerosis msnews msawareness msresearch
129,"Data from a meta-analysis of trials evaluating dietary approaches in #MS showed that there are several effective approaches in reducing fatigue and improving physical and mental quality of life. @uiowa #MultipleSclerosis @ECTRIMS #ECTRIMS2022 

View: https://t.co/49H6i0hov3",twitter,USA,neurology_live,,data from a meta-analysis of trials evaluating dietary approaches in #ms showed that there are several effective approaches in reducing fatigue and improving physical and mental quality of life. @uiowa #multiplesclerosis @ectrims #ectrims2022 view: https://t.co/49h6i0hov3,,"#ms, #multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,data from a meta-analysis of trials evaluating dietary approaches in ms showed that there are several effective approaches in reducing fatigue and improving physical and mental quality of life. multiple sclerosis ec trims view:
130,"#ECTRIMS2022  - Among people with MS, lower smartphone tapping speeds were linked to worse disability, poorer dexterity and walking abilities, and lower cognitive function. https://t.co/LeT8xXXmGh

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/cgICIHiWEP",twitter,USA,MSNewsToday,,"#ectrims2022 - among people with ms, lower smartphone tapping speeds were linked to worse disability, poorer dexterity and walking abilities, and lower cognitive function. https://t.co/let8xxxmgh #multiplesclerosis #msnews #msawareness #msresearch https://t.co/cgicihiwep",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - among people with ms, lower smartphone tapping speeds were linked to worse disability, poorer dexterity and walking abilities, and lower cognitive function. multiple sclerosis msnews msawareness msresearch"
131,"An open-label extension phase 2 trial showed that evobrutinib-treated patients with #RMS had increased S1/S2 immunoglobuin (IgG) antibody levels after being given two doses of the mRNA #COVID-19 vaccination. @PennNeurology @ECTRIMS

üëâ Read: https://t.co/5s1nRbuzu3",twitter,USA,neurology_live,,an open-label extension phase 2 trial showed that evobrutinib-treated patients with #rms had increased s1/s2 immunoglobuin (igg) antibody levels after being given two doses of the mrna #covid-19 vaccination. @pennneurology @ectrims üëâ read: https://t.co/5s1nrbuzu3,,"#rms, #covid",Beauty/Health & Fitness,,an open-label extension phase 2 trial showed that evobrutinib-treated patients with #rms had increased s1/s2 immunoglobuin (igg) antibody levels after being given two doses of the mrna #covid-19 vaccination. read:
132,"#ECTRIMS2022 - In trial, Tecfidera¬†was found to significantly reduce the risk of first MS symptoms in adults with radiologically isolated syndrome. https://t.co/ck4jTI6Jdn #ectrims2022 #news

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/Kwl8qvIx0G",twitter,USA,MSNewsToday,,"#ectrims2022 - in trial, tecfidera was found to significantly reduce the risk of first ms symptoms in adults with radiologically isolated syndrome. https://t.co/ck4jti6jdn #ectrims2022 #news #multiplesclerosis #msnews #msawareness #msresearch https://t.co/kwl8qvix0g",female,"#ectrims2022, #ectrims2022, #news, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - in trial, tecfidera was found to significantly reduce the risk of first ms symptoms in adults with radiologically isolated syndrome. ec trims #news multiple sclerosis msnews msawareness msresearch"
133,"#ECTRIMS2022 - Long-term¬†Gilenya use effectively continues to outperform Avonex at lowering relapse rates in children and adolescents with MS, data show. https://t.co/CxC6z0MHPi #ectrims2022 #news

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/9rL3iDUAK3",twitter,USA,MSNewsToday,,"#ectrims2022 - long-term gilenya use effectively continues to outperform avonex at lowering relapse rates in children and adolescents with ms, data show. https://t.co/cxc6z0mhpi #ectrims2022 #news #multiplesclerosis #msnews #msawareness #msresearch https://t.co/9rl3iduak3",female,"#ectrims2022, #ectrims2022, #news, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - long-term gilenya use effectively continues to outperform avonex at lowering relapse rates in children and adolescents with ms, data show. ec trims #news multiple sclerosis msnews msawareness msresearch"
134,"#ECTRIMS2022 - New findings show that EBV antibodies preceded an increase in NfL levels, an early biomarker of nerve cell damage, in people who went on to develop MS. https://t.co/ShuUrCG5KT

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/o1YTolWdNG",twitter,USA,MSNewsToday,,"#ectrims2022 - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. https://t.co/shuurcg5kt #multiplesclerosis #msnews #msawareness #msresearch https://t.co/o1ytolwdng",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch"
135,"#ECTRIMS2022 - Progression independent of relapse activity is also common in pediatric MS, study finds, and DMTs can effectively lower the risk. https://t.co/HG0tfUJcMi 

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/GKPRb7X8uR",twitter,USA,MSNewsToday,,"#ectrims2022 - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. https://t.co/hg0tfujcmi #multiplesclerosis #msnews #msawareness #msresearch https://t.co/gkprb7x8ur",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch"
136,"#ECTRIMS2022 - The higher cancer lesion risk seen in MS patients on high-efficacy DMTs may be due to immunosuppression and exposure to HPV, scientists say. https://t.co/gSpokfurB5

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/211Wyvj1st",twitter,USA,MSNewsToday,,"#ectrims2022 - the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say. https://t.co/gspokfurb5 #multiplesclerosis #msnews #msawareness #msresearch https://t.co/211wyvj1st",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say. multiple sclerosis msnews msawareness msresearch"
138,"#ECTRIMS2022 - New findings indicate that nearly 80% of people with early-stage RRMS show no evidence of disease activity after two years of treatment with Ocrevus. https://t.co/Kuk5vvYiew

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/EsvlWXGzPf",twitter,USA,MSNewsToday,,#ectrims2022 - new findings indicate that nearly 80% of people with early-stage rrms show no evidence of disease activity after two years of treatment with ocrevus. https://t.co/kuk5vvyiew #multiplesclerosis #msnews #msawareness #msresearch https://t.co/esvlwxgzpf,female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,ec trims - new findings indicate that nearly 80% of people with early-stage rrms show no evidence of disease activity after two years of treatment with ocrevus. multiple sclerosis msnews msawareness msresearch
139,"#ECTRIMS2022 - Data on SPMS and PPMS patients given ATA188 for up to four years in EMBOLD trial show continued gains in disability scores, MRI findings. https://t.co/tZOUzOdfkc 

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/SGsYZ6o18v",twitter,USA,MSNewsToday,,"#ectrims2022 - data on spms and ppms patients given ata188 for up to four years in embold trial show continued gains in disability scores, mri findings. https://t.co/tzouzodfkc #multiplesclerosis #msnews #msawareness #msresearch https://t.co/sgsyz6o18v",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - data on spms and ppms patients given ata188 for up to four years in embold trial show continued gains in disability scores, mri findings. multiple sclerosis msnews msawareness msresearch"
140,ECTRIMS2022 - Cervical Cancer Risk and High-efficacy DMTs | Study Finds Elevated Risk in MS Patients | #MultipleSclerosis News Today https://t.co/apKHZU6wCv,twitter,GBR,AbiBuddComms,,ectrims2022 - cervical cancer risk and high-efficacy dmts | study finds elevated risk in ms patients | #multiplesclerosis news today https://t.co/apkhzu6wcv,unknown,#multiplesclerosis,Books,,ectrims2022 - cervical cancer risk and high-efficacy dmts | study finds elevated risk in ms patients | multiple sclerosis news today
141,"Tomas Kalincik, MD, PhD, discussed the role of stem cell transplantation as it gains popularity within the #MS field. He also mentioned the progress previously made in terms of stem cell research and patients with MS. @UniMelb  @TheRMH @ECTRIMS 

üé¶ Watch: https://t.co/afb2CZnLEa",twitter,USA,neurology_live,,"tomas kalincik, md, phd, discussed the role of stem cell transplantation as it gains popularity within the #ms field. he also mentioned the progress previously made in terms of stem cell research and patients with ms. @unimelb @thermh @ectrims üé¶ watch: https://t.co/afb2cznlea",,#ms,Beauty/Health & Fitness,,"tomas kalincik, md, phd, discussed the role of stem cell transplantation as it gains popularity within the ms field. he also mentioned the progress previously made in terms of stem cell research and patients with ms. watch:"
142,Dr Rozanna Meijboom presented her work on upper cervical spinal cord atrophy in early relapsing-remitting MS at #ECTRIMS2022 #FutureMS #iWiMS @MeijboomR @AnneRowlClinic @EdinUniImaging https://t.co/coeXU8duRz,twitter,GBR,MSImaGE2,,dr rozanna meijboom presented her work on upper cervical spinal cord atrophy in early relapsing-remitting ms at #ectrims2022 #futurems #iwims @meijboomr @annerowlclinic @edinuniimaging https://t.co/coexu8durz,,"#ectrims2022, #futurems, #iwims",Beauty/Health & Fitness,,dr rozanna meijboom presented her work on upper cervical spinal cord atrophy in early relapsing-remitting ms at ec trims #futurems #iwims
143,"Why clinicians need to get better at delivering an MS diagnosis
#ECTRIMS2022 @preventiveneur1 @shiftms @GavinGiovannoni @somehow_related @drruthdobson @gpeps 
https://t.co/2r9udDOwAV",twitter,,_heathermah,,why clinicians need to get better at delivering an ms diagnosis #ectrims2022 @preventiveneur1 @shiftms @gavingiovannoni @somehow_related @drruthdobson @gpeps https://t.co/2r9uddowav,female,#ectrims2022,"Travel, Food & Drinks","{profession=Scientist & Researcher, jobTitle=Researcher}",why clinicians need to get better at delivering an ms diagnosis ec trims
144,"#ECTRIMS2022 - Progression independent of relapse activity (PIRA) also can be common in pediatric MS, study finds, and DMTs can effectively lower the risk. https://t.co/HG0tfUJcMi 

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/46SlHHMdCa",twitter,USA,MSNewsToday,,"#ectrims2022 - progression independent of relapse activity (pira) also can be common in pediatric ms, study finds, and dmts can effectively lower the risk. https://t.co/hg0tfujcmi #multiplesclerosis #msnews #msawareness #msresearch https://t.co/46slhhmdca",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - progression independent of relapse activity (pira) also can be common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch"
146,"Laurits Taul Madsen, PhD student at Aarhus University provided insight on his study presented at #ECTRIMS2022 Congress on an innovative way using neuromuscular measures to discriminate those with MS at high risk for falls. 

Watch: https://t.co/SfyF9gwHhO",twitter,USA,neurology_live,,"laurits taul madsen, phd student at aarhus university provided insight on his study presented at #ectrims2022 congress on an innovative way using neuromuscular measures to discriminate those with ms at high risk for falls. watch: https://t.co/sfyf9gwhho",,#ectrims2022,Beauty/Health & Fitness,,"laurits taul madsen, phd student at aarhus university provided insight on his study presented at ec trims congress on an innovative way using neuromuscular measures to discriminate those with ms at high risk for falls. watch:"
147,"Columnist Ed Tobias comments on the week's top MS news, including important reports from this year's¬†ECTRIMS conference. https://t.co/DA48ElFqEU #columns #ectrims2022 #themswireacolumnbyedtobias https://t.co/XKYGylifhe",twitter,USA,MSNewsToday,,"columnist ed tobias comments on the week's top ms news, including important reports from this year's ectrims conference. https://t.co/da48elfqeu #columns #ectrims2022 #themswireacolumnbyedtobias https://t.co/xkygylifhe",female,"#columns, #ectrims2022, #themswireacolumnbyedtobias","Beauty/Health & Fitness, Science",,"columnist ed tobias comments on the week's top ms news, including important reports from this year's ectrims conference. #columns ec trims #themswireacolumnbyedtobias"
148,"#ECTRIMS2022 - New findings that identify genetic variants tied to faster multiple sclerosis progression may help 'prioritize' treatment development in MS. https://t.co/EgNyBRkP4k #ectrims2022 #news

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/a2M4LcWDd1",twitter,USA,MSNewsToday,,#ectrims2022 - new findings that identify genetic variants tied to faster multiple sclerosis progression may help 'prioritize' treatment development in ms. https://t.co/egnybrkp4k #ectrims2022 #news #multiplesclerosis #msnews #msawareness #msresearch https://t.co/a2m4lcwdd1,female,"#ectrims2022, #ectrims2022, #news, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,ec trims - new findings that identify genetic variants tied to faster multiple sclerosis progression may help 'prioritize' treatment development in ms. ec trims #news multiple sclerosis msnews msawareness msresearch
149,#ECTRIMS2022 ‚Äì Tecfidera Lowers Risk of 1st Symptoms in RIS in Trial: https://t.co/8QYA7Suc05,twitter,USA,blue24x7,,#ectrims2022 ‚Äì tecfidera lowers risk of 1st symptoms in ris in trial: https://t.co/8qya7suc05,female,#ectrims2022,"Animals & Pets, Family & Parenting, Environment",,ec trims tecfidera lowers risk of 1st symptoms in ris in trial:
152,"Continuing treatment with two common #MS medications during #pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. #ECTRIMS2022 https://t.co/ucVRUd73E4",twitter,,MedscapeObGyn,,"continuing treatment with two common #ms medications during #pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. #ectrims2022 https://t.co/ucvrud73e4",,"#ms, #pregnancy, #ectrims2022",Beauty/Health & Fitness,,"continuing treatment with two common ms medications during #pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. ec trims"
153,"#ECTRIMS2022  - Treatment with Ocrevus before or during pregnancy does not appear to increase the risk of major complications, with 79% of the pregnancies leading to live births. https://t.co/IcRVYmhycO

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/2NdMrDdCnJ",twitter,USA,MSNewsToday,,"#ectrims2022 - treatment with ocrevus before or during pregnancy does not appear to increase the risk of major complications, with 79% of the pregnancies leading to live births. https://t.co/icrvymhyco #multiplesclerosis #msnews #msawareness #msresearch https://t.co/2ndmrddcnj",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ec trims - treatment with ocrevus before or during pregnancy does not appear to increase the risk of major complications, with 79% of the pregnancies leading to live births. multiple sclerosis msnews msawareness msresearch"
154,"At #ECTRIMS2022, Tomas Kalincik spoke on his research looking at stem cell transplantation and its efficacy vs previously approved DMTs for MS.

https://t.co/BdddIXfoG8",twitter,USA,neurology_live,,"at #ectrims2022, tomas kalincik spoke on his research looking at stem cell transplantation and its efficacy vs previously approved dmts for ms. https://t.co/bdddixfog8",,#ectrims2022,Beauty/Health & Fitness,,"at ec trims, tomas kalincik spoke on his research looking at stem cell transplantation and its efficacy vs previously approved dmts for ms."
155,#ECTRIMS2022 ‚Äì Genetic Variants Tied to Worse MS ID'd in Study | Findings Will Help Scientists to Prioritize MS Therapy Development | #MultipleSclerosis News Today https://t.co/jAVBjrzkSU,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì genetic variants tied to worse ms id'd in study | findings will help scientists to prioritize ms therapy development | #multiplesclerosis news today https://t.co/javbjrzksu,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims genetic variants tied to worse ms id'd in study | findings will help scientists to prioritize ms therapy development | multiple sclerosis news today
156,"MS News Notes: ECTRIMS, Ocrevus, Kesimpta, Epstein-Barr, DMTs | #MultipleSclerosis News Today https://t.co/vFHtLJwG6d",twitter,GBR,AbiBuddComms,,"ms news notes: ectrims, ocrevus, kesimpta, epstein-barr, dmts | #multiplesclerosis news today https://t.co/vfhtljwg6d",unknown,#multiplesclerosis,Books,,"ms news notes: ectrims, ocrevus, kesimpta, epstein-barr, dmts | multiple sclerosis news today"
157,"@GhantousA @Brandon_Beaber Dr. Beaber, did you see the null vitamin D trial in CIs presented at ECTRIMS:

No benefit for 
1,000IU/day
5,000IU/day
10,000IU/day 
compared to placebo 

Over 48 weeks

https://t.co/hgcpIc1BWu

#vitamind #multiplesclerosis #MS",twitter,IRL,ConorKerley,,"@ghantousa @brandon_beaber dr. beaber, did you see the null vitamin d trial in cis presented at ectrims: no benefit for 1,000iu/day 5,000iu/day 10,000iu/day compared to placebo over 48 weeks https://t.co/hgcpic1bwu #vitamind #multiplesclerosis #ms",male,"#vitamind, #multiplesclerosis, #ms",Science,"{profession=Health practitioner, jobTitle=Dietitian}, {profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Researcher}","dr. beaber, did you see the null vitamin d trial in cis presented at ectrims: no benefit for 1,000iu/day 5,000iu/day 10,000iu/day compared to placebo over 48 weeks #vitamind multiple sclerosis ms"
158,commonly asked questions about #ocrelizumab #ean2019 #ECTRIMS2022,twitter,AUS,jtho4262,,commonly asked questions about #ocrelizumab #ean2019 #ectrims2022,female,"#ocrelizumab, #ean2019, #ectrims2022",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",commonly asked questions about #ocrelizumab #ean2019 ec trims
159,"It was amazing to see so many people from the global #MSresearch community come together last week for #ECTRIMS2022. Representatives from 108 countries came together to share learnings, ideas and research findings. Here are some photo highlights. üì∏ https://t.co/KAEFHsSI6r",twitter,,MSIntFederation,,"it was amazing to see so many people from the global #msresearch community come together last week for #ectrims2022. representatives from 108 countries came together to share learnings, ideas and research findings. here are some photo highlights. üì∏ https://t.co/kaefhssi6r",female,"#msresearch, #ectrims2022",,,"it was amazing to see so many people from the global msresearch community come together last week for ec trims. representatives from 108 countries came together to share learnings, ideas and research findings. here are some photo highlights."
160,"Have you caught up on the latest in remyelination? üëâ https://t.co/AT8KE0Z6KU

With @drbarrysinger and @themsguide üé•

#MultipleSclerosis #ECTRIMS",twitter,,LivedHealth,,have you caught up on the latest in remyelination? üëâ https://t.co/at8ke0z6ku with @drbarrysinger and @themsguide üé• #multiplesclerosis #ectrims,unknown,"#multiplesclerosis, #ectrims","Beauty/Health & Fitness, Photo & Video",,have you caught up on the latest in remyelination? with and multiple sclerosis ec trims
161,"@Brandon_Beaber @drbarrysinger Thanks for spreading the word üó£ We've covered more trending topics in MS treatment and research from @ECTRIMS, including #HSCT, high efficacy DMTs and #fatigue üëâ https://t.co/sEhOxRtNJ8",twitter,,LivedHealth,,"@brandon_beaber @drbarrysinger thanks for spreading the word üó£ we've covered more trending topics in ms treatment and research from @ectrims, including #hsct, high efficacy dmts and #fatigue üëâ https://t.co/sehoxrtnj8",unknown,"#hsct, #fatigue","Beauty/Health & Fitness, Photo & Video",,"thanks for spreading the word we've covered more trending topics in ms treatment and research from , including #hsct, high efficacy dmts and #fatigue"
162,"Since the #ECTRIMS2022 later-breaker showing that ocrelizumab is superior to rituximab in treating MS,  this #MS_Seflife case study on ""Ocrelizumab vs  Ofatumumab, which would you choose?"" has been getting a lot of attention. Does it make sense to you? => https://t.co/ipoEKsRGcy https://t.co/VWlqpkiwCP",twitter,GBR,GavinGiovannoni,,"since the #ectrims2022 later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this #ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? => https://t.co/ipoeksrgcy https://t.co/vwlqpkiwcp",male,"#ectrims2022, #ms_seflife",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}","since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>"
163,"Tjalf Ziemssen, a good friend and colleague, gave me a personal copy of 'Stay Connected' a collection of hilarious and well-considered cartoons created by one of his patients about MS and its management. Thank you. #ECTRIMS2022  @TZiemssen https://t.co/3HHlcWRozj",twitter,GBR,GavinGiovannoni,,"tjalf ziemssen, a good friend and colleague, gave me a personal copy of 'stay connected' a collection of hilarious and well-considered cartoons created by one of his patients about ms and its management. thank you. #ectrims2022 @tziemssen https://t.co/3hhlcwrozj",male,#ectrims2022,Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}","tjalf ziemssen, a good friend and colleague, gave me a personal copy of 'stay connected' a collection of hilarious and well-considered cartoons created by one of his patients about ms and its management. thank you. ec trims"
164,"In a late-breaking poster at ECTRIMS, data showed that rituximab failed to show noninferiority to ocrelizumab. Additionally, the therapy had a higher annualized relapse rate ratio. 

https://t.co/xjLT608frQ",twitter,USA,neurology_live,,"in a late-breaking poster at ectrims, data showed that rituximab failed to show noninferiority to ocrelizumab. additionally, the therapy had a higher annualized relapse rate ratio. https://t.co/xjlt608frq",,,Beauty/Health & Fitness,,"in a late-breaking poster at ectrims, data showed that rituximab failed to show noninferiority to ocrelizumab. additionally, the therapy had a higher annualized relapse rate ratio."
165,"In a late-breaking presentation in ECTRIMS, data from the MSBase international registry was suggestive of higher disability accumulation risk compared with those who did not experience relapse, in both treated and untreated patients with MS.

https://t.co/WGqYiQrDQI",twitter,USA,neurology_live,,"in a late-breaking presentation in ectrims, data from the msbase international registry was suggestive of higher disability accumulation risk compared with those who did not experience relapse, in both treated and untreated patients with ms. https://t.co/wgqyiqrdqi",,,Beauty/Health & Fitness,,"in a late-breaking presentation in ectrims, data from the msbase international registry was suggestive of higher disability accumulation risk compared with those who did not experience relapse, in both treated and untreated patients with ms."
166,"#ECTRIMS2022 - Fertility treatments do not significantly increase the risk of relapse in women with MS, even among those undergoing treatment linked to greater levels of hormone exposure. https://t.co/MmA7Y2d7y1

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/soaOLG4XOR",twitter,USA,MSNewsToday,,"#ectrims2022 - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. https://t.co/mma7y2d7y1 #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/soaolg4xor",female,"#ectrims2022, #multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims"
167,"Personalised DMT dosing - the future?
Pre-Covid pandemic, it was thought Tysabri/natalizumab shld be taken every 4 weeks. However neuro Zoe van Kempen at #ECTRIMS2022
showed this could be pushed to 8 weeks - with no disease rebound.
Personalised dosing of Ocrevus poss too. https://t.co/4gpbW7FlKp",twitter,GBR,RachelHorne19,,"personalised dmt dosing - the future? pre-covid pandemic, it was thought tysabri/natalizumab shld be taken every 4 weeks. however neuro zoe van kempen at #ectrims2022 showed this could be pushed to 8 weeks - with no disease rebound. personalised dosing of ocrevus poss too. https://t.co/4gpbw7flkp",female,#ectrims2022,Books,"{profession=Journalist, jobTitle=Journalist}, {profession=Artist, jobTitle=Co-author}, {profession=Scientist & Researcher, jobTitle=Research Fellow}","personalised dmt dosing - the future? pre-covid pandemic, it was thought tysabri/natalizumab shld be taken every 4 weeks. however neuro zoe van kempen at ec trims showed this could be pushed to 8 weeks - with no disease rebound. personalised dosing of ocrevus poss too."
168,"Today I had the honour of meeting @weinerlabhms of @BrighamResearch, @harvarmed & @TizianaLS. He is an inspiration and will change the world for a better place with his research into #MS #MULTIPLESCLEROSIS #SPMS. #ECTRIMS2022 $TLSA #TILS #foralumab https://t.co/co0e2bBmLF",twitter,GBR,AshfordPlumber,,"today i had the honour of meeting @weinerlabhms of @brighamresearch, @harvarmed & @tizianals. he is an inspiration and will change the world for a better place with his research into #ms #multiplesclerosis #spms. #ectrims2022 $tlsa #tils #foralumab https://t.co/co0e2bbmlf",male,"#ms, #multiplesclerosis, #spms, #ectrims2022, #tils, #foralumab",Business,,"today i had the honour of meeting of , & . he is an inspiration and will change the world for a better place with his research into ms multiple sclerosis #spms. ec trims $tlsa #tils #foralumab"
169,@ImmunicInc @ECTRIMS How Many People in this Picture have Multiple Sclerosis?,twitter,,HJW711,,@immunicinc @ectrims how many people in this picture have multiple sclerosis?,female,,,,how many people in this picture have multiple sclerosis?
171,@C_OrejaGuevara @drbarrysinger @MarTintore @ECTRIMS @cemcat_em @J_SastreGarriga @XMontalban @esclerosiseme @seneurologia @KlausSchmierer @IntNatlWiMS @GeoArrambide @AaronBosterMD How many of these People in the Picture have Multiple Sclerosis? We do not need more DMD's we Need Research for #CURE4MS.,twitter,,HJW711,,@c_orejaguevara @drbarrysinger @martintore @ectrims @cemcat_em @j_sastregarriga @xmontalban @esclerosiseme @seneurologia @klausschmierer @intnatlwims @geoarrambide @aaronbostermd how many of these people in the picture have multiple sclerosis? we do not need more dmd's we need research for #cure4ms.,female,#cure4ms,,,how many of these people in the picture have multiple sclerosis? we do not need more dmd's we need research for cure ms.
172,This double-blind placebo-controlled randomized study of #vitaminD supplementation in high-risk #CIS indicates that vitamin D supplementation is not an effective treatment to prevent development of #RRMS. #ECTRIMS2022 #ICYMI,twitter,,IJMSCtweets,,this double-blind placebo-controlled randomized study of #vitamind supplementation in high-risk #cis indicates that vitamin d supplementation is not an effective treatment to prevent development of #rrms. #ectrims2022 #icymi,,"#vitamind, #cis, #rrms, #ectrims2022, #icymi",,,this double-blind placebo-controlled randomized study of #vitamind supplementation in high-risk #cis indicates that vitamin d supplementation is not an effective treatment to prevent development of #rrms. ec trims #icymi
173,"@GavinGiovannoni's Top #ECTRIMS2022 Takeaways:
1. #EBV
2. Bruton Tyrosine Kinase (#BTK) inhibitors (BTKi)
3. Radiologically-isolated syndrome (#RIS)
4. Ocrelizumab vs. Rituximab
5. #AHSCT vs. Natalizumab
6. Flipping the pyramid and smoldering MS (#TimeIsBrain)
7. #VitaminD",twitter,,IJMSCtweets,,@gavingiovannoni's top #ectrims2022 takeaways: 1. #ebv 2. bruton tyrosine kinase (#btk) inhibitors (btki) 3. radiologically-isolated syndrome (#ris) 4. ocrelizumab vs. rituximab 5. #ahsct vs. natalizumab 6. flipping the pyramid and smoldering ms (#timeisbrain) 7. #vitamind,,"#ectrims2022, #ebv, #btk, #ris, #ahsct, #timeisbrain, #vitamind",,,'s top ec trims takeaways: 1. #ebv 2. bruton tyrosine kinase (#btk) inhibitors (btki) 3. radiologically-isolated syndrome (#ris) 4. ocrelizumab vs. rituximab 5. #ahsct vs. natalizumab 6. flipping the pyramid and smoldering ms (#timeisbrain) 7. #vitamind
174,"#VitaminD to Ameliorate #MS (#VIDAMS) trial is a multicenter, randomized controlled, double blind trial: findings provide Class I evidence that high dose vitamin D3supplementation, as add-on to GA therapy, does not reduce disease activity in established #RRMS. #ECTRIMS2022 #ICYMI",twitter,,IJMSCtweets,,"#vitamind to ameliorate #ms (#vidams) trial is a multicenter, randomized controlled, double blind trial: findings provide class i evidence that high dose vitamin d3supplementation, as add-on to ga therapy, does not reduce disease activity in established #rrms. #ectrims2022 #icymi",,"#vitamind, #ms, #vidams, #rrms, #ectrims2022, #icymi",,,"#vitamind to ameliorate ms (#vidams) trial is a multicenter, randomized controlled, double blind trial: findings provide class i evidence that high dose vitamin d3supplementation, as add-on to ga therapy, does not reduce disease activity in established #rrms. ec trims #icymi"
176,"ECTRIMS 2022: Network lens could explain paradox in multiple sclerosis 
https://t.co/MVBn0Ew1fd 
#ECTRIMS2022 #Neurology",twitter,USA,BioWorldMedTech,,ectrims 2022: network lens could explain paradox in multiple sclerosis https://t.co/mvbn0ew1fd #ectrims2022 #neurology,unknown,"#ectrims2022, #neurology",Technology,,ectrims 2022: network lens could explain paradox in multiple sclerosis ec trims #neurology
177,"Thank you @ECTRIMS and #Amsterdam for hosting a well organized, very productive #ECTRIMS2022 Congress. We already look forward to attending #ECTRIMS2023 in #Milan!

#Immunic $IMUX #ScientificResearch #MSresearch https://t.co/y2kkHcW9cC",twitter,USA,ImmunicInc,,"thank you @ectrims and #amsterdam for hosting a well organized, very productive #ectrims2022 congress. we already look forward to attending #ectrims2023 in #milan! #immunic $imux #scientificresearch #msresearch https://t.co/y2kkhcw9cc",,"#amsterdam, #ectrims2022, #ectrims2023, #milan, #immunic, #scientificresearch, #msresearch","Beauty/Health & Fitness, Business",,"thank you and #amsterdam for hosting a well organized, very productive ec trims congress. we already look forward to attending ec trims2023 in #milan! #immunic $imux #scientificresearch msresearch"
178,"ECTRIMS 2022: Network lens could explain paradox in multiple sclerosis
https://t.co/hWu7t5FqR2
#biotech #pharma",twitter,USA,BioWorld,,ectrims 2022: network lens could explain paradox in multiple sclerosis https://t.co/hwu7t5fqr2 #biotech #pharma,unknown,"#biotech, #pharma",,,ectrims 2022: network lens could explain paradox in multiple sclerosis #biotech #pharma
179,"A huge congratulations to our medical student Pavel, who presented a poster at the European Committee for Treatment and Research in Multiple Sclerosis in Amsterdam, the largest event dedicated to MS in the world! 

#ECTRIMS22 https://t.co/8c5VemFwja",twitter,,ExeterMed,,"a huge congratulations to our medical student pavel, who presented a poster at the european committee for treatment and research in multiple sclerosis in amsterdam, the largest event dedicated to ms in the world! #ectrims22 https://t.co/8c5vemfwja",,#ectrims22,,,"a huge congratulations to our medical student pavel, who presented a poster at the european committee for treatment and research in multiple sclerosis in amsterdam, the largest event dedicated to ms in the world! ec trims22"
180,@HannekeHulst Early #MS & the Amsterdam ‚ÄúTemprano‚Äù cohort: Findings replicate previous that cognitive impairment is present in ~25% of patients #early after diagnosis & that #visuospatial memory problems are one of the first domains affected. #ECTRIMS2022 #ICYMI,twitter,,IJMSCtweets,,@hannekehulst early #ms & the amsterdam ‚Äútemprano‚Äù cohort: findings replicate previous that cognitive impairment is present in ~25% of patients #early after diagnosis & that #visuospatial memory problems are one of the first domains affected. #ectrims2022 #icymi,,"#ms, #early, #visuospatial, #ectrims2022, #icymi",,,early ms & the amsterdam temprano cohort: findings replicate previous that cognitive impairment is present in ~25% of patients #early after diagnosis & that #visuospatial memory problems are one of the first domains affected. ec trims #icymi
181,@Birgitpower @ECTRIMS I think this is a great idea!  I love to see more about the nuances of autoimmune disease on women including the impact of menopause @ECTRIMS #MS #Autoimmunedisease,twitter,GBR,pharmaguapa,,@birgitpower @ectrims i think this is a great idea! i love to see more about the nuances of autoimmune disease on women including the impact of menopause @ectrims #ms #autoimmunedisease,female,"#ms, #autoimmunedisease","Beauty/Health & Fitness, Animals & Pets","{profession=Sales/Marketing/PR, jobTitle=Social Media Expert}",i think this is a great idea! i love to see more about the nuances of autoimmune disease on women including the impact of menopause ms #autoimmunedisease
182,"How can using neuromuscular function measures predict fallers vs non-fallers among patients with #MS? Laurits Taul Madsen of @AarhusUni discussed his presentation from #ECTRIMS2022 üß†

https://t.co/w2GzqHkzxr",twitter,USA,neurology_live,,how can using neuromuscular function measures predict fallers vs non-fallers among patients with #ms? laurits taul madsen of @aarhusuni discussed his presentation from #ectrims2022 üß† https://t.co/w2gzqhkzxr,,"#ms, #ectrims2022",Beauty/Health & Fitness,,how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims
183,My #ECTRIMS2022 highlights - it is all about flipping the pyramid and going beyond inflammatory disease activity and focusing on smouldering MS. The latter includes targeting EBV as a potential driver of MS disease activity. Do you agree => https://t.co/x4RcvBoEHh https://t.co/bnhahfKYh5,twitter,GBR,GavinGiovannoni,,my #ectrims2022 highlights - it is all about flipping the pyramid and going beyond inflammatory disease activity and focusing on smouldering ms. the latter includes targeting ebv as a potential driver of ms disease activity. do you agree => https://t.co/x4rcvboehh https://t.co/bnhahfkyh5,male,#ectrims2022,Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}",my ec trims highlights - it is all about flipping the pyramid and going beyond inflammatory disease activity and focusing on smouldering ms. the latter includes targeting ebv as a potential driver of ms disease activity. do you agree =>
184,"Biogen #Data at ECTRIMS 2022 Highlight Innovation in #DigitalHealth Focused on Advancing Treatment & Personalized Care of People Living with MS
#AI¬†#ArtificialIntelligence #Algorithm¬†#ML #MachineLearning #DeepLearning #DL¬†#neuroscience #HealthCare #MedTech
https://t.co/e2mw8yngj5",twitter,ESP,andresvilarino,,biogen #data at ectrims 2022 highlight innovation in #digitalhealth focused on advancing treatment & personalized care of people living with ms #ai #artificialintelligence #algorithm #ml #machinelearning #deeplearning #dl #neuroscience #healthcare #medtech https://t.co/e2mw8yngj5,male,"#data, #digitalhealth, #ai, #artificialintelligence, #algorithm, #ml, #machinelearning, #deeplearning, #dl, #neuroscience, #healthcare, #medtech",,,biogen #data at ectrims 2022 highlight innovation in #digitalhealth focused on advancing treatment & personalized care of people living with ms #ai #artificialintelligence #algorithm #ml #machinelearning #deeplearning #dl #neuroscience #healthcare #medtech
185,"Professor Alan Thompson spoke at a patient meeting at the European Committee for Treatment and Research in #MultipleSclerosis (@ECTRIMS) conference in Amsterdam on Saturday. 

#ECTRIMS2022 https://t.co/6swurmjZs6",twitter,GBR,UCLBrainScience,,professor alan thompson spoke at a patient meeting at the european committee for treatment and research in #multiplesclerosis (@ectrims) conference in amsterdam on saturday. #ectrims2022 https://t.co/6swurmjzs6,,"#multiplesclerosis, #ectrims2022","Beauty/Health & Fitness, Science",,professor alan thompson spoke at a patient meeting at the european committee for treatment and research in multiple sclerosis () conference in amsterdam on saturday. ec trims
186,ECTRIMS2022. HSCT is no better than current high efficay DMT https://t.co/WhqnLBFMm3,twitter,ESP,alvareto5,,ectrims2022. hsct is no better than current high efficay dmt https://t.co/whqnlbfmm3,unknown,,,,ectrims2022. hsct is no better than current high efficay dmt
188,"DMT discontinuation in #MultipleSclerosis - ECTRIMS 2022 data: Chappuis et al üá´üá∑: 49 patients >45 y treated with high/moderate-efficacy DMT: relapse risk in the year after discontinuation 6% if on moderate-efficacy DMTs, 9% if on fingolimod and 43% if on natalizumab (EP1163) 1/1",twitter,LBN,GMacaronMD,,"dmt discontinuation in #multiplesclerosis - ectrims 2022 data: chappuis et al üá´üá∑: 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1",female,#multiplesclerosis,,,"dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1"
189,"@JeffCohenMD discussed his takeaways from the #latebreaker study presented at 2022 @ECTRIMS. He spoke about a subgroup analysis from the open-label extension and his reactions to the findings.  #ECTRIMS2022 #MS @sanofi @KESIMPTA_USHCP 

üé¶ Watch üé¶: https://t.co/Gs9jw9Ym2I",twitter,USA,neurology_live,,@jeffcohenmd discussed his takeaways from the #latebreaker study presented at 2022 @ectrims. he spoke about a subgroup analysis from the open-label extension and his reactions to the findings. #ectrims2022 #ms @sanofi @kesimpta_ushcp üé¶ watch üé¶: https://t.co/gs9jw9ym2i,,"#latebreaker, #ectrims2022, #ms",Beauty/Health & Fitness,,discussed his takeaways from the #latebreaker study presented at 2022 . he spoke about a subgroup analysis from the open-label extension and his reactions to the findings. ec trims ms watch :
190,"@tripping_onair @ECTRIMS My first thought. But not surprised as my MS neurologist effectively told me it was 'over', most cases were now mild & as I'm fully vaxxed I'll be fine. Mmmmm.....",twitter,GBR,GrumpyoldGould,,"@tripping_onair @ectrims my first thought. but not surprised as my ms neurologist effectively told me it was 'over', most cases were now mild & as i'm fully vaxxed i'll be fine. mmmmm.....",female,,Animals & Pets,,"my first thought. but not surprised as my ms neurologist effectively told me it was 'over', most cases were now mild & as i'm fully vaxxed i'll be fine. mmmmm....."
191,"Bruce Cree, MD, PhD, @UCSF spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with MS. #ECTRIMS #ECTRIMS2022 @ECTRIMS #MultipleSclerosis #MS https://t.co/foAAXJTxrX",twitter,USA,neurology_live,,"bruce cree, md, phd, @ucsf spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. #ectrims #ectrims2022 @ectrims #multiplesclerosis #ms https://t.co/foaaxjtxrx",,"#ectrims, #ectrims2022, #multiplesclerosis, #ms",Beauty/Health & Fitness,,"bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms"
193,"@MarisaMcginley, DO, @ClevelandClinic, shares her thoughts on #telehealth care, increasing access to care and addressing health disparities in the neurology field. #ECTRIMS2022 #ECTRIMS #MS @ECTRIMS https://t.co/k6qP2WaJfg",twitter,USA,neurology_live,,"@marisamcginley, do, @clevelandclinic, shares her thoughts on #telehealth care, increasing access to care and addressing health disparities in the neurology field. #ectrims2022 #ectrims #ms @ectrims https://t.co/k6qp2wajfg",,"#telehealth, #ectrims2022, #ectrims, #ms",Beauty/Health & Fitness,,", do, , shares her thoughts on #telehealth care, increasing access to care and addressing health disparities in the neurology field. ec trims ec trims ms"
194,"New data suggest that among patients with #MS treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #Covid-19 vaccine.  @OCREVUS_USA @genentech @Novartis #ECTRIMS2022 @ECTRIMS 

View: https://t.co/1QpiWvxAGw",twitter,USA,neurology_live,,"new data suggest that among patients with #ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. @ocrevus_usa @genentech @novartis #ectrims2022 @ectrims view: https://t.co/1qpiwvxagw",,"#ms, #covid, #ectrims2022",Beauty/Health & Fitness,,"new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:"
195,#ECTRIMS2022 ‚Äì Long-term Gilenya Reduces Pediatric Relapses | #MultipleSclerosis News Today https://t.co/gqSBLNY7c7,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì long-term gilenya reduces pediatric relapses | #multiplesclerosis news today https://t.co/gqsblny7c7,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims long-term gilenya reduces pediatric relapses | multiple sclerosis news today
196,"Brenda Branwell, MD, @ChildrensPhila, talks about her background with pediatric-onset MS and the transformation that she saw her patients go through over time with the disease. #ECTRIMS2022 #ECTRIMS @ECTRIMS https://t.co/Y809hUdO9n",twitter,USA,neurology_live,,"brenda branwell, md, @childrensphila, talks about her background with pediatric-onset ms and the transformation that she saw her patients go through over time with the disease. #ectrims2022 #ectrims @ectrims https://t.co/y809hudo9n",,"#ectrims2022, #ectrims",Beauty/Health & Fitness,,"brenda branwell, md, , talks about her background with pediatric-onset ms and the transformation that she saw her patients go through over time with the disease. ec trims ec trims"
197,"High-efficacy therapies for MS have improved disease outcomes for many patients, but there are concerns over long-term safety, and some physicians and patients remain wary of them. #ECTRIMS2022 https://t.co/5LdhKHCuip",twitter,,MedscapeNeuro,,"high-efficacy therapies for ms have improved disease outcomes for many patients, but there are concerns over long-term safety, and some physicians and patients remain wary of them. #ectrims2022 https://t.co/5ldhkhcuip",,#ectrims2022,Beauty/Health & Fitness,,"high-efficacy therapies for ms have improved disease outcomes for many patients, but there are concerns over long-term safety, and some physicians and patients remain wary of them. ec trims"
198,"At the end of #ECTRIMS2022, our co-founder, Brett Drummond, & @NovoronBio CEO, Dr Travis Stiles, reviewed the final day. A key focus of this chat is the role of lipids in #MultipleSclerosis, exploring interesting & innovative work by Prof @JeromeHendriks. https://t.co/J5wuW30UEe",twitter,AUS,MStranslate,,"at the end of #ectrims2022, our co-founder, brett drummond, & @novoronbio ceo, dr travis stiles, reviewed the final day. a key focus of this chat is the role of lipids in #multiplesclerosis, exploring interesting & innovative work by prof @jeromehendriks. https://t.co/j5wuw30uee",,"#ectrims2022, #multiplesclerosis",,,"at the end of ec trims, our co-founder, brett drummond, & ceo, dr travis stiles, reviewed the final day. a key focus of this chat is the role of lipids in multiple sclerosis, exploring interesting & innovative work by prof ."
199,"@ECTRIMS How Many People in this Picture have Multiple Sclerosis? How about the New President? We Need a #CURE4MS!!. We Need Scientist working on a  CURE, we Don't need more ""New"" DMD""s.",twitter,,HJW711,,"@ectrims how many people in this picture have multiple sclerosis? how about the new president? we need a #cure4ms!!. we need scientist working on a cure, we don't need more ""new"" dmd""s.",female,#cure4ms,,,"how many people in this picture have multiple sclerosis? how about the new president? we need a cure ms!!. we need scientist working on a cure, we don't need more ""new"" dmd""s."
200,"@bollo_luca @MarTintore @ECTRIMS @BragaNathane @ReneCarvajalMD @paula_tagliani How many People in this Picture have Multiple Sclerosis? #CURE4MS!!! We do not want more 
DMD's. Promote HSCT the ONLY. OPTION FOR  REMISSION. https://t.co/vgxfeBbVBX",twitter,,HJW711,,@bollo_luca @martintore @ectrims @braganathane @renecarvajalmd @paula_tagliani how many people in this picture have multiple sclerosis? #cure4ms!!! we do not want more dmd's. promote hsct the only. option for remission. https://t.co/vgxfebbvbx,female,#cure4ms,,,how many people in this picture have multiple sclerosis? cure ms!!! we do not want more dmd's. promote hsct the only. option for remission.
201,"Continuing treatment with two common #MS medications during pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. #ECTRIMS2022 https://t.co/jixbn7gfVc",twitter,,MedscapeNeuro,,"continuing treatment with two common #ms medications during pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. #ectrims2022 https://t.co/jixbn7gfvc",,"#ms, #ectrims2022",Beauty/Health & Fitness,,"continuing treatment with two common ms medications during pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. ec trims"
202,"To diagnose #MS, the central vein sign on brain MRI appears to work as well as oligoclonal bands in CSF, and combining the two biomarkers yields the highest predictive value for MS, a new study indicates. #ECTRIMS2022 https://t.co/6tBHwX4iKF",twitter,USA,Medscape,,"to diagnose #ms, the central vein sign on brain mri appears to work as well as oligoclonal bands in csf, and combining the two biomarkers yields the highest predictive value for ms, a new study indicates. #ectrims2022 https://t.co/6tbhwx4ikf",unknown,"#ms, #ectrims2022",Beauty/Health & Fitness,,"to diagnose ms, the central vein sign on brain mri appears to work as well as oligoclonal bands in csf, and combining the two biomarkers yields the highest predictive value for ms, a new study indicates. ec trims"
203,@MarTintore @ECTRIMS Do you have Multiple Sclerosis?,twitter,,HJW711,,@martintore @ectrims do you have multiple sclerosis?,female,,,,do you have multiple sclerosis?
204,@DanOntaneda @SilverGorilla2 @ECTRIMS @MarTintore @mssociety @mssocietyuk @ClevelandClinic #CURE4MS!!! I Wish the MS Society/Foundation would of been a Champion for HSCT. The Only Option for Remission for us. Dr.Richard Burt's Book is available for Pre-Order. He's a Great Champion of HSCT. The MS Society told me I could Die :( Well at 53 had HSCT & it Saved my Life.,twitter,,HJW711,,@danontaneda @silvergorilla2 @ectrims @martintore @mssociety @mssocietyuk @clevelandclinic #cure4ms!!! i wish the ms society/foundation would of been a champion for hsct. the only option for remission for us. dr.richard burt's book is available for pre-order. he's a great champion of hsct. the ms society told me i could die :( well at 53 had hsct & it saved my life.,female,#cure4ms,,,cure ms!!! i wish the ms society/foundation would of been a champion for hsct. the only option for remission for us. dr.richard burt's book is available for pre-order. he's a great champion of hsct. the ms society told me i could die well at 53 had hsct & it saved my life.
205,"A great pic of @AminZarghami18 from our #MultipleSclerosis Research Flagship expertly presenting his research 'Longitudinal Transitions of Employment Status after a First Episode of CNS Demyelination' @ECTRIMS from Hobart, Tasmania to attendees in Amsterdam üëè #ECTRIMS2022 https://t.co/EWHbQ137Tp",twitter,AUS,ResearchMenzies,,"a great pic of @aminzarghami18 from our #multiplesclerosis research flagship expertly presenting his research 'longitudinal transitions of employment status after a first episode of cns demyelination' @ectrims from hobart, tasmania to attendees in amsterdam üëè #ectrims2022 https://t.co/ewhbq137tp",male,"#multiplesclerosis, #ectrims2022",,,"a great pic of from our multiple sclerosis research flagship expertly presenting his research 'longitudinal transitions of employment status after a first episode of cns demyelination' from hobart, tasmania to attendees in amsterdam ec trims"
206,Falls are common in patients with MS and a new study suggests impairment in a specific aspect of neuromuscular function can identify those at highest risk. #ECTRIMS2022 https://t.co/pkW6Y9LjqR,twitter,,MedscapeNeuro,,falls are common in patients with ms and a new study suggests impairment in a specific aspect of neuromuscular function can identify those at highest risk. #ectrims2022 https://t.co/pkw6y9ljqr,,#ectrims2022,Beauty/Health & Fitness,,falls are common in patients with ms and a new study suggests impairment in a specific aspect of neuromuscular function can identify those at highest risk. ec trims
207,@MStranslate @ECTRIMS @NovoronBio Insight Living well without Multiple Sclerosis SO happens when CCSVI causative factor SymptoMS is treated with Venous Angioplasty SymptoMS of the UNPROVEN AUTOIMMUNE THEORY MS often ease/DISAPPEAR!!!,twitter,CAN,ms_matko,,@mstranslate @ectrims @novoronbio insight living well without multiple sclerosis so happens when ccsvi causative factor symptoms is treated with venous angioplasty symptoms of the unproven autoimmune theory ms often ease/disappear!!!,male,,Beauty/Health & Fitness,,insight living well without multiple sclerosis so happens when ccsvi causative factor symptoms is treated with venous angioplasty symptoms of the unproven autoimmune theory ms often ease/disappear!!!
209,Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS | Biogen - Biogen https://t.co/mOJQvKftOw,twitter,MEX,Egutz_,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms | biogen - biogen https://t.co/mojqvkftow,unknown,,,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms | biogen - biogen
211,"üéôÔ∏è For years pregnancy has been an absent or rarely addressed topic in #MS. This is changing & we now have many sessions on how to face pregnancy & integrate it into the patients‚Äô journey: ECTRIMS President @MarTintore  

Listen on Spotify ‚û°Ô∏è https://t.co/LPPCoPYVpA https://t.co/pZtWZ6f2Hr",twitter,CHE,ECTRIMS,,üéôÔ∏è for years pregnancy has been an absent or rarely addressed topic in #ms. this is changing & we now have many sessions on how to face pregnancy & integrate it into the patients‚Äô journey: ectrims president @martintore listen on spotify ‚û°Ô∏è https://t.co/lppcopyvpa https://t.co/pztwz6f2hr,,#ms,,,for years pregnancy has been an absent or rarely addressed topic in ms. this is changing & we now have many sessions on how to face pregnancy & integrate it into the patients journey: ectrims president listen on spotify
212,Awaiting news & data from #ECTRIMS2022 abot #MS #exercise #research @cidumh,twitter,ESP,rjgi_training,,awaiting news & data from #ectrims2022 abot #ms #exercise #research @cidumh,male,"#ectrims2022, #ms, #exercise, #research",Sports,,awaiting news & data from ec trims abot ms #exercise #research
214,It is been a fantastic closing event for @ECTRIMS #ECTRIMS2022. Thanks to Helga Weiland and @JanaHlavacova for showing us the path we need to follow as a leading organization in #MultipleSclerosis,twitter,NLD,MarTintore,,it is been a fantastic closing event for @ectrims #ectrims2022. thanks to helga weiland and @janahlavacova for showing us the path we need to follow as a leading organization in #multiplesclerosis,unknown,"#ectrims2022, #multiplesclerosis",,,it is been a fantastic closing event for ec trims. thanks to helga weiland and for showing us the path we need to follow as a leading organization in multiple sclerosis
215,"Big thanks to @ECTRIMS for bringing information to patients in a session dedicated for people with MS today! With more than 900 patricipants online and in person! With @MarTintore @DanOntaneda @buitdehaag @DanOntaneda Alan Thompson, Birgit de Jong, Helga Weiland @JanaHlavacova https://t.co/j9eTIP15CK",twitter,BEL,eumsplatform,,"big thanks to @ectrims for bringing information to patients in a session dedicated for people with ms today! with more than 900 patricipants online and in person! with @martintore @danontaneda @buitdehaag @danontaneda alan thompson, birgit de jong, helga weiland @janahlavacova https://t.co/j9etip15ck",female,,,,"big thanks to for bringing information to patients in a session dedicated for people with ms today! with more than 900 patricipants online and in person! with alan thompson, birgit de jong, helga weiland"
216,"Wellness service at Amsterdam airport! 4 days of #ectrims2022 marathon.

Mastermind, do your thing!

#meditation 
#multiplesclerosis 
#wellbeing 
#livingwell https://t.co/azTmMA03b8",twitter,GBR,AgneStraukiene,,"wellness service at amsterdam airport! 4 days of #ectrims2022 marathon. mastermind, do your thing! #meditation #multiplesclerosis #wellbeing #livingwell https://t.co/aztmma03b8",unknown,"#ectrims2022, #meditation, #multiplesclerosis, #wellbeing, #livingwell",Beauty/Health & Fitness,"{profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}","wellness service at amsterdam airport! 4 days of ec trims marathon. mastermind, do your thing! #meditation multiple sclerosis #wellbeing #livingwell"
217,"Poster on the role of insula üß† in modulating aerobic training üèÉ effects in people with multiple sclerosis
#ectrims2022 #rehab @ RAI Amsterdam https://t.co/yDxJJNAMKJ",twitter,ITA,AlbergoniMatteo,,poster on the role of insula üß† in modulating aerobic training üèÉ effects in people with multiple sclerosis #ectrims2022 #rehab @ rai amsterdam https://t.co/ydxjjnamkj,male,"#ectrims2022, #rehab","Sports, Environment",,poster on the role of insula in modulating aerobic training effects in people with multiple sclerosis ec trims #rehab rai amsterdam
218,"Patients with relapsing-remitting #MS treated with autologous hematopoietic stem cell transplantation were 74% more likely than those taking fingolimod to be relapse-free 1 year after treatment, a new study suggests. #ECTRIMS2022 https://t.co/Ei9xiNwBoO",twitter,,MedscapeNeuro,,"patients with relapsing-remitting #ms treated with autologous hematopoietic stem cell transplantation were 74% more likely than those taking fingolimod to be relapse-free 1 year after treatment, a new study suggests. #ectrims2022 https://t.co/ei9xinwboo",,"#ms, #ectrims2022",Beauty/Health & Fitness,,"patients with relapsing-remitting ms treated with autologous hematopoietic stem cell transplantation were 74% more likely than those taking fingolimod to be relapse-free 1 year after treatment, a new study suggests. ec trims"
219,#ECTRIMS2022 ‚Äî EBV Antibodies Precede Nerve Damage Signs | Developing MS Triggered by EBV Infection: Study | #MultipleSclerosis News Today https://t.co/Zscns1xrAC,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äî ebv antibodies precede nerve damage signs | developing ms triggered by ebv infection: study | #multiplesclerosis news today https://t.co/zscns1xrac,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims ebv antibodies precede nerve damage signs | developing ms triggered by ebv infection: study | multiple sclerosis news today
220,#ECTRIMS2022 ‚Äì Smartphone Tap Speed May Help to Monitor MS | Slower Tapping on Keyboard Linked to Worse MS Disability: Study | #MultipleSclerosis News Today https://t.co/nb3Zz3JnoN,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì smartphone tap speed may help to monitor ms | slower tapping on keyboard linked to worse ms disability: study | #multiplesclerosis news today https://t.co/nb3zz3jnon,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims smartphone tap speed may help to monitor ms | slower tapping on keyboard linked to worse ms disability: study | multiple sclerosis news today
221,"1/2 In this poster presented at #ECTRIMS2022 we show that #MS patients treated with #cladribine tablets have sustained positive vaccine-specific serology response following the second and third vaccine dose of the BNT162b2 mRNA vaccine. 

https://t.co/GFoPGnXUFT",twitter,ISR,AVDlaboratory,,1/2 in this poster presented at #ectrims2022 we show that #ms patients treated with #cladribine tablets have sustained positive vaccine-specific serology response following the second and third vaccine dose of the bnt162b2 mrna vaccine. https://t.co/gfopgnxuft,,"#ectrims2022, #ms, #cladribine",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",1/2 in this poster presented at ec trims we show that ms patients treated with #cladribine tablets have sustained positive vaccine-specific serology response following the second and third vaccine dose of the bnt162b2 mrna vaccine.
222,And that's a wrap for #ECTRIMS2022! It was invigorating to talk with visionaries from across the world about #MultipleSclerosis. Braindates were a fun way to link up with folks with shared interests and missions. Pumped for the joint #ECTRIMS - #ACTRIMS meeting in #MSMilan2023! https://t.co/SnUmqKYDzu,twitter,USA,Heena_Manglani,,and that's a wrap for #ectrims2022! it was invigorating to talk with visionaries from across the world about #multiplesclerosis. braindates were a fun way to link up with folks with shared interests and missions. pumped for the joint #ectrims - #actrims meeting in #msmilan2023! https://t.co/snumqkydzu,female,"#ectrims2022, #multiplesclerosis, #ectrims, #actrims, #msmilan2023",Beauty/Health & Fitness,,and that's a wrap for ec trims! it was invigorating to talk with visionaries from across the world about multiple sclerosis. braindates were a fun way to link up with folks with shared interests and missions. pumped for the joint ec trims - #actrims meeting in msmilan2023!
223,"üéôÔ∏è In this ECTRIMS Podcast episode, #ECTRIMS President @Mar_Tintore wraps up #ECTRIMS2022, offering insight on key topics & discussing new initiatives to expand learning opportunities for the #MSresearch community @MStranslate 

Listen on Apple Podcasts ‚û°Ô∏è https://t.co/IIUlRdhEv8 https://t.co/K1uU1j6Uyd",twitter,CHE,ECTRIMS,,"üéôÔ∏è in this ectrims podcast episode, #ectrims president @mar_tintore wraps up #ectrims2022, offering insight on key topics & discussing new initiatives to expand learning opportunities for the #msresearch community @mstranslate listen on apple podcasts ‚û°Ô∏è https://t.co/iiulrdhev8 https://t.co/k1uu1j6uyd",,"#ectrims, #ectrims2022, #msresearch",,,"in this ectrims podcast episode, ec trims president wraps up ec trims, offering insight on key topics & discussing new initiatives to expand learning opportunities for the msresearch community listen on apple podcasts"
224,"Team LNI immensely enjoyed our first ever @ECTRIMS meeting over the past couple of days! ü§ì

Amazing #MS science was displayed and this was skillfully summarized by @akproebstel üìù

Already looking forward to #ECTRIMSMILAN2023 ‚òÄÔ∏è

@StijnSwinnen @ItsMargauxDavid @Dries_De_Wit https://t.co/1zomiwHv22",twitter,BEL,BelienJarne,,team lni immensely enjoyed our first ever @ectrims meeting over the past couple of days! ü§ì amazing #ms science was displayed and this was skillfully summarized by @akproebstel üìù already looking forward to #ectrimsmilan2023 ‚òÄÔ∏è @stijnswinnen @itsmargauxdavid @dries_de_wit https://t.co/1zomiwhv22,unknown,"#ms, #ectrimsmilan2023",Science,"{profession=Scientist & Researcher, jobTitle=Researcher}",team lni immensely enjoyed our first ever meeting over the past couple of days! amazing ms science was displayed and this was skillfully summarized by already looking forward to ec trimsmilan2023
225,@eumsplatform's Interim CEO @JanaHlavacova proudly wrapping up @ECTRIMS sessions by highlighting the indispensable & central role people with #MS have in research! More patient engagement and involvement is needed | People with MS need to be the center in every step #ECTRIMS2022 https://t.co/nDicwDWjSd,twitter,BEL,eumsplatform,,@eumsplatform's interim ceo @janahlavacova proudly wrapping up @ectrims sessions by highlighting the indispensable & central role people with #ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step #ectrims2022 https://t.co/ndicwdwjsd,female,"#ms, #ectrims2022",,,'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims
226,"A big thank you to @ECTRIMS for their session this morning with highlights from the last 3 days for people living with #MS, and also for including the #patientvoice with speakers Helga Weiland (@PromsInitiative) and @JanaHlavacova - very impactful!#ECTRIMS2022 #plainlanguage https://t.co/ECKEvSUSOZ",twitter,,Laura_Dormer,,"a big thank you to @ectrims for their session this morning with highlights from the last 3 days for people living with #ms, and also for including the #patientvoice with speakers helga weiland (@promsinitiative) and @janahlavacova - very impactful!#ectrims2022 #plainlanguage https://t.co/eckevsusoz",female,"#ms, #patientvoice, #ectrims2022, #plainlanguage",,"{profession=Executive, jobTitle=Co-founder}, {profession=Journalist, jobTitle=Editorial Director}","a big thank you to for their session this morning with highlights from the last 3 days for people living with ms, and also for including the #patientvoice with speakers helga weiland () and - very impactful!ec trims #plainlanguage"
227,Proud to have presented at the most important session of #ECTRIMS2022 Event for people with #multiplesclerosis @ECTRIMS @MarTintore @mssociety @mssocietyuk @ClevelandClinic https://t.co/eaIVRfAVil,twitter,USA,DanOntaneda,,proud to have presented at the most important session of #ectrims2022 event for people with #multiplesclerosis @ectrims @martintore @mssociety @mssocietyuk @clevelandclinic https://t.co/eaivrfavil,male,"#ectrims2022, #multiplesclerosis",,,proud to have presented at the most important session of ec trims event for people with multiple sclerosis
228,"Starting in 15mins, all the highlights from #ECTRIMS2022 for people living with #MultipleSclerosis >>>",twitter,,TheEviBase,,"starting in 15mins, all the highlights from #ectrims2022 for people living with #multiplesclerosis >>>",,"#ectrims2022, #multiplesclerosis","Beauty/Health & Fitness, Business",,"starting in 15mins, all the highlights from ec trims for people living with multiple sclerosis >>>"
229,"Progressive multiple sclerosis

Anti-Inflammatory, antioxidant-rich diet 
+ synbiotic supplementation

reduced gut inflammation (faecal calprotectin)
+'improved clinical manifestations'

6m randomized trial (n=69)
https://t.co/6hRAMAR8EU

#ECTRIMS #ECTRIMS2022 #PPMS #SPMS https://t.co/EgS2kvRtBt",twitter,IRL,ConorKerley,,"progressive multiple sclerosis anti-inflammatory, antioxidant-rich diet + synbiotic supplementation reduced gut inflammation (faecal calprotectin) +'improved clinical manifestations' 6m randomized trial (n=69) https://t.co/6hramar8eu #ectrims #ectrims2022 #ppms #spms https://t.co/egs2kvrtbt",male,"#ectrims, #ectrims2022, #ppms, #spms",Science,"{profession=Health practitioner, jobTitle=Dietitian}, {profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Researcher}","progressive multiple sclerosis anti-inflammatory, antioxidant-rich diet + synbiotic supplementation reduced gut inflammation (faecal calprotectin) +'improved clinical manifestations' 6m randomized trial (n=69) ec trims ec trims #ppms #spms"
230,ECTRIMS2022 https://t.co/hRjNkOGNCp,twitter,GBR,the_MSBlog,,ectrims2022 https://t.co/hrjnkogncp,unknown,,,,ectrims2022
231,"It‚Äôs time to tailor therapy with mAb!
#ECTRIMS2022 #ECTRIMS #MultipleSclerosis https://t.co/xyLGHJUkU2",twitter,ITA,gianmarcoabba,,it‚Äôs time to tailor therapy with mab! #ectrims2022 #ectrims #multiplesclerosis https://t.co/xylghjuku2,male,"#ectrims2022, #ectrims, #multiplesclerosis","Beauty/Health & Fitness, Science","{profession=Student, jobTitle=Student}, {profession=Scientist & Researcher, jobTitle=Neurologist}",its time to tailor therapy with mab! ec trims ec trims multiple sclerosis
232,@MStranslate @NovoronBio @ECTRIMS SOLUTION FLGHTING FOR TREATMENT CAUSE OF THE SYMPTOMS OF SO CALLED MULTIPLE SCLEROSIS!!!,twitter,CAN,ms_matko,,@mstranslate @novoronbio @ectrims solution flghting for treatment cause of the symptoms of so called multiple sclerosis!!!,male,,Beauty/Health & Fitness,,solution flghting for treatment cause of the symptoms of so called multiple sclerosis!!!
233,"üì£ An invitation for ALL people living with #MS

Join us today for ""ECTRIMS 2022: For people living with MS"" in Amsterdam at the RAI & online, where MS experts will breakdown the latest insight from #ECTRIMS2022

Register now for this free event ‚û°Ô∏è https://t.co/GHq9cP5Ctq https://t.co/hrBsw5zZ7Z",twitter,CHE,ECTRIMS,,"üì£ an invitation for all people living with #ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from #ectrims2022 register now for this free event ‚û°Ô∏è https://t.co/ghq9cp5ctq https://t.co/hrbsw5zz7z",,"#ms, #ectrims2022",,,"an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event"
234,"The best talk, amazing, in my opinion, of #ECTRIMS2022 congress: Confavreux Lecture: ""The future of neuropathology in MS"", by Christine Stadelmann Nessler. The neuropathology is and will be the main driver of new visions of #MultipleSclerosis. https://t.co/HCz4o7fepM",twitter,NLD,bereniceanabel,,"the best talk, amazing, in my opinion, of #ectrims2022 congress: confavreux lecture: ""the future of neuropathology in ms"", by christine stadelmann nessler. the neuropathology is and will be the main driver of new visions of #multiplesclerosis. https://t.co/hcz4o7fepm",female,"#ectrims2022, #multiplesclerosis",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}","the best talk, amazing, in my opinion, of ec trims congress: confavreux lecture: ""the future of neuropathology in ms"", by christine stadelmann nessler. the neuropathology is and will be the main driver of new visions of multiple sclerosis."
235,"Cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. #ECTRIMS2022 https://t.co/B5l5BIf4wZ",twitter,USA,Medscape,,"cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. #ectrims2022 https://t.co/b5l5bif4wz",unknown,#ectrims2022,Beauty/Health & Fitness,,"cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims"
236,"Data suggest that glial fibrillary acidic protein is a more useful biomarker for progression in #multiplesclerosis compared with neurofilament light. @JensKuhle @UniSpitalBasel @ECTRIMS #ECTRIMS2022 #MS

View: https://t.co/nJgBM2plsR",twitter,USA,neurology_live,,data suggest that glial fibrillary acidic protein is a more useful biomarker for progression in #multiplesclerosis compared with neurofilament light. @jenskuhle @unispitalbasel @ectrims #ectrims2022 #ms view: https://t.co/njgbm2plsr,,"#multiplesclerosis, #ectrims2022, #ms",Beauty/Health & Fitness,,data suggest that glial fibrillary acidic protein is a more useful biomarker for progression in multiple sclerosis compared with neurofilament light. ec trims ms view:
239,"Cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. #ECTRIMS2022 #NeuroTwitter https://t.co/hiV3Tr2atD",twitter,,MedscapeNeuro,,"cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. #ectrims2022 #neurotwitter https://t.co/hiv3tr2atd",,"#ectrims2022, #neurotwitter",Beauty/Health & Fitness,,"cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter"
240,@MStranslate @NovoronBio @ECTRIMS HELP Facilitate Research Cerebrospinal Venous Blood Flow Baseline Primary Care Option Treating Neurovascular Disease like Covid-19 and so called MS! Longevity Quality life depend! @ms_matko #BloodFlowMatters #LongCovid,twitter,CAN,ms_matko,,@mstranslate @novoronbio @ectrims help facilitate research cerebrospinal venous blood flow baseline primary care option treating neurovascular disease like covid-19 and so called ms! longevity quality life depend! @ms_matko #bloodflowmatters #longcovid,male,"#bloodflowmatters, #longcovid",Beauty/Health & Fitness,,help facilitate research cerebrospinal venous blood flow baseline primary care option treating neurovascular disease like covid-19 and so called ms! longevity quality life depend! #bloodflowmatters #longcovid
241,Future #MS research needs. Do you agree? #ECTRIMS2022,twitter,,IJMSCtweets,,future #ms research needs. do you agree? #ectrims2022,,"#ms, #ectrims2022",,,future ms research needs. do you agree? ec trims
242,Some ways to increase #cooperation to leverage #global understanding and move #MS treatment forward. Do you agree? #ECTRIMS2022,twitter,,IJMSCtweets,,some ways to increase #cooperation to leverage #global understanding and move #ms treatment forward. do you agree? #ectrims2022,,"#cooperation, #global, #ms, #ectrims2022",,,some ways to increase #cooperation to leverage #global understanding and move ms treatment forward. do you agree? ec trims
243,"disease management, from clinical studies utilizing ViewMind's motor function and precision neurocognitive digital biomarkers. #multiplesclerosis #ectrims2022 #precisionmedicine #healthcare #pharma",twitter,USA,ViewMind_,,"disease management, from clinical studies utilizing viewmind's motor function and precision neurocognitive digital biomarkers. #multiplesclerosis #ectrims2022 #precisionmedicine #healthcare #pharma",,"#multiplesclerosis, #ectrims2022, #precisionmedicine, #healthcare, #pharma","Beauty/Health & Fitness, Business",,"disease management, from clinical studies utilizing viewmind's motor function and precision neurocognitive digital biomarkers. multiple sclerosis ec trims #precisionmedicine #healthcare #pharma"
244,"Attending #ECTRIMS2022? Join us for ViewMind Inc.'s poster presentations sharing our latest data on #MultipleSclerosis 

#multiplesclerosis #ectrims2022 #precisionmedicine #healthcare #pharma https://t.co/SpPiqO159U",twitter,USA,ViewMind_,,attending #ectrims2022? join us for viewmind inc.'s poster presentations sharing our latest data on #multiplesclerosis #multiplesclerosis #ectrims2022 #precisionmedicine #healthcare #pharma https://t.co/sppiqo159u,,"#ectrims2022, #multiplesclerosis, #multiplesclerosis, #ectrims2022, #precisionmedicine, #healthcare, #pharma","Beauty/Health & Fitness, Business",,attending ec trims? join us for viewmind inc.'s poster presentations sharing our latest data on multiple sclerosis multiple sclerosis ec trims #precisionmedicine #healthcare #pharma
245,Excellent talk by Dr. Bove about E-Health in #MultipleSclerosis at the #ECTRIMS2022 https://t.co/F88YacVN2a,twitter,SAU,monamarwan,,excellent talk by dr. bove about e-health in #multiplesclerosis at the #ectrims2022 https://t.co/f88yacvn2a,unknown,"#multiplesclerosis, #ectrims2022",Business,,excellent talk by dr. bove about e-health in multiple sclerosis at the ec trims
246,"#ECTRIMS2022 Awards! 
Meier: Serum glial fibrillary acidic protein compared w neurofilament light chain as biomarker for MS disease progression @RC2NB 
Colombi: CSF inflammatory profile in pts w chronic active lesions distinctive & consistent w innate & adaptive immune activation https://t.co/ZtTMT9qBd6",twitter,,IJMSCtweets,,#ectrims2022 awards! meier: serum glial fibrillary acidic protein compared w neurofilament light chain as biomarker for ms disease progression @rc2nb colombi: csf inflammatory profile in pts w chronic active lesions distinctive & consistent w innate & adaptive immune activation https://t.co/zttmt9qbd6,,#ectrims2022,,,ec trims awards! meier: serum glial fibrillary acidic protein compared w neurofilament light chain as biomarker for ms disease progression colombi: csf inflammatory profile in pts w chronic active lesions distinctive & consistent w innate & adaptive immune activation
247,"Dr Tomas Kalincik: compared AHSCT - bone marrow stem cell treatment- with natalizumab to control disability in progressive MS, reduce relapses, and assess adverse events #ECTRIMS2022 https://t.co/SdotDAlcK6",twitter,CAN,PamelaKanellis,,"dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events #ectrims2022 https://t.co/sdotdalck6",female,#ectrims2022,,,"dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims"
248,#Pediatric #MS: #cognitive #impairment is associated with posterior & subcortical resting state functional connectivity abnormalities. B16=severe RS FC reduction with worse cognitive scores; A16=maladaptive RS FC increase. Maturation=significant impact. @Lauz_Caccia #ECTRIMS2022,twitter,,IJMSCtweets,,#pediatric #ms: #cognitive #impairment is associated with posterior & subcortical resting state functional connectivity abnormalities. b16=severe rs fc reduction with worse cognitive scores; a16=maladaptive rs fc increase. maturation=significant impact. @lauz_caccia #ectrims2022,,"#pediatric, #ms, #cognitive, #impairment, #ectrims2022",,,#pediatric ms: #cognitive #impairment is associated with posterior & subcortical resting state functional connectivity abnormalities. b16evere rs fc reduction with worse cognitive scores; a16=maladaptive rs fc increase. maturationignificant impact. ec trims
249,Dr Darin Okuda: RIS radiologically isolated syndrome is the earliest detectable preclinical phase of MS - he looked at early treatment to prevent clinical onset of MS #ECTRIMS2022 https://t.co/yoYglLj2rm,twitter,CAN,PamelaKanellis,,dr darin okuda: ris radiologically isolated syndrome is the earliest detectable preclinical phase of ms - he looked at early treatment to prevent clinical onset of ms #ectrims2022 https://t.co/yoygllj2rm,female,#ectrims2022,,,dr darin okuda: ris radiologically isolated syndrome is the earliest detectable preclinical phase of ms - he looked at early treatment to prevent clinical onset of ms ec trims
251,"Completely blown away by the city of canals and #ECTRIMS2022 . What a great conference, we had a fantastic time. 

Can‚Äôt wait for next year! 

 #neurology #MultipleSclerosis https://t.co/1TxEUgCHnn",twitter,USA,SpherixNeuro,,"completely blown away by the city of canals and #ectrims2022 . what a great conference, we had a fantastic time. can‚Äôt wait for next year! #neurology #multiplesclerosis https://t.co/1txeugchnn",unknown,"#ectrims2022, #neurology, #multiplesclerosis","Beauty/Health & Fitness, Business",,"completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis"
252,"Impact of #environment factors on employment difficulties is ‚â• disease-related factors. Changes in attitudes of coworkers & workplace flexibility can enable people with #MS to #work longer. ""You don't realize that you still have #value until somebody tells you."" #ECTRIMS2022",twitter,,IJMSCtweets,,"impact of #environment factors on employment difficulties is ‚â• disease-related factors. changes in attitudes of coworkers & workplace flexibility can enable people with #ms to #work longer. ""you don't realize that you still have #value until somebody tells you."" #ectrims2022",,"#environment, #ms, #work, #value, #ectrims2022",,,"impact of #environment factors on employment difficulties is disease-related factors. changes in attitudes of coworkers & workplace flexibility can enable people with ms to #work longer. ""you don't realize that you still have #value until somebody tells you."" ec trims"
253,An important discussion on spinal cord atrophy in MS and our data on cervical spinal cord imaging in patients with MS @ECTRIMS #ECTRIMS2022,twitter,,burcuzeydanmd,,an important discussion on spinal cord atrophy in ms and our data on cervical spinal cord imaging in patients with ms @ectrims #ectrims2022,female,#ectrims2022,Beauty/Health & Fitness,,an important discussion on spinal cord atrophy in ms and our data on cervical spinal cord imaging in patients with ms ec trims
254,"@themsguide Not bad, @themsguide, for your first @ECTRIMS.  Thanks for bringing the latest research to the #MS community! Enjoyed finally meeting you in person, Dom.  Loved talking to you about #remyelination with @LivedHealth. Keep up the advocacy!!!",twitter,USA,drbarrysinger,,"@themsguide not bad, @themsguide, for your first @ectrims. thanks for bringing the latest research to the #ms community! enjoyed finally meeting you in person, dom. loved talking to you about #remyelination with @livedhealth. keep up the advocacy!!!",male,"#ms, #remyelination",Science,,"not bad, , for your first . thanks for bringing the latest research to the ms community! enjoyed finally meeting you in person, dom. loved talking to you about #remyelination with . keep up the advocacy!!!"
255,"Late breaking #ECTRIMS2022: Among patients with progressive #MS, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #AHSCT is not superior in reducing disability progression or allowing reduction of disability than natalizumab.",twitter,,IJMSCtweets,,"late breaking #ectrims2022: among patients with progressive #ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.",,"#ectrims2022, #ms, #ahsct",,,"late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab."
256,"We made a splash at #ectrims2022 this year! So thankful for all the wonderful colleagues I met at @ECTRIMS and also my incredible @OctaveBio colleagues. #precisionmedicine #multiplesclerosis #biomarkers #mri #PatientCare #neuroscience #neurology

https://t.co/i9cUlrs8w5",twitter,NLD,patinc91,,we made a splash at #ectrims2022 this year! so thankful for all the wonderful colleagues i met at @ectrims and also my incredible @octavebio colleagues. #precisionmedicine #multiplesclerosis #biomarkers #mri #patientcare #neuroscience #neurology https://t.co/i9culrs8w5,female,"#ectrims2022, #precisionmedicine, #multiplesclerosis, #biomarkers, #mri, #patientcare, #neuroscience, #neurology","Science, Animals & Pets, Family & Parenting, Music","{profession=Scientist & Researcher, jobTitle=Neuroscientist}",we made a splash at ec trims this year! so thankful for all the wonderful colleagues i met at and also my incredible colleagues. #precisionmedicine multiple sclerosis #biomarkers #mri #patientcare #neuroscience #neurology
257,What a league table - well done Barry & all #TweetMS activists for keeping #PPIE & colleagues in #MS involved in #ECTRIMS2022 @Iamsterdam @ectrims See you soonü§û,twitter,GBR,KlausSchmierer,,what a league table - well done barry & all #tweetms activists for keeping #ppie & colleagues in #ms involved in #ectrims2022 @iamsterdam @ectrims see you soonü§û,male,"#tweetms, #ppie, #ms, #ectrims2022",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",what a league table - well done barry & all #tweetms activists for keeping #ppie & colleagues in ms involved in ec trims see you soon
258,"At Atara, we draw inspiration from those who face a daily battle against serious diseases. At @ECTRIMS, we presented a late-breaking poster highlighting open-label extension & imaging data for investigational ATA188 in progressive forms of #MS. More: https://t.co/NYuzo79qFe https://t.co/WqUzYmR3ov",twitter,USA,Atarabio,,"at atara, we draw inspiration from those who face a daily battle against serious diseases. at @ectrims, we presented a late-breaking poster highlighting open-label extension & imaging data for investigational ata188 in progressive forms of #ms. more: https://t.co/nyuzo79qfe https://t.co/wquzymr3ov",unknown,#ms,,,"at atara, we draw inspiration from those who face a daily battle against serious diseases. at , we presented a late-breaking poster highlighting open-label extension & imaging data for investigational ata188 in progressive forms of ms. more:"
259,Great seeing everyone at #ECTRIMS2022! Looking forward to implementing advancements from biomarker testing to RIS treatment to our #MS patients in the clinic. See U soon! @ECTRIMS @J_SastreGarriga @cemcat_em @KlausSchmierer @IntNatlWiMS @C_OrejaGuevara @GeoArrambide @themsguide https://t.co/rLZztnNNhP,twitter,USA,drbarrysinger,,great seeing everyone at #ectrims2022! looking forward to implementing advancements from biomarker testing to ris treatment to our #ms patients in the clinic. see u soon! @ectrims @j_sastregarriga @cemcat_em @klausschmierer @intnatlwims @c_orejaguevara @geoarrambide @themsguide https://t.co/rlzztnnnhp,male,"#ectrims2022, #ms",Science,,great seeing everyone at ec trims! looking forward to implementing advancements from biomarker testing to ris treatment to our ms patients in the clinic. see u soon!
260,"Tianrong Yeo, PhD, discussed what he looks forward to at the upcoming @ECTRIMS meeting such as hearing about the newest happenings in #MS, including the latest treatments, and his colleague‚Äôs presentation as well. @SingHealthSG 

Watch: https://t.co/oknN7YySfQ",twitter,USA,neurology_live,,"tianrong yeo, phd, discussed what he looks forward to at the upcoming @ectrims meeting such as hearing about the newest happenings in #ms, including the latest treatments, and his colleague‚Äôs presentation as well. @singhealthsg watch: https://t.co/oknn7yysfq",,#ms,Beauty/Health & Fitness,,"tianrong yeo, phd, discussed what he looks forward to at the upcoming meeting such as hearing about the newest happenings in ms, including the latest treatments, and his colleagues presentation as well. watch:"
261,"Last day of #ECTRIMS2022 was great! Lots of espresso, Saw my @IntNatlWiMS #mentor @anneke_vdw & can‚Äôt wait to work together on a new #MultipleSclerosis #MRI project! Also so proud of @DariusMewes for his ePoster on #myelin changes in #MOGAD & now time to relax a bit! @ECTRIMS Ty! https://t.co/4J3s8mKya0",twitter,DEU,ClaudiaAcadem,,"last day of #ectrims2022 was great! lots of espresso, saw my @intnatlwims #mentor @anneke_vdw & can‚Äôt wait to work together on a new #multiplesclerosis #mri project! also so proud of @dariusmewes for his eposter on #myelin changes in #mogad & now time to relax a bit! @ectrims ty! https://t.co/4j3s8mkya0",female,"#ectrims2022, #mentor, #multiplesclerosis, #mri, #myelin, #mogad","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Teacher}","last day of ec trims was great! lots of espresso, saw my #mentor & cant wait to work together on a new multiple sclerosis #mri project! also so proud of for his eposter on #myelin changes in #mogad & now time to relax a bit! ty!"
262,"#ECTRIMS2022 Plenary Session 2: closing session. @C_OrejaGuevara and @hwiendl present the clinical highlights: reconsidering how we envision MS as a disease and its evolution, imaging and molecular biomarkers closer to clinical use, and HET/individualised treatment. @ECTRIMS https://t.co/ini9fzVnIl",twitter,ESP,GeoArrambide,,"#ectrims2022 plenary session 2: closing session. @c_orejaguevara and @hwiendl present the clinical highlights: reconsidering how we envision ms as a disease and its evolution, imaging and molecular biomarkers closer to clinical use, and het/individualised treatment. @ectrims https://t.co/ini9fzvnil",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","ec trims plenary session 2: closing session. and present the clinical highlights: reconsidering how we envision ms as a disease and its evolution, imaging and molecular biomarkers closer to clinical use, and het/individualised treatment."
263,"Wonderful experience with @proebstellab team at @ECTRIMS. Going home with new ideas, exciting collaborations and fresh energy to tackle #ms https://t.co/3tZPoAHWOr",twitter,CHE,akproebstel,,"wonderful experience with @proebstellab team at @ectrims. going home with new ideas, exciting collaborations and fresh energy to tackle #ms https://t.co/3tzpoahwor",female,#ms,Science,"{profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}","wonderful experience with team at . going home with new ideas, exciting collaborations and fresh energy to tackle ms"
264,"üå∑Late breaking news at #ECTRIMS2022 @Iamsterdam Surprising or not? Propensity matched study of #HSCT versus #Natalizumab in #progressive #MS revealed no difference in efficacy. Early treatment best, applies to bothüí° https://t.co/X41ivERaVk",twitter,GBR,KlausSchmierer,,"üå∑late breaking news at #ectrims2022 @iamsterdam surprising or not? propensity matched study of #hsct versus #natalizumab in #progressive #ms revealed no difference in efficacy. early treatment best, applies to bothüí° https://t.co/x41iveravk",male,"#ectrims2022, #hsct, #natalizumab, #progressive, #ms",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}","late breaking news at ec trims surprising or not? propensity matched study of #hsct versus #natalizumab in #progressive ms revealed no difference in efficacy. early treatment best, applies to both"
265,I was Honored and humbled to speak alongside Dr @SKriegerMD Dr Elliot and Dr. D‚ÄôSouza on New Tools & Challenges in #MS @ECTRIMS 2022! @IntNatlWiMS @DrJim4MS @OhioHealth #ectrims2022 https://t.co/Yqb4IesBgP,twitter,USA,DrJNicholas,,i was honored and humbled to speak alongside dr @skriegermd dr elliot and dr. d‚Äôsouza on new tools & challenges in #ms @ectrims 2022! @intnatlwims @drjim4ms @ohiohealth #ectrims2022 https://t.co/yqb4iesbgp,female,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",i was honored and humbled to speak alongside dr dr elliot and dr. dsouza on new tools & challenges in ms 2022! ec trims
266,"Listen to @tim_coetzee, Chief Advocacy, Services & Science Officer at the National MS Society, discuss highlights from day two of #ECTRIMS2022, including lifestyle, well-being and progressive MS.

Listen here to the #ECTRIMSPodcast: https://t.co/tLvYKs3yxz. @ECTRIMS https://t.co/vNDIgpDXnp",twitter,,mssociety,,"listen to @tim_coetzee, chief advocacy, services & science officer at the national ms society, discuss highlights from day two of #ectrims2022, including lifestyle, well-being and progressive ms. listen here to the #ectrimspodcast: https://t.co/tlvyks3yxz. @ectrims https://t.co/vndigpdxnp",female,"#ectrims2022, #ectrimspodcast",,,"listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: ."
267,"Hot-off-the-press from Late Breaking News at @ECTRIMS üëâ https://t.co/PBvwdkxACN 

@themsguide gives his summary of #ECTRIMS2022 and the most up-to-date information in MS research it's possible to have üó£

#MultipleSclerosis",twitter,,LivedHealth,,hot-off-the-press from late breaking news at @ectrims üëâ https://t.co/pbvwdkxacn @themsguide gives his summary of #ectrims2022 and the most up-to-date information in ms research it's possible to have üó£ #multiplesclerosis,unknown,"#ectrims2022, #multiplesclerosis","Beauty/Health & Fitness, Photo & Video",,hot-off-the-press from late breaking news at gives his summary of ec trims and the most up-to-date information in ms research it's possible to have multiple sclerosis
268,MS HANGOUT LIVE FROM ECTRIMS2022 https://t.co/AShPBOanEu,twitter,GBR,the_MSBlog,,ms hangout live from ectrims2022 https://t.co/ashpboaneu,unknown,,,,ms hangout live from ectrims2022
269,Dr. Oreja-Guevara knocks the #Ectrims2022 clinical summary out of the park highlighting Paramagnetic Rim Lesions #PRLs as a marker of disability in #MS and predictor of #MS in #CIS among many other research from @ectrims @C_OrejaGuevara  #ectrims2022 #MultipleSclerosis üëèüëèüëè https://t.co/iXVimp4yAd,twitter,USA,DrJNicholas,,dr. oreja-guevara knocks the #ectrims2022 clinical summary out of the park highlighting paramagnetic rim lesions #prls as a marker of disability in #ms and predictor of #ms in #cis among many other research from @ectrims @c_orejaguevara #ectrims2022 #multiplesclerosis üëèüëèüëè https://t.co/ixvimp4yad,female,"#ectrims2022, #prls, #ms, #ms, #cis, #ectrims2022, #multiplesclerosis",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",dr. oreja-guevara knocks the ec trims clinical summary out of the park highlighting paramagnetic rim lesions #prls as a marker of disability in ms and predictor of ms in #cis among many other research from ec trims multiple sclerosis
270,ECTRIMS 2022: Network lens could explain paradox in multiple sclerosis (free article access w/ registration) #ECTRIMS2022 #Neurology https://t.co/w3hw0eAaJq,twitter,,BioWorldScience,,ectrims 2022: network lens could explain paradox in multiple sclerosis (free article access w/ registration) #ectrims2022 #neurology https://t.co/w3hw0eaajq,,"#ectrims2022, #neurology",,,ectrims 2022: network lens could explain paradox in multiple sclerosis (free article access w/ registration) ec trims #neurology
271,"#ECTRIMS2022 : Darin Okuda, UT Southwestern, shared first trial showing that treating people who have RIS (#MS-like MRI with no symptoms) with Tecfidera over 96 weeks reduced risk of having a first neurological symptom: https://t.co/KDxQGvQpOr https://t.co/aeKuAPZ6bs",twitter,,mssociety,,"#ectrims2022 : darin okuda, ut southwestern, shared first trial showing that treating people who have ris (#ms-like mri with no symptoms) with tecfidera over 96 weeks reduced risk of having a first neurological symptom: https://t.co/kdxqgvqpor https://t.co/aekuapz6bs",female,"#ectrims2022, #ms",,,"ec trims : darin okuda, ut southwestern, shared first trial showing that treating people who have ris (ms-like mri with no symptoms) with tecfidera over 96 weeks reduced risk of having a first neurological symptom:"
272,Fantastic overview of clinical highlights ‚Å¶@ECTRIMS‚Å© and perspectives of #MSresearch ‚Å¶@hwiendl‚Å© ‚Å¶@C_OrejaGuevara‚Å© https://t.co/lb28o8BcfF,twitter,DEU,schirmerlab,,fantastic overview of clinical highlights ‚Å¶@ectrims‚Å© and perspectives of #msresearch ‚Å¶@hwiendl‚Å© ‚Å¶@c_orejaguevara‚Å© https://t.co/lb28o8bcff,male,#msresearch,Science,"{profession=Scientist & Researcher, jobTitle=Neurologist}",fantastic overview of clinical highlights and perspectives of msresearch
273,"Results showed autologous hematopoietic stem cell transplantation to not be more beneficial for reducing disability progression than #natalizumab  among patients with progressive #MS. #latebreaker #ECTRIMS2022 @ECTRIMS @tysabri @biogen  @TheRMH 

üî¥ View: https://t.co/scLeiA6rnL",twitter,USA,neurology_live,,results showed autologous hematopoietic stem cell transplantation to not be more beneficial for reducing disability progression than #natalizumab among patients with progressive #ms. #latebreaker #ectrims2022 @ectrims @tysabri @biogen @thermh üî¥ view: https://t.co/scleia6rnl,,"#natalizumab, #ms, #latebreaker, #ectrims2022",Beauty/Health & Fitness,,results showed autologous hematopoietic stem cell transplantation to not be more beneficial for reducing disability progression than #natalizumab among patients with progressive ms. #latebreaker ec trims view:
274,Progression Independent of Relapses #PIRA in #MS is a key area of focus in working to decrease/halt progression in #MS - Dr Weindel #ectrims2022 https://t.co/Yqm9S3CuPk,twitter,USA,DrJNicholas,,progression independent of relapses #pira in #ms is a key area of focus in working to decrease/halt progression in #ms - dr weindel #ectrims2022 https://t.co/yqm9s3cupk,female,"#pira, #ms, #ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",progression independent of relapses #pira in ms is a key area of focus in working to decrease/halt progression in ms - dr weindel ec trims
275,I missed face-to-face @ECTRIMS!Great feedbacks for my poster ‚ÄúCognitive function and imaging correlates in #MOGAD: a comparison with #MS and #NMOSD-AQP4‚Äù https://t.co/tHFeibtD0I,twitter,GBR,silvia06,,i missed face-to-face @ectrims!great feedbacks for my poster ‚Äúcognitive function and imaging correlates in #mogad: a comparison with #ms and #nmosd-aqp4‚Äù https://t.co/thfeibtd0i,female,"#mogad, #ms, #nmosd",Business,,i missed face-to-face !great feedbacks for my poster cognitive function and imaging correlates in #mogad: a comparison with ms and #nmosd-aqp4
276,Award winner! P179 #ECTRIMS2022 @VickyLeavittPhD Women are better able to maintain cognitive and fine motor dexterity in the face of increasing #MS #neurodegeneration than men. This is the first demonstration of #SexDifferences in reserve against #neurofunctional decline in MS.,twitter,,IJMSCtweets,,award winner! p179 #ectrims2022 @vickyleavittphd women are better able to maintain cognitive and fine motor dexterity in the face of increasing #ms #neurodegeneration than men. this is the first demonstration of #sexdifferences in reserve against #neurofunctional decline in ms.,,"#ectrims2022, #ms, #neurodegeneration, #sexdifferences, #neurofunctional",,,award winner! p179 ec trims women are better able to maintain cognitive and fine motor dexterity in the face of increasing ms #neurodegeneration than men. this is the first demonstration of #sexdifferences in reserve against #neurofunctional decline in ms.
277,"Wonderful and visionary talk ‚Å¶@ECTRIMS‚Å© given by one my mentors Christine Stadelmann-Nessler ‚Å¶@uniGoettingen‚Å© about the future of neuropathology in  #MSresearch - the future looks very bright! Congrats, Christine, to be the 2022 Confavreux awardee! https://t.co/eWgiE4Lnl9",twitter,DEU,schirmerlab,,"wonderful and visionary talk ‚Å¶@ectrims‚Å© given by one my mentors christine stadelmann-nessler ‚Å¶@unigoettingen‚Å© about the future of neuropathology in #msresearch - the future looks very bright! congrats, christine, to be the 2022 confavreux awardee! https://t.co/ewgie4lnl9",male,#msresearch,Science,"{profession=Scientist & Researcher, jobTitle=Neurologist}","wonderful and visionary talk given by one my mentors christine stadelmann-nessler about the future of neuropathology in msresearch - the future looks very bright! congrats, christine, to be the 2022 confavreux awardee!"
278,"Congratulations to Professor Krzysztof Selmaj, member of @MSIntFederation medical and scientific board, for his @ECTRIMS Honorary Member award, in recognition for his outstanding contribution to the #MultipleSclerosis  field 

 #ECTRIMS2022 https://t.co/MYLAI2ApwC",twitter,GBR,AnneHelme,,"congratulations to professor krzysztof selmaj, member of @msintfederation medical and scientific board, for his @ectrims honorary member award, in recognition for his outstanding contribution to the #multiplesclerosis field #ectrims2022 https://t.co/mylai2apwc",female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,"congratulations to professor krzysztof selmaj, member of medical and scientific board, for his honorary member award, in recognition for his outstanding contribution to the multiple sclerosis field ec trims"
279,Great to see this new and very important award recognizing and empowering #diversity and #women in #MSresearch - Thanks ‚Å¶@RachelHorne19‚Å© ‚Å¶@IntNatlWiMS‚Å© ‚Å¶@ECTRIMS‚Å© https://t.co/95OJfErxh4,twitter,DEU,schirmerlab,,great to see this new and very important award recognizing and empowering #diversity and #women in #msresearch - thanks ‚Å¶@rachelhorne19‚Å© ‚Å¶@intnatlwims‚Å© ‚Å¶@ectrims‚Å© https://t.co/95ojferxh4,male,"#diversity, #women, #msresearch",Science,"{profession=Scientist & Researcher, jobTitle=Neurologist}",great to see this new and very important award recognizing and empowering #diversity and #women in msresearch - thanks
280,"We shared a variety of new data about OCREVUS at
#ECTRIMS2022. Please see full Prescribing Information at https://t.co/k33kg2JUmT. Intended for US healthcare professionals only. 

Which learning did you find the most informative?",twitter,USA,OCREVUSHCP_USA,,we shared a variety of new data about ocrevus at #ectrims2022. please see full prescribing information at https://t.co/k33kg2jumt. intended for us healthcare professionals only. which learning did you find the most informative?,,#ectrims2022,,,we shared a variety of new data about ocrevus at ec trims. please see full prescribing information at . intended for us healthcare professionals only. which learning did you find the most informative?
281,Thank you @RachelHorne19 for recognizing and supporting #women #MS researchers and their contributions to advancing knowledge and care for women with #MultipleSclerosis @IntNatlWiMS #ectrims2022 https://t.co/H7to1G5F0p,twitter,USA,DrJNicholas,,thank you @rachelhorne19 for recognizing and supporting #women #ms researchers and their contributions to advancing knowledge and care for women with #multiplesclerosis @intnatlwims #ectrims2022 https://t.co/h7to1g5f0p,female,"#women, #ms, #multiplesclerosis, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",thank you for recognizing and supporting #women ms researchers and their contributions to advancing knowledge and care for women with multiple sclerosis ec trims
282,"We're at #ECTRIMS2022 talking to experts about #ClinicalTrials, #DiseaseModifyingTreatments & developments in #MultipleSclerosis. Register for FREE #MS clinical resources on @Medthority for #healthcareprofessionals only

https://t.co/olok0hAfDx
#MS #HCP #MedTwitter #NurseTwitter https://t.co/07lC9ojhHS",twitter,,Medthority,,"we're at #ectrims2022 talking to experts about #clinicaltrials, #diseasemodifyingtreatments & developments in #multiplesclerosis. register for free #ms clinical resources on @medthority for #healthcareprofessionals only https://t.co/olok0hafdx #ms #hcp #medtwitter #nursetwitter https://t.co/07lc9ojhhs",,"#ectrims2022, #clinicaltrials, #diseasemodifyingtreatments, #multiplesclerosis, #ms, #healthcareprofessionals, #ms, #hcp, #medtwitter, #nursetwitter",,,"we're at ec trims talking to experts about #clinicaltrials, #diseasemodifyingtreatments & developments in multiple sclerosis. register for free ms clinical resources on for #healthcareprofessionals only ms #hcp #medtwitter #nursetwitter"
283,"P110 #ECTRIMS2022 Evidence suggests: #Black patients with #MS experience more aggressive disease  & worse outcomes; schisms in patient-provider perceptions may impact. Data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.",twitter,,IJMSCtweets,,"p110 #ectrims2022 evidence suggests: #black patients with #ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.",,"#ectrims2022, #black, #ms",,,"p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity."
284,"It was a week full of scientific and clinical discussions at #ECTRIMS2022 @ECTRIMS.
It was great to meet face to face again and have lively relevant discussions. I was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in #MS. https://t.co/zBjFFUaL8l",twitter,,TiaGlia,,it was a week full of scientific and clinical discussions at #ectrims2022 @ectrims. it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in #ms. https://t.co/zbjffual8l,male,"#ectrims2022, #microglia, #remyelination, #ms",Science,"{profession=Student, jobTitle=Student}",it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.
285,Amazing #MS research shared and awarded @ectrims #ectrims2022 @IntNatlWiMS https://t.co/AZpWaJqe9q,twitter,USA,DrJNicholas,,amazing #ms research shared and awarded @ectrims #ectrims2022 @intnatlwims https://t.co/azpwajqe9q,female,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",amazing ms research shared and awarded ec trims
286,Lots of new insights around MS at #ECTRIMS2022. We enjoyed interesting discussions with neurologists and nurses around research and the issues they face in their daily practice. We keep up the good work chasing the miracles of science to help people with #MS and HCPS! #Sanofi https://t.co/JHR3U993CD,twitter,NLD,SijntjeWidlak,,lots of new insights around ms at #ectrims2022. we enjoyed interesting discussions with neurologists and nurses around research and the issues they face in their daily practice. we keep up the good work chasing the miracles of science to help people with #ms and hcps! #sanofi https://t.co/jhr3u993cd,unknown,"#ectrims2022, #ms, #sanofi",,,lots of new insights around ms at ec trims. we enjoyed interesting discussions with neurologists and nurses around research and the issues they face in their daily practice. we keep up the good work chasing the miracles of science to help people with ms and hcps! #sanofi
287,"Final day of #ECTRIMS2022

We very much enjoyed the exchange with the #MS community about latest scientific and medical findings around the disease. Let's stay connected and keep on working together to find treatments for #MultipleSclerosis!

#MSresearch @ECTRIMS #Immunic $IMUX https://t.co/AEd5pn20FG",twitter,USA,ImmunicInc,,final day of #ectrims2022 we very much enjoyed the exchange with the #ms community about latest scientific and medical findings around the disease. let's stay connected and keep on working together to find treatments for #multiplesclerosis! #msresearch @ectrims #immunic $imux https://t.co/aed5pn20fg,,"#ectrims2022, #ms, #multiplesclerosis, #msresearch, #immunic","Beauty/Health & Fitness, Business",,final day of ec trims we very much enjoyed the exchange with the ms community about latest scientific and medical findings around the disease. let's stay connected and keep on working together to find treatments for multiple sclerosis! msresearch #immunic $imux
288,"#ECTRIMS2022 : Early reports from ECTRIMS suggest vitamin D supplements do not reduce ongoing MS disease activity. However, these studies do not answer whether vitamin D can prevent MS: https://t.co/v4FE7M64hg",twitter,,mssociety,,"#ectrims2022 : early reports from ectrims suggest vitamin d supplements do not reduce ongoing ms disease activity. however, these studies do not answer whether vitamin d can prevent ms: https://t.co/v4fe7m64hg",female,#ectrims2022,,,"ec trims : early reports from ectrims suggest vitamin d supplements do not reduce ongoing ms disease activity. however, these studies do not answer whether vitamin d can prevent ms:"
289,"We joined over 7,000 #healthcareprofessionals at #ECTRIMS2022 & asked for their event highlights. Here's what Prof. @VickyLeavittPhD told us

#MultipleSclerosis #MedEd #HCP #MS

https://t.co/fkYzyhOFTE

Register on #Medthority for FREE. For healthcare professionals only. https://t.co/t3JOT0L0nn",twitter,,Medthority,,"we joined over 7,000 #healthcareprofessionals at #ectrims2022 & asked for their event highlights. here's what prof. @vickyleavittphd told us #multiplesclerosis #meded #hcp #ms https://t.co/fkyzyhofte register on #medthority for free. for healthcare professionals only. https://t.co/t3jot0l0nn",,"#healthcareprofessionals, #ectrims2022, #multiplesclerosis, #meded, #hcp, #ms, #medthority",,,"we joined over 7,000 #healthcareprofessionals at ec trims & asked for their event highlights. here's what prof. told us multiple sclerosis #meded #hcp ms register on #medthority for free. for healthcare professionals only."
290,"So happy to read #fertility in #multiplesclerosis is discussed at #ECTRIMS2022 

The evidence we had were very bad, but now we know that better communication among neurologists + repro docs AND the continuation of DMTs right to IVF are keys! No increased risk of relapse!",twitter,ITA,maclaudiaa,,"so happy to read #fertility in #multiplesclerosis is discussed at #ectrims2022 the evidence we had were very bad, but now we know that better communication among neurologists + repro docs and the continuation of dmts right to ivf are keys! no increased risk of relapse!",female,"#fertility, #multiplesclerosis, #ectrims2022",,"{profession=Executive, jobTitle=Founder}, {profession=Teacher & Lecturer, jobTitle=Prof}","so happy to read #fertility in multiple sclerosis is discussed at ec trims the evidence we had were very bad, but now we know that better communication among neurologists + repro docs and the continuation of dmts right to ivf are keys! no increased risk of relapse!"
291,"#ECTRIMS2022 : National MS Society Harry Weaver Scholar Dr. Riley Bove of UCSF:  ‚Äònatural experiment‚Äô doing remote research visits during pandemic lowered costs and worked fine, opening the door to better outreach to more people living with #MS : https://t.co/Tcn6fwyQ24",twitter,,mssociety,,"#ectrims2022 : national ms society harry weaver scholar dr. riley bove of ucsf: ‚Äònatural experiment‚Äô doing remote research visits during pandemic lowered costs and worked fine, opening the door to better outreach to more people living with #ms : https://t.co/tcn6fwyq24",female,"#ectrims2022, #ms",,,"ec trims : national ms society harry weaver scholar dr. riley bove of ucsf: natural experiment doing remote research visits during pandemic lowered costs and worked fine, opening the door to better outreach to more people living with ms :"
292,Proud of Johanna Oechtering presenting our team's research on how complement activation predicts disease severity in MS #ECTRIMS2022 https://t.co/kwOs5xC8nJ,twitter,CHE,RC2NB,,proud of johanna oechtering presenting our team's research on how complement activation predicts disease severity in ms #ectrims2022 https://t.co/kwos5xc8nj,,#ectrims2022,Beauty/Health & Fitness,,proud of johanna oechtering presenting our team's research on how complement activation predicts disease severity in ms ec trims
293,Kalincik @MSBase_Registry study: Propensity-matched #progressive #MS patients treated with AHSCT or natalizumab. No difference on relapse rates and disability progression. #ECTRIMS2022 https://t.co/YImB0AHOSV,twitter,USA,drbarrysinger,,kalincik @msbase_registry study: propensity-matched #progressive #ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. #ectrims2022 https://t.co/yimb0ahosv,male,"#progressive, #ms, #ectrims2022",Science,,kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims
294,"Kalincik: MSBase study compared aHSCT vs Natalizumab in Progressive MS (PPMS and SPMS). On a group level no difference in relapse rate or disability worsening or improvement was seen. Limitation is ao low number of pts (39 aHSCT pts) studied.
#ECTRIMS2022 https://t.co/6cC8ELoLNI",twitter,BEL,bart_professor,,kalincik: msbase study compared ahsct vs natalizumab in progressive ms (ppms and spms). on a group level no difference in relapse rate or disability worsening or improvement was seen. limitation is ao low number of pts (39 ahsct pts) studied. #ectrims2022 https://t.co/6cc8elolni,unknown,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",kalincik: msbase study compared ahsct vs natalizumab in progressive ms (ppms and spms). on a group level no difference in relapse rate or disability worsening or improvement was seen. limitation is ao low number of pts (39 ahsct pts) studied. ec trims
295,"After preliminary data suggested that humoral response may be delayed among those vaccinated against #COVID19 treated with ocrelizumab, new data from #ECTRIMS suggest a third booster dose can revive such response safely.
https://t.co/PK2ijsYMq5",twitter,USA,byMattHoffman,,"after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from #ectrims suggest a third booster dose can revive such response safely. https://t.co/pk2ijsymq5",male,"#covid19, #ectrims",Books,"{profession=Journalist, jobTitle=Editor}","after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely."
296,"#ECTRIMS2022 James Sumowski of Mt. Sinai, NYC: Newer data makes clear that cognitive issues in #MS can‚Äôt be blamed on just slow info processing.",twitter,,mssociety,,"#ectrims2022 james sumowski of mt. sinai, nyc: newer data makes clear that cognitive issues in #ms can‚Äôt be blamed on just slow info processing.",female,"#ectrims2022, #ms",,,"ec trims james sumowski of mt. sinai, nyc: newer data makes clear that cognitive issues in ms cant be blamed on just slow info processing."
297,"We previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (https://t.co/7fE8BIHSRo). This is now real-world evidence! #ECTRIMS2022 https://t.co/TDAfqEv8iP",twitter,NLD,MarcelloMoccia_,,"we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (https://t.co/7fe8bihsro). this is now real-world evidence! #ectrims2022 https://t.co/tdafqev8ip",male,#ectrims2022,"Food & Drinks, Sports, Travel",,"we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims"
298,"Brenda Banwell, MD, of @ChildrensPhila, shared the inspiration that she gets from her patients with pediatric-onset #MS, which was the subject of her lecture here at #ECTRIMS2022. https://t.co/HbE5jnIreQ",twitter,USA,byMattHoffman,,"brenda banwell, md, of @childrensphila, shared the inspiration that she gets from her patients with pediatric-onset #ms, which was the subject of her lecture here at #ectrims2022. https://t.co/hbe5jnireq",male,"#ms, #ectrims2022",Books,"{profession=Journalist, jobTitle=Editor}","brenda banwell, md, of , shared the inspiration that she gets from her patients with pediatric-onset ms, which was the subject of her lecture here at ec trims."
299,"#ECTRIMS2022 : Dr. Laura Piccio of WashU: 12 weeks of intermittent fasting in small trial produced changes in brain structures and reduced inflammation, suggesting benefit in relapsing #MS: https://t.co/4w4jL1lmzw",twitter,,mssociety,,"#ectrims2022 : dr. laura piccio of washu: 12 weeks of intermittent fasting in small trial produced changes in brain structures and reduced inflammation, suggesting benefit in relapsing #ms: https://t.co/4w4jl1lmzw",female,"#ectrims2022, #ms",,,"ec trims : dr. laura piccio of washu: 12 weeks of intermittent fasting in small trial produced changes in brain structures and reduced inflammation, suggesting benefit in relapsing ms:"
300,First evidence-based data on the possibility to prevent #MultipleSclerosis in at-risk individuals (radiologically isolated syndrome) #ECTRIMS2022 @ECTRIMS https://t.co/0acfqdpng6,twitter,NLD,MarcelloMoccia_,,first evidence-based data on the possibility to prevent #multiplesclerosis in at-risk individuals (radiologically isolated syndrome) #ectrims2022 @ectrims https://t.co/0acfqdpng6,male,"#multiplesclerosis, #ectrims2022","Food & Drinks, Sports, Travel",,first evidence-based data on the possibility to prevent multiple sclerosis in at-risk individuals (radiologically isolated syndrome) ec trims
301,Early non disabling relapses are associated with increased risk of disability accumulation. This was NOT seen if #pwMS were on high efficacy DMT! More reasons to use high efficacy #DMT early in #MS #ECTRIMS2022 https://t.co/Ypm45PjMVF,twitter,USA,DrJNicholas,,early non disabling relapses are associated with increased risk of disability accumulation. this was not seen if #pwms were on high efficacy dmt! more reasons to use high efficacy #dmt early in #ms #ectrims2022 https://t.co/ypm45pjmvf,female,"#pwms, #dmt, #ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",early non disabling relapses are associated with increased risk of disability accumulation. this was not seen if #pwms were on high efficacy dmt! more reasons to use high efficacy #dmt early in ms ec trims
302,"@GeoArrambide from @cemcat_em presented in ‚ÄúLate Breaking Abstracs‚Äùsession how NFL can increase MS diagnosis specificity in CIS patients not fulfilling McDonald criteria.  

#ECTRIMS2022 @ECTRIMS https://t.co/1XuGZYVf7g",twitter,NLD,bollo_luca,,@geoarrambide from @cemcat_em presented in ‚Äúlate breaking abstracs‚Äùsession how nfl can increase ms diagnosis specificity in cis patients not fulfilling mcdonald criteria. #ectrims2022 @ectrims https://t.co/1xugzyvf7g,male,#ectrims2022,,,from presented in late breaking abstracssession how nfl can increase ms diagnosis specificity in cis patients not fulfilling mcdonald criteria. ec trims
303,"Discussing innovations in technology-supported rehabilitation in #MS at #ECTRIMS2022 

@peterfeys_ introduces novel high cost devices, low cost virtual solutions & mHealth apps!

#MultipleSclerosis #NeuroTwitter #Neurology https://t.co/YATvvRxOLB",twitter,,VJNeurology,,"discussing innovations in technology-supported rehabilitation in #ms at #ectrims2022 @peterfeys_ introduces novel high cost devices, low cost virtual solutions & mhealth apps! #multiplesclerosis #neurotwitter #neurology https://t.co/yatvvrxolb",,"#ms, #ectrims2022, #multiplesclerosis, #neurotwitter, #neurology",Photo & Video,,"discussing innovations in technology-supported rehabilitation in ms at ec trims introduces novel high cost devices, low cost virtual solutions & mhealth apps! multiple sclerosis #neurotwitter #neurology"
304,"Time for Late Breaking News at @ECTRIMS üéâüß†

The latest breakthroughs in MS treatment and research. Wrap up video coming soon‚Ä¶

Ft @GeoArrambide üëè

#ECTRIMS #ECTRIMS2022 https://t.co/mJFgFecJJr",twitter,,LivedHealth,,time for late breaking news at @ectrims üéâüß† the latest breakthroughs in ms treatment and research. wrap up video coming soon‚Ä¶ ft @geoarrambide üëè #ectrims #ectrims2022 https://t.co/mjfgfecjjr,unknown,"#ectrims, #ectrims2022","Beauty/Health & Fitness, Photo & Video",,time for late breaking news at the latest breakthroughs in ms treatment and research. wrap up video coming soon ft ec trims ec trims
305,"@AlbertoCalvi3, currently ectrims fellow at @imaginem in @neuroimmun.. talking about relationship between slowly expanding lesions and paramagnetic rim lesions in people with multiple sclerosis
#ECTRIMS2022 https://t.co/pTOMpA8xBD",twitter,ESP,neuroimmuclinic,,"@albertocalvi3, currently ectrims fellow at @imaginem in @neuroimmun.. talking about relationship between slowly expanding lesions and paramagnetic rim lesions in people with multiple sclerosis #ectrims2022 https://t.co/ptompa8xbd",unknown,#ectrims2022,,,", currently ectrims fellow at in .. talking about relationship between slowly expanding lesions and paramagnetic rim lesions in people with multiple sclerosis ec trims"
306,"Our reflections on Day 2 of #ECTRIMS2022 are now available. Our co-founder, Brett Drummond, & @NovoronBio CEO, Dr Travis Stiles, discuss lifestyle interventions, remyelination, progressive #MultipleSclerosis & more. Tweet us your highlights. @ECTRIMS #MS https://t.co/nY390LYc6w",twitter,AUS,MStranslate,,"our reflections on day 2 of #ectrims2022 are now available. our co-founder, brett drummond, & @novoronbio ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive #multiplesclerosis & more. tweet us your highlights. @ectrims #ms https://t.co/ny390lyc6w",,"#ectrims2022, #multiplesclerosis, #ms",,,"our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms"
307,"Another fruitful #ECTRIMS2022 for our team.
We are delighted to participate and contribute with our small portion in developing better cares for patients living with MS. @llramio @garinho29 @Claudia_cll @htrueta @iasgirona @idibgi https://t.co/scI1soLiGe",twitter,,UNIEMTGirona,,another fruitful #ectrims2022 for our team. we are delighted to participate and contribute with our small portion in developing better cares for patients living with ms. @llramio @garinho29 @claudia_cll @htrueta @iasgirona @idibgi https://t.co/sci1solige,unknown,#ectrims2022,,,another fruitful ec trims for our team. we are delighted to participate and contribute with our small portion in developing better cares for patients living with ms.
308,"‚ÄòDo aging MS patients need a specialised approach?‚Äô
Professor Zsolt Illes gave a highly inspiring talk on the management of aging MS patients at #ECTRIMS 2022 https://t.co/0OAi5jW0jg",twitter,NLD,SijntjeWidlak,,‚Äòdo aging ms patients need a specialised approach?‚Äô professor zsolt illes gave a highly inspiring talk on the management of aging ms patients at #ectrims 2022 https://t.co/0oai5jw0jg,unknown,#ectrims,,,do aging ms patients need a specialised approach? professor zsolt illes gave a highly inspiring talk on the management of aging ms patients at ec trims 2022
309,"@Brandon_Beaber @drbarrysinger @ECTRIMS I had mono in middle school & was diagnosed with #MS at age 50. Never had symptoms until around age 47 to 48. I‚Äôm 53 now. My body has fought hard against MS and to keep me ‚Äúlooking normal‚Äù. You‚Äôd never know I have MS by looking at me, but I feel it every day in my legs though. üò≥",twitter,,MLipham222,,"@brandon_beaber @drbarrysinger @ectrims i had mono in middle school & was diagnosed with #ms at age 50. never had symptoms until around age 47 to 48. i‚Äôm 53 now. my body has fought hard against ms and to keep me ‚Äúlooking normal‚Äù. you‚Äôd never know i have ms by looking at me, but i feel it every day in my legs though. üò≥",unknown,#ms,,"{profession=Executive, jobTitle=President}, {profession=Executive, jobTitle=Founder}","i had mono in middle school & was diagnosed with ms at age 50. never had symptoms until around age 47 to 48. im 53 now. my body has fought hard against ms and to keep me looking normal. youd never know i have ms by looking at me, but i feel it every day in my legs though."
310,"Here at #ECTRIMS2022, I spoke with @fede_picariello about the mechanisms underlying #MS fatigue, and she shared some great insight on how it is measured. https://t.co/hGjEMFBJzt",twitter,USA,byMattHoffman,,"here at #ectrims2022, i spoke with @fede_picariello about the mechanisms underlying #ms fatigue, and she shared some great insight on how it is measured. https://t.co/hgjemfbjzt",male,"#ectrims2022, #ms",Books,"{profession=Journalist, jobTitle=Editor}","here at ec trims, i spoke with about the mechanisms underlying ms fatigue, and she shared some great insight on how it is measured."
311,#ECTRIMS2022 ‚Äì Poor Myelin Repair Offers Clues in Disease Progression | Patients With Late-onset MS Have Fewer Myelin-making Cells | #MultipleSclerosis News Today https://t.co/lhlO26pCLg,twitter,GBR,AbiBuddComms,,#ectrims2022 ‚Äì poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | #multiplesclerosis news today https://t.co/lhlo26pclg,unknown,"#ectrims2022, #multiplesclerosis",Books,,ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today
312,"Our own @HannekeHulst presented at #ECTRIMS2022 today, stressing the point of also maintaining cognitive functioning of people without cognitive impairments. #MindSlab #MultipleSclerosis https://t.co/Gpg1NHGFlT",twitter,NLD,MindSlab_LU,,"our own @hannekehulst presented at #ectrims2022 today, stressing the point of also maintaining cognitive functioning of people without cognitive impairments. #mindslab #multiplesclerosis https://t.co/gpg1nhgflt",,"#ectrims2022, #mindslab, #multiplesclerosis",,,"our own presented at ec trims today, stressing the point of also maintaining cognitive functioning of people without cognitive impairments. #mindslab multiple sclerosis"
313,"#ECTRIMS2022 is covering important news beyond #MS

@VJNeurology spoke with Kazuo Fujihara on how & when to treat AQP4-IgG+ NMOSD, unmet needs and novel agents!

Thank you for your insights Dr Fujihara!

#NMOSD #MultipleSclerosis #NeuroTwitter https://t.co/y2ujPGbItq",twitter,,VJNeurology,,"#ectrims2022 is covering important news beyond #ms @vjneurology spoke with kazuo fujihara on how & when to treat aqp4-igg+ nmosd, unmet needs and novel agents! thank you for your insights dr fujihara! #nmosd #multiplesclerosis #neurotwitter https://t.co/y2ujpgbitq",,"#ectrims2022, #ms, #nmosd, #multiplesclerosis, #neurotwitter",Photo & Video,,"ec trims is covering important news beyond ms spoke with kazuo fujihara on how & when to treat aqp4-igg+ nmosd, unmet needs and novel agents! thank you for your insights dr fujihara! #nmosd multiple sclerosis #neurotwitter"
314,"Attendees are delighted to be here in Amsterdam for the 3rd day of #ECTRIMS2022. Today‚Äôs sessions hold out the promise of more high-quality interactions between leading #MS researchers & practitioners 
 
 üëâ üëâ üëâ Scroll right

See more pictures of the day https://t.co/yc6BIhnxEH https://t.co/Ve8Nr2TQAK",twitter,CHE,ECTRIMS,,attendees are delighted to be here in amsterdam for the 3rd day of #ectrims2022. today‚Äôs sessions hold out the promise of more high-quality interactions between leading #ms researchers & practitioners üëâ üëâ üëâ scroll right see more pictures of the day https://t.co/yc6bihnxeh https://t.co/ve8nr2tqak,,"#ectrims2022, #ms",,,attendees are delighted to be here in amsterdam for the 3rd day of ec trims. todays sessions hold out the promise of more high-quality interactions between leading ms researchers & practitioners scroll right see more pictures of the day
315,"Jaume Sastre-Garriga's research focuses on MRI techniques & neurorehabilitation

At #ECTRIMS2022, we discussed the 2017 McDonald criteria, the future of MRI in #MS diagnosis, & spinal cord volumetric MRI to determine resilience
üí≠üîú https://t.co/FB5htuqt0q

#MultipleSclerosis https://t.co/mkqb21rTWb",twitter,,VJNeurology,,"jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at #ectrims2022, we discussed the 2017 mcdonald criteria, the future of mri in #ms diagnosis, & spinal cord volumetric mri to determine resilience üí≠üîú https://t.co/fb5htuqt0q #multiplesclerosis https://t.co/mkqb21rtwb",,"#ectrims2022, #ms, #multiplesclerosis",Photo & Video,,"jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis"
316,Great to announce at the @ECTRIMS that the Start2Cure Foundation will co-sponsor the MACSiMiSE-BRAIN Study: Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration. @drBWillekens https://t.co/WiX2TriDFk,twitter,NLD,Boaz_Spermon,,great to announce at the @ectrims that the start2cure foundation will co-sponsor the macsimise-brain study: metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration. @drbwillekens https://t.co/wix2tridfk,male,,Beauty/Health & Fitness,,great to announce at the that the start2cure foundation will co-sponsor the macsimise-brain study: metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration.
317,"Brian, Patrick, Graham and Karolina share their personal experiences of living with #multiplesclerosis, and how they manage their condition every day to continue pursuing what‚Äôs important to them. Read more: https://t.co/c5KSsEaQqJ #MyMSPortrait #ECTRIMS2022 #diseaseprogression",twitter,,kombiglyze_XR,,"brian, patrick, graham and karolina share their personal experiences of living with #multiplesclerosis, and how they manage their condition every day to continue pursuing what‚Äôs important to them. read more: https://t.co/c5ksseaqqj #mymsportrait #ectrims2022 #diseaseprogression",unknown,"#multiplesclerosis, #mymsportrait, #ectrims2022, #diseaseprogression",,,"brian, patrick, graham and karolina share their personal experiences of living with multiple sclerosis, and how they manage their condition every day to continue pursuing whats important to them. read more: #mymsportrait ec trims #diseaseprogression"
318,"More interviews from #ECTRIMS coming soon to https://t.co/fwiS7IhM3r:

‚Ä¢ Dr. Tomas Kalincik on #HSCT use in MS
‚Ä¢ Dr. Brenda Banwell on the state of care for pediatric-onset #MS
‚Ä¢ Dr. Bruce Cree on the latest from inebilizumab in #NMOSD https://t.co/QQLAr2VIsv",twitter,USA,neurology_live,,more interviews from #ectrims coming soon to https://t.co/fwis7ihm3r: ‚Ä¢ dr. tomas kalincik on #hsct use in ms ‚Ä¢ dr. brenda banwell on the state of care for pediatric-onset #ms ‚Ä¢ dr. bruce cree on the latest from inebilizumab in #nmosd https://t.co/qqlar2visv,,"#ectrims, #hsct, #ms, #nmosd",Beauty/Health & Fitness,,more interviews from ec trims coming soon to : dr. tomas kalincik on #hsct use in ms dr. brenda banwell on the state of care for pediatric-onset ms dr. bruce cree on the latest from inebilizumab in #nmosd
319,Our #ECTRIMS2022 poster presenting #COVID19 vaccine hesitancy data in people with #MultipleSclerosis @alastair_kwok @profevasegelov @SCSMonash https://t.co/jxRl071GAV,twitter,NLD,LisaGrech4,,our #ectrims2022 poster presenting #covid19 vaccine hesitancy data in people with #multiplesclerosis @alastair_kwok @profevasegelov @scsmonash https://t.co/jxrl071gav,female,"#ectrims2022, #covid19, #multiplesclerosis","Science, Animals & Pets, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Health practitioner, jobTitle=Psychologist}",our ec trims poster presenting #covid19 vaccine hesitancy data in people with multiple sclerosis
320,"Dr Laura Cacciaguerra finishes the cognition session at #ECTRIMS2022: Pediatric MS patients show very extensive functional connectivity changes, related to cognition. Results differed in patients above and below age 16. https://t.co/hYMbPtznfZ",twitter,,imscogs,,"dr laura cacciaguerra finishes the cognition session at #ectrims2022: pediatric ms patients show very extensive functional connectivity changes, related to cognition. results differed in patients above and below age 16. https://t.co/hymbptznfz",unknown,#ectrims2022,Beauty/Health & Fitness,,"dr laura cacciaguerra finishes the cognition session at ec trims: pediatric ms patients show very extensive functional connectivity changes, related to cognition. results differed in patients above and below age 16."
321,"Talented @ExeterMed medical student @loginovic sharing our team's work on risk of #MS following first #opticneuritis @ECTRIMS in @uk_biobank with @RAOram this week in Amsterdam, making new connections and friends to collaborate with, to extend this research for patient benefit https://t.co/eebYOqAaoP",twitter,GBR,tasbraithwaite,,"talented @exetermed medical student @loginovic sharing our team's work on risk of #ms following first #opticneuritis @ectrims in @uk_biobank with @raoram this week in amsterdam, making new connections and friends to collaborate with, to extend this research for patient benefit https://t.co/eebyoqaaop",unknown,"#ms, #opticneuritis",Business,,"talented medical student sharing our team's work on risk of ms following first #opticneuritis in with this week in amsterdam, making new connections and friends to collaborate with, to extend this research for patient benefit"
322,"Dr. Carolina Rimkus at the cognition session at ##ECTRIMS2022: People with #MS can be stratified based on cognitive performance combined with anxiety and depression, which is reflected by different neurodegenerative profiles. https://t.co/PEow3BpWyN",twitter,,imscogs,,"dr. carolina rimkus at the cognition session at ##ectrims2022: people with #ms can be stratified based on cognitive performance combined with anxiety and depression, which is reflected by different neurodegenerative profiles. https://t.co/peow3bpwyn",unknown,"#ectrims2022, #ms",Beauty/Health & Fitness,,"dr. carolina rimkus at the cognition session at #ec trims: people with ms can be stratified based on cognitive performance combined with anxiety and depression, which is reflected by different neurodegenerative profiles."
323,Nauta: Cognitive Rehab Therapy and Mindfulness-Based üßò‚Äç‚ôÄÔ∏è Therapy reduced cognitive patient symptoms in clinical trial in 100 #MS patients. Mindfulness led to prolonged improvements in processing speed. @yogamovesms #ECTRIMS2022 https://t.co/Ec3KpXplyi,twitter,USA,drbarrysinger,,nauta: cognitive rehab therapy and mindfulness-based üßò‚Äç‚ôÄÔ∏è therapy reduced cognitive patient symptoms in clinical trial in 100 #ms patients. mindfulness led to prolonged improvements in processing speed. @yogamovesms #ectrims2022 https://t.co/ec3kpxplyi,male,"#ms, #ectrims2022",Science,,nauta: cognitive rehab therapy and mindfulness-based therapy reduced cognitive patient symptoms in clinical trial in 100 ms patients. mindfulness led to prolonged improvements in processing speed. ec trims
324,Cognition at #ECTRIMS2022 continues with submitted abstracts. Dr Sumowski: Are we really measuring information processing speed with the SDMT? Other speed tests are not impaired in #MS. Time for a re-appraisal? https://t.co/apNNPRREI5,twitter,,imscogs,,cognition at #ectrims2022 continues with submitted abstracts. dr sumowski: are we really measuring information processing speed with the sdmt? other speed tests are not impaired in #ms. time for a re-appraisal? https://t.co/apnnprrei5,unknown,"#ectrims2022, #ms",Beauty/Health & Fitness,,cognition at ec trims continues with submitted abstracts. dr sumowski: are we really measuring information processing speed with the sdmt? other speed tests are not impaired in ms. time for a re-appraisal?
325,"#ECTRIMS2022  Cognitive rehabilitation and mindfulness reduce cognitive complaints in #MS (REMIND-MS): a randomized controlled trial presented by Ilse Nauta üá≥üá± MS Center Amsterdam

@ECTRIMS https://t.co/XBLcG1cxHw",twitter,NLD,eumsplatform,,#ectrims2022 cognitive rehabilitation and mindfulness reduce cognitive complaints in #ms (remind-ms): a randomized controlled trial presented by ilse nauta üá≥üá± ms center amsterdam @ectrims https://t.co/xblcg1cxhw,female,"#ectrims2022, #ms",,,ec trims cognitive rehabilitation and mindfulness reduce cognitive complaints in ms (remind-ms): a randomized controlled trial presented by ilse nauta ms center amsterdam
326,"Patients with #MS in a real-world setting who switched their treatment to cladribine from infusion therapies experienced reduced annualized relapse rates and tolerated the oral purine antimetabolite well. @FSUCoM @EMDSerono @ECTRIMS #ECTRIMS22

‚¨áÔ∏è View ‚¨áÔ∏è: https://t.co/l8FhWxJPzz",twitter,USA,neurology_live,,patients with #ms in a real-world setting who switched their treatment to cladribine from infusion therapies experienced reduced annualized relapse rates and tolerated the oral purine antimetabolite well. @fsucom @emdserono @ectrims #ectrims22 ‚¨áÔ∏è view ‚¨áÔ∏è: https://t.co/l8fhwxjpzz,,"#ms, #ectrims22",Beauty/Health & Fitness,,patients with ms in a real-world setting who switched their treatment to cladribine from infusion therapies experienced reduced annualized relapse rates and tolerated the oral purine antimetabolite well. ec trims22 view :
327,Great #cognition session at #ECTRIMS2022 in the main hall! We kicked off with prof. Amato discussing cognitive profiles in elderly patients. How should we approach cognitive evaluations in these people with MS? https://t.co/V0hYIODohJ,twitter,,imscogs,,great #cognition session at #ectrims2022 in the main hall! we kicked off with prof. amato discussing cognitive profiles in elderly patients. how should we approach cognitive evaluations in these people with ms? https://t.co/v0hyiodohj,unknown,"#cognition, #ectrims2022",Beauty/Health & Fitness,,great #cognition session at ec trims in the main hall! we kicked off with prof. amato discussing cognitive profiles in elderly patients. how should we approach cognitive evaluations in these people with ms?
328,Fantastic talks on #cognition in patients with #MultipleSclerosis at #ECTRIMS2022 . Great future ahead for the research in this field!  @CANTABconnect,twitter,,MartyDL87,,fantastic talks on #cognition in patients with #multiplesclerosis at #ectrims2022 . great future ahead for the research in this field! @cantabconnect,female,"#cognition, #multiplesclerosis, #ectrims2022",,,fantastic talks on #cognition in patients with multiple sclerosis at ec trims . great future ahead for the research in this field!
329,Sumowski: Processing speed is not specific in #MS. Important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each MS patient. @imscogs @AbbeyJHughesPhD #ECTRIMS2022 @MustStopMS @themsguide @AaronBosterMD @Brandon_Beaber @ECTRIMS https://t.co/VsFPfzodXE,twitter,USA,drbarrysinger,,sumowski: processing speed is not specific in #ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. @imscogs @abbeyjhughesphd #ectrims2022 @muststopms @themsguide @aaronbostermd @brandon_beaber @ectrims https://t.co/vsfpfzodxe,male,"#ms, #ectrims2022",Science,,sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims
330,"#ECTRIMS2022 | Translating what people experience to scientific language is as equally important as translating scientific findings to lay language. ""Silent #MS progression is only silent because we don't listen to it."" @ECTRIMS",twitter,BEL,eumsplatform,,"#ectrims2022 | translating what people experience to scientific language is as equally important as translating scientific findings to lay language. ""silent #ms progression is only silent because we don't listen to it."" @ectrims",female,"#ectrims2022, #ms",,,"ec trims | translating what people experience to scientific language is as equally important as translating scientific findings to lay language. ""silent ms progression is only silent because we don't listen to it."""
331,"Understanding specific cognitive complaints in #MS patient is important to improve research, prevention and treatment. 
By James Sumowski 
#ECTRIMS2022 https://t.co/sjxPcmGGeB",twitter,CAN,HindNajashi,,"understanding specific cognitive complaints in #ms patient is important to improve research, prevention and treatment. by james sumowski #ectrims2022 https://t.co/sjxpcmggeb",unknown,"#ms, #ectrims2022",,"{profession=Teacher & Lecturer, jobTitle=Associate Professor}","understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims"
332,"In 2020-2021, social distancing & masks abolished influenza season. we asked the question: did this also stop JC virus from spreading in people with #MS? we looked at 20,000 patients in TOUCH registry. 

The answer was‚Ä¶no. ü§î

@ECTRIMS https://t.co/6Lmw1uIT0X",twitter,USA,SKriegerMD,,"in 2020-2021, social distancing & masks abolished influenza season. we asked the question: did this also stop jc virus from spreading in people with #ms? we looked at 20,000 patients in touch registry. the answer was‚Ä¶no. ü§î @ectrims https://t.co/6lmw1uit0x",male,#ms,Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Neurologist}","in 2020-2021, social distancing & masks abolished influenza season. we asked the question: did this also stop jc virus from spreading in people with ms? we looked at 20,000 patients in touch registry. the answer wasno."
333,"Insightful talk by Prof @HannekeHulst highlighting the need for preventative interventions for cognitive problems in multiple sclerosis - ""Sooner may be better than later"" #ECTRIMS2022",twitter,GBR,NEuRoMSproject,,"insightful talk by prof @hannekehulst highlighting the need for preventative interventions for cognitive problems in multiple sclerosis - ""sooner may be better than later"" #ectrims2022",unknown,#ectrims2022,Beauty/Health & Fitness,,"insightful talk by prof highlighting the need for preventative interventions for cognitive problems in multiple sclerosis - ""sooner may be better than later"" ec trims"
334,"We have a fantastic team of editorial board members at @VJNeurology!

Today we had the pleasure of catching up w/ @C_OrejaGuevara (@ClinicoSCarlos) on important topics in #MultipleSclerosis

Discussing cognitive impairment in #MS, pregnancy & OCT angiography
#ECTRIMS2022 https://t.co/s8kYbsIhbc",twitter,,VJNeurology,,"we have a fantastic team of editorial board members at @vjneurology! today we had the pleasure of catching up w/ @c_orejaguevara (@clinicoscarlos) on important topics in #multiplesclerosis discussing cognitive impairment in #ms, pregnancy & oct angiography #ectrims2022 https://t.co/s8kybsihbc",,"#multiplesclerosis, #ms, #ectrims2022",Photo & Video,,"we have a fantastic team of editorial board members at ! today we had the pleasure of catching up w/ () on important topics in multiple sclerosis discussing cognitive impairment in ms, pregnancy & oct angiography ec trims"
335,"Sumowski: MS cognition in the modern era - evolution in thinking of MS as a neurodegenerative disease, increase treatment efficacy improved diagnostic sensitivity and evolving understanding of MS cognition #ECTRIMS2022 https://t.co/Aoj97qTygd",twitter,CAN,PamelaKanellis,,"sumowski: ms cognition in the modern era - evolution in thinking of ms as a neurodegenerative disease, increase treatment efficacy improved diagnostic sensitivity and evolving understanding of ms cognition #ectrims2022 https://t.co/aoj97qtygd",female,#ectrims2022,,,"sumowski: ms cognition in the modern era - evolution in thinking of ms as a neurodegenerative disease, increase treatment efficacy improved diagnostic sensitivity and evolving understanding of ms cognition ec trims"
336,"Hulst: Cognitive rehab should be implemented in #MS patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. #ECTRIMS2022 üß† https://t.co/bUBIt0tiH3",twitter,USA,drbarrysinger,,"hulst: cognitive rehab should be implemented in #ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. #ectrims2022 üß† https://t.co/bubit0tih3",male,"#ms, #ectrims2022",Science,,"hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims"
337,"Another busy morning for all of us at #ECTRIMS2022!

@VJNeurology spoke with @joaojcerqueira on the 7-year ocrelizumab data from the OPERA OLEs & the importance of aggressive early treatment in #MS!

Catch Prof. Cerqueira's insights soon on https://t.co/FB5htuqt0q https://t.co/qOk0uM9W7s",twitter,,VJNeurology,,another busy morning for all of us at #ectrims2022! @vjneurology spoke with @joaojcerqueira on the 7-year ocrelizumab data from the opera oles & the importance of aggressive early treatment in #ms! catch prof. cerqueira's insights soon on https://t.co/fb5htuqt0q https://t.co/qok0um9w7s,,"#ectrims2022, #ms",Photo & Video,,another busy morning for all of us at ec trims! spoke with on the 7-year ocrelizumab data from the opera oles & the importance of aggressive early treatment in ms! catch prof. cerqueira's insights soon on
338,What DMT should we give MS patients who have developed PML on natalizumab? Injectables and teriflunomide have been used. Dr Joep Killestein also reports there are some patients that have done well on B cell therapies following PML #ECTRIMS2022,twitter,GBR,RayDorsey7,,what dmt should we give ms patients who have developed pml on natalizumab? injectables and teriflunomide have been used. dr joep killestein also reports there are some patients that have done well on b cell therapies following pml #ectrims2022,male,#ectrims2022,"Beauty/Health & Fitness, Family & Parenting, Business, Sports","{profession=Health practitioner, jobTitle=Pharmacist}",what dmt should we give ms patients who have developed pml on natalizumab? injectables and teriflunomide have been used. dr joep killestein also reports there are some patients that have done well on b cell therapies following pml ec trims
339,"Long time ago, Wolswijk argued that spinal cord lesions in patients with #multiplesclerosis are older than those in the brain. I feel we need more neuropathological data on the spinal cord, especially regarding early events #ECTRIMS2022",twitter,ESP,TepavcevicVanja,,"long time ago, wolswijk argued that spinal cord lesions in patients with #multiplesclerosis are older than those in the brain. i feel we need more neuropathological data on the spinal cord, especially regarding early events #ectrims2022",unknown,"#multiplesclerosis, #ectrims2022",,,"long time ago, wolswijk argued that spinal cord lesions in patients with multiple sclerosis are older than those in the brain. i feel we need more neuropathological data on the spinal cord, especially regarding early events ec trims"
340,"#ECTRIMS2022
In real-world settings, relapsing #ms patients on #ocrelizumab achieved ‚â•28% greater NEDA-3 rates compared to ones treated with other disease-modifying agents
#VisualAbstract 
https://t.co/NqOIfC5StT https://t.co/rMzRko0heN",twitter,FRA,mdwrtcom,,"#ectrims2022 in real-world settings, relapsing #ms patients on #ocrelizumab achieved ‚â•28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract https://t.co/nqoifc5stt https://t.co/rmzrko0hen",unknown,"#ectrims2022, #ms, #ocrelizumab, #visualabstract","Beauty/Health & Fitness, Books","{profession=Journalist, jobTitle=Editor}","ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract"
341,Possibly my favorite talk of #ECTRIMS2022 @JeromeHendriks of @uhasselt discussing his work elucidation the mechanisms underlying lipid-mediated changes to cholesterol efflux. Can't help but see implications beyond #MS.  @MStranslate https://t.co/xpH4qZwor5,twitter,USA,titostiles,,possibly my favorite talk of #ectrims2022 @jeromehendriks of @uhasselt discussing his work elucidation the mechanisms underlying lipid-mediated changes to cholesterol efflux. can't help but see implications beyond #ms. @mstranslate https://t.co/xph4qzwor5,male,"#ectrims2022, #ms","Science, Politics, Business","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Entrepreneur}, {profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Neuroscientist}",possibly my favorite talk of ec trims of discussing his work elucidation the mechanisms underlying lipid-mediated changes to cholesterol efflux. can't help but see implications beyond ms.
342,@JeromeHendriks at #ECTRIMS2022 : Targeting foamy macrophages provides a promising strategy to halt lesion progression and induce lesion repair in multiple sclerosis - very nice examples from his and @BogieJeroen's lab https://t.co/hgP3spPoJK,twitter,BEL,BIOMED_UHasselt,,@jeromehendriks at #ectrims2022 : targeting foamy macrophages provides a promising strategy to halt lesion progression and induce lesion repair in multiple sclerosis - very nice examples from his and @bogiejeroen's lab https://t.co/hgp3sppojk,unknown,#ectrims2022,,,at ec trims : targeting foamy macrophages provides a promising strategy to halt lesion progression and induce lesion repair in multiple sclerosis - very nice examples from his and 's lab
343,"Aging effect on inflammatory process in MS in a way that could diminish the DMTs impact and allow for stopping treatment when having a stable disease and on one of the platform injectables. Stopping NAT and Sp1 modulators is risky due to rebound.
#ECTRIMS2022 https://t.co/DI0IsD2F2q",twitter,NLD,LubnaEssam,,aging effect on inflammatory process in ms in a way that could diminish the dmts impact and allow for stopping treatment when having a stable disease and on one of the platform injectables. stopping nat and sp1 modulators is risky due to rebound. #ectrims2022 https://t.co/di0isd2f2q,female,#ectrims2022,"Beauty/Health & Fitness, Science","{profession=Student, jobTitle=Student}, {profession=Teacher & Lecturer, jobTitle=Lecturer}",aging effect on inflammatory process in ms in a way that could diminish the dmts impact and allow for stopping treatment when having a stable disease and on one of the platform injectables. stopping nat and sp1 modulators is risky due to rebound. ec trims
344,Amato: peak age prevalence of #MS is changing #ECTRIMS2022 https://t.co/5ciUIRHBKx,twitter,CAN,PamelaKanellis,,amato: peak age prevalence of #ms is changing #ectrims2022 https://t.co/5ciuirhbkx,female,"#ms, #ectrims2022",,,amato: peak age prevalence of ms is changing ec trims
345,Great session summarising what we have learned so far about MS & Covid-19. Take home message remains - reduced Ab response in pts on fingolimod & anti 20s but increase in risk is really only in those on antiCD20s. The jury is still out on when to vaccinate ‚Ä¶ü§î #ECTRIMS2022,twitter,GBR,RayDorsey7,,great session summarising what we have learned so far about ms & covid-19. take home message remains - reduced ab response in pts on fingolimod & anti 20s but increase in risk is really only in those on anticd20s. the jury is still out on when to vaccinate ‚Ä¶ü§î #ectrims2022,male,#ectrims2022,"Beauty/Health & Fitness, Family & Parenting, Business, Sports","{profession=Health practitioner, jobTitle=Pharmacist}",great session summarising what we have learned so far about ms & covid-19. take home message remains - reduced ab response in pts on fingolimod & anti 20s but increase in risk is really only in those on anticd20s. the jury is still out on when to vaccinate ec trims
346,"Thanks for sharing, @Birgitpower. Thanks for the coverage üôè #ECTRIMS2022",twitter,CHE,ECTRIMS,,"thanks for sharing, @birgitpower. thanks for the coverage üôè #ectrims2022",,#ectrims2022,,,"thanks for sharing, . thanks for the coverage ec trims"
347,"Live at #ECTRIMS2022 | Cristina Granziera (@ThINk_Basel) shares insights on all things remyelination!

Monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice

#MS #NeuroTwitter #MultipleSclerosis https://t.co/f8eKWrP17H",twitter,,VJNeurology,,"live at #ectrims2022 | cristina granziera (@think_basel) shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice #ms #neurotwitter #multiplesclerosis https://t.co/f8ekwrp17h",,"#ectrims2022, #ms, #neurotwitter, #multiplesclerosis",Photo & Video,,"live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis"
348,"I am delighted to see the results of our feasibility study of a new #cognitive #therapy for people living with #MultipleSclerosis being presented at #ECTRIMS2022. #patients have been involved at every stage of this #trial. 
@shiftms @themsguide @MSIRELAND @mssocietyuk #research",twitter,IRL,A30MinuteLife,,i am delighted to see the results of our feasibility study of a new #cognitive #therapy for people living with #multiplesclerosis being presented at #ectrims2022. #patients have been involved at every stage of this #trial. @shiftms @themsguide @msireland @mssocietyuk #research,male,"#cognitive, #therapy, #multiplesclerosis, #ectrims2022, #patients, #trial, #research",,,i am delighted to see the results of our feasibility study of a new #cognitive #therapy for people living with multiple sclerosis being presented at ec trims. #patients have been involved at every stage of this #trial. #research
349,@Boaz_Spermon @ECTRIMS @GavinGiovannoni All MS patients have silent progression / smouldering MS. Relapses are just the immune system‚Äôs response. Lazy researchers and greedy pharma focused on relapses. Trials are always ‚Äúabout to start‚Äù.,twitter,,charnbrook,,@boaz_spermon @ectrims @gavingiovannoni all ms patients have silent progression / smouldering ms. relapses are just the immune system‚Äôs response. lazy researchers and greedy pharma focused on relapses. trials are always ‚Äúabout to start‚Äù.,unknown,,,,all ms patients have silent progression / smouldering ms. relapses are just the immune systems response. lazy researchers and greedy pharma focused on relapses. trials are always about to start.
350,Barriers for people with #MS to access healthcare services are multifactorial and need to be addressed by all stakeholders together! This is crucial as the lack of access has detrimental negative effects that can indeed be prevented #ECTRIMS2022 @ECTRIMS https://t.co/AIdg66HYA2,twitter,BEL,eumsplatform,,barriers for people with #ms to access healthcare services are multifactorial and need to be addressed by all stakeholders together! this is crucial as the lack of access has detrimental negative effects that can indeed be prevented #ectrims2022 @ectrims https://t.co/aidg66hya2,female,"#ms, #ectrims2022",,,barriers for people with ms to access healthcare services are multifactorial and need to be addressed by all stakeholders together! this is crucial as the lack of access has detrimental negative effects that can indeed be prevented ec trims
351,"Amato: Tremendous barriers to access quality #MS care: disparity in  access to specialists, health literacy, transportation and costs. As a #MS community, we must all work on reducing these obstacles. #ECTRIMS2022 @ECTRIMS https://t.co/2kNgPhc1lW",twitter,USA,drbarrysinger,,"amato: tremendous barriers to access quality #ms care: disparity in access to specialists, health literacy, transportation and costs. as a #ms community, we must all work on reducing these obstacles. #ectrims2022 @ectrims https://t.co/2kngphc1lw",male,"#ms, #ms, #ectrims2022",Science,,"amato: tremendous barriers to access quality ms care: disparity in access to specialists, health literacy, transportation and costs. as a ms community, we must all work on reducing these obstacles. ec trims"
352,Our @BlancaDios from Nottingham MS Research Group giving a talk about optimising employment and preventing job loss in people with Multiple Sclerosis #ECTRIMS2022 https://t.co/WIkxwhkFRL,twitter,GBR,NEuRoMSproject,,our @blancadios from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis #ectrims2022 https://t.co/wikxwhkfrl,unknown,#ectrims2022,Beauty/Health & Fitness,,our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims
353,"Find out more about @MSIntFederation work in access to #MultipleSclerosis healthcare online, or come and talk to us at stand B07! 

#ECTRIMS2022 

https://t.co/DUB9p2L8jg https://t.co/9Ctj77GUxy",twitter,GBR,AnneHelme,,"find out more about @msintfederation work in access to #multiplesclerosis healthcare online, or come and talk to us at stand b07! #ectrims2022 https://t.co/dub9p2l8jg https://t.co/9ctj77guxy",female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,"find out more about work in access to multiple sclerosis healthcare online, or come and talk to us at stand b07! ec trims"
354,@charnbrook @ECTRIMS @GavinGiovannoni The utilization goals is to implement metformin treatment in the MS clinical care pathway directly after the project.,twitter,NLD,Boaz_Spermon,,@charnbrook @ectrims @gavingiovannoni the utilization goals is to implement metformin treatment in the ms clinical care pathway directly after the project.,male,,Beauty/Health & Fitness,,the utilization goals is to implement metformin treatment in the ms clinical care pathway directly after the project.
355,"@charnbrook @ECTRIMS @GavinGiovannoni This is a very important trial as for MS patients with ‚Äòsilent progression‚Äô (inflammatory inactive disease, either treated with DMT or not, but who show clinical disability progression), currently no therapies are available.",twitter,NLD,Boaz_Spermon,,"@charnbrook @ectrims @gavingiovannoni this is a very important trial as for ms patients with ‚Äòsilent progression‚Äô (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.",male,,Beauty/Health & Fitness,,"this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available."
356,@charnbrook @ECTRIMS @GavinGiovannoni Start2Cure has recently awarded  a new research grant co-supporting the MACSiMiSE-BRAIN Study: Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration.,twitter,NLD,Boaz_Spermon,,@charnbrook @ectrims @gavingiovannoni start2cure has recently awarded a new research grant co-supporting the macsimise-brain study: metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration.,male,,Beauty/Health & Fitness,,start2cure has recently awarded a new research grant co-supporting the macsimise-brain study: metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration.
357,"üîîIt‚Äôs the final day of @ECTRIMS! 

Come and stop by booth B02 to talk all things #triMSonline and to find out more about the initiative that aims to reach a diverse global audience of professionals in order to advance equality for everyone working in the field of #MS. 

#ECTRIMS https://t.co/Em8YZsOuML",twitter,,triMSonline,,üîîit‚Äôs the final day of @ectrims! come and stop by booth b02 to talk all things #trimsonline and to find out more about the initiative that aims to reach a diverse global audience of professionals in order to advance equality for everyone working in the field of #ms. #ectrims https://t.co/em8yzsouml,,"#trimsonline, #ms, #ectrims",,,its the final day of ! come and stop by booth b02 to talk all things #trimsonline and to find out more about the initiative that aims to reach a diverse global audience of professionals in order to advance equality for everyone working in the field of ms. ec trims
358,Improving patient and health care professional education is needed. Dr. Emmanuelle Waubant highlights the importance to have patient-centered educational material on #MS using diversified materials #ECTRIMS2022 @ECTRIMS https://t.co/RUMDsbw7nH,twitter,BEL,eumsplatform,,improving patient and health care professional education is needed. dr. emmanuelle waubant highlights the importance to have patient-centered educational material on #ms using diversified materials #ectrims2022 @ectrims https://t.co/rumdsbw7nh,female,"#ms, #ectrims2022",,,improving patient and health care professional education is needed. dr. emmanuelle waubant highlights the importance to have patient-centered educational material on ms using diversified materials ec trims
359,#ECTRIMS2022 | Evaluation of work difficulties in #MS subjects & its association with socio-demographic factors & performance measures showed that 50% of PwMS are unemployed! We found the same in the https://t.co/WTYQKLvZMQ Workability must be a priority outcome of clinical care! https://t.co/gzS6kXYQwf,twitter,NLD,eumsplatform,,#ectrims2022 | evaluation of work difficulties in #ms subjects & its association with socio-demographic factors & performance measures showed that 50% of pwms are unemployed! we found the same in the https://t.co/wtyqklvzmq workability must be a priority outcome of clinical care! https://t.co/gzs6kxyqwf,female,"#ectrims2022, #ms",,,ec trims | evaluation of work difficulties in ms subjects & its association with socio-demographic factors & performance measures showed that 50% of pwms are unemployed! we found the same in the workability must be a priority outcome of clinical care!
360,"Manuela Buxo, Sr. Vice President Sanofi Europe Specialty Care,  is visiting #ECTRIMS2022. She explains ‚ÄúIt‚Äôs important to be here. Next to our current MS treatments, we are committed to accelerating the development of potential treatments for #MS #Sanofi #ECTRIMS2022 https://t.co/iZKzMeQORV",twitter,NLD,SijntjeWidlak,,"manuela buxo, sr. vice president sanofi europe specialty care, is visiting #ectrims2022. she explains ‚Äúit‚Äôs important to be here. next to our current ms treatments, we are committed to accelerating the development of potential treatments for #ms #sanofi #ectrims2022 https://t.co/izkzmeqorv",unknown,"#ectrims2022, #ms, #sanofi, #ectrims2022",,,"manuela buxo, sr. vice president sanofi europe specialty care, is visiting ec trims. she explains its important to be here. next to our current ms treatments, we are committed to accelerating the development of potential treatments for ms #sanofi ec trims"
361,Octave Presents Data from 13 Abstracts at ECTRIMS Forum 2022 Following Commercial Launch of Precision Care Solution for Multiple Sclerosis Octave announced the presentation of data from 13 abstracts presented at the European Committee for Treatment and‚Ä¶ https://t.co/DW7oJxSibB,twitter,USA,BioCalifornia,,octave presents data from 13 abstracts at ectrims forum 2022 following commercial launch of precision care solution for multiple sclerosis octave announced the presentation of data from 13 abstracts presented at the european committee for treatment and‚Ä¶ https://t.co/dw7ojxsibb,unknown,,"Beauty/Health & Fitness, Environment",,octave presents data from 13 abstracts at ectrims forum 2022 following commercial launch of precision care solution for multiple sclerosis octave announced the presentation of data from 13 abstracts presented at the european committee for treatment and
362,"Viswanathan: In Southeast Asian countries, many #MS patients do not have access to on-label #DMTs via government healthcare systems based on cost. Off-label azathioprine and rituximab frequently used. Global üåç #MS health equity needed!! #ECTRIMS2022 @ECTRIMS #PACTRIMS https://t.co/ar8ktdKn7d",twitter,USA,drbarrysinger,,"viswanathan: in southeast asian countries, many #ms patients do not have access to on-label #dmts via government healthcare systems based on cost. off-label azathioprine and rituximab frequently used. global üåç #ms health equity needed!! #ectrims2022 @ectrims #pactrims https://t.co/ar8ktdkn7d",male,"#ms, #dmts, #ms, #ectrims2022, #pactrims",Science,,"viswanathan: in southeast asian countries, many ms patients do not have access to on-label #dmts via government healthcare systems based on cost. off-label azathioprine and rituximab frequently used. global ms health equity needed!! ec trims #pactrims"
363,"Good morning from @ECTRIMS!

Do you know any MS centre, HCP or patient advocate that should be nominated for an #MSBHAward? 

Have they gone the extra mile to enhance outcomes for people with #MS? If so, come and visit booth B02 to find out more. https://t.co/zaLZmcICE4",twitter,,MSBrainHealth,,"good morning from @ectrims! do you know any ms centre, hcp or patient advocate that should be nominated for an #msbhaward? have they gone the extra mile to enhance outcomes for people with #ms? if so, come and visit booth b02 to find out more. https://t.co/zalzmcice4",female,"#msbhaward, #ms",,,"good morning from ! do you know any ms centre, hcp or patient advocate that should be nominated for an msbhaward? have they gone the extra mile to enhance outcomes for people with ms? if so, come and visit booth b02 to find out more."
364,"Drs. Alan Thompson and Bianca Weinstock-Guttman: There is no ""right age‚Äù to stop DMT in MS. Must consider comorbidities, MRI, disease stability and patient preference. #ECTRIMS2022 @NMNeurology",twitter,,EdieGrahamMD,,"drs. alan thompson and bianca weinstock-guttman: there is no ""right age‚Äù to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. #ectrims2022 @nmneurology",unknown,#ectrims2022,Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Assistant Prof}, {profession=Health practitioner, jobTitle=Clinical Assistant}","drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims"
365,"Thank you Dr Shanthi Viswanathan from PACTRIMS for all your efforts in the collaborative work on off-label treatment and essential medicines for #MultipleSclerosis - and for sharing it in this session! 

#ECTRIMS2022 https://t.co/jRINAEqyfN",twitter,GBR,AnneHelme,,thank you dr shanthi viswanathan from pactrims for all your efforts in the collaborative work on off-label treatment and essential medicines for #multiplesclerosis - and for sharing it in this session! #ectrims2022 https://t.co/jrinaeqyfn,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,thank you dr shanthi viswanathan from pactrims for all your efforts in the collaborative work on off-label treatment and essential medicines for multiple sclerosis - and for sharing it in this session! ec trims
366,Excellent presentation from @nikosevangelou3 on effectiveness of COVID-19 vaccines in people with multiple sclerosis receiving disease-modifying therapies #ECTRIMS2022 @nuhresearch @NCMSNI https://t.co/zVwQxUqa67,twitter,GBR,NEuRoMSproject,,excellent presentation from @nikosevangelou3 on effectiveness of covid-19 vaccines in people with multiple sclerosis receiving disease-modifying therapies #ectrims2022 @nuhresearch @ncmsni https://t.co/zvwqxuqa67,unknown,#ectrims2022,Beauty/Health & Fitness,,excellent presentation from on effectiveness of covid-19 vaccines in people with multiple sclerosis receiving disease-modifying therapies ec trims
367,"There are more than 20 #DMTs, but none are on @WHO' list of essential medications! Global efforts are still needed to improve access to treatment for people with #MS. @ECTRIMS #ECTRIMS2022 https://t.co/i7hdrXDl2r",twitter,BEL,eumsplatform,,"there are more than 20 #dmts, but none are on @who' list of essential medications! global efforts are still needed to improve access to treatment for people with #ms. @ectrims #ectrims2022 https://t.co/i7hdrxdl2r",female,"#dmts, #ms, #ectrims2022",,,"there are more than 20 #dmts, but none are on ' list of essential medications! global efforts are still needed to improve access to treatment for people with ms. ec trims"
368,"Final big day at #ECTRIMS Almost got my sessions worked out: Diagnosis, global health care access, emerging role of lipids, late breaking abstracts, treatment of progressive MS, closing session. @DrJMorahan https://t.co/hrM2WoUsJW",twitter,AUS,RohanGreenland,,"final big day at #ectrims almost got my sessions worked out: diagnosis, global health care access, emerging role of lipids, late breaking abstracts, treatment of progressive ms, closing session. @drjmorahan https://t.co/hrm2wousjw",male,#ectrims,"Beauty/Health & Fitness, Business","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Vice President}","final big day at ec trims almost got my sessions worked out: diagnosis, global health care access, emerging role of lipids, late breaking abstracts, treatment of progressive ms, closing session."
369,"Dr Milena Sales Pitombeira from BCTRIMS discusses the impact of COVID-19 on #MultipleSclerosis care - highlighting @MSIntFederation work on guidance for pwMS and our collaborative data sharing initiative

#ECTRIMS2022 https://t.co/MbATRTV6sO",twitter,GBR,AnneHelme,,dr milena sales pitombeira from bctrims discusses the impact of covid-19 on #multiplesclerosis care - highlighting @msintfederation work on guidance for pwms and our collaborative data sharing initiative #ectrims2022 https://t.co/mbatrtv6so,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,dr milena sales pitombeira from bctrims discusses the impact of covid-19 on multiple sclerosis care - highlighting work on guidance for pwms and our collaborative data sharing initiative ec trims
370,"@Birgitpower @ECTRIMS #ECTRIMS2022 | Great idea from @Birgitpower to organise a session about and with women with #MS at #ECTRIMS2023 during @ECTRIMS in Milan, Italy. We hope it will become a reality.",twitter,NLD,eumsplatform,,"@birgitpower @ectrims #ectrims2022 | great idea from @birgitpower to organise a session about and with women with #ms at #ectrims2023 during @ectrims in milan, italy. we hope it will become a reality.",female,"#ectrims2022, #ms, #ectrims2023",,,"ec trims | great idea from to organise a session about and with women with ms at ec trims2023 during in milan, italy. we hope it will become a reality."
371,"COVID-19: vaccination in #MS patients - Anat Achiron, Israel: MS patients had similar frequency of adverse events in response to #COVID19 #vaccination as the rest of the population #ECTRIMS2022 https://t.co/BIvynEhSsz",twitter,BEL,eumsplatform,,"covid-19: vaccination in #ms patients - anat achiron, israel: ms patients had similar frequency of adverse events in response to #covid19 #vaccination as the rest of the population #ectrims2022 https://t.co/bivynehssz",female,"#ms, #covid19, #vaccination, #ectrims2022",,,"covid-19: vaccination in ms patients - anat achiron, israel: ms patients had similar frequency of adverse events in response to #covid19 #vaccination as the rest of the population ec trims"
372,"Our final day at #ECTRIMS2022 and there‚Äôs no one I‚Äôd rather match with than my very favorite postdoc @rahileftekhari ‚ù§Ô∏èüñ§‚ù§Ô∏è  

I‚Äôve learned so much and can‚Äôt wait to bring new discoveries, perspectives, and ideas back to my #MS community in Calgary @ECTRIMS #womeninSTEM #MSSOC https://t.co/qqLtP4G8o6",twitter,,1formidablelady,,"our final day at #ectrims2022 and there‚Äôs no one i‚Äôd rather match with than my very favorite postdoc @rahileftekhari ‚ù§Ô∏èüñ§‚ù§Ô∏è i‚Äôve learned so much and can‚Äôt wait to bring new discoveries, perspectives, and ideas back to my #ms community in calgary @ectrims #womeninstem #mssoc https://t.co/qqltp4g8o6",female,"#ectrims2022, #ms, #womeninstem, #mssoc","Science, Food & Drinks, Animals & Pets, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neuroscientist}","our final day at ec trims and theres no one id rather match with than my very favorite postdoc ive learned so much and cant wait to bring new discoveries, perspectives, and ideas back to my ms community in calgary #womeninstem mssoc"
373,"Join EMSP's interim CEO, Jana Hlavacova, tomorrow as she joins efforts to highlight The Patient Experience! People with #MS should be at the center of services, support, care, and research @ECTRIMS #ECTRIMS2022",twitter,BEL,eumsplatform,,"join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with #ms should be at the center of services, support, care, and research @ectrims #ectrims2022",female,"#ms, #ectrims2022",,,"join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"
374,Starting the last #ECTRIMS2022 day with a super interesting Hot Topic Session about pediatric MOGAD! @ECTRIMS #MOGAD #MS #Pediatrics https://t.co/81E2GVDmsj,twitter,,SophiaSchwarz15,,starting the last #ectrims2022 day with a super interesting hot topic session about pediatric mogad! @ectrims #mogad #ms #pediatrics https://t.co/81e2gvdmsj,female,"#ectrims2022, #mogad, #ms, #pediatrics",,"{profession=Student, jobTitle=Student}",starting the last ec trims day with a super interesting hot topic session about pediatric mogad! #mogad ms #pediatrics
375,"Fresh from @ECTRIMS 22 |  Clinical effectiveness of AHSCT is comparable to two immune reconstitution therapies ‚Äì alemtuzumab and cladribine
https://t.co/rp7aUIcUZB",twitter,GBR,Pluchinolab,,fresh from @ectrims 22 | clinical effectiveness of ahsct is comparable to two immune reconstitution therapies ‚Äì alemtuzumab and cladribine https://t.co/rp7auicuzb,unknown,,Beauty/Health & Fitness,,fresh from 22 | clinical effectiveness of ahsct is comparable to two immune reconstitution therapies alemtuzumab and cladribine
376,"Postcard from #ECTRIMS2022! 
üìç Join us at booth #B06 for the last day of the congress!

#rims #ms #ectrims2022 #ectrims https://t.co/0RVYngwXdj",twitter,BEL,eurims,,postcard from #ectrims2022! üìç join us at booth #b06 for the last day of the congress! #rims #ms #ectrims2022 #ectrims https://t.co/0rvyngwxdj,,"#ectrims2022, #b06, #rims, #ms, #ectrims2022, #ectrims",,,postcard from ec trims! join us at booth #b06 for the last day of the congress! #rims ms ec trims ec trims
377,Galleguillos: Dramatic increase globally üåç in people living with #MS from 2013 and 2020. Prevalence increased 50%! True increase in disease or better reporting/diagnosis/awareness?  #ECTRIMS2022 https://t.co/oOnaH6RL4R,twitter,USA,drbarrysinger,,galleguillos: dramatic increase globally üåç in people living with #ms from 2013 and 2020. prevalence increased 50%! true increase in disease or better reporting/diagnosis/awareness? #ectrims2022 https://t.co/oonah6rl4r,male,"#ms, #ectrims2022",Science,,galleguillos: dramatic increase globally in people living with ms from 2013 and 2020. prevalence increased 50%! true increase in disease or better reporting/diagnosis/awareness? ec trims
378,"If you're in the #ECTRIMS22 session on #COVID19 and #MultipleSclerosis, this is the paper on humoral immune responses to COVID vaccines in patients with MS that Prof Anat Achiron just referred to: https://t.co/OOSbAj70h2 üîì https://t.co/mUKcpMs2gt",twitter,GBR,TANeurolDisord,,"if you're in the #ectrims22 session on #covid19 and #multiplesclerosis, this is the paper on humoral immune responses to covid vaccines in patients with ms that prof anat achiron just referred to: https://t.co/oosbaj70h2 üîì https://t.co/mukcpms2gt",,"#ectrims22, #covid19, #multiplesclerosis",Beauty/Health & Fitness,,"if you're in the ec trims22 session on #covid19 and multiple sclerosis, this is the paper on humoral immune responses to covid vaccines in patients with ms that prof anat achiron just referred to:"
379,"Prof Amato introduces the work of @MSIntFederation aiming to address healthcare disparities for people with #MultipleSclerosis

#ECTRIMS2022 https://t.co/G2c83nJ6G6",twitter,GBR,AnneHelme,,prof amato introduces the work of @msintfederation aiming to address healthcare disparities for people with #multiplesclerosis #ectrims2022 https://t.co/g2c83nj6g6,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,prof amato introduces the work of aiming to address healthcare disparities for people with multiple sclerosis ec trims
380,"*You don't realise that you still have value until somebody tells you"".
Such an insightful and informative presentation on vocational rehabilitation for people with #multiplesclerosis by @BlancaDios @ECTRIMS #ECTRIMS2022 https://t.co/EqLyIUesgp",twitter,,sineadnieidhin,,"*you don't realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with #multiplesclerosis by @blancadios @ectrims #ectrims2022 https://t.co/eqlyiuesgp",female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Lecturer}","*you don't realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims"
381,"üéØLast Day at #Ectrims2022. See you at Satellite Symposium 11: New Tools for New Challenges in Multiple Sclerosis.

üßë‚Äç‚öïÔ∏èMarcus D'Souza will introduce the work of the #PROMSInitiative to participants of the event.  

Hall 12 of the Amsterdam venue at 14:15 ‚Äì 15:15pm https://t.co/baFoi91D1N",twitter,,PromsInitiative,,üéØlast day at #ectrims2022. see you at satellite symposium 11: new tools for new challenges in multiple sclerosis. üßë‚Äç‚öïÔ∏èmarcus d'souza will introduce the work of the #promsinitiative to participants of the event. hall 12 of the amsterdam venue at 14:15 ‚Äì 15:15pm https://t.co/bafoi91d1n,unknown,"#ectrims2022, #promsinitiative",,,last day at ec trims. see you at satellite symposium 11: new tools for new challenges in multiple sclerosis. marcus d'souza will introduce the work of the #promsinitiative to participants of the event. hall 12 of the amsterdam venue at 14:15 15:15pm
382,"#ECTRIMS2022 Educational Session 17: Diagnosis of MS. Interesting reviews and (too short) discussion about diagnosing MS with typical and atypical symptoms and early identification of disease progression, with Per Soerensen, Tomas Berger, @GeoArrambide and Jiwon Oh. @cemcat_em https://t.co/1dQi9FrZaJ",twitter,ESP,GeoArrambide,,"#ectrims2022 educational session 17: diagnosis of ms. interesting reviews and (too short) discussion about diagnosing ms with typical and atypical symptoms and early identification of disease progression, with per soerensen, tomas berger, @geoarrambide and jiwon oh. @cemcat_em https://t.co/1dqi9frzaj",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","ec trims educational session 17: diagnosis of ms. interesting reviews and (too short) discussion about diagnosing ms with typical and atypical symptoms and early identification of disease progression, with per soerensen, tomas berger, and jiwon oh."
383,"It‚Äôs the final day of #ECTRIMS2022 but the fun isn‚Äôt over yet! 

Don‚Äôt miss out on these cutting-edge developments in #MSresearch üß†catch up on the last 3 days of @ECTRIMS by watching our interviews at https://t.co/FB5htuqt0q!

#MultipleSclerosis https://t.co/HsIkKOdGls",twitter,,VJNeurology,,it‚Äôs the final day of #ectrims2022 but the fun isn‚Äôt over yet! don‚Äôt miss out on these cutting-edge developments in #msresearch üß†catch up on the last 3 days of @ectrims by watching our interviews at https://t.co/fb5htuqt0q! #multiplesclerosis https://t.co/hsikkodgls,,"#ectrims2022, #msresearch, #multiplesclerosis",Photo & Video,,its the final day of ec trims but the fun isnt over yet! dont miss out on these cutting-edge developments in msresearch catch up on the last 3 days of by watching our interviews at ! multiple sclerosis
384,"#ECTRIMS2022: Dose-dependent reductions in NfL were observed at week 144 in both those who continued on #evobrutinib from the double-blind period and those who switched from placebo.

For more:
https://t.co/lHMoSjaS2R",twitter,USA,byMattHoffman,,#ectrims2022: dose-dependent reductions in nfl were observed at week 144 in both those who continued on #evobrutinib from the double-blind period and those who switched from placebo. for more: https://t.co/lhmosjas2r,male,"#ectrims2022, #evobrutinib",Books,"{profession=Journalist, jobTitle=Editor}",ec trims: dose-dependent reductions in nfl were observed at week 144 in both those who continued on #evobrutinib from the double-blind period and those who switched from placebo. for more:
385,Octave Presents Data from 13 Abstracts at ECTRIMS Forum 2022 Following Commercial Launch of Precision Care Solution for Multiple¬†Sclerosis https://t.co/iYXUycdgyD,twitter,USA,EMdelosNEGOCIOS,,octave presents data from 13 abstracts at ectrims forum 2022 following commercial launch of precision care solution for multiple sclerosis https://t.co/iyxuycdgyd,unknown,,TV,,octave presents data from 13 abstracts at ectrims forum 2022 following commercial launch of precision care solution for multiple sclerosis
386,ectrims2022 Is HSTC really better? https://t.co/MfIr1i5gJL,twitter,GBR,the_MSBlog,,ectrims2022 is hstc really better? https://t.co/mfir1i5gjl,unknown,,,,ectrims2022 is hstc really better?
388,"@VJNeurology continues to interview experts at #ECTRIMS2022 üìΩÔ∏è

@melindamagyari shared important insights on pregnancy planning in #MultipleSclerosis and #NMOSD ü§∞

More to come on https://t.co/FB5htur0PY

@ECTRIMS #MS https://t.co/hfZj2HaYDy",twitter,,VJNeurology,,@vjneurology continues to interview experts at #ectrims2022 üìΩÔ∏è @melindamagyari shared important insights on pregnancy planning in #multiplesclerosis and #nmosd ü§∞ more to come on https://t.co/fb5htur0py @ectrims #ms https://t.co/hfzj2haydy,,"#ectrims2022, #multiplesclerosis, #nmosd, #ms",Photo & Video,,continues to interview experts at ec trims shared important insights on pregnancy planning in multiple sclerosis and #nmosd more to come on ms
389,I was pleased to present my 1st poster and show my data at #ECTRIMS 2022 and I am very proud to be chosen from the #ECTRIMS2022 committee for recieving a grant. #Immunology #neuroscience #MultipleSclerosis https://t.co/5tasTRALAR,twitter,DEU,Eyad_AlSaedi,,i was pleased to present my 1st poster and show my data at #ectrims 2022 and i am very proud to be chosen from the #ectrims2022 committee for recieving a grant. #immunology #neuroscience #multiplesclerosis https://t.co/5tastralar,male,"#ectrims, #ectrims2022, #immunology, #neuroscience, #multiplesclerosis",Science,"{profession=Student, jobTitle=Student}",i was pleased to present my 1st poster and show my data at ec trims 2022 and i am very proud to be chosen from the ec trims committee for recieving a grant. #immunology #neuroscience multiple sclerosis
390,"Last day #ECTRIMS2022 already. Great reconnecting with global colleagues and sharing advancements for those living with #MS. Looking forward to continuing the conversation: https://t.co/EyWr3bzNFW 
@ECTRIMS @KlausSchmierer @C_OrejaGuevara @anneke_vdw @themsguide @MustStopMS https://t.co/LnENuNnT5M",twitter,USA,drbarrysinger,,last day #ectrims2022 already. great reconnecting with global colleagues and sharing advancements for those living with #ms. looking forward to continuing the conversation: https://t.co/eywr3bznfw @ectrims @klausschmierer @c_orejaguevara @anneke_vdw @themsguide @muststopms https://t.co/lnenunnt5m,male,"#ectrims2022, #ms",Science,,last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:
391,"üéôÔ∏èÔ∏è In episode two of The ECTRIMS Podcast, @Tim_Coetzee from @mssociety discusses day two of #ECTRIMS2022 with @MStranslate, including Hot Topic 7 on lifestyle & wellness factors, plus the importance of supporting #MSresearch in this area  
Listen now ‚û°Ô∏è https://t.co/p535EGgoWX https://t.co/DRubvv1eV5",twitter,CHE,ECTRIMS,,"üéôÔ∏èÔ∏è in episode two of the ectrims podcast, @tim_coetzee from @mssociety discusses day two of #ectrims2022 with @mstranslate, including hot topic 7 on lifestyle & wellness factors, plus the importance of supporting #msresearch in this area listen now ‚û°Ô∏è https://t.co/p535eggowx https://t.co/drubvv1ev5",,"#ectrims2022, #msresearch",,,"in episode two of the ectrims podcast, from discusses day two of ec trims with , including hot topic 7 on lifestyle & wellness factors, plus the importance of supporting msresearch in this area listen now"
392,"@Brandon_Beaber @drbarrysinger @ECTRIMS In my case I had glandular fever in 2008, first MS symptom was 2014 (paresthesia) , diagnosed in 2022",twitter,GBR,BacklundJames,,"@brandon_beaber @drbarrysinger @ectrims in my case i had glandular fever in 2008, first ms symptom was 2014 (paresthesia) , diagnosed in 2022",male,,,,"in my case i had glandular fever in 2008, first ms symptom was 2014 (paresthesia) , diagnosed in 2022"
393,Last day of #ECTRIMS2022 and early morning run in Amsterdam. Met the #chariotms team @KlausSchmierer raising awareness of research focussing on hand function in #MS https://t.co/2iraS7cE7Q,twitter,GBR,Helenlouiseford,,last day of #ectrims2022 and early morning run in amsterdam. met the #chariotms team @klausschmierer raising awareness of research focussing on hand function in #ms https://t.co/2iras7ce7q,female,"#ectrims2022, #chariotms, #ms",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",last day of ec trims and early morning run in amsterdam. met the #chariotms team raising awareness of research focussing on hand function in ms
394,"@MStranslate @ECTRIMS @tim_coetzee @mssociety #CCSVI
Venous Hypertension
>microbleedings
>iron
>inflammation
>free radicals 
>neurodegeneration
#multiplesclerosis

M.S. - Mystery Solved

Mysterious Autoimmunity
= CCSVI Neurodegeneration",twitter,CAN,ms_matko,,@mstranslate @ectrims @tim_coetzee @mssociety #ccsvi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration #multiplesclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration,male,"#ccsvi, #multiplesclerosis",Beauty/Health & Fitness,,ccs vi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration multiple sclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration
395,"Day 2 #ECTRIMS2022 was a blast! Optic neuritis lesion detection by #MRI inclusion in #MultipleSclerosis criteria in the works from @FBarkhof, presented our work on raw MRI  #MachineLearning in predicting disease activity in #RRMS & my 1st faculty dinner was amazing! @ECTRIMS TY! https://t.co/Oxjx6K6GUE",twitter,DEU,ClaudiaAcadem,,"day 2 #ectrims2022 was a blast! optic neuritis lesion detection by #mri inclusion in #multiplesclerosis criteria in the works from @fbarkhof, presented our work on raw mri #machinelearning in predicting disease activity in #rrms & my 1st faculty dinner was amazing! @ectrims ty! https://t.co/oxjx6k6gue",female,"#ectrims2022, #mri, #multiplesclerosis, #machinelearning, #rrms","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Teacher}","day 2 ec trims was a blast! optic neuritis lesion detection by #mri inclusion in multiple sclerosis criteria in the works from , presented our work on raw mri #machinelearning in predicting disease activity in #rrms & my 1st faculty dinner was amazing! ty!"
396,@MStranslate @ECTRIMS @tim_coetzee @mssociety Bizarre! Multiple Sclerosis (MS) is/HAS been an UNPROVEN autoimmune THEORY solely based on Symptoms. Neurologists who exclusively encompass leading treatment for the condition are the so called MS unknown origin affliction experts!!!,twitter,CAN,ms_matko,,@mstranslate @ectrims @tim_coetzee @mssociety bizarre! multiple sclerosis (ms) is/has been an unproven autoimmune theory solely based on symptoms. neurologists who exclusively encompass leading treatment for the condition are the so called ms unknown origin affliction experts!!!,male,,Beauty/Health & Fitness,,bizarre! multiple sclerosis (ms) is/has been an unproven autoimmune theory solely based on symptoms. neurologists who exclusively encompass leading treatment for the condition are the so called ms unknown origin affliction experts!!!
397,"Hungover on #ECTRIMS2022 Day 3? Exchange your brain this am with a refreshing (sobering?) discussion on the use of assistive MRI technology in #MS clinical practice - see you 9:30 at the theatre, exhibition hall 11 @ECTRIMS @Iamsterdam #AssistMS @RachelHorne19 @nikosevangelou3",twitter,GBR,KlausSchmierer,,"hungover on #ectrims2022 day 3? exchange your brain this am with a refreshing (sobering?) discussion on the use of assistive mri technology in #ms clinical practice - see you 9:30 at the theatre, exhibition hall 11 @ectrims @iamsterdam #assistms @rachelhorne19 @nikosevangelou3",male,"#ectrims2022, #ms, #assistms",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}","hungover on ec trims day 3? exchange your brain this am with a refreshing (sobering?) discussion on the use of assistive mri technology in ms clinical practice - see you 9:30 at the theatre, exhibition hall 11 #assistms"
398,"Fabulous to see our colleague Ying Li, from our MS Research Flagship, presenting her poster ""Sun exposure and the risk of progressive-onset multiple sclerosis"" @ECTRIMS in Amsterdam. Congratulations! üëè#ECTRIMS2022 #MultipleSclerosis https://t.co/s7QEuYTi8O",twitter,AUS,ResearchMenzies,,"fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" @ectrims in amsterdam. congratulations! üëè#ectrims2022 #multiplesclerosis https://t.co/s7qeuyti8o",male,"#ectrims2022, #multiplesclerosis",,,"fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis"
400,"A ground-breaking clinical trial has found that vitamin D supplements do not prevent #multiplesclerosis development in people at high risk.

We look at the questions yet to be answered and what these results mean for people living with #MS.

#ECTRIMS2022
https://t.co/aqz7u5X6ul",twitter,AUS,MS_Australia,,a ground-breaking clinical trial has found that vitamin d supplements do not prevent #multiplesclerosis development in people at high risk. we look at the questions yet to be answered and what these results mean for people living with #ms. #ectrims2022 https://t.co/aqz7u5x6ul,female,"#multiplesclerosis, #ms, #ectrims2022",,,a ground-breaking clinical trial has found that vitamin d supplements do not prevent multiple sclerosis development in people at high risk. we look at the questions yet to be answered and what these results mean for people living with ms. ec trims
401,Congratulations to Dr Julie Campbell from our MS Research Flagship whose research on the lived experience of the COVID-19 pandemic for people with #MultipleSclerosis ‚Äï based on evidence from the Australian MS Longitudinal Study ‚Äï was presented @ECTRIMS in Amsterdam #ECTRIMS2022,twitter,AUS,ResearchMenzies,,congratulations to dr julie campbell from our ms research flagship whose research on the lived experience of the covid-19 pandemic for people with #multiplesclerosis ‚Äï based on evidence from the australian ms longitudinal study ‚Äï was presented @ectrims in amsterdam #ectrims2022,male,"#multiplesclerosis, #ectrims2022",,,congratulations to dr julie campbell from our ms research flagship whose research on the lived experience of the covid-19 pandemic for people with multiple sclerosis based on evidence from the australian ms longitudinal study was presented in amsterdam ec trims
402,We were excited to join with colleagues in Amsterdam for #ECTRIMS2022 and to see the important research driving future MS treatments for patients. https://t.co/VmKpo5urba,twitter,USA,frequencytx,,we were excited to join with colleagues in amsterdam for #ectrims2022 and to see the important research driving future ms treatments for patients. https://t.co/vmkpo5urba,unknown,#ectrims2022,Beauty/Health & Fitness,,we were excited to join with colleagues in amsterdam for ec trims and to see the important research driving future ms treatments for patients.
403,Ocrelizumab treatment before or during pregnancy does not seem to increase the risk of major complications in women with MS or their babies. https://t.co/wSV2C4aLKL  #ECTRIMS2022 @ECTRIMS #multiplesclerosis,twitter,ESP,C_OrejaGuevara,,ocrelizumab treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. https://t.co/wsv2c4alkl #ectrims2022 @ectrims #multiplesclerosis,female,"#ectrims2022, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",ocrelizumab treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. ec trims multiple sclerosis
404,"Fantastic days at @ECTRIMS : "" The predictive value of diffusion tensor imaging on clinical, physical and cognitive disability in multiple sclerosis"" #ECTRIMS2022 @SaraLlufriu @josemariacm_ @fonseca_elianet @EmImagin https://t.co/99W18yT7Hv",twitter,ESP,neuroimmuclinic,,"fantastic days at @ectrims : "" the predictive value of diffusion tensor imaging on clinical, physical and cognitive disability in multiple sclerosis"" #ectrims2022 @sarallufriu @josemariacm_ @fonseca_elianet @emimagin https://t.co/99w18yt7hv",unknown,#ectrims2022,,,"fantastic days at : "" the predictive value of diffusion tensor imaging on clinical, physical and cognitive disability in multiple sclerosis"" ec trims"
405,"1/2 In this poster presented at #ECTRIMS2022 we show that #MS patients with #natalizumab develop a positive serology response to the #COVID19 vaccine at the same level as HCs.

https://t.co/Ooc39YNapi",twitter,ISR,AVDlaboratory,,1/2 in this poster presented at #ectrims2022 we show that #ms patients with #natalizumab develop a positive serology response to the #covid19 vaccine at the same level as hcs. https://t.co/ooc39ynapi,,"#ectrims2022, #ms, #natalizumab, #covid19",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",1/2 in this poster presented at ec trims we show that ms patients with #natalizumab develop a positive serology response to the #covid19 vaccine at the same level as hcs.
406,#ECTRIMS2022 ‚Äì Poor Myelin Repair Offers Clues in Disease Progression | Patients With Late-onset MS Have Fewer Myelin-making Cells  https://t.co/lHr7Hrii5k,twitter,USA,modalthetortois,,#ectrims2022 ‚Äì poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells https://t.co/lhr7hrii5k,unknown,#ectrims2022,"Beauty/Health & Fitness, Animals & Pets, Fine arts, Environment",,ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells
407,#Lifestyle choices: general better health or #MS-specific effects? More #research needed. #ECTRIMS2022,twitter,,IJMSCtweets,,#lifestyle choices: general better health or #ms-specific effects? more #research needed. #ectrims2022,,"#lifestyle, #ms, #research, #ectrims2022",,,#lifestyle choices: general better health or ms-specific effects? more #research needed. ec trims
408,"#ECTRIMS2022 Syamala Buragadda (Canada) Walking improves with better cardiorespiratory fitness, pointing to a heart-brain connection.

Abstract: https://t.co/eV84D5iw0b
Get help for walking problems: https://t.co/35j1GQCnAu https://t.co/9ztJFqljKQ",twitter,,mssociety,,"#ectrims2022 syamala buragadda (canada) walking improves with better cardiorespiratory fitness, pointing to a heart-brain connection. abstract: https://t.co/ev84d5iw0b get help for walking problems: https://t.co/35j1gqcnau https://t.co/9ztjfqljkq",female,#ectrims2022,,,"ec trims syamala buragadda (canada) walking improves with better cardiorespiratory fitness, pointing to a heart-brain connection. abstract: get help for walking problems:"
409,Dr. Eva Strijbis: Discontinuation of DMTs in older patients with stable #MS on a case-to-case basis. #ECTRIMS2022 @Eef111,twitter,,IJMSCtweets,,dr. eva strijbis: discontinuation of dmts in older patients with stable #ms on a case-to-case basis. #ectrims2022 @eef111,,"#ms, #ectrims2022",,,dr. eva strijbis: discontinuation of dmts in older patients with stable ms on a case-to-case basis. ec trims
410,"Harroud: first identification of two genetic variations that are associated with MS disease severity! And are CNS expressed genes, meaning that this relates to ‚ÄòMS resilience in the brain itself‚Äô! 
Early identification might help us in treatment strategy?
#ECTRIMS2022 https://t.co/mE9KH3ITCG",twitter,BEL,bart_professor,,"harroud: first identification of two genetic variations that are associated with ms disease severity! and are cns expressed genes, meaning that this relates to ‚Äòms resilience in the brain itself‚Äô! early identification might help us in treatment strategy? #ectrims2022 https://t.co/me9kh3itcg",unknown,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}","harroud: first identification of two genetic variations that are associated with ms disease severity! and are cns expressed genes, meaning that this relates to ms resilience in the brain itself! early identification might help us in treatment strategy? ec trims"
411,#ECTRIMS2022 ‚Äì Poor Myelin Repair Offers Clues in Disease‚Ä¶ ‚Äì Multiple Sclerosis News¬†Today https://t.co/1TfZjBnfE3,twitter,,Anggun19933,,#ectrims2022 ‚Äì poor myelin repair offers clues in disease‚Ä¶ ‚Äì multiple sclerosis news today https://t.co/1tfzjbnfe3,unknown,#ectrims2022,,,ec trims poor myelin repair offers clues in disease multiple sclerosis news today
415,"What are the barriers to accessing #MultipleSclerosis treatments in the Middle East and North Africa? üíäüåç

Maya Zeineddine's poster at #ECTRIMS2022 presents an analysis of #AtlasofMS data üëá https://t.co/RXqztSPbaN",twitter,GBR,AnneHelme,,what are the barriers to accessing #multiplesclerosis treatments in the middle east and north africa? üíäüåç maya zeineddine's poster at #ectrims2022 presents an analysis of #atlasofms data üëá https://t.co/rxqztspban,female,"#multiplesclerosis, #ectrims2022, #atlasofms",Beauty/Health & Fitness,,what are the barriers to accessing multiple sclerosis treatments in the middle east and north africa? maya zeineddine's poster at ec trims presents an analysis of #atlasofms data
416,"Grateful for opportunity to discuss fatigue #mechanisms at #ECTRIMS2022 & share work @RonaMossMorris has led on to improve fatigue care in #MS. Thank you to the @mssocietyuk, KHP Challenge Fund & @UKMSRegister. Excited about REFUEL-MS - co-funded by @NIHRresearch & @mssocietyuk https://t.co/SzTg5Qgts4",twitter,GBR,fede_picariello,,"grateful for opportunity to discuss fatigue #mechanisms at #ectrims2022 & share work @ronamossmorris has led on to improve fatigue care in #ms. thank you to the @mssocietyuk, khp challenge fund & @ukmsregister. excited about refuel-ms - co-funded by @nihrresearch & @mssocietyuk https://t.co/sztg5qgts4",female,"#mechanisms, #ectrims2022, #ms","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Health practitioner, jobTitle=Psychologist}","grateful for opportunity to discuss fatigue #mechanisms at ec trims & share work has led on to improve fatigue care in ms. thank you to the , khp challenge fund & . excited about refuel-ms - co-funded by &"
417,@ECTRIMS May I recommend a theme for #ECTRIMS next year? Can we have a session about and with women and #ms? #ECTRIMS2022,twitter,DEU,Birgitpower,,@ectrims may i recommend a theme for #ectrims next year? can we have a session about and with women and #ms? #ectrims2022,female,"#ectrims, #ms, #ectrims2022",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",may i recommend a theme for ec trims next year? can we have a session about and with women and ms? ec trims
418,New format at #ECTRIMS2022 : braindates. I really like it. Today morning I had my first with three wonderful ladies about women and ms and possible issues they might have. I really enjoyed it. #ms https://t.co/jz2MmxMIb5,twitter,DEU,Birgitpower,,new format at #ectrims2022 : braindates. i really like it. today morning i had my first with three wonderful ladies about women and ms and possible issues they might have. i really enjoyed it. #ms https://t.co/jz2mmxmib5,female,"#ectrims2022, #ms",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",new format at ec trims : braindates. i really like it. today morning i had my first with three wonderful ladies about women and ms and possible issues they might have. i really enjoyed it. ms
419,"Our #MultipleSclerosis team taking our @hbellvitge projects to the European #ECTRIMS2022 Congress! 

@ECTRIMS #EMXarxa #EsclerosisM√∫ltiple @esclerosismSCN 
#NeurologyHUB #EquipHUB https://t.co/8NpufqtcIp",twitter,,NeurologiaHUB,,our #multiplesclerosis team taking our @hbellvitge projects to the european #ectrims2022 congress! @ectrims #emxarxa #esclerosism√∫ltiple @esclerosismscn #neurologyhub #equiphub https://t.co/8npufqtcip,unknown,"#multiplesclerosis, #ectrims2022, #emxarxa, #esclerosism√∫ltiple, #neurologyhub, #equiphub",,,our multiple sclerosis team taking our projects to the european ec trims congress! #emxarxa #esclerosismltiple #neurologyhub #equiphub
420,"New data suggests that GFAP may be a more reliable biomarker to track MS disease progression than neurofilament light. #ECTRIMS2022

Read more on the findings from Jens Kuhle, MD, et al: https://t.co/wOYXr4ll23",twitter,USA,neurology_live,,"new data suggests that gfap may be a more reliable biomarker to track ms disease progression than neurofilament light. #ectrims2022 read more on the findings from jens kuhle, md, et al: https://t.co/woyxr4ll23",,#ectrims2022,Beauty/Health & Fitness,,"new data suggests that gfap may be a more reliable biomarker to track ms disease progression than neurofilament light. ec trims read more on the findings from jens kuhle, md, et al:"
421,"@HAImedicines, one of our champion üá™üá∏ Spanish nurse was present #ECTRIMS2022 üôå

@eumsplatform MS Nurse PRO organised a session on the evolving role of #MS nurses in üî¨ research & üíä treatment!",twitter,NLD,PeterfiSimina,,"@haimedicines, one of our champion üá™üá∏ spanish nurse was present #ectrims2022 üôå @eumsplatform ms nurse pro organised a session on the evolving role of #ms nurses in üî¨ research & üíä treatment!",female,"#ectrims2022, #ms",,"{profession=Sales/Marketing/PR, jobTitle=Community Manager}",", one of our champion spanish nurse was present ec trims ms nurse pro organised a session on the evolving role of ms nurses in research & treatment!"
422,"It was great to catch up with @burcuzeydanmd of @MayoClinicNeuro about the importance of spinal cord atrophy in #MS and her work on brain MRI versus spinal cord MRI in measuring cervical spinal cord atrophy

#ECTRIMS2022 @ECTRIMS #MultipleSclerosis https://t.co/jYmG0Y9cl6",twitter,,VJNeurology,,it was great to catch up with @burcuzeydanmd of @mayoclinicneuro about the importance of spinal cord atrophy in #ms and her work on brain mri versus spinal cord mri in measuring cervical spinal cord atrophy #ectrims2022 @ectrims #multiplesclerosis https://t.co/jymg0y9cl6,,"#ms, #ectrims2022, #multiplesclerosis",Photo & Video,,it was great to catch up with of about the importance of spinal cord atrophy in ms and her work on brain mri versus spinal cord mri in measuring cervical spinal cord atrophy ec trims multiple sclerosis
423,"#ECTRIMS2022: In total, 5 relapses in 4 unique patients occurred within 3 months post-FT after observing 110 cycles of FT in 55 individuals with either #MS or #CIS.
https://t.co/6w1OCrMdwA",twitter,USA,byMattHoffman,,"#ectrims2022: in total, 5 relapses in 4 unique patients occurred within 3 months post-ft after observing 110 cycles of ft in 55 individuals with either #ms or #cis. https://t.co/6w1ocrmdwa",male,"#ectrims2022, #ms, #cis",Books,"{profession=Journalist, jobTitle=Editor}","ec trims: in total, 5 relapses in 4 unique patients occurred within 3 months post-ft after observing 110 cycles of ft in 55 individuals with either ms or #cis."
424,"Attending #ECTRIMS2022 virtually? üñ•Ô∏è

Be sure to check out Octave's ePosters on #MS-specific biomarkers & advanced imaging analytics on Wednesday, Oct. 26 & Friday, Oct. 28! 

Learn more ‚¨áÔ∏è https://t.co/4Zph8cZYlH https://t.co/GmyfwwQfd8",twitter,USA,OctaveBio,,"attending #ectrims2022 virtually? üñ•Ô∏è be sure to check out octave's eposters on #ms-specific biomarkers & advanced imaging analytics on wednesday, oct. 26 & friday, oct. 28! learn more ‚¨áÔ∏è https://t.co/4zph8czylh https://t.co/gmyfwwqfd8",male,"#ectrims2022, #ms",Beauty/Health & Fitness,,"attending ec trims virtually? be sure to check out octave's eposters on ms-specific biomarkers & advanced imaging analytics on wednesday, oct. 26 & friday, oct. 28! learn more"
425,"Working towards personalized medicine in #MultipleSclerosis üí™

Eva Havrdov√° (@CharlesUniPRG) shares insights on optimizing treatment DMT type & dose for an individual patient. Thanks for sharing Prof. Havrdov√°!

Learn more on üí•https://t.co/FB5htuqt0qüí•

#ECTRIMS2022 #MS https://t.co/njeM9JQ338",twitter,,VJNeurology,,working towards personalized medicine in #multiplesclerosis üí™ eva havrdov√° (@charlesuniprg) shares insights on optimizing treatment dmt type & dose for an individual patient. thanks for sharing prof. havrdov√°! learn more on üí•https://t.co/fb5htuqt0qüí• #ectrims2022 #ms https://t.co/njem9jq338,,"#multiplesclerosis, #ectrims2022, #ms",Photo & Video,,working towards personalized medicine in multiple sclerosis eva havrdov () shares insights on optimizing treatment dmt type & dose for an individual patient. thanks for sharing prof. havrdov! learn more on ec trims ms
426,Excellent talk by @annalauralerede from at #ECTRIMS2022 presenting on the  different ways MS can progress over time (using MS Register data) and how important online registers are for tracking disease long term üëçüèº https://t.co/PXrrQAkxMS,twitter,,UKMSRegister,,excellent talk by @annalauralerede from at #ectrims2022 presenting on the different ways ms can progress over time (using ms register data) and how important online registers are for tracking disease long term üëçüèº https://t.co/pxrrqakxms,,#ectrims2022,,,excellent talk by from at ec trims presenting on the different ways ms can progress over time (using ms register data) and how important online registers are for tracking disease long term
427,"It was a great session where even the questions and answers were a lesson in themselves, and EBV factor in MS disease was the biggest question.
All the answers rising the new questions in #ECTRIMS2022 https://t.co/xqYTCxI09X",twitter,TUR,asliacil_md,,"it was a great session where even the questions and answers were a lesson in themselves, and ebv factor in ms disease was the biggest question. all the answers rising the new questions in #ectrims2022 https://t.co/xqytcxi09x",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Scientist & Researcher, jobTitle=Neuroscientist}","it was a great session where even the questions and answers were a lesson in themselves, and ebv factor in ms disease was the biggest question. all the answers rising the new questions in ec trims"
428,"At #ECTRIMS2022, Prof. @YGoverover gave a fantastic talk on the use of web-based tech to improve everyday functioning & quality of life in people with #MS

We'll be sharing her valuable insights on technology-supported rehabilitation on https://t.co/FB5htuI3RY!
#MultipleSclerosis https://t.co/poDzRLEq38",twitter,,VJNeurology,,"at #ectrims2022, prof. @ygoverover gave a fantastic talk on the use of web-based tech to improve everyday functioning & quality of life in people with #ms we'll be sharing her valuable insights on technology-supported rehabilitation on https://t.co/fb5htui3ry! #multiplesclerosis https://t.co/podzrleq38",,"#ectrims2022, #ms, #multiplesclerosis",Photo & Video,,"at ec trims, prof. gave a fantastic talk on the use of web-based tech to improve everyday functioning & quality of life in people with ms we'll be sharing her valuable insights on technology-supported rehabilitation on ! multiple sclerosis"
429,"@AVidalJordana taught us how to diagnose an episode of optic neuritis (VEP are more useful in the first 3 months, and OCT later on).
Once the diagnosis of optic neuritis related to MS is confirmed, optic nerve topography should be included in the diagnostic process #ECTRIMS https://t.co/TueWrkbZOk",twitter,ESP,andreuvilaseca7,,"@avidaljordana taught us how to diagnose an episode of optic neuritis (vep are more useful in the first 3 months, and oct later on). once the diagnosis of optic neuritis related to ms is confirmed, optic nerve topography should be included in the diagnostic process #ectrims https://t.co/tuewrkbzok",male,#ectrims,,,"taught us how to diagnose an episode of optic neuritis (vep are more useful in the first 3 months, and oct later on). once the diagnosis of optic neuritis related to ms is confirmed, optic nerve topography should be included in the diagnostic process ec trims"
430,"Important emphasis on mechanistic research by @VickyLeavittPhD and @fede_picariello at #ECTRIMS2022! There is a need for tailored interventions that target self-efficacy, agency, and fatigue to improve quality of life in people with #MultipleSclerosis. https://t.co/T1DJzrfGEK",twitter,USA,Heena_Manglani,,"important emphasis on mechanistic research by @vickyleavittphd and @fede_picariello at #ectrims2022! there is a need for tailored interventions that target self-efficacy, agency, and fatigue to improve quality of life in people with #multiplesclerosis. https://t.co/t1djzrfgek",female,"#ectrims2022, #multiplesclerosis",Beauty/Health & Fitness,,"important emphasis on mechanistic research by and at ec trims! there is a need for tailored interventions that target self-efficacy, agency, and fatigue to improve quality of life in people with multiple sclerosis."
431,"MS News Today is providing comprehensive, in-depth coverage of the 2022 ECTRIMS conference focused on MS clinical research and care. https://t.co/TsOvK9YqDy

#multiplesclerosis #msnews #msawareness #msresearch #ECTRIMS2022 https://t.co/SZHdidgbAU",twitter,USA,MSNewsToday,,"ms news today is providing comprehensive, in-depth coverage of the 2022 ectrims conference focused on ms clinical research and care. https://t.co/tsovk9yqdy #multiplesclerosis #msnews #msawareness #msresearch #ectrims2022 https://t.co/szhdidgbau",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch, #ectrims2022","Beauty/Health & Fitness, Science",,"ms news today is providing comprehensive, in-depth coverage of the 2022 ectrims conference focused on ms clinical research and care. multiple sclerosis msnews msawareness msresearch ec trims"
432,National Swedish #MS Registry study. #EBV EBNA1 antibodies appear 10-15 years before onset of disease.  sNfL levels rise 5-10 years prior to #MS onset. #ECTRIMS2022 @ECTRIMS https://t.co/6MpCOTKaZw,twitter,USA,drbarrysinger,,national swedish #ms registry study. #ebv ebna1 antibodies appear 10-15 years before onset of disease. snfl levels rise 5-10 years prior to #ms onset. #ectrims2022 @ectrims https://t.co/6mpcotkazw,male,"#ms, #ebv, #ms, #ectrims2022",Science,,national swedish ms registry study. #ebv ebna1 antibodies appear 10-15 years before onset of disease. snfl levels rise 5-10 years prior to ms onset. ec trims
433,The future is cell therapy in #MS #ectrims22 @neuroimmuclinic https://t.co/fiiTq1ydJZ,twitter,ESP,josemariacm_,,the future is cell therapy in #ms #ectrims22 @neuroimmuclinic https://t.co/fiitq1ydjz,male,"#ms, #ectrims22",,,the future is cell therapy in ms ec trims22
434,#Inclusive research matters. #MS #ECTRIMS2022,twitter,,IJMSCtweets,,#inclusive research matters. #ms #ectrims2022,,"#inclusive, #ms, #ectrims2022",,,#inclusive research matters. ms ec trims
435,"Lovely to catch up with @AdilHarroud on his latest work on #MS genetics üß¨

He shared data on a novel locus identified as the first genome-wide significant & replicated genetic modifier of MS severity!

More to come on https://t.co/FB5htuI3RY!

#ECTRIMS2022 #MultipleSclerosis https://t.co/YjZfxCa70R",twitter,,VJNeurology,,lovely to catch up with @adilharroud on his latest work on #ms genetics üß¨ he shared data on a novel locus identified as the first genome-wide significant & replicated genetic modifier of ms severity! more to come on https://t.co/fb5htui3ry! #ectrims2022 #multiplesclerosis https://t.co/yjzfxca70r,,"#ms, #ectrims2022, #multiplesclerosis",Photo & Video,,lovely to catch up with on his latest work on ms genetics he shared data on a novel locus identified as the first genome-wide significant & replicated genetic modifier of ms severity! more to come on ! ec trims multiple sclerosis
436,Importance of physical activity to help manage fatigue in #MS highlighted at excellent quality of life session at #ECTRIMS2022 Great to hear @mssocietyuk has just funded more fatigue research in UK. @ECTRIMS @Nick_MSsoc @GavinGiovannoni https://t.co/QUDzlnGL8g,twitter,AUS,RohanGreenland,,importance of physical activity to help manage fatigue in #ms highlighted at excellent quality of life session at #ectrims2022 great to hear @mssocietyuk has just funded more fatigue research in uk. @ectrims @nick_mssoc @gavingiovannoni https://t.co/qudzlngl8g,male,"#ms, #ectrims2022","Beauty/Health & Fitness, Business","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Vice President}",importance of physical activity to help manage fatigue in ms highlighted at excellent quality of life session at ec trims great to hear has just funded more fatigue research in uk.
437,"What causes MS? EBV remains a plausible instigator, but why does MS happen years after infection and why are there no EBV proteins in the CSF of MS patients? Peter Stys (Calgary) found a unique amyloid in MS brains... maybe this is triggered by EBV #ECTRIMS @NMNeurology https://t.co/1XP5soV8aR",twitter,,EdieGrahamMD,,"what causes ms? ebv remains a plausible instigator, but why does ms happen years after infection and why are there no ebv proteins in the csf of ms patients? peter stys (calgary) found a unique amyloid in ms brains... maybe this is triggered by ebv #ectrims @nmneurology https://t.co/1xp5sov8ar",unknown,#ectrims,Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Assistant Prof}, {profession=Health practitioner, jobTitle=Clinical Assistant}","what causes ms? ebv remains a plausible instigator, but why does ms happen years after infection and why are there no ebv proteins in the csf of ms patients? peter stys (calgary) found a unique amyloid in ms brains... maybe this is triggered by ebv ec trims"
438,"Lots of talk at #ECTRIMS2022 about the need for biomarkers of progression. Could GFAP be one such marker? New research from Kuhle et al suggest that it might be.
https://t.co/azyg229ply",twitter,USA,byMattHoffman,,lots of talk at #ectrims2022 about the need for biomarkers of progression. could gfap be one such marker? new research from kuhle et al suggest that it might be. https://t.co/azyg229ply,male,#ectrims2022,Books,"{profession=Journalist, jobTitle=Editor}",lots of talk at ec trims about the need for biomarkers of progression. could gfap be one such marker? new research from kuhle et al suggest that it might be.
439,Podcast interview with Dr. Ascherio on #MS & #EBV. #ECTRIMS2022,twitter,USA,drbarrysinger,,podcast interview with dr. ascherio on #ms & #ebv. #ectrims2022,male,"#ms, #ebv, #ectrims2022",Science,,podcast interview with dr. ascherio on ms & #ebv. ec trims
440,"Yesterday, we shared informative OCREVUS data at #ECTRIMS2022. If you are here in Amsterdam, the Netherlands, come find us at booth A22 to learn more! Please see full Prescribing Information at https://t.co/k33kg323B1. Intended for US healthcare professionals only. https://t.co/cpOAsyADnX",twitter,USA,OCREVUSHCP_USA,,"yesterday, we shared informative ocrevus data at #ectrims2022. if you are here in amsterdam, the netherlands, come find us at booth a22 to learn more! please see full prescribing information at https://t.co/k33kg323b1. intended for us healthcare professionals only. https://t.co/cpoasyadnx",,#ectrims2022,,,"yesterday, we shared informative ocrevus data at ec trims. if you are here in amsterdam, the netherlands, come find us at booth a22 to learn more! please see full prescribing information at . intended for us healthcare professionals only."
442,"Ascherio:  Molecular mimicry may be how multiple sclerosis #MS occurs after Epstein-Barr #EBV virus.  GlialCAM, Alpha-b crystallin, anoctamin and myelin basic protein may be targets. #ECTRIMS2022 @ECTRIMS https://t.co/LkUWRnhkUu",twitter,USA,drbarrysinger,,"ascherio: molecular mimicry may be how multiple sclerosis #ms occurs after epstein-barr #ebv virus. glialcam, alpha-b crystallin, anoctamin and myelin basic protein may be targets. #ectrims2022 @ectrims https://t.co/lkuwrnhkuu",male,"#ms, #ebv, #ectrims2022",Science,,"ascherio: molecular mimicry may be how multiple sclerosis ms occurs after epstein-barr #ebv virus. glialcam, alpha-b crystallin, anoctamin and myelin basic protein may be targets. ec trims"
445,Poster 777 @LaurenATaylor26 #Memory #rehabilitation for people with #MultipleSclerosis  #ECTRIMS2022 https://t.co/m1Q6dNjrBI,twitter,,IJMSCtweets,,poster 777 @laurenataylor26 #memory #rehabilitation for people with #multiplesclerosis #ectrims2022 https://t.co/m1q6dnjrbi,,"#memory, #rehabilitation, #multiplesclerosis, #ectrims2022",,,poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims
446,"Dr Ulrik Dalgas (@AarhusUni):  ‚ÄúPrehabilitation‚Äù exercise can help build reserve capacity, rather than just trying to restore lost capacity.  #ECTRIMS2022 #MS How about Nordic walking? https://t.co/kMgMHWwYjE",twitter,,IJMSCtweets,,"dr ulrik dalgas (@aarhusuni): ‚Äúprehabilitation‚Äù exercise can help build reserve capacity, rather than just trying to restore lost capacity. #ectrims2022 #ms how about nordic walking? https://t.co/kmgmhwwyje",,"#ectrims2022, #ms",,,"dr ulrik dalgas (): prehabilitation exercise can help build reserve capacity, rather than just trying to restore lost capacity. ec trims ms how about nordic walking?"
447,"Come to visit our EPoster 1022 at #ECTRIMS2022 about MDSCs as biomarker to predict the therapeutic response to Fingolimod in EAE and MS by Celia Camacho-Toledano et al in colaboration with @Novartis @VHIR_ @Biodonostia @UemDonosti & Ramon y Cajal hospital

@HNParaplejicos https://t.co/SwHt8tE8OM",twitter,ESP,DrDiegoClemente,,come to visit our eposter 1022 at #ectrims2022 about mdscs as biomarker to predict the therapeutic response to fingolimod in eae and ms by celia camacho-toledano et al in colaboration with @novartis @vhir_ @biodonostia @uemdonosti & ramon y cajal hospital @hnparaplejicos https://t.co/swht8te8om,male,#ectrims2022,Beauty/Health & Fitness,,come to visit our eposter 1022 at ec trims about mdscs as biomarker to predict the therapeutic response to fingolimod in eae and ms by celia camacho-toledano et al in colaboration with & ramon y cajal hospital
448,"Second day at #ECTRIMS2022 . Come visit our Spherix Neurology Team at Booth #D19. Our Insights Director of Neurology, Emma McFadden will be presenting today! 

We can't wait to meet you!

 #insights #neurology #multiplesclerosis",twitter,USA,SpherixNeuro,,"second day at #ectrims2022 . come visit our spherix neurology team at booth #d19. our insights director of neurology, emma mcfadden will be presenting today! we can't wait to meet you! #insights #neurology #multiplesclerosis",unknown,"#ectrims2022, #d19, #insights, #neurology, #multiplesclerosis","Beauty/Health & Fitness, Business",,"second day at ec trims . come visit our spherix neurology team at booth #d19. our insights director of neurology, emma mcfadden will be presenting today! we can't wait to meet you! #insights #neurology multiple sclerosis"
449,"Prof Alberto Ascherio (@HarvardChanSPH) shares the latest  on the role of EBV in #MultipleSclerosis. As data suggests  EBV infection is necessary for MS to develop, research moves to working out how it‚Äôs involved, molecular mimicry with myelin proteins seems possible #ECTRIMS2022 https://t.co/1gRV88TC7I",twitter,AUS,MStranslate,,"prof alberto ascherio (@harvardchansph) shares the latest on the role of ebv in #multiplesclerosis. as data suggests ebv infection is necessary for ms to develop, research moves to working out how it‚Äôs involved, molecular mimicry with myelin proteins seems possible #ectrims2022 https://t.co/1grv88tc7i",,"#multiplesclerosis, #ectrims2022",,,"prof alberto ascherio () shares the latest on the role of ebv in multiple sclerosis. as data suggests ebv infection is necessary for ms to develop, research moves to working out how its involved, molecular mimicry with myelin proteins seems possible ec trims"
450,"This #ECTRIMS2022 we update our data on the predictive role of blood MDSCs in MS patient at relapse on the lymphoid component and relapse recovery one year later. Come to visit our ePoster 1029 by @leticalahorra et al, in colaboration with CHUT and Gregorio Mara√±on Hospital https://t.co/Rd7UCrDsrP",twitter,ESP,DrDiegoClemente,,"this #ectrims2022 we update our data on the predictive role of blood mdscs in ms patient at relapse on the lymphoid component and relapse recovery one year later. come to visit our eposter 1029 by @leticalahorra et al, in colaboration with chut and gregorio mara√±on hospital https://t.co/rd7ucrdsrp",male,#ectrims2022,Beauty/Health & Fitness,,"this ec trims we update our data on the predictive role of blood mdscs in ms patient at relapse on the lymphoid component and relapse recovery one year later. come to visit our eposter 1029 by et al, in colaboration with chut and gregorio maraon hospital"
451,"#ECTRIMS2022: Dr. Christoph Heesen of Germany points to need for more #MSResearch for better strategies that improve sleep, reduce stress, and stop smoking to reduce MS symptoms: https://t.co/uj94b8brAB",twitter,,mssociety,,"#ectrims2022: dr. christoph heesen of germany points to need for more #msresearch for better strategies that improve sleep, reduce stress, and stop smoking to reduce ms symptoms: https://t.co/uj94b8brab",female,"#ectrims2022, #msresearch",,,"ec trims: dr. christoph heesen of germany points to need for more msresearch for better strategies that improve sleep, reduce stress, and stop smoking to reduce ms symptoms:"
452,Always room for more and more diverse #research. #MS #ECTRIMS2022,twitter,,IJMSCtweets,,always room for more and more diverse #research. #ms #ectrims2022,,"#research, #ms, #ectrims2022",,,always room for more and more diverse #research. ms ec trims
453,Reynolds: A gradient of neuronal loss in the cortex in #MS; more loss on outer layers. Cytokines diffusing from CSF into cortex seems to be a driver of neuronal loss. #ECTRIMS2022 https://t.co/PnEE3BTVjc,twitter,USA,drbarrysinger,,reynolds: a gradient of neuronal loss in the cortex in #ms; more loss on outer layers. cytokines diffusing from csf into cortex seems to be a driver of neuronal loss. #ectrims2022 https://t.co/pnee3btvjc,male,"#ms, #ectrims2022",Science,,reynolds: a gradient of neuronal loss in the cortex in ms; more loss on outer layers. cytokines diffusing from csf into cortex seems to be a driver of neuronal loss. ec trims
454,"Ulrik Dalgas, PhD, shared an important message about incorporating lifestyle interventions early in #MS, before problems related to them begin to arise. #ECTRIMS2022 https://t.co/ngyG8dy0VY",twitter,USA,byMattHoffman,,"ulrik dalgas, phd, shared an important message about incorporating lifestyle interventions early in #ms, before problems related to them begin to arise. #ectrims2022 https://t.co/ngyg8dy0vy",male,"#ms, #ectrims2022",Books,"{profession=Journalist, jobTitle=Editor}","ulrik dalgas, phd, shared an important message about incorporating lifestyle interventions early in ms, before problems related to them begin to arise. ec trims"
455,"Day 2 at #ECTRIMS2022 has already given some exciting insights on #immunetrafficking into the #CNS ü§ì

Ready now for the scientific session on #Tcells and #Bcells in #MS! https://t.co/Uat91qZCKz",twitter,BEL,BelienJarne,,day 2 at #ectrims2022 has already given some exciting insights on #immunetrafficking into the #cns ü§ì ready now for the scientific session on #tcells and #bcells in #ms! https://t.co/uat91qzckz,unknown,"#ectrims2022, #immunetrafficking, #cns, #tcells, #bcells, #ms",Science,"{profession=Scientist & Researcher, jobTitle=Researcher}",day 2 at ec trims has already given some exciting insights on #immunetrafficking into the #cns ready now for the scientific session on #tcells and #bcells in ms!
456,Interesting talk from Sarah Knowles at #ECTRIMS2022 using data from the @UKMSRegister to discuss late-onset #MultipleSclerosis (LOMS). It was suggested that people with LOMS could be good participants in #clinicaltrials of therapies targeting neurodegeneration in progressive #MS. https://t.co/PE5oStvEq9,twitter,AUS,MStranslate,,interesting talk from sarah knowles at #ectrims2022 using data from the @ukmsregister to discuss late-onset #multiplesclerosis (loms). it was suggested that people with loms could be good participants in #clinicaltrials of therapies targeting neurodegeneration in progressive #ms. https://t.co/pe5ostveq9,,"#ectrims2022, #multiplesclerosis, #clinicaltrials, #ms",,,interesting talk from sarah knowles at ec trims using data from the to discuss late-onset multiple sclerosis (loms). it was suggested that people with loms could be good participants in #clinicaltrials of therapies targeting neurodegeneration in progressive ms.
457,MADS @just_madsen presenting his   7T MRI work on cortical lesions in multiple sclerosis at #ECTRIMS2022 https://t.co/82Kyqfultk,twitter,DNK,HSiebner,,mads @just_madsen presenting his 7t mri work on cortical lesions in multiple sclerosis at #ectrims2022 https://t.co/82kyqfultk,male,#ectrims2022,Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Teacher & Lecturer, jobTitle=Prof}",mads presenting his 7t mri work on cortical lesions in multiple sclerosis at ec trims
458,"The #MS #community is so involved and active--patients, organizations, societies. #Research IS accessible and the community DOES follow it. If your #CareTeam isn't supportive of looking at all opportunities, you need to add to it. #ECTRIMS2022",twitter,,IJMSCtweets,,"the #ms #community is so involved and active--patients, organizations, societies. #research is accessible and the community does follow it. if your #careteam isn't supportive of looking at all opportunities, you need to add to it. #ectrims2022",,"#ms, #community, #research, #careteam, #ectrims2022",,,"the ms #community is so involved and active--patients, organizations, societies. #research is accessible and the community does follow it. if your #careteam isn't supportive of looking at all opportunities, you need to add to it. ec trims"
459,"We are at the 38th Congress of the European Committee for Treatment and Research in #MultipleSclerosis taking place right now in Amsterdam!

Swing by our booth (B24) and say hello üñêÔ∏è 

We will be here until tomorrow, Oct 28.

See you soon!

#ECTRIMS2022 #MS @ECTRIMS https://t.co/wJBfzx7127",twitter,AUT,EANeurology,,"we are at the 38th congress of the european committee for treatment and research in #multiplesclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello üñêÔ∏è we will be here until tomorrow, oct 28. see you soon! #ectrims2022 #ms @ectrims https://t.co/wjbfzx7127",unknown,"#multiplesclerosis, #ectrims2022, #ms",,,"we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms"
460,"And finally, stop by Poster session 2 to check out P748-Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. 

We can‚Äôt wait to share our work with you! #ECTRIMS2022",twitter,DEU,NeurologyMainz,,"and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we can‚Äôt wait to share our work with you! #ectrims2022",,#ectrims2022,,,"and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims"
461,"Also in #ECTRIMS2022 Poster session 2: 

P485 Impaired visual discrimination and object recognition in RRMS patients despite intact visual pathway

P687 Attenuation of immune activation in patients with multiple sclerosis on a wheat free diet: A pilot crossover trial https://t.co/p49sEUY7VX",twitter,DEU,NeurologyMainz,,also in #ectrims2022 poster session 2: p485 impaired visual discrimination and object recognition in rrms patients despite intact visual pathway p687 attenuation of immune activation in patients with multiple sclerosis on a wheat free diet: a pilot crossover trial https://t.co/p49seuy7vx,,#ectrims2022,,,also in ec trims poster session 2: p485 impaired visual discrimination and object recognition in rrms patients despite intact visual pathway p687 attenuation of immune activation in patients with multiple sclerosis on a wheat free diet: a pilot crossover trial
462,Cognitive impairment in #MS impacts employment and correlates with SDMT. Cognitive impairment negatively impacts QoL more than physical impairment -Dr. Penner #ECTRIMS2022 https://t.co/fmKzjd0dot,twitter,USA,DrJNicholas,,cognitive impairment in #ms impacts employment and correlates with sdmt. cognitive impairment negatively impacts qol more than physical impairment -dr. penner #ectrims2022 https://t.co/fmkzjd0dot,female,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",cognitive impairment in ms impacts employment and correlates with sdmt. cognitive impairment negatively impacts qol more than physical impairment -dr. penner ec trims
463,"Come to Poster Session 2 today (17h-19h) and check out several posters by our group, including P662 ‚ÄúSerum neurofilament light chain identifies multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort‚Äù being presented by @_fSteffen #ECTRIMS2022 https://t.co/u2SbXGwi77",twitter,DEU,NeurologyMainz,,"come to poster session 2 today (17h-19h) and check out several posters by our group, including p662 ‚Äúserum neurofilament light chain identifies multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort‚Äù being presented by @_fsteffen #ectrims2022 https://t.co/u2sbxgwi77",,#ectrims2022,,,"come to poster session 2 today (17h-19h) and check out several posters by our group, including p662 serum neurofilament light chain identifies multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort being presented by ec trims"
464,"I‚Äôve enjoyed and learned a lot with the talks and discussion of these outstanding neurologists, Dr. Hauser and Dr. Kappos. Dr. Hauser has presented a provocative slide to help  decision making for relapsing MS patients #ECTRIMS2022 https://t.co/GseX475kIz",twitter,,AngelPSempere,,"i‚Äôve enjoyed and learned a lot with the talks and discussion of these outstanding neurologists, dr. hauser and dr. kappos. dr. hauser has presented a provocative slide to help decision making for relapsing ms patients #ectrims2022 https://t.co/gsex475kiz",male,#ectrims2022,Science,,"ive enjoyed and learned a lot with the talks and discussion of these outstanding neurologists, dr. hauser and dr. kappos. dr. hauser has presented a provocative slide to help decision making for relapsing ms patients ec trims"
465,"(2/2) He will highligt the excellent results of $IMUX's phase 2 #EMPhASIS trial of our lead asset, #VidofludimusCalcium (#IMU838).

The presentation will be accessible on the ‚ÄúEvents and Presentations‚Äù section of #Immunic's website: https://t.co/96cIpuBnOh

#MSresearch @ECTRIMS",twitter,USA,ImmunicInc,,"(2/2) he will highligt the excellent results of $imux's phase 2 #emphasis trial of our lead asset, #vidofludimuscalcium (#imu838). the presentation will be accessible on the ‚Äúevents and presentations‚Äù section of #immunic's website: https://t.co/96cipubnoh #msresearch @ectrims",,"#emphasis, #vidofludimuscalcium, #imu838, #immunic's, #msresearch","Beauty/Health & Fitness, Business",,"(2/2) he will highligt the excellent results of $imux's phase 2 #emphasis trial of our lead asset, #vidofludimuscalcium (#imu838). the presentation will be accessible on the events and presentations section of #immunic's website: msresearch"
466,"üî¨#MSResearch has the pleasure of funding a researcher to attend this year's @ECTRIMS #conference in #Amsterdam.

If you are #researcher looking for funding we may be able to help. 
üëãGet in touch with us for more information: https://t.co/5oAIREo6n9
#ECTRIMS #multiplesclerosis https://t.co/FSX8RyHCfu",twitter,GBR,msresearch,,üî¨#msresearch has the pleasure of funding a researcher to attend this year's @ectrims #conference in #amsterdam. if you are #researcher looking for funding we may be able to help. üëãget in touch with us for more information: https://t.co/5oaireo6n9 #ectrims #multiplesclerosis https://t.co/fsx8ryhcfu,female,"#msresearch, #conference, #amsterdam, #researcher, #ectrims, #multiplesclerosis",,,msresearch has the pleasure of funding a researcher to attend this year's #conference in #amsterdam. if you are #researcher looking for funding we may be able to help. get in touch with us for more information: ec trims multiple sclerosis
467,"In addition to learning from other scientists and presenting our work, congresses also remind us of why we do what we do #ECTRIMS2022 #MultipleSclerosis #MS #Science #Passion https://t.co/DMzcnzT0NH",twitter,NLD,MindSlab_LU,,"in addition to learning from other scientists and presenting our work, congresses also remind us of why we do what we do #ectrims2022 #multiplesclerosis #ms #science #passion https://t.co/dmzcnzt0nh",,"#ectrims2022, #multiplesclerosis, #ms, #science, #passion",,,"in addition to learning from other scientists and presenting our work, congresses also remind us of why we do what we do ec trims multiple sclerosis ms #science #passion"
468,Muscle strength can get reduced while aging with #ms. But we need it also not to fall. Therefore we need to have a proper rehabilitation plan while aging to reduce the rate of fallings. But it seems we need to do more studies to understand the different perspectives. #ECTRIMS2022,twitter,DEU,Birgitpower,,muscle strength can get reduced while aging with #ms. but we need it also not to fall. therefore we need to have a proper rehabilitation plan while aging to reduce the rate of fallings. but it seems we need to do more studies to understand the different perspectives. #ectrims2022,female,"#ms, #ectrims2022",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",muscle strength can get reduced while aging with ms. but we need it also not to fall. therefore we need to have a proper rehabilitation plan while aging to reduce the rate of fallings. but it seems we need to do more studies to understand the different perspectives. ec trims
469,Happy to participate and present our data at #ECTRIMS2022 definitely among the most rewarding moments for a researcher ‚ú® #research #neurology #neuroscience #MultipleSclerosis https://t.co/hEam1KUxGW,twitter,NLD,elena_rossi20,,happy to participate and present our data at #ectrims2022 definitely among the most rewarding moments for a researcher ‚ú® #research #neurology #neuroscience #multiplesclerosis https://t.co/heam1kuxgw,female,"#ectrims2022, #research, #neurology, #neuroscience, #multiplesclerosis","Beauty/Health & Fitness, Science",,happy to participate and present our data at ec trims definitely among the most rewarding moments for a researcher #research #neurology #neuroscience multiple sclerosis
470,"Have you heard of the @UKMSRegister? If not, you're missing out.

We spoke to Rod Middleton at @ECTRIMS about how the work they do will benefit those of you living with MS üëâ https://t.co/mjk7VLYXnR

#ECTRIMS #ECTRIMS2022 #MultipleSclerosis",twitter,,LivedHealth,,"have you heard of the @ukmsregister? if not, you're missing out. we spoke to rod middleton at @ectrims about how the work they do will benefit those of you living with ms üëâ https://t.co/mjk7vlyxnr #ectrims #ectrims2022 #multiplesclerosis",unknown,"#ectrims, #ectrims2022, #multiplesclerosis","Beauty/Health & Fitness, Photo & Video",,"have you heard of the ? if not, you're missing out. we spoke to rod middleton at about how the work they do will benefit those of you living with ms ec trims ec trims multiple sclerosis"
471,If #ECTRIMS2022 is the Olympics of #MS I met Michael Phelps today üòú Lovely to meet you @AaronBosterMD üß° https://t.co/aNbFO7duxA,twitter,NLD,MSWarriorMJ,,if #ectrims2022 is the olympics of #ms i met michael phelps today üòú lovely to meet you @aaronbostermd üß° https://t.co/anbfo7duxa,female,"#ectrims2022, #ms",Books,,if ec trims is the olympics of ms i met michael phelps today lovely to meet you
472,"Seen our ePosters at #ECTRIMS2022 yet? Meet our co-authors, like Thibo Billiet at our booth and get the nitty gritty on #Brain volume analysis in #MOGAD #NMOSD & #MS. https://t.co/O7bXCIMxTg",twitter,BEL,icometrix,,"seen our eposters at #ectrims2022 yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & #ms. https://t.co/o7bxcimxtg",unknown,"#ectrims2022, #brain, #mogad, #nmosd, #ms",Beauty/Health & Fitness,,"seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms."
473,Dr Adil Harroud shares analysis of genetic variants and MS disease progression finding some variants have a faster time to disability #ECTRIMS2022 https://t.co/7AvrCSHAyP,twitter,CAN,PamelaKanellis,,dr adil harroud shares analysis of genetic variants and ms disease progression finding some variants have a faster time to disability #ectrims2022 https://t.co/7avrcshayp,female,#ectrims2022,,,dr adil harroud shares analysis of genetic variants and ms disease progression finding some variants have a faster time to disability ec trims
474,People with ms affected with MCR = Motorik cognitive risk syndrome have clearly more problems with #fatigue #ECTRIMS2022 #ms https://t.co/6hPiv8UvRL,twitter,DEU,Birgitpower,,people with ms affected with mcr = motorik cognitive risk syndrome have clearly more problems with #fatigue #ectrims2022 #ms https://t.co/6hpiv8uvrl,female,"#fatigue, #ectrims2022, #ms",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",people with ms affected with mcr = motorik cognitive risk syndrome have clearly more problems with #fatigue ec trims ms
475,Interesting point! Could the metaverse bring profitable effects in (cognitive) rehabilitation? #MindSlab #ECTRIMS2022 #MultipleSclerosis #rehabilitation #cognition https://t.co/pejoOqBEk5,twitter,NLD,MindSlab_LU,,interesting point! could the metaverse bring profitable effects in (cognitive) rehabilitation? #mindslab #ectrims2022 #multiplesclerosis #rehabilitation #cognition https://t.co/pejooqbek5,,"#mindslab, #ectrims2022, #multiplesclerosis, #rehabilitation, #cognition",,,interesting point! could the metaverse bring profitable effects in (cognitive) rehabilitation? #mindslab ec trims multiple sclerosis #rehabilitation #cognition
476,"Is #remyelination the cure for MS?

@themsguide quizzes @drbarrysinger about this trending topic in #multiplesclerosis treatment at @ECTRIMS üëâ https://t.co/AT8KE0Z6KU

#ECTRIMS #ECTRIMS2022",twitter,,LivedHealth,,is #remyelination the cure for ms? @themsguide quizzes @drbarrysinger about this trending topic in #multiplesclerosis treatment at @ectrims üëâ https://t.co/at8ke0z6ku #ectrims #ectrims2022,unknown,"#remyelination, #multiplesclerosis, #ectrims, #ectrims2022","Beauty/Health & Fitness, Photo & Video",,is #remyelination the cure for ms? quizzes about this trending topic in multiple sclerosis treatment at ec trims ec trims
477,Some lovely pictures of @LaurenATaylor26's poster presentation at #ECTRIMS2022 on memory rehabilitation for people with multiple sclerosis. Come check her poster (no. 777) in the poster area! https://t.co/ys1iVlBzvI,twitter,GBR,NEuRoMSproject,,some lovely pictures of @laurenataylor26's poster presentation at #ectrims2022 on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area! https://t.co/ys1ivlbzvi,unknown,#ectrims2022,Beauty/Health & Fitness,,some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!
478,Meet the expert: choosing therapy.. #ECTRIMS2022 #ms #Amsterdam #Neurology https://t.co/nVC4CjKq5J,twitter,,_M_Fragoso_,,meet the expert: choosing therapy.. #ectrims2022 #ms #amsterdam #neurology https://t.co/nvc4cjkq5j,unknown,"#ectrims2022, #ms, #amsterdam, #neurology",Sports,,meet the expert: choosing therapy.. ec trims ms #amsterdam #neurology
479,"Prof @MLFinlayson challenging us all in improving research, collaboration, and outcomes in #MultipleSclerosis research. Particular challenges in paediatric and older people with #MS @ECTRIMS @eurims session. #ECTRIMS2022 https://t.co/WM3ReHEtIE",twitter,,sineadnieidhin,,"prof @mlfinlayson challenging us all in improving research, collaboration, and outcomes in #multiplesclerosis research. particular challenges in paediatric and older people with #ms @ectrims @eurims session. #ectrims2022 https://t.co/wm3rehetie",female,"#multiplesclerosis, #ms, #ectrims2022",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Lecturer}","prof challenging us all in improving research, collaboration, and outcomes in multiple sclerosis research. particular challenges in paediatric and older people with ms session. ec trims"
480,"de Groot: 3D gait analysis with EMG provides tailored treatment for #gait improvement. Physical therapy, orthotics, Botox, dalfampridine and spasticity meds can be utilized in appropriate #MS patients. #ECTRIMS2022 https://t.co/epBZJyiGYl",twitter,USA,drbarrysinger,,"de groot: 3d gait analysis with emg provides tailored treatment for #gait improvement. physical therapy, orthotics, botox, dalfampridine and spasticity meds can be utilized in appropriate #ms patients. #ectrims2022 https://t.co/epbzjyigyl",male,"#gait, #ms, #ectrims2022",Science,,"de groot: 3d gait analysis with emg provides tailored treatment for #gait improvement. physical therapy, orthotics, botox, dalfampridine and spasticity meds can be utilized in appropriate ms patients. ec trims"
481,Great to have a session at #ECTRIMS2022 devoted entirely to improving research & #clinicaltrials in progressive #MultipleSclerosis. Finding ways to identify & test potential treatments for people living with progressive #MS is a critical challenge that we must overcome. https://t.co/yZgvHI50rB,twitter,AUS,MStranslate,,great to have a session at #ectrims2022 devoted entirely to improving research & #clinicaltrials in progressive #multiplesclerosis. finding ways to identify & test potential treatments for people living with progressive #ms is a critical challenge that we must overcome. https://t.co/yzgvhi50rb,,"#ectrims2022, #clinicaltrials, #multiplesclerosis, #ms",,,great to have a session at ec trims devoted entirely to improving research & #clinicaltrials in progressive multiple sclerosis. finding ways to identify & test potential treatments for people living with progressive ms is a critical challenge that we must overcome.
482,"Rehabilitation in #ms : very Limited with children & older PwMS. We need more consistent research, to collaborate across regions for bigger groups, #digitalhealth can play a role. I would also recommend to share data across countries to learn more. #ECTRIMS2022 #ehds",twitter,DEU,Birgitpower,,"rehabilitation in #ms : very limited with children & older pwms. we need more consistent research, to collaborate across regions for bigger groups, #digitalhealth can play a role. i would also recommend to share data across countries to learn more. #ectrims2022 #ehds",female,"#ms, #digitalhealth, #ectrims2022, #ehds",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}","rehabilitation in ms : very limited with children & older pwms. we need more consistent research, to collaborate across regions for bigger groups, #digitalhealth can play a role. i would also recommend to share data across countries to learn more. ec trims #ehds"
483,"We're enjoying #ECTRIMS2022 so far! If you are considering digital cognitive assessments for MS research we have some suggested tests on our website: https://t.co/6ulErKksBd 

Contact us at enquiries@camcog.com for a more indepth discussion about which tests might best suit you. https://t.co/g99waBpqXk",twitter,GBR,CANTABconnect,,we're enjoying #ectrims2022 so far! if you are considering digital cognitive assessments for ms research we have some suggested tests on our website: https://t.co/6ulerkksbd contact us at enquiries@camcog.com for a more indepth discussion about which tests might best suit you. https://t.co/g99wabpqxk,,#ectrims2022,"Beauty/Health & Fitness, Technology, Business",,we're enjoying ec trims so far! if you are considering digital cognitive assessments for ms research we have some suggested tests on our website: contact us at enquiries.com for a more indepth discussion about which tests might best suit you.
484,Tacchino: #Metaverse may be very useful for people living with #MS; stimulating neuroplasticity.  Can improve social inclusion and well-being.  #ECTRIMS2022 @ECTRIMS @AaronBosterMD @Brandon_Beaber @MustStopMS @shiftms @themsguide https://t.co/Md1qIhxB5W,twitter,USA,drbarrysinger,,tacchino: #metaverse may be very useful for people living with #ms; stimulating neuroplasticity. can improve social inclusion and well-being. #ectrims2022 @ectrims @aaronbostermd @brandon_beaber @muststopms @shiftms @themsguide https://t.co/md1qihxb5w,male,"#metaverse, #ms, #ectrims2022",Science,,tacchino: #metaverse may be very useful for people living with ms; stimulating neuroplasticity. can improve social inclusion and well-being. ec trims
485,"#FrancescaBridge presenting our work demonstrating an increased risk of cervical pre-cancer in women exposed to high efficacy MS disease modifying therapy at #ECTRIMS2022 
üëèüèªüëèüèªüëèüèª https://t.co/bJTEgr7Z0U",twitter,,vjokubaitis,,#francescabridge presenting our work demonstrating an increased risk of cervical pre-cancer in women exposed to high efficacy ms disease modifying therapy at #ectrims2022 üëèüèªüëèüèªüëèüèª https://t.co/bjtegr7z0u,unknown,"#francescabridge, #ectrims2022","Beauty/Health & Fitness, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neuroscientist}",#francescabridge presenting our work demonstrating an increased risk of cervical pre-cancer in women exposed to high efficacy ms disease modifying therapy at ec trims
486,"@eurims brings up an hot topic: aging and #ms and I am sitting outside because room is full, this shows us that there are unmet needs, guidelines are needed and so: more research must be be done. #ECTRIMS2022 https://t.co/crvZppCjMP",twitter,DEU,Birgitpower,,"@eurims brings up an hot topic: aging and #ms and i am sitting outside because room is full, this shows us that there are unmet needs, guidelines are needed and so: more research must be be done. #ectrims2022 https://t.co/crvzppcjmp",female,"#ms, #ectrims2022",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}","brings up an hot topic: aging and ms and i am sitting outside because room is full, this shows us that there are unmet needs, guidelines are needed and so: more research must be be done. ec trims"
487,Marrie: Need to capture cognition and patient-reported outcomes for more comprehensive assessment of progressive MS trials #ECTRIMS2022 https://t.co/A5clULrUwz,twitter,CAN,PamelaKanellis,,marrie: need to capture cognition and patient-reported outcomes for more comprehensive assessment of progressive ms trials #ectrims2022 https://t.co/a5clulruwz,female,#ectrims2022,,,marrie: need to capture cognition and patient-reported outcomes for more comprehensive assessment of progressive ms trials ec trims
488,"Great interview with Prof. Hans Lassmann about the similarities and differences between #MS and MOGAD pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive #MultipleSclerosis 

#ECTRIMS2022 @ECTRIMS #Neurology #NeuroTwitter https://t.co/VmBj0O6XDU",twitter,,VJNeurology,,great interview with prof. hans lassmann about the similarities and differences between #ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive #multiplesclerosis #ectrims2022 @ectrims #neurology #neurotwitter https://t.co/vmbj0o6xdu,,"#ms, #multiplesclerosis, #ectrims2022, #neurology, #neurotwitter",Photo & Video,,great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter
489,"Great presentation yesterday by Matthew Davis of @TizianaLS on Foralumab. The world's ONLY FULLY HUMAN anti CD3 monoclonal antibody, via nasal delivery to MS patients at @BWHNeurology by @weinerlabhms showcased at @ECTRIMS 2022 $TLSA #TILS #ectrims2022 
https://t.co/TQgDWwW5Jq",twitter,GBR,AshfordPlumber,,"great presentation yesterday by matthew davis of @tizianals on foralumab. the world's only fully human anti cd3 monoclonal antibody, via nasal delivery to ms patients at @bwhneurology by @weinerlabhms showcased at @ectrims 2022 $tlsa #tils #ectrims2022 https://t.co/tqgdwww5jq",male,"#tils, #ectrims2022",Business,,"great presentation yesterday by matthew davis of on foralumab. the world's only fully human anti cd3 monoclonal antibody, via nasal delivery to ms patients at by showcased at 2022 $tlsa #tils ec trims"
490,"Congratulations to Amin Zarghai from our #MultipleSclerosis Research Flagship who presented at @ECTRIMS his study of 237 people with a first clinical diagnosis of CNS demyelination determining clinical predictors of retaining, losing or gaining employment over time #ECTRIMS2022",twitter,AUS,ResearchMenzies,,"congratulations to amin zarghai from our #multiplesclerosis research flagship who presented at @ectrims his study of 237 people with a first clinical diagnosis of cns demyelination determining clinical predictors of retaining, losing or gaining employment over time #ectrims2022",male,"#multiplesclerosis, #ectrims2022",,,"congratulations to amin zarghai from our multiple sclerosis research flagship who presented at his study of 237 people with a first clinical diagnosis of cns demyelination determining clinical predictors of retaining, losing or gaining employment over time ec trims"
491,In the Lifestyle session Brigit de Jong addressed the benefits of a healthy lifestyle and specifically diet for people with MS. More research is needed in this area to identify underlying mechanisms. #ECTRIMS2022 #MS https://t.co/g15gNarjBV,twitter,NLD,MindSlab_LU,,in the lifestyle session brigit de jong addressed the benefits of a healthy lifestyle and specifically diet for people with ms. more research is needed in this area to identify underlying mechanisms. #ectrims2022 #ms https://t.co/g15gnarjbv,,"#ectrims2022, #ms",,,in the lifestyle session brigit de jong addressed the benefits of a healthy lifestyle and specifically diet for people with ms. more research is needed in this area to identify underlying mechanisms. ec trims ms
492,Excellent question posed during the lifestyle intervention session at #ECTRIMS2022. Why don‚Äôt we have ‚Äúmarketing departments‚Äù to promote the benefits of #exercise and #diet in #MultipleSclerosis? Maybe we can take on this challenge together! https://t.co/mar8UBOec9,twitter,AUS,MStranslate,,excellent question posed during the lifestyle intervention session at #ectrims2022. why don‚Äôt we have ‚Äúmarketing departments‚Äù to promote the benefits of #exercise and #diet in #multiplesclerosis? maybe we can take on this challenge together! https://t.co/mar8uboec9,,"#ectrims2022, #exercise, #diet, #multiplesclerosis",,,excellent question posed during the lifestyle intervention session at ec trims. why dont we have marketing departments to promote the benefits of #exercise and #diet in multiple sclerosis? maybe we can take on this challenge together!
493,"@SmetsIde making an impressive case AGAINST active monitoring AND treatment of people with #RIS or presymptomatic ""MS"" - what would you do? Vote now https://t.co/Rp0MjVfIiE @ECTRIMS @Iamsterdam #ECTRIMS2022 https://t.co/LhdkVpZx1X",twitter,GBR,KlausSchmierer,,"@smetside making an impressive case against active monitoring and treatment of people with #ris or presymptomatic ""ms"" - what would you do? vote now https://t.co/rp0mjvfiie @ectrims @iamsterdam #ectrims2022 https://t.co/lhdkvpzx1x",male,"#ris, #ectrims2022",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}","making an impressive case against active monitoring and treatment of people with #ris or presymptomatic ""ms"" - what would you do? vote now ec trims"
494,Interesting üî• burning debate @ECTRIMS2022- should we treat RIS? 50% of patients with RIS will go on to develop MS 10 years after first MRI scan. Watch this space for results of ARISE trial tomorrow https://t.co/KvexLjrJhg,twitter,GBR,DrRhiRafty,,interesting üî• burning debate @ectrims2022- should we treat ris? 50% of patients with ris will go on to develop ms 10 years after first mri scan. watch this space for results of arise trial tomorrow https://t.co/kvexljrjhg,female,,,,interesting burning debate - should we treat ris? 50% of patients with ris will go on to develop ms 10 years after first mri scan. watch this space for results of arise trial tomorrow
495,"#ECTRIMS2022| Join Industry Sessions at Day 2 of congress and engage with leaders in #MS research. 
Today‚Äôs sessions are supported by @sanofi @biogen @Roche @Merck @bmsnews and #Aegirbio
 
Full programme of Industry Sessions ‚û°Ô∏è https://t.co/9PLrja15rU",twitter,CHE,ECTRIMS,,#ectrims2022| join industry sessions at day 2 of congress and engage with leaders in #ms research. today‚Äôs sessions are supported by @sanofi @biogen @roche @merck @bmsnews and #aegirbio full programme of industry sessions ‚û°Ô∏è https://t.co/9plrja15ru,,"#ectrims2022, #ms, #aegirbio",,,ec trims| join industry sessions at day 2 of congress and engage with leaders in ms research. todays sessions are supported by and #aegirbio full programme of industry sessions
496,"triMSonline: Good morning from @ECTRIMS! 

Are you interested in increasing your reach and raising your profile within the #MS community? Don't miss out on the opportunity to #sponsor or #exhibit at the seventh #triMSonline conference!

Find out more information by visiting ‚Ä¶",twitter,GBR,GavinGiovannoni,,trimsonline: good morning from @ectrims! are you interested in increasing your reach and raising your profile within the #ms community? don't miss out on the opportunity to #sponsor or #exhibit at the seventh #trimsonline conference! find out more information by visiting ‚Ä¶,male,"#ms, #sponsor, #exhibit, #trimsonline",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}",trimsonline: good morning from ! are you interested in increasing your reach and raising your profile within the ms community? don't miss out on the opportunity to #sponsor or #exhibit at the seventh #trimsonline conference! find out more information by visiting
497,"Good morning from @ECTRIMS! 

Are you interested in increasing your reach and raising your profile within the #MS community? Don't miss out on the opportunity to #sponsor or #exhibit at the seventh #triMSonline conference!

Find out more information by visiting us at booth B02!",twitter,,triMSonline,,good morning from @ectrims! are you interested in increasing your reach and raising your profile within the #ms community? don't miss out on the opportunity to #sponsor or #exhibit at the seventh #trimsonline conference! find out more information by visiting us at booth b02!,,"#ms, #sponsor, #exhibit, #trimsonline",,,good morning from ! are you interested in increasing your reach and raising your profile within the ms community? don't miss out on the opportunity to #sponsor or #exhibit at the seventh #trimsonline conference! find out more information by visiting us at booth b02!
498,"Dra. Strijbis

But what about in long-term stable MS on platform therapies?

Answer: depends. We'd look at immunosenescency, age and MS history.

#ECTRIMS2022 https://t.co/umv8KovXhI",twitter,,IlNeuroDoktorMS,,"dra. strijbis but what about in long-term stable ms on platform therapies? answer: depends. we'd look at immunosenescency, age and ms history. #ectrims2022 https://t.co/umv8kovxhi",male,#ectrims2022,,,"dra. strijbis but what about in long-term stable ms on platform therapies? answer: depends. we'd look at immunosenescency, age and ms history. ec trims"
499,"Tomorrow Slowly Expanding Lesions and Paramagnetic Rim Lesions in PwMS at Free Communication 6: Imaging Session (10 - 11 AM CEST) 
#ECTRIMS2022 #MultipleSclerosis #MRI 
Please view and participate with your questions! https://t.co/BjqXyDciNm",twitter,,AlbertoCalvi3,,tomorrow slowly expanding lesions and paramagnetic rim lesions in pwms at free communication 6: imaging session (10 - 11 am cest) #ectrims2022 #multiplesclerosis #mri please view and participate with your questions! https://t.co/bjqxydcinm,male,"#ectrims2022, #multiplesclerosis, #mri",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Research Fellow}",tomorrow slowly expanding lesions and paramagnetic rim lesions in pwms at free communication 6: imaging session (10 - 11 am cest) ec trims multiple sclerosis #mri please view and participate with your questions!
500,De Smets: should we do a better job of detecting #MS earlier and treat these individuals? #ECTRIMS2022,twitter,CAN,PamelaKanellis,,de smets: should we do a better job of detecting #ms earlier and treat these individuals? #ectrims2022,female,"#ms, #ectrims2022",,,de smets: should we do a better job of detecting ms earlier and treat these individuals? ec trims
501,"Poster from a research from Australia says, that telehealth was used very often from PwMS during the #pandemic in the first year, it‚Äôs needed for health services & #MS organization to prepare guidance info for patients and offering other #digithealth models too. #ECTRIMS2022",twitter,DEU,Birgitpower,,"poster from a research from australia says, that telehealth was used very often from pwms during the #pandemic in the first year, it‚Äôs needed for health services & #ms organization to prepare guidance info for patients and offering other #digithealth models too. #ectrims2022",female,"#pandemic, #ms, #digithealth, #ectrims2022",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}","poster from a research from australia says, that telehealth was used very often from pwms during the #pandemic in the first year, its needed for health services & ms organization to prepare guidance info for patients and offering other #digithealth models too. ec trims"
502,"What risk factors increase risk of #RIS converting to #MS? Age <37, enhancing lesions, spinal cord lesion, infratentorial lesions & oligoclonal bands. 3 factors: 91% chance of developing MS in 2 years.  #ECTRIMS2022 https://t.co/74VE3eAadU",twitter,USA,drbarrysinger,,"what risk factors increase risk of #ris converting to #ms? age <37, enhancing lesions, spinal cord lesion, infratentorial lesions & oligoclonal bands. 3 factors: 91% chance of developing ms in 2 years. #ectrims2022 https://t.co/74ve3eaadu",male,"#ris, #ms, #ectrims2022",Science,,"what risk factors increase risk of #ris converting to ms? age <37, enhancing lesions, spinal cord lesion, infratentorial lesions & oligoclonal bands. 3 factors: 91% chance of developing ms in 2 years. ec trims"
503,"Dr Ulrik Dalgas (@AarhusUni) tells #ECTRIMS2022 that starting exercise early in people living with #MultipleSclerosis may be the best approach to improve long-term outcomes. ‚ÄúPrehabilitation‚Äù can help build reserve capacity, rather than just trying to restore lost capacity. https://t.co/ZvOiYKvKwJ",twitter,AUS,MStranslate,,"dr ulrik dalgas (@aarhusuni) tells #ectrims2022 that starting exercise early in people living with #multiplesclerosis may be the best approach to improve long-term outcomes. ‚Äúprehabilitation‚Äù can help build reserve capacity, rather than just trying to restore lost capacity. https://t.co/zvoiykvkwj",,"#ectrims2022, #multiplesclerosis",,,"dr ulrik dalgas () tells ec trims that starting exercise early in people living with multiple sclerosis may be the best approach to improve long-term outcomes. prehabilitation can help build reserve capacity, rather than just trying to restore lost capacity."
504,Prof @GoldLabCharite presenting in wellbeing for people with #MultipleSclerosis at @eurims education session at @ECTRIMS #ECTRIMS2022 https://t.co/XoqZIxYPf4,twitter,,sineadnieidhin,,prof @goldlabcharite presenting in wellbeing for people with #multiplesclerosis at @eurims education session at @ectrims #ectrims2022 https://t.co/xoqzixypf4,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Lecturer}",prof presenting in wellbeing for people with multiple sclerosis at education session at ec trims
505,@drbarrysinger @C_OrejaGuevara @AaronBosterMD @anneke_vdw @DocforMS @ECTRIMS @themsguide Really enjoyed a fringe meeting chaired by Anat Achiron about their coaching programme for pwMS at diagnosis - significant impact on time to starting #MS #DMT Check their poster #754  for details. Insights pertinent to  #AttackMS @QMULBartsTheLon @Iamsterdam @ECTRIMS #ECTRIMS2022,twitter,GBR,KlausSchmierer,,@drbarrysinger @c_orejaguevara @aaronbostermd @anneke_vdw @docforms @ectrims @themsguide really enjoyed a fringe meeting chaired by anat achiron about their coaching programme for pwms at diagnosis - significant impact on time to starting #ms #dmt check their poster #754 for details. insights pertinent to #attackms @qmulbartsthelon @iamsterdam @ectrims #ectrims2022,male,"#ms, #dmt, #attackms, #ectrims2022",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",really enjoyed a fringe meeting chaired by anat achiron about their coaching programme for pwms at diagnosis - significant impact on time to starting ms #dmt check their poster #754 for details. insights pertinent to #attackms ec trims
506,"Diet & #MS symptoms: Adherence to Mediterranean Diet promising, superiority of one diet over another remains unclear -Dr de Jong #ECTRIMS2022 https://t.co/jOZ3e2eyyA",twitter,USA,DrJNicholas,,"diet & #ms symptoms: adherence to mediterranean diet promising, superiority of one diet over another remains unclear -dr de jong #ectrims2022 https://t.co/joz3e2eyya",female,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}","diet & ms symptoms: adherence to mediterranean diet promising, superiority of one diet over another remains unclear -dr de jong ec trims"
507,"When someone is diagnosed with MS, 9 out of 10 ask, what can I do? Can I module my disease with diet? 
A #healthy #lifestyle is just as beneficial for MS. - Brigit de Jong. #ECTRIMS2022",twitter,,OliviaWills20,,"when someone is diagnosed with ms, 9 out of 10 ask, what can i do? can i module my disease with diet? a #healthy #lifestyle is just as beneficial for ms. - brigit de jong. #ectrims2022",female,"#healthy, #lifestyle, #ectrims2022","Beauty/Health & Fitness, Science, Politics, Food & Drinks","{profession=Student, jobTitle=PhD Candidate}","when someone is diagnosed with ms, 9 out of 10 ask, what can i do? can i module my disease with diet? a #healthy #lifestyle is just as beneficial for ms. - brigit de jong. ec trims"
508,Dr Lebrun-Frenay looks at evidence on treating people with radiologically isolated syndrome RIS and risk factors for #MS diagnosis #ECTRIMS2022 https://t.co/oDaHh2fE8m,twitter,CAN,PamelaKanellis,,dr lebrun-frenay looks at evidence on treating people with radiologically isolated syndrome ris and risk factors for #ms diagnosis #ectrims2022 https://t.co/odahh2fe8m,female,"#ms, #ectrims2022",,,dr lebrun-frenay looks at evidence on treating people with radiologically isolated syndrome ris and risk factors for ms diagnosis ec trims
509,Congratulations  @LCoelewij and @alexandraoppong #ECTRIMS2022 presenting their work investigating immunogenicity and disease progression in MS! Great collaboration with @RFarrell_CNR üèÖüëèüëèüëè,twitter,GBR,Jury_Lab,,congratulations @lcoelewij and @alexandraoppong #ectrims2022 presenting their work investigating immunogenicity and disease progression in ms! great collaboration with @rfarrell_cnr üèÖüëèüëèüëè,unknown,#ectrims2022,,,congratulations and ec trims presenting their work investigating immunogenicity and disease progression in ms! great collaboration with
510,"Day 2 of #ECTRIMS2022 and you‚Äôve supercharged our batteries yesterday thx to all existing discussions & ideas on fighting #ms through collaboration & #brainAI. Drop by our booth, see how we can tackle your needs & challenges! #digitalhealth #weareicometrix #icobrain #icompanion https://t.co/JZA5QViozY",twitter,BEL,icometrix,,"day 2 of #ectrims2022 and you‚Äôve supercharged our batteries yesterday thx to all existing discussions & ideas on fighting #ms through collaboration & #brainai. drop by our booth, see how we can tackle your needs & challenges! #digitalhealth #weareicometrix #icobrain #icompanion https://t.co/jza5qviozy",unknown,"#ectrims2022, #ms, #brainai, #digitalhealth, #weareicometrix, #icobrain, #icompanion",Beauty/Health & Fitness,,"day 2 of ec trims and youve supercharged our batteries yesterday thx to all existing discussions & ideas on fighting ms through collaboration & #brainai. drop by our booth, see how we can tackle your needs & challenges! #digitalhealth #weareicometrix #icobrain #icompanion"
511,My #ECTRIMS2022 poster is up and hanging. Come meet me this afternoon at P632 and have a chat about #MRspectroscopy and #Cortical lesions in #MS. Or find me Friday at the ePoster tour. https://t.co/sIffIrDBIx,twitter,,just_madsen,,my #ectrims2022 poster is up and hanging. come meet me this afternoon at p632 and have a chat about #mrspectroscopy and #cortical lesions in #ms. or find me friday at the eposter tour. https://t.co/siffirdbix,male,"#ectrims2022, #mrspectroscopy, #cortical, #ms",Sports,"{profession=Scientist & Researcher, jobTitle=Neuroscientist}",my ec trims poster is up and hanging. come meet me this afternoon at p632 and have a chat about #mrspectroscopy and #cortical lesions in ms. or find me friday at the eposter tour.
512,"We are here at @ECTRIMS! Come visit us at booth B03 to say hi üëã to our team in the exhibition hall and to learn more about our projects and initiatives.üîµ@‚ö™üî¥

#MS #MultipleSclerosis #ECTRIMS2022 https://t.co/sVbJcSaa3Y",twitter,BEL,eumsplatform,,we are here at @ectrims! come visit us at booth b03 to say hi üëã to our team in the exhibition hall and to learn more about our projects and initiatives.üîµ@‚ö™üî¥ #ms #multiplesclerosis #ectrims2022 https://t.co/svbjcsaa3y,female,"#ms, #multiplesclerosis, #ectrims2022",,,we are here at ! come visit us at booth b03 to say hi to our team in the exhibition hall and to learn more about our projects and initiatives. ms multiple sclerosis ec trims
513,"Our co-founder, Brett Drummond, is joined by Dr Travis Stiles (CEO, @NovoronBio) to review Day 1 of #ECTRIMS2022. Topics covered include paediatric #MultipleSclerosis, remyelination, biomarkers, AHSCT & treatment dosing. What were your highlights? @ECTRIMS https://t.co/OKk4420K4a",twitter,AUS,MStranslate,,"our co-founder, brett drummond, is joined by dr travis stiles (ceo, @novoronbio) to review day 1 of #ectrims2022. topics covered include paediatric #multiplesclerosis, remyelination, biomarkers, ahsct & treatment dosing. what were your highlights? @ectrims https://t.co/okk4420k4a",,"#ectrims2022, #multiplesclerosis",,,"our co-founder, brett drummond, is joined by dr travis stiles (ceo, ) to review day 1 of ec trims. topics covered include paediatric multiple sclerosis, remyelination, biomarkers, ahsct & treatment dosing. what were your highlights?"
514,We are with the North-European team at #ECTRIMS2022. Please visit our booth and follow us for the latest updates on our treatments and pipeline. #Sanofi ‚Äã#Neurology #MS https://t.co/nxcdkfYwOE,twitter,NLD,SijntjeWidlak,,we are with the north-european team at #ectrims2022. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology #ms https://t.co/nxcdkfywoe,unknown,"#ectrims2022, #sanofi, #neurology, #ms",,,we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms
515,"We‚Äôre proud to announce new data at #ECTRIMS2022 showing important clinical and economic outcomes of early treatment in relapse-remitting #multiplesclerosis, pregnancy outcomes from 2,000+ women, and 9-year safety data: https://t.co/28GAnU8AeV $RHHBY $ROG https://t.co/TlNplxRDSI",twitter,CHE,Roche,,"we‚Äôre proud to announce new data at #ectrims2022 showing important clinical and economic outcomes of early treatment in relapse-remitting #multiplesclerosis, pregnancy outcomes from 2,000+ women, and 9-year safety data: https://t.co/28ganu8aev $rhhby $rog https://t.co/tlnplxrdsi",,"#ectrims2022, #multiplesclerosis",,,"were proud to announce new data at ec trims showing important clinical and economic outcomes of early treatment in relapse-remitting multiple sclerosis, pregnancy outcomes from 2,000+ women, and 9-year safety data: $rhhby $rog"
516,"A sculptural installation for ECTRIMS 2022 to gain awareness around  Smouldering disease, a new discovery in the early stages of MS. 
The head fills with smoke so you can‚Äôt see the lettering until the button is pressed and the smoke is released to reveal the message #ECTRIMS2022 https://t.co/6qdstC9a9w",twitter,GBR,lazerian,,"a sculptural installation for ectrims 2022 to gain awareness around smouldering disease, a new discovery in the early stages of ms. the head fills with smoke so you can‚Äôt see the lettering until the button is pressed and the smoke is released to reveal the message #ectrims2022 https://t.co/6qdstc9a9w",male,#ectrims2022,Fine arts,"{profession=Artist, jobTitle=Artist}","a sculptural installation for ectrims 2022 to gain awareness around smouldering disease, a new discovery in the early stages of ms. the head fills with smoke so you cant see the lettering until the button is pressed and the smoke is released to reveal the message ec trims"
517,Good morning #MS community! Looking forward to Day 2 #ECTRIMS2022. Great sessions. What‚Äôs been impactful for you to improve the future care of people living with #MS? @KlausSchmierer @C_OrejaGuevara @AaronBosterMD @anneke_vdw @DocforMS @ECTRIMS @themsguide https://t.co/9U0c9VPvmk,twitter,USA,drbarrysinger,,good morning #ms community! looking forward to day 2 #ectrims2022. great sessions. what‚Äôs been impactful for you to improve the future care of people living with #ms? @klausschmierer @c_orejaguevara @aaronbostermd @anneke_vdw @docforms @ectrims @themsguide https://t.co/9u0c9vpvmk,male,"#ms, #ectrims2022, #ms",Science,,good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?
518,"The very first #ECTRIMS2022 podcast is now live, hosted by our co-founder, Brett Drummond.  Available on all of your favourite #podcast platforms. Thank you to Professor Brenda Banwell for her participation. @Penn @ChildrensPhila #MultipleSclerosis #MS",twitter,AUS,MStranslate,,"the very first #ectrims2022 podcast is now live, hosted by our co-founder, brett drummond. available on all of your favourite #podcast platforms. thank you to professor brenda banwell for her participation. @penn @childrensphila #multiplesclerosis #ms",,"#ectrims2022, #podcast, #multiplesclerosis, #ms",,,"the very first ec trims podcast is now live, hosted by our co-founder, brett drummond. available on all of your favourite #podcast platforms. thank you to professor brenda banwell for her participation. multiple sclerosis ms"
519,@SilverGorilla2 @Atarabio Thank you for your message. This is indeed a wonderful reminder that ECTRIMS remains grateful for everyone's contribution dedicated to the treatment of #MS.,twitter,CHE,ECTRIMS,,@silvergorilla2 @atarabio thank you for your message. this is indeed a wonderful reminder that ectrims remains grateful for everyone's contribution dedicated to the treatment of #ms.,,#ms,,,thank you for your message. this is indeed a wonderful reminder that ectrims remains grateful for everyone's contribution dedicated to the treatment of ms.
520,"üéôÔ∏è ‚ÄúMy patients & their families are truly incredible w/ coping with MS at a time when they should be worrying about Grade 2 not about whether or not their therapy is going to work‚Äù: ECTRIMS Podcast Guest Brenda Banwell w/ @ChildrensPhila. 

Listen now ‚û°Ô∏è https://t.co/vIdHXfaG5Y https://t.co/vkVn5z92yu",twitter,CHE,ECTRIMS,,üéôÔ∏è ‚Äúmy patients & their families are truly incredible w/ coping with ms at a time when they should be worrying about grade 2 not about whether or not their therapy is going to work‚Äù: ectrims podcast guest brenda banwell w/ @childrensphila. listen now ‚û°Ô∏è https://t.co/vidhxfag5y https://t.co/vkvn5z92yu,,,,,my patients & their families are truly incredible w/ coping with ms at a time when they should be worrying about grade 2 not about whether or not their therapy is going to work: ectrims podcast guest brenda banwell w/ . listen now
521,"#ECTRIMS2022 | Welcome to day 2! There are 5 Scientific Sessions to choose from today, as well as 10 Hot Topics. View the entire Scientific Programme here ‚û°Ô∏è ECTRIMS (https://t.co/gR3vdlFI54)
 
Don‚Äôt forget to share your congress photos with us #JointheConversation #MSresearch https://t.co/RCtvW9yCAG",twitter,CHE,ECTRIMS,,"#ectrims2022 | welcome to day 2! there are 5 scientific sessions to choose from today, as well as 10 hot topics. view the entire scientific programme here ‚û°Ô∏è ectrims (https://t.co/gr3vdlfi54) don‚Äôt forget to share your congress photos with us #jointheconversation #msresearch https://t.co/rctvw9ycag",,"#ectrims2022, #jointheconversation, #msresearch",,,"ec trims | welcome to day 2! there are 5 scientific sessions to choose from today, as well as 10 hot topics. view the entire scientific programme here ectrims () dont forget to share your congress photos with us #jointheconversation msresearch"
522,"What a first day back to in person yesterday @ECTRIMS! Started off with #MAGNIMS educational workshop, amazing sand art, #pediatric #NMOSD #MS #MOGAD plenary, & honoured to present our recent #MachineLearning results & thoughts on #MultipleSclerosis #prognostics! #ECTRIMS2022 https://t.co/q5ch1g10Us",twitter,DEU,ClaudiaAcadem,,"what a first day back to in person yesterday @ectrims! started off with #magnims educational workshop, amazing sand art, #pediatric #nmosd #ms #mogad plenary, & honoured to present our recent #machinelearning results & thoughts on #multiplesclerosis #prognostics! #ectrims2022 https://t.co/q5ch1g10us",female,"#magnims, #pediatric, #nmosd, #ms, #mogad, #machinelearning, #multiplesclerosis, #prognostics, #ectrims2022","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Teacher}","what a first day back to in person yesterday ! started off with #magnims educational workshop, amazing sand art, #pediatric #nmosd ms #mogad plenary, & honoured to present our recent #machinelearning results & thoughts on multiple sclerosis #prognostics! ec trims"
523,"The presentation of our ""Charcot Multiple Sclerosis Management Master of Science"" - a cooperation project of ECF and DIU now is online on Youtube: https://t.co/l1J64fO4ia. We are at #ECTRIMS2022 at ECF booth. All info on:https://t.co/7a0nPuF5ss https://t.co/LEpqHDCjF5",twitter,DEU,TZiemssen,,"the presentation of our ""charcot multiple sclerosis management master of science"" - a cooperation project of ecf and diu now is online on youtube: https://t.co/l1j64fo4ia. we are at #ectrims2022 at ecf booth. all info on:https://t.co/7a0npuf5ss https://t.co/lepqhdcjf5",unknown,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","the presentation of our ""charcot multiple sclerosis management master of science"" - a cooperation project of ecf and diu now is online on youtube: . we are at ec trims at ecf booth. all info on:"
524,Congratulations to Ying Li from our MS Research Flagship who presented her poster @ECTRIMS in Amsterdam. Ying Li's study found that high sun exposure was associated with a reduced risk of developing progressive-onset #MultipleSclerosis  #ECTRIMS2022,twitter,AUS,ResearchMenzies,,congratulations to ying li from our ms research flagship who presented her poster @ectrims in amsterdam. ying li's study found that high sun exposure was associated with a reduced risk of developing progressive-onset #multiplesclerosis #ectrims2022,male,"#multiplesclerosis, #ectrims2022",,,congratulations to ying li from our ms research flagship who presented her poster in amsterdam. ying li's study found that high sun exposure was associated with a reduced risk of developing progressive-onset multiple sclerosis ec trims
525,"I am very happy to share in #ECTRIMS2022 congress my work on longitudinal immune response to adenovirus based COVID-19 vaccine Astrazeneca and Sputnik V in Argentina, a collaborative multicenter study @fundacionleloir
@cuemramosmejia #MultipleSclerosis #vaccine https://t.co/HPZB89WktD",twitter,NLD,bereniceanabel,,"i am very happy to share in #ectrims2022 congress my work on longitudinal immune response to adenovirus based covid-19 vaccine astrazeneca and sputnik v in argentina, a collaborative multicenter study @fundacionleloir @cuemramosmejia #multiplesclerosis #vaccine https://t.co/hpzb89wktd",female,"#ectrims2022, #multiplesclerosis, #vaccine",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}","i am very happy to share in ec trims congress my work on longitudinal immune response to adenovirus based covid-19 vaccine astrazeneca and sputnik v in argentina, a collaborative multicenter study multiple sclerosis #vaccine"
526,Proud to show a collaborative Argentine research about RWE:  #MultipleSclerosis activity between cycles in RRMS under Mavenclad treatment. #ECTRIMS congress #ECTRIMS2022 @hta_italiano @cuemramosmejia https://t.co/TLuvPQPIfs,twitter,NLD,bereniceanabel,,proud to show a collaborative argentine research about rwe: #multiplesclerosis activity between cycles in rrms under mavenclad treatment. #ectrims congress #ectrims2022 @hta_italiano @cuemramosmejia https://t.co/tluvpqpifs,female,"#multiplesclerosis, #ectrims, #ectrims2022",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}",proud to show a collaborative argentine research about rwe: multiple sclerosis activity between cycles in rrms under mavenclad treatment. ec trims congress ec trims
527,"Presenting our work on aHSCT therapy for #MultipleSclerosis at #ECTRIMS2022.
Great colleagues and research from all over the world! 

#karolinskainstitutet, #ECTRIMS https://t.co/6zph3oPq7T",twitter,NLD,mavromati_sofia,,"presenting our work on ahsct therapy for #multiplesclerosis at #ectrims2022. great colleagues and research from all over the world! #karolinskainstitutet, #ectrims https://t.co/6zph3opq7t",female,"#multiplesclerosis, #ectrims2022, #karolinskainstitutet, #ectrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}","presenting our work on ahsct therapy for multiple sclerosis at ec trims. great colleagues and research from all over the world! #karolinskainstitutet, ec trims"
528,"There has long been interest in the possible benefits of vitamin D supplements for those living with #MultipleSclerosis and whether they can be used to prevent the development of #MS.

#ECTRIMS2022",twitter,AUS,MS_Australia,,there has long been interest in the possible benefits of vitamin d supplements for those living with #multiplesclerosis and whether they can be used to prevent the development of #ms. #ectrims2022,female,"#multiplesclerosis, #ms, #ectrims2022",,,there has long been interest in the possible benefits of vitamin d supplements for those living with multiple sclerosis and whether they can be used to prevent the development of ms. ec trims
529,#ECTRIMS2022 ‚Äì Fertility Treatment Won‚Äôt Raise MS Relapse Risk | Use of DMTs Found to Help Keep Relapse Rate Low in MS¬†Women https://t.co/W1ucW3jaun,twitter,,fluidinknee_,,#ectrims2022 ‚Äì fertility treatment won‚Äôt raise ms relapse risk | use of dmts found to help keep relapse rate low in ms women https://t.co/w1ucw3jaun,,#ectrims2022,Beauty/Health & Fitness,,ec trims fertility treatment wont raise ms relapse risk | use of dmts found to help keep relapse rate low in ms women
530,Very honored to present our latest data on #neuroglial potassium channels as therapeutic targets in inflammatory demyelination at #ECTRIMS2022 today. Thanks for this great opportunity @ECTRIMS @schirmerlab #MultipleSclerosis #MS,twitter,DEU,hannah_kapell,,very honored to present our latest data on #neuroglial potassium channels as therapeutic targets in inflammatory demyelination at #ectrims2022 today. thanks for this great opportunity @ectrims @schirmerlab #multiplesclerosis #ms,female,"#neuroglial, #ectrims2022, #multiplesclerosis, #ms",,,very honored to present our latest data on #neuroglial potassium channels as therapeutic targets in inflammatory demyelination at ec trims today. thanks for this great opportunity multiple sclerosis ms
531,"Great poster session 1 at @ECTRIMS #ectrims2022 early assesment of ovarian reserve @IntNatlWiMS, #RWE of ocrelizumab, and OCT/Corpus Callosum atrophy @adelcanto @loregarmi @SOCHEDEM1 @SoterodelRio @FacMedicinaUC https://t.co/M2kdMi6WCq",twitter,,EthelScl,,"great poster session 1 at @ectrims #ectrims2022 early assesment of ovarian reserve @intnatlwims, #rwe of ocrelizumab, and oct/corpus callosum atrophy @adelcanto @loregarmi @sochedem1 @soterodelrio @facmedicinauc https://t.co/m2kdmi6wcq",unknown,"#ectrims2022, #rwe",,"{profession=Scientist & Researcher, jobTitle=Neurologist}","great poster session 1 at ec trims early assesment of ovarian reserve , #rwe of ocrelizumab, and oct/corpus callosum atrophy"
532,"Day 1 at @ECTRIMS: the highlights from @themsguide üôå

Remyelination, high efficacy therapies and an unexpected surprise about @drbarrysinger ü§´

 https://t.co/Qy4gBwEKei

#ECTRIMS #MultipleSclerosis",twitter,,LivedHealth,,"day 1 at @ectrims: the highlights from @themsguide üôå remyelination, high efficacy therapies and an unexpected surprise about @drbarrysinger ü§´ https://t.co/qy4gbwekei #ectrims #multiplesclerosis",unknown,"#ectrims, #multiplesclerosis","Beauty/Health & Fitness, Photo & Video",,"day 1 at : the highlights from remyelination, high efficacy therapies and an unexpected surprise about ec trims multiple sclerosis"
533,"üÜï‚¨áÔ∏è People with newly diagnosed MS have increased postural sway and lower muscle strength compared to healthy individuals, even if they have no complaints (EDSS‚â§1.5). Early rehabilitation can prevent insidious progression. #neurorehabilitation #prevention #ECTRIMS2022 https://t.co/WxukLbNfp0",twitter,,FerayGungor,,"üÜï‚¨áÔ∏è people with newly diagnosed ms have increased postural sway and lower muscle strength compared to healthy individuals, even if they have no complaints (edss‚â§1.5). early rehabilitation can prevent insidious progression. #neurorehabilitation #prevention #ectrims2022 https://t.co/wxuklbnfp0",female,"#neurorehabilitation, #prevention, #ectrims2022","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Research Assistant}","people with newly diagnosed ms have increased postural sway and lower muscle strength compared to healthy individuals, even if they have no complaints (edss1.5). early rehabilitation can prevent insidious progression. #neurorehabilitation #prevention ec trims"
534,#ECTRIMS2022 : Banwell: ~30% of pediatric onset MS #POMS have cognitive impairment. 30-50% have anxiety or depression. Get help for navigating a diagnosis of pediatric MS: https://t.co/usPneXqoqW,twitter,,mssociety,,#ectrims2022 : banwell: ~30% of pediatric onset ms #poms have cognitive impairment. 30-50% have anxiety or depression. get help for navigating a diagnosis of pediatric ms: https://t.co/uspnexqoqw,female,"#ectrims2022, #poms",,,ec trims : banwell: ~30% of pediatric onset ms #poms have cognitive impairment. 30-50% have anxiety or depression. get help for navigating a diagnosis of pediatric ms:
535,"MS News Today is providing comprehensive, in-depth coverage of the 2022 ECTRIMS conference focused on MS clinical research and care. https://t.co/TsOvK9XSO0

#multiplesclerosis #msnews #msawareness #msresearch https://t.co/rUGaOS5oBr",twitter,USA,MSNewsToday,,"ms news today is providing comprehensive, in-depth coverage of the 2022 ectrims conference focused on ms clinical research and care. https://t.co/tsovk9xso0 #multiplesclerosis #msnews #msawareness #msresearch https://t.co/rugaos5obr",female,"#multiplesclerosis, #msnews, #msawareness, #msresearch","Beauty/Health & Fitness, Science",,"ms news today is providing comprehensive, in-depth coverage of the 2022 ectrims conference focused on ms clinical research and care. multiple sclerosis msnews msawareness msresearch"
536,Enabling innovative approaches aimed at personalizing #MultipleSclerosis (MS) care is a continued pursuit of our #DigitalHealth initiatives. Watch to learn more about our real-world data being presented at #ECTRIMS2022 focused on advancing this goal.,twitter,USA,biogen,,enabling innovative approaches aimed at personalizing #multiplesclerosis (ms) care is a continued pursuit of our #digitalhealth initiatives. watch to learn more about our real-world data being presented at #ectrims2022 focused on advancing this goal.,,"#multiplesclerosis, #digitalhealth, #ectrims2022","Beauty/Health & Fitness, Science",,enabling innovative approaches aimed at personalizing multiple sclerosis (ms) care is a continued pursuit of our #digitalhealth initiatives. watch to learn more about our real-world data being presented at ec trims focused on advancing this goal.
537,"Investigators found no increased risk of #relapse with #fertility treatments. In total, 5 relapses in 4 unique patients occurred within 3 months post-FT after observing 110 cycles of FT in 55 individuals with either #MS (48) or #CIS (7). #ECTRIMS2022 https://t.co/cGVDokTklm",twitter,,IJMSCtweets,,"investigators found no increased risk of #relapse with #fertility treatments. in total, 5 relapses in 4 unique patients occurred within 3 months post-ft after observing 110 cycles of ft in 55 individuals with either #ms (48) or #cis (7). #ectrims2022 https://t.co/cgvdoktklm",,"#relapse, #fertility, #ms, #cis, #ectrims2022",,,"investigators found no increased risk of #relapse with #fertility treatments. in total, 5 relapses in 4 unique patients occurred within 3 months post-ft after observing 110 cycles of ft in 55 individuals with either ms (48) or #cis (7). ec trims"
538,"Congratulations @alexandraoppong, nice way of starting your PhD journey.

#ECTRIMS2022 #postersession #MultipleSclerosis",twitter,GBR,luciamg21,,"congratulations @alexandraoppong, nice way of starting your phd journey. #ectrims2022 #postersession #multiplesclerosis",female,"#ectrims2022, #postersession, #multiplesclerosis",Science,,"congratulations , nice way of starting your phd journey. ec trims #postersession multiple sclerosis"
539,"Next at #ECTRIMS2022: Claire Bridel, MD, PhD, of @UNIGEmedianews, who shared her perspective on the upcoming novel biomarker sun #MS. 

Clips: https://t.co/WkxIc2za7F https://t.co/QjbNgYxQCm",twitter,USA,byMattHoffman,,"next at #ectrims2022: claire bridel, md, phd, of @unigemedianews, who shared her perspective on the upcoming novel biomarker sun #ms. clips: https://t.co/wkxic2za7f https://t.co/qjbngyxqcm",male,"#ectrims2022, #ms",Books,"{profession=Journalist, jobTitle=Editor}","next at ec trims: claire bridel, md, phd, of , who shared her perspective on the upcoming novel biomarker sun ms. clips:"
540,"Dr Majid Pahlevan Kakhki held an @MSIntFederation @ECTRIMS McDonald fellowship and studies epigenetics of progressive #MultipleSclerosis 

https://t.co/zS2K2LopOA

#ECTRIMS2022 https://t.co/SBsWWXwofR",twitter,GBR,AnneHelme,,dr majid pahlevan kakhki held an @msintfederation @ectrims mcdonald fellowship and studies epigenetics of progressive #multiplesclerosis https://t.co/zs2k2lopoa #ectrims2022 https://t.co/sbswwxwofr,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,dr majid pahlevan kakhki held an mcdonald fellowship and studies epigenetics of progressive multiple sclerosis ec trims
541,It was a great pleasure to present our latest data on cross-regional transcriptomic reactivity in MS @ECTRIMS - the first study to integrate three CNS regions on single cell resolution in human disease ü•≥ many thanks for this opportunity @schirmerlab #ECTRIMS2022 #MS #SingleCell,twitter,,TimTrobisch,,it was a great pleasure to present our latest data on cross-regional transcriptomic reactivity in ms @ectrims - the first study to integrate three cns regions on single cell resolution in human disease ü•≥ many thanks for this opportunity @schirmerlab #ectrims2022 #ms #singlecell,male,"#ectrims2022, #ms, #singlecell",Science,,it was a great pleasure to present our latest data on cross-regional transcriptomic reactivity in ms - the first study to integrate three cns regions on single cell resolution in human disease many thanks for this opportunity ec trims ms #singlecell
542,"Newest Updates in Multiple Sclerosis at ECTRIMS 2022: Tianrong Yeo, MBBS, MRCP, MMED, FAMS, MCI, PhD 

#MedPub #MedTwitter #MedEd #MedNews
https://t.co/iZYyvtcRfH",twitter,USA,MedPubApp,,"newest updates in multiple sclerosis at ectrims 2022: tianrong yeo, mbbs, mrcp, mmed, fams, mci, phd #medpub #medtwitter #meded #mednews https://t.co/izyyvtcrfh",unknown,"#medpub, #medtwitter, #meded, #mednews",,,"newest updates in multiple sclerosis at ectrims 2022: tianrong yeo, mbbs, mrcp, mmed, fams, mci, phd #medpub #medtwitter #meded #mednews"
543,"Newest Updates in Multiple Sclerosis at ECTRIMS 2022: Tianrong Yeo, MBBS, MRCP, MMED, FAMS, MCI, PhD 

#MedPub #NeuroTwitter #MedEd #Neurology
https://t.co/Ypjq2aETCK",twitter,,MedPubNeurology,,"newest updates in multiple sclerosis at ectrims 2022: tianrong yeo, mbbs, mrcp, mmed, fams, mci, phd #medpub #neurotwitter #meded #neurology https://t.co/ypjq2aetck",,"#medpub, #neurotwitter, #meded, #neurology",,,"newest updates in multiple sclerosis at ectrims 2022: tianrong yeo, mbbs, mrcp, mmed, fams, mci, phd #medpub #neurotwitter #meded #neurology"
544,‚Å¶@hannah_kapell‚Å© gave another beautiful talk ‚Å¶@ECTRIMS‚Å© on #neuroglial potassium channel interaction as a therapeutic target in #MS - wonderful presentation putting the node of Ranvier center stage - very happy to work with this amazing team ‚Å¶@schirmerlab‚Å© https://t.co/bNxW5jTojl,twitter,DEU,schirmerlab,,‚Å¶@hannah_kapell‚Å© gave another beautiful talk ‚Å¶@ectrims‚Å© on #neuroglial potassium channel interaction as a therapeutic target in #ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team ‚Å¶@schirmerlab‚Å© https://t.co/bnxw5jtojl,male,"#neuroglial, #ms",Science,"{profession=Scientist & Researcher, jobTitle=Neurologist}",gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team
545,"Treating the depression or the disease? Pseudo-trial with the UK MS Register. Our Dr Jeff Rodgers, senior analyst‚Äôs poster #ECTRIMS2022 https://t.co/1y0ial2BjG",twitter,,UKMSRegister,,"treating the depression or the disease? pseudo-trial with the uk ms register. our dr jeff rodgers, senior analyst‚Äôs poster #ectrims2022 https://t.co/1y0ial2bjg",,#ectrims2022,,,"treating the depression or the disease? pseudo-trial with the uk ms register. our dr jeff rodgers, senior analysts poster ec trims"
546,"The impact of healthcare symptoms on clinical diagnosis and DMT usage in relapse-onset MS: a real world perspective in five registries across Europe. Our clinical lead, Dr Richard Nicholas‚Äô poster #ECTRIMS2022 https://t.co/L3r5C3l5Oo",twitter,,UKMSRegister,,"the impact of healthcare symptoms on clinical diagnosis and dmt usage in relapse-onset ms: a real world perspective in five registries across europe. our clinical lead, dr richard nicholas‚Äô poster #ectrims2022 https://t.co/l3r5c3l5oo",,#ectrims2022,,,"the impact of healthcare symptoms on clinical diagnosis and dmt usage in relapse-onset ms: a real world perspective in five registries across europe. our clinical lead, dr richard nicholas poster ec trims"
547,"Women supporting women üôåüèª

@IntNatlWiMS @ECTRIMS #MultipleSclerosis #ECTRIMS2022",twitter,USA,EleniVasileiou_,,women supporting women üôåüèª @intnatlwims @ectrims #multiplesclerosis #ectrims2022,female,"#multiplesclerosis, #ectrims2022",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}",women supporting women multiple sclerosis ec trims
548,Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with¬†MS https://t.co/eCA9ZYE8QW,twitter,USA,Biotech_Winners,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms https://t.co/eca9zye8qw,unknown,,,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms
549,New Data at ECTRIMS 2022 Highlight Biogen‚Äôs Commitment to Advancing Individualized Disease Management for People Living with¬†MS https://t.co/heLo6jLhub,twitter,USA,Biotech_Winners,,new data at ectrims 2022 highlight biogen‚Äôs commitment to advancing individualized disease management for people living with ms https://t.co/helo6jlhub,unknown,,,,new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people living with ms
550,OCREVUS has 7+ years of clinical data. See what's next at #ECTRIMS2022. Please see full Prescribing Information at https://t.co/k33kg31vLt. Intended for US healthcare professionals only. https://t.co/DcXYiFH1qT,twitter,USA,OCREVUSHCP_USA,,ocrevus has 7+ years of clinical data. see what's next at #ectrims2022. please see full prescribing information at https://t.co/k33kg31vlt. intended for us healthcare professionals only. https://t.co/dcxyifh1qt,,#ectrims2022,,,ocrevus has 7+ years of clinical data. see what's next at ec trims. please see full prescribing information at . intended for us healthcare professionals only.
551,#ECTRIMS2022 Another form of progress in #MSResearch: 5 out of 6 presenters at myelin repair session were women: https://t.co/53RVij6z4Q,twitter,,mssociety,,#ectrims2022 another form of progress in #msresearch: 5 out of 6 presenters at myelin repair session were women: https://t.co/53rvij6z4q,female,"#ectrims2022, #msresearch",,,ec trims another form of progress in msresearch: 5 out of 6 presenters at myelin repair session were women:
552,"@ECTRIMS Professor Desmond Graham, board member at MSIF and president of @MS_Australia co-chaired this important session alongside Dr Maya Zeineeddine, MS specialist and faculty member at the Middle East North Africa Committee for Treatment and Research in MS (MENACTRIMS). https://t.co/pX2uqENghv",twitter,,MSIntFederation,,"@ectrims professor desmond graham, board member at msif and president of @ms_australia co-chaired this important session alongside dr maya zeineeddine, ms specialist and faculty member at the middle east north africa committee for treatment and research in ms (menactrims). https://t.co/px2uqenghv",female,,,,"professor desmond graham, board member at msif and president of co-chaired this important session alongside dr maya zeineeddine, ms specialist and faculty member at the middle east north africa committee for treatment and research in ms (menactrims)."
553,"One of our research analysts, James standing next to his poster #ECTRIMS2022 The impact of changing diagnostic criteria on the incidence, prevalence and disease impact of MS using Welsh routine data https://t.co/SSkbW031AN",twitter,,UKMSRegister,,"one of our research analysts, james standing next to his poster #ectrims2022 the impact of changing diagnostic criteria on the incidence, prevalence and disease impact of ms using welsh routine data https://t.co/sskbw031an",,#ectrims2022,,,"one of our research analysts, james standing next to his poster ec trims the impact of changing diagnostic criteria on the incidence, prevalence and disease impact of ms using welsh routine data"
554,We are working to realize a future where data is more readily leveraged to improve the lives of people living with #MultipleSclerosis (MS). Read our news release to learn more about our digital health advancements. #ECTRIMS2022,twitter,USA,biogen,,we are working to realize a future where data is more readily leveraged to improve the lives of people living with #multiplesclerosis (ms). read our news release to learn more about our digital health advancements. #ectrims2022,,"#multiplesclerosis, #ectrims2022","Beauty/Health & Fitness, Science",,we are working to realize a future where data is more readily leveraged to improve the lives of people living with multiple sclerosis (ms). read our news release to learn more about our digital health advancements. ec trims
555,"Meet our Spherix Neurology team! All ready to go and set up for success at the ECTRIMS conference in Amsterdam, NL!

Be sure to visit us at booth #D19, see you there!!  

#ECTRIMS2022 #neurology #multiplesclerosis https://t.co/oef0x1u58u",twitter,USA,SpherixNeuro,,"meet our spherix neurology team! all ready to go and set up for success at the ectrims conference in amsterdam, nl! be sure to visit us at booth #d19, see you there!! #ectrims2022 #neurology #multiplesclerosis https://t.co/oef0x1u58u",unknown,"#d19, #ectrims2022, #neurology, #multiplesclerosis","Beauty/Health & Fitness, Business",,"meet our spherix neurology team! all ready to go and set up for success at the ectrims conference in amsterdam, nl! be sure to visit us at booth #d19, see you there!! ec trims #neurology multiple sclerosis"
556,Are you a digital health company developing tools based on #PRO measures for #MS? Are you attending #ECTRIMS2022? WG3 Co-Leaders Letizia Leocani and Rob Hyde will explain to you how to contribute to our e-health catalogue on 27-28/10. More info at: https://t.co/1MpB8jFRTv https://t.co/zinDlqDvJk,twitter,,PromsInitiative,,are you a digital health company developing tools based on #pro measures for #ms? are you attending #ectrims2022? wg3 co-leaders letizia leocani and rob hyde will explain to you how to contribute to our e-health catalogue on 27-28/10. more info at: https://t.co/1mpb8jfrtv https://t.co/zindlqdvjk,unknown,"#pro, #ms, #ectrims2022",,,are you a digital health company developing tools based on #pro measures for ms? are you attending ec trims? wg3 co-leaders letizia leocani and rob hyde will explain to you how to contribute to our e-health catalogue on 27-28/10. more info at:
557,#ECTRIMS2022 @GavinGiovannoni: Growing #MSResearch suggests undertreatment with less effective therapies a significant problem & can lead to poorer outcomes: https://t.co/jkhkkPuBsQ,twitter,,mssociety,,#ectrims2022 @gavingiovannoni: growing #msresearch suggests undertreatment with less effective therapies a significant problem & can lead to poorer outcomes: https://t.co/jkhkkpubsq,female,"#ectrims2022, #msresearch",,,ec trims : growing msresearch suggests undertreatment with less effective therapies a significant problem & can lead to poorer outcomes:
558,"Live at #ECTRIMS2022 üìΩÔ∏è√Ängela Vidal-Jordana (@cemcat_em) shared updates on the clinical implementation of optic nerve lesions in the McDonald criteria & her work analyzing the association between OCT measures and serum and CSF biomarkers

@ECTRIMS #MS #Neurology #NeuroTwitter https://t.co/EKF0VBRFDM",twitter,,VJNeurology,,live at #ectrims2022 üìΩÔ∏è√†ngela vidal-jordana (@cemcat_em) shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers @ectrims #ms #neurology #neurotwitter https://t.co/ekf0vbrfdm,,"#ectrims2022, #ms, #neurology, #neurotwitter",Photo & Video,,live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter
559,"Always a pleasure to speak with w/ Ferhan Qureshi of @OctaveBio about their multivariate proteomic MS disease activity test

Interview coming soon at ‚ú®https://t.co/FB5htuqt0q‚ú®

#ECTRIMS2022 @ECTRIMS #MS #Neurology #NeuroTwitter https://t.co/1cNGx14WXO",twitter,,VJNeurology,,always a pleasure to speak with w/ ferhan qureshi of @octavebio about their multivariate proteomic ms disease activity test interview coming soon at ‚ú®https://t.co/fb5htuqt0q‚ú® #ectrims2022 @ectrims #ms #neurology #neurotwitter https://t.co/1cngx14wxo,,"#ectrims2022, #ms, #neurology, #neurotwitter",Photo & Video,,always a pleasure to speak with w/ ferhan qureshi of about their multivariate proteomic ms disease activity test interview coming soon at ec trims ms #neurology #neurotwitter
560,‚Å¶@ECTRIMS‚Å© Dr Schoonheim discusses that MS is a network disease. Using #fmri can measure network flexibility https://t.co/11vpuMsfhC,twitter,CAN,michploughman,,‚Å¶@ectrims‚Å© dr schoonheim discusses that ms is a network disease. using #fmri can measure network flexibility https://t.co/11vpumsfhc,female,#fmri,Beauty/Health & Fitness,,dr schoonheim discusses that ms is a network disease. using fmri can measure network flexibility
561,"The Braindate team is in Amsterdam üá≥üá±

@ECTRIMS  

We are very happy to announce that we are hosting Neuro leaders in knowledge-sharing conversations at #ectrims2022 in the NeuroNetwork Braindate Lounge to accelerate research in #MS 

#ECTRIMS2022 #research https://t.co/x9Lfj7O8iY",twitter,CAN,e180,,the braindate team is in amsterdam üá≥üá± @ectrims we are very happy to announce that we are hosting neuro leaders in knowledge-sharing conversations at #ectrims2022 in the neuronetwork braindate lounge to accelerate research in #ms #ectrims2022 #research https://t.co/x9lfj7o8iy,,"#ectrims2022, #ms, #ectrims2022, #research",,,the braindate team is in amsterdam we are very happy to announce that we are hosting neuro leaders in knowledge-sharing conversations at ec trims in the neuronetwork braindate lounge to accelerate research in ms ec trims #research
562,Post 2 of the Postersession at #ECTRIMS2022 : many studies about pregnancy and young ladies. Where are the studies about women in their 40s or #menopause? #ms,twitter,DEU,Birgitpower,,post 2 of the postersession at #ectrims2022 : many studies about pregnancy and young ladies. where are the studies about women in their 40s or #menopause? #ms,female,"#ectrims2022, #menopause, #ms",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",post 2 of the postersession at ec trims : many studies about pregnancy and young ladies. where are the studies about women in their 40s or #menopause? ms
563,"Attending #ECTRIMS2022? Hear more about Janssen‚Äôs work in #MultipleSclerosis from Allitia DiBernardo, M.D., and check out our 15 abstracts at this year‚Äôs congress. https://t.co/VtTFo1zAGe https://t.co/km3krchQKO",twitter,USA,JanssenGlobal,,"attending #ectrims2022? hear more about janssen‚Äôs work in #multiplesclerosis from allitia dibernardo, m.d., and check out our 15 abstracts at this year‚Äôs congress. https://t.co/vttfo1zage https://t.co/km3krchqko",,"#ectrims2022, #multiplesclerosis",Beauty/Health & Fitness,,"attending ec trims? hear more about janssens work in multiple sclerosis from allitia dibernardo, m.d., and check out our 15 abstracts at this years congress."
564,"‚Å¶Pleased to share the first MRI evaluation of the topographical model of #MS introducing a new metric ‚Äî lesion parenchymal fraction (LPF) ‚Äî as an ePoster @ECTRIMS. 
A wonderful collab with ‚Å¶@icometrix‚Å©! #ECTRIMS2022 https://t.co/eND4qGyIrF",twitter,USA,SKriegerMD,,‚Å¶pleased to share the first mri evaluation of the topographical model of #ms introducing a new metric ‚Äî lesion parenchymal fraction (lpf) ‚Äî as an eposter @ectrims. a wonderful collab with ‚Å¶@icometrix‚Å©! #ectrims2022 https://t.co/end4qgyirf,male,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Neurologist}",pleased to share the first mri evaluation of the topographical model of ms introducing a new metric lesion parenchymal fraction (lpf) as an eposter . a wonderful collab with ! ec trims
565,#HCPs: Register and join our #ECTRIMS2022 symposium for discussion on strategies in #MultipleSclerosis (#MS) care across the patient lifespan. Learn more here:,twitter,USA,biogen,,#hcps: register and join our #ectrims2022 symposium for discussion on strategies in #multiplesclerosis (#ms) care across the patient lifespan. learn more here:,,"#hcps, #ectrims2022, #multiplesclerosis, #ms","Beauty/Health & Fitness, Science",,#hcps: register and join our ec trims symposium for discussion on strategies in multiple sclerosis (ms) care across the patient lifespan. learn more here:
566,"Jan Hillert: MS is a ‚Äòhomogeneous disease‚Äô in terms of onset/serverity and treatment responses, so therefore ‚Äòprecision medicine‚Äô, tailored to a specific individual disease mechanism is likely not possible‚Ä¶but does emphasize on going for personalized approach! 
#ECTRIMS2022 https://t.co/spmykrVmbF",twitter,BEL,bart_professor,,"jan hillert: ms is a ‚Äòhomogeneous disease‚Äô in terms of onset/serverity and treatment responses, so therefore ‚Äòprecision medicine‚Äô, tailored to a specific individual disease mechanism is likely not possible‚Ä¶but does emphasize on going for personalized approach! #ectrims2022 https://t.co/spmykrvmbf",unknown,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}","jan hillert: ms is a homogeneous disease in terms of onset/serverity and treatment responses, so therefore precision medicine, tailored to a specific individual disease mechanism is likely not possiblebut does emphasize on going for personalized approach! ec trims"
567,Poster Session at #ECTRIMS2022 and I Wonder why study / research projects don‚Äôt differ in women and men when it comes to find out thing. There are differences and we should have data about it. Or find. #ms #datasaveslives,twitter,DEU,Birgitpower,,poster session at #ectrims2022 and i wonder why study / research projects don‚Äôt differ in women and men when it comes to find out thing. there are differences and we should have data about it. or find. #ms #datasaveslives,female,"#ectrims2022, #ms, #datasaveslives",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",poster session at ec trims and i wonder why study / research projects dont differ in women and men when it comes to find out thing. there are differences and we should have data about it. or find. ms #datasaveslives
568,"Prof Tomas Kalincik (@UniMelb, @TheRMH) presents data at #ECTRIMS2022 suggesting #AHSCT is superior to fingolimod & natalizumab in preventing relapses in people living with #MultipleSclerosis. What does the future hold for stem cell transplants as a treatment option in #MS? https://t.co/X19JpbwZbN",twitter,AUS,MStranslate,,"prof tomas kalincik (@unimelb, @thermh) presents data at #ectrims2022 suggesting #ahsct is superior to fingolimod & natalizumab in preventing relapses in people living with #multiplesclerosis. what does the future hold for stem cell transplants as a treatment option in #ms? https://t.co/x19jpbwzbn",,"#ectrims2022, #ahsct, #multiplesclerosis, #ms",,,"prof tomas kalincik (, ) presents data at ec trims suggesting #ahsct is superior to fingolimod & natalizumab in preventing relapses in people living with multiple sclerosis. what does the future hold for stem cell transplants as a treatment option in ms?"
569,"Joelle Massouh: #MS prevalence on the rise in #MiddleEast/#NorthAfrica. 2011 brought in MS #nursing, but many challenges. Now: lots of efforts to improve training, certification, access to care. #ECTRIMS2022",twitter,,IJMSCtweets,,"joelle massouh: #ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. #ectrims2022",,"#ms, #middleeast, #northafrica, #nursing, #ectrims2022",,,"joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims"
570,"Keeping working on #MTR in the  #optic pathway. Come and have a look to our poster on ‚ÄúThe use of MTR in demonstrating the neuroprotective effect of Phenytoin in patients with acute optic neuritis‚Äù at #ECTRIMS (poster P320).

#ECTRIMS2022 #MultipleSclerosis #MRI https://t.co/HWEsqffc9N",twitter,GBR,alessia_bia,,keeping working on #mtr in the #optic pathway. come and have a look to our poster on ‚Äúthe use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis‚Äù at #ectrims (poster p320). #ectrims2022 #multiplesclerosis #mri https://t.co/hwesqffc9n,female,"#mtr, #optic, #ectrims, #ectrims2022, #multiplesclerosis, #mri",Science,"{profession=Student, jobTitle=Student}, {profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}",keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri
571,We‚Äôre pleased to be in Amsterdam this week at #ECTRIMS! We‚Äôre ready to tackle the latest in #MultipleSclerosis research and innovation. Drop by our booth #D07: https://t.co/xWEXhNZFAV https://t.co/tHFZAsmR7k,twitter,USA,QuanterixSimoa,,we‚Äôre pleased to be in amsterdam this week at #ectrims! we‚Äôre ready to tackle the latest in #multiplesclerosis research and innovation. drop by our booth #d07: https://t.co/xwexhnzfav https://t.co/thfzasmr7k,unknown,"#ectrims, #multiplesclerosis, #d07",,,were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:
572,"Joelle Massouh, #MultipleSclerosis nurse, describes some of the methods used to increase the number of specialist nurses in the MENA region - and the importance of building trust with people affected by MS

#ECTRIMS2022 https://t.co/ZhaEFuj5gF",twitter,GBR,AnneHelme,,"joelle massouh, #multiplesclerosis nurse, describes some of the methods used to increase the number of specialist nurses in the mena region - and the importance of building trust with people affected by ms #ectrims2022 https://t.co/zhaefuj5gf",female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,"joelle massouh, multiple sclerosis nurse, describes some of the methods used to increase the number of specialist nurses in the mena region - and the importance of building trust with people affected by ms ec trims"
573,Could ECM be a factor for successful remyelination in #multiplesclerosis - great presentation by @JodydeJong3 at #ECTRIMS2022 https://t.co/6r04G7nSw0,twitter,NLD,GaultierAlban,,could ecm be a factor for successful remyelination in #multiplesclerosis - great presentation by @jodydejong3 at #ectrims2022 https://t.co/6r04g7nsw0,male,"#multiplesclerosis, #ectrims2022",,"{profession=Scientist & Researcher, jobTitle=Researcher}",could ecm be a factor for successful remyelination in multiple sclerosis - great presentation by at ec trims
574,"""Wellness is not the absence of illness‚Äù ~Dr. Brenda Banwell #MS #ECTRIMS2022",twitter,,IJMSCtweets,,"""wellness is not the absence of illness‚Äù ~dr. brenda banwell #ms #ectrims2022",,"#ms, #ectrims2022",,,"""wellness is not the absence of illness ~dr. brenda banwell ms ec trims"
575,#MS #pregnancy #ECTRIMS2022,twitter,,IJMSCtweets,,#ms #pregnancy #ectrims2022,,"#ms, #pregnancy, #ectrims2022",,,ms #pregnancy ec trims
576,"Do MS nurses improve outcomes for patients? Massively! And the evidence is well now documented. https://t.co/i2RqepBt2k So, why is our Australian MS nurse workforce shrinking, not growing to meet unmet need? Belinda Bardsley presenting at #ECTRIMS2022 https://t.co/wjLJcqFFJY",twitter,AUS,RohanGreenland,,"do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. https://t.co/i2rqepbt2k so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at #ectrims2022 https://t.co/wjljcqffjy",male,#ectrims2022,"Beauty/Health & Fitness, Business","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Vice President}","do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims"
577,@drruthdobson @ECTRIMS Looking at your tweets this seems very poor organisation. I was diagnosed with MS just after my daughter was born - but had I been a patient with MS considering pregnancy/DMTs etc this information for me (and my HCPs) is so important. How will it be disseminated?,twitter,GBR,PatriciaMunn604,,@drruthdobson @ectrims looking at your tweets this seems very poor organisation. i was diagnosed with ms just after my daughter was born - but had i been a patient with ms considering pregnancy/dmts etc this information for me (and my hcps) is so important. how will it be disseminated?,female,,"Books, Food & Drinks, Family & Parenting, Fine arts","{profession=Teacher & Lecturer, jobTitle=Teacher}, {profession=Sales/Marketing/PR, jobTitle=Marketeer}",looking at your tweets this seems very poor organisation. i was diagnosed with ms just after my daughter was born - but had i been a patient with ms considering pregnancy/dmts etc this information for me (and my hcps) is so important. how will it be disseminated?
578,"Come to see our on site posters number 48 (MDSCs and disease severity in MS) and 307 (Evobrutinib @Merck effect over classical Dendritic Cells in EAE) , this Wednesday, 16:30 at #ECTRIMS2022 presented by @MCrisOrtega14 and @MariPazSerReg respectively. @HNParaplejicos https://t.co/wYhUeoZQAe",twitter,ESP,DrDiegoClemente,,"come to see our on site posters number 48 (mdscs and disease severity in ms) and 307 (evobrutinib @merck effect over classical dendritic cells in eae) , this wednesday, 16:30 at #ectrims2022 presented by @mcrisortega14 and @maripazserreg respectively. @hnparaplejicos https://t.co/wyhueozqae",male,#ectrims2022,Beauty/Health & Fitness,,"come to see our on site posters number 48 (mdscs and disease severity in ms) and 307 (evobrutinib effect over classical dendritic cells in eae) , this wednesday, 16:30 at ec trims presented by and respectively."
579,"Belinda Bardsley presents research from @MS_Australia demonstrating poorer health outcomes if you have no access to a #MultipleSclerosis nurse

#ECTRIMS2022 https://t.co/ddqI4KuaVK",twitter,GBR,AnneHelme,,belinda bardsley presents research from @ms_australia demonstrating poorer health outcomes if you have no access to a #multiplesclerosis nurse #ectrims2022 https://t.co/ddqi4kuavk,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,belinda bardsley presents research from demonstrating poorer health outcomes if you have no access to a multiple sclerosis nurse ec trims
580,Dosing of monoclonal antibodies in #MS should not be one size fits all - Dr. van Kempen #ECTRIMS2022 https://t.co/x8RPYEjSJl,twitter,USA,DrJNicholas,,dosing of monoclonal antibodies in #ms should not be one size fits all - dr. van kempen #ectrims2022 https://t.co/x8rpyejsjl,female,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",dosing of monoclonal antibodies in ms should not be one size fits all - dr. van kempen ec trims
581,"It's a pleasure to be back in ECTRIMS presenting our data on site! Come and see our results today from 4:30 to 6:30 p.m  on posters P48 and P307! We have also 2 eposters presented by Camacho-Toledano, C and @leticalahorra #ECTRIMS2022 #MDSCs #MultipleSclerosis
@DrDiegoClemente",twitter,,MCrisOrtega14,,"it's a pleasure to be back in ectrims presenting our data on site! come and see our results today from 4:30 to 6:30 p.m on posters p48 and p307! we have also 2 eposters presented by camacho-toledano, c and @leticalahorra #ectrims2022 #mdscs #multiplesclerosis @drdiegoclemente",female,"#ectrims2022, #mdscs, #multiplesclerosis",,,"it's a pleasure to be back in ectrims presenting our data on site! come and see our results today from 4:30 to 6:30 p.m on posters p48 and p307! we have also 2 eposters presented by camacho-toledano, c and ec trims #mdscs multiple sclerosis"
582,"Dra. van Kempen.

EID of natalizumab is as effective as 4wk interval. We've already known but is important to remember it. Personal note: it's not reduce PML risk.
We'll see if extend ocrelizumab is effective.

#ECTRIMS2022",twitter,,IlNeuroDoktorMS,,dra. van kempen. eid of natalizumab is as effective as 4wk interval. we've already known but is important to remember it. personal note: it's not reduce pml risk. we'll see if extend ocrelizumab is effective. #ectrims2022,male,#ectrims2022,,,dra. van kempen. eid of natalizumab is as effective as 4wk interval. we've already known but is important to remember it. personal note: it's not reduce pml risk. we'll see if extend ocrelizumab is effective. ec trims
583,Happy to present this @StarMStrial poster at #ECTRIMS2022. #aHSCT #MS https://t.co/OsYSeJIUiT,twitter,NLD,gavinbrittain,,happy to present this @starmstrial poster at #ectrims2022. #ahsct #ms https://t.co/osysejiuit,male,"#ectrims2022, #ahsct, #ms","Beauty/Health & Fitness, Science, Sports","{profession=Student, jobTitle=PhD Candidate}",happy to present this poster at ec trims. #ahsct ms
584,Catherine Lubetzki at #ECTRIMS2022 : Remyelination is currently THE major challenge in multiple sclerosis. Luckily we have quite some expertise about this at @BIOMED_UHasselt üòâ https://t.co/KyLD8U8XBD,twitter,,AnVoets,,catherine lubetzki at #ectrims2022 : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at @biomed_uhasselt üòâ https://t.co/kyld8u8xbd,unknown,#ectrims2022,"Business, Technology","{profession=Sales/Marketing/PR, jobTitle=Business Developer}, {profession=Software developer & IT, jobTitle=Developer}",catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at
585,Fantastic talk from ‚Å¶@J_SastreGarriga‚Å© on personalised medicine in multiple sclerosis ‚Å¶@ECTRIMS‚Å© https://t.co/6FvQjTQvNT,twitter,GBR,nikosevangelou3,,fantastic talk from ‚Å¶@j_sastregarriga‚Å© on personalised medicine in multiple sclerosis ‚Å¶@ectrims‚Å© https://t.co/6fvqjtqvnt,unknown,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",fantastic talk from on personalised medicine in multiple sclerosis
586,‚Å¶@SophiaSchwarz15‚Å© gave a terrific talk ‚Å¶@ECTRIMS‚Å© about optic neuritis in #MS going for paired #SingleCell #Spatial w/ @Cels121 - Great collaboration w/ Kate Fitzgerald and ‚Å¶@Calabre04804429‚Å© - Very proud of ‚Å¶@schirmerlab‚Å© ‚Å¶for all the efforts & science! https://t.co/0fk3qT0rC1,twitter,DEU,schirmerlab,,‚Å¶@sophiaschwarz15‚Å© gave a terrific talk ‚Å¶@ectrims‚Å© about optic neuritis in #ms going for paired #singlecell #spatial w/ @cels121 - great collaboration w/ kate fitzgerald and ‚Å¶@calabre04804429‚Å© - very proud of ‚Å¶@schirmerlab‚Å© ‚Å¶for all the efforts & science! https://t.co/0fk3qt0rc1,male,"#ms, #singlecell, #spatial",Science,"{profession=Scientist & Researcher, jobTitle=Neurologist}",gave a terrific talk about optic neuritis in ms going for paired #singlecell #spatial w/ - great collaboration w/ kate fitzgerald and - very proud of for all the efforts & science!
587,Dr Therese Burke of @MS_Australia and past president of MS Nurses Australasia at #ECTRIMS2022 discussing what MS nurses do and how they use patient experience to enhance nursing care. Powerful presentation all politicians should hear! https://t.co/29dPIr5M8p,twitter,AUS,RohanGreenland,,dr therese burke of @ms_australia and past president of ms nurses australasia at #ectrims2022 discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear! https://t.co/29dpir5m8p,male,#ectrims2022,"Beauty/Health & Fitness, Business","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Vice President}",dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!
588,@AnneHelme How would you describe the role of the #MultipleSclerosis nurse? #ECTRIMS2022 https://t.co/2ViyOS8O7d,twitter,GBR,AnneHelme,,@annehelme how would you describe the role of the #multiplesclerosis nurse? #ectrims2022 https://t.co/2viyos8o7d,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,how would you describe the role of the multiple sclerosis nurse? ec trims
589,"Dr Therese Burke @MS_Australia starts the @MSIntFederation session on why we urgently need more #MultipleSclerosis nurses across the globe üßë‚Äç‚öïÔ∏èüåè

#ECTRIMS2022 https://t.co/FlQ2w2lqDE",twitter,GBR,AnneHelme,,dr therese burke @ms_australia starts the @msintfederation session on why we urgently need more #multiplesclerosis nurses across the globe üßë‚Äç‚öïÔ∏èüåè #ectrims2022 https://t.co/flq2w2lqde,female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,dr therese burke starts the session on why we urgently need more multiple sclerosis nurses across the globe ec trims
590,We are pleased to present new data from across our portfolio of #MultipleSclerosis (#MS) therapies at #ECTRIMS2022. Read more:,twitter,USA,biogen,,we are pleased to present new data from across our portfolio of #multiplesclerosis (#ms) therapies at #ectrims2022. read more:,,"#multiplesclerosis, #ms, #ectrims2022","Beauty/Health & Fitness, Science",,we are pleased to present new data from across our portfolio of multiple sclerosis (ms) therapies at ec trims. read more:
591,"Congratulations @weinerlabhms and $Tanuja Chitnis on your presentation @ECTRIMS today: Nasal anti-CD3 monoclonal antibody (Foralumab) reduces PET microglial activation and blood inflammatory biomarkers in two patients with non-active SPMS

#MultipleSclerosis #ECTRIMS2022",twitter,,TizianaLS,,congratulations @weinerlabhms and $tanuja chitnis on your presentation @ectrims today: nasal anti-cd3 monoclonal antibody (foralumab) reduces pet microglial activation and blood inflammatory biomarkers in two patients with non-active spms #multiplesclerosis #ectrims2022,unknown,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,congratulations and $tanuja chitnis on your presentation today: nasal anti-cd3 monoclonal antibody (foralumab) reduces pet microglial activation and blood inflammatory biomarkers in two patients with non-active spms multiple sclerosis ec trims
592,"Great to talk about improving #MS care via blood #biomarkers, advanced imaging metrics and innovative biosensor digital monitoring with @SKriegerMD, Dr. Chitnis & Dr. Graves. #ECTRIMS2022 @themsguide @MustStopMS https://t.co/seoZ0m5mQP",twitter,USA,drbarrysinger,,"great to talk about improving #ms care via blood #biomarkers, advanced imaging metrics and innovative biosensor digital monitoring with @skriegermd, dr. chitnis & dr. graves. #ectrims2022 @themsguide @muststopms https://t.co/seoz0m5mqp",male,"#ms, #biomarkers, #ectrims2022",Science,,"great to talk about improving ms care via blood #biomarkers, advanced imaging metrics and innovative biosensor digital monitoring with , dr. chitnis & dr. graves. ec trims"
593,"More than 8,200 participants from 109 countries #ECTRIMS2022 to accelerate research in #MS https://t.co/EzoleLTyaa",twitter,CAN,PamelaKanellis,,"more than 8,200 participants from 109 countries #ectrims2022 to accelerate research in #ms https://t.co/ezoleltyaa",female,"#ectrims2022, #ms",,,"more than 8,200 participants from 109 countries ec trims to accelerate research in ms"
594,"Can MS be prevented by treating it in the subclinical/prodromal (before characteristic symptoms) phase? Trials mentioned during ‚ÄòEvolving the Paradigm of Patient Care in MS and Forging a Path Ahead‚Äô (CELLO, TERIS and ARISE) aim to explore just that. #ECTRIMS2022",twitter,IRL,aoifemkirwan,,"can ms be prevented by treating it in the subclinical/prodromal (before characteristic symptoms) phase? trials mentioned during ‚Äòevolving the paradigm of patient care in ms and forging a path ahead‚Äô (cello, teris and arise) aim to explore just that. #ectrims2022",female,#ectrims2022,,,"can ms be prevented by treating it in the subclinical/prodromal (before characteristic symptoms) phase? trials mentioned during evolving the paradigm of patient care in ms and forging a path ahead (cello, teris and arise) aim to explore just that. ec trims"
595,Today we presented new MRI biomarker data and updated open-label extension (OLE) clinical data from our Phase 1 study of investigational ATA188 for progressive forms of #MS at @ECTRIMS. Catch the details below: https://t.co/NYuzo79qFe #ECTRIMS2022 https://t.co/MGUYh82zaI,twitter,USA,Atarabio,,today we presented new mri biomarker data and updated open-label extension (ole) clinical data from our phase 1 study of investigational ata188 for progressive forms of #ms at @ectrims. catch the details below: https://t.co/nyuzo79qfe #ectrims2022 https://t.co/mguyh82zai,unknown,"#ms, #ectrims2022",,,today we presented new mri biomarker data and updated open-label extension (ole) clinical data from our phase 1 study of investigational ata188 for progressive forms of ms at . catch the details below: ec trims
596,The positive impact of #research and DMT for #MultipleSclerosis patients #ECTRIMS2022 https://t.co/h7nTq1q868,twitter,NLD,GaultierAlban,,the positive impact of #research and dmt for #multiplesclerosis patients #ectrims2022 https://t.co/h7ntq1q868,male,"#research, #multiplesclerosis, #ectrims2022",,"{profession=Scientist & Researcher, jobTitle=Researcher}",the positive impact of #research and dmt for multiple sclerosis patients ec trims
597,Progress in #MS Dr. Giovannoni. We still must do better #ECTRIMS2022 https://t.co/FSHETwEPjV,twitter,USA,DrJNicholas,,progress in #ms dr. giovannoni. we still must do better #ectrims2022 https://t.co/fshetwepjv,female,"#ms, #ectrims2022",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",progress in ms dr. giovannoni. we still must do better ec trims
598,#ECTRIMS2022 Kickoff: $TGTX will be presenting data from the Ph3 ULTIMATE I & II trials of #ublituximab in #MS @ ECTRIMS this Wed & Thurs. Check out our 5 presentations @ https://t.co/SvwvfBm7rZ - Visit our Booth-D30. Schedule/Details: https://t.co/2iCMe3iuU7 #FearlessForPatients https://t.co/lwTOLxeFdS,twitter,USA,TGTherapeutics,,#ectrims2022 kickoff: $tgtx will be presenting data from the ph3 ultimate i & ii trials of #ublituximab in #ms @ ectrims this wed & thurs. check out our 5 presentations @ https://t.co/svwvfbm7rz - visit our booth-d30. schedule/details: https://t.co/2icme3iuu7 #fearlessforpatients https://t.co/lwtolxefds,,"#ectrims2022, #ublituximab, #ms, #fearlessforpatients","Beauty/Health & Fitness, Business",,ec trims kickoff: $tgtx will be presenting data from the ph3 ultimate i & ii trials of ublituximab in ms ectrims this wed & thurs. check out our 5 presentations - visit our booth-d30. schedule/details: #fearlessforpatients
599,$ATRA Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022 https://t.co/XXMwU3P2xp,twitter,,GetOnTrade,,$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 https://t.co/xxmwu3p2xp,unknown,,Business,,$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022
600,"ECTRIMS2022:
All anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes
https://t.co/w4VJ1pSqDH
#Ofatumumab #Rituximab #Ocrelizumab #ublituximab $TGTX $RHHBY #ECTRIMS22 #ECTRIMS2022",twitter,CHE,Franca_ole,,ectrims2022: all anti-cd20 monoclonal antibodies have similar efficacy and safety risks: yes https://t.co/w4vj1psqdh #ofatumumab #rituximab #ocrelizumab #ublituximab $tgtx $rhhby #ectrims22 #ectrims2022,female,"#ofatumumab, #rituximab, #ocrelizumab, #ublituximab, #ectrims22, #ectrims2022",,,ectrims2022: all anti-cd20 monoclonal antibodies have similar efficacy and safety risks: yes #ofatumumab #rituximab #ocrelizumab ublituximab $tgtx $rhhby ec trims22 ec trims
601,Come and have a chat with me & team on trends in fertility and pregnancy in #MultipleSclerosis @ECTRIMS (Poster 082) https://t.co/zXL0BT1wQi,twitter,NLD,MarcelloMoccia_,,come and have a chat with me & team on trends in fertility and pregnancy in #multiplesclerosis @ectrims (poster 082) https://t.co/zxl0bt1wqi,male,#multiplesclerosis,"Food & Drinks, Sports, Travel",,come and have a chat with me & team on trends in fertility and pregnancy in multiple sclerosis (poster 082)
602,Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS - GlobeNewswire https://t.co/c3Ry40RGJD,twitter,,P7Type,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms - globenewswire https://t.co/c3ry40rgjd,unknown,,Technology,"{profession=Student, jobTitle=Student}",biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms - globenewswire
603,Fascinating opening lecture on Paediatric Onset MS by Dr Brenda Banwell. Treat early. Fingolimod established as effective. Trials of ocrelizumab & dimethyl fumarate are recruiting #neuropharmacy #ECTRIMS2022 https://t.co/SUqRBbcaVn,twitter,GBR,RayDorsey7,,fascinating opening lecture on paediatric onset ms by dr brenda banwell. treat early. fingolimod established as effective. trials of ocrelizumab & dimethyl fumarate are recruiting #neuropharmacy #ectrims2022 https://t.co/suqrbbcavn,male,"#neuropharmacy, #ectrims2022","Beauty/Health & Fitness, Family & Parenting, Business, Sports","{profession=Health practitioner, jobTitle=Pharmacist}",fascinating opening lecture on paediatric onset ms by dr brenda banwell. treat early. fingolimod established as effective. trials of ocrelizumab & dimethyl fumarate are recruiting #neuropharmacy ec trims
604,"The European Committee for Treatment & Research in Multiple Sclerosis conference is taking place

I'm not there, but great to see nutrition being highlighting by @EllenMowryMD, one of the leaders in the field 

Highlighted by fellow dietitian & MSer @YasmineProbst 
#ECTRIMS https://t.co/QFndOK6aOx",twitter,IRL,ConorKerley,,"the european committee for treatment & research in multiple sclerosis conference is taking place i'm not there, but great to see nutrition being highlighting by @ellenmowrymd, one of the leaders in the field highlighted by fellow dietitian & mser @yasmineprobst #ectrims https://t.co/qfndok6aox",male,#ectrims,Science,"{profession=Health practitioner, jobTitle=Dietitian}, {profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Researcher}","the european committee for treatment & research in multiple sclerosis conference is taking place i'm not there, but great to see nutrition being highlighting by , one of the leaders in the field highlighted by fellow dietitian & mser ec trims"
605,‚ÄúTreatment is not all we have‚Ä¶Wellness is a therapy [in MS] too.‚Äù - Prof Brenda Banwell #ECTRIMS2022,twitter,,OliviaWills20,,‚Äútreatment is not all we have‚Ä¶wellness is a therapy [in ms] too.‚Äù - prof brenda banwell #ectrims2022,female,#ectrims2022,"Beauty/Health & Fitness, Science, Politics, Food & Drinks","{profession=Student, jobTitle=PhD Candidate}",treatment is not all we havewellness is a therapy [in ms] too. - prof brenda banwell ec trims
606,"@EuropeanCharcot @PromsInitiative In these pictures are Professor Mario Battaglia, president of the AISM - Associazione Italiana Sclerosi Multipla sharing an overview of the PROMS initiative and Helga Weiland, Co-Chair of the PROMS Engagement and Coordination team introducing the session. #ECTRIMS2022 https://t.co/bhyvICOV0F",twitter,,MSIntFederation,,"@europeancharcot @promsinitiative in these pictures are professor mario battaglia, president of the aism - associazione italiana sclerosi multipla sharing an overview of the proms initiative and helga weiland, co-chair of the proms engagement and coordination team introducing the session. #ectrims2022 https://t.co/bhyvicov0f",female,#ectrims2022,,,"in these pictures are professor mario battaglia, president of the aism - associazione italiana sclerosi multipla sharing an overview of the proms initiative and helga weiland, co-chair of the proms engagement and coordination team introducing the session. ec trims"
607,Today representatives at #ECTRIMS2022 have been talking about the role of patient reported outcomes in MS research. @EuropeanCharcot shone a spotlight on the @PromsInitiative. Read more about the Global PROMS Initiative here: https://t.co/paDJJu9mJc,twitter,,MSIntFederation,,today representatives at #ectrims2022 have been talking about the role of patient reported outcomes in ms research. @europeancharcot shone a spotlight on the @promsinitiative. read more about the global proms initiative here: https://t.co/padjju9mjc,female,#ectrims2022,,,today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:
608,A captivating sand performance at #ECTRIMS2022 instilling hope through #multiplesclerosis research and clinical care grounded in patient engagement. https://t.co/9BUZD9BRzQ,twitter,USA,Heena_Manglani,,a captivating sand performance at #ectrims2022 instilling hope through #multiplesclerosis research and clinical care grounded in patient engagement. https://t.co/9buzd9brzq,female,"#ectrims2022, #multiplesclerosis",Beauty/Health & Fitness,,a captivating sand performance at ec trims instilling hope through multiple sclerosis research and clinical care grounded in patient engagement.
609,Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS¬†2022 https://t.co/x71qf0HQMJ,twitter,,PharmacDaily,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 https://t.co/x71qf0hqmj,,,,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022
610,"Beautiful opening to #ECTRIMS2022
Looking forward to learning the latest on multiple sclerosis and related conditions over the coming days https://t.co/RRA4iCZz3H",twitter,,wz_yeh,,beautiful opening to #ectrims2022 looking forward to learning the latest on multiple sclerosis and related conditions over the coming days https://t.co/rra4iczz3h,unknown,#ectrims2022,"Games, Science","{profession=Student, jobTitle=Student}, {profession=Scientist & Researcher, jobTitle=Neurologist}",beautiful opening to ec trims looking forward to learning the latest on multiple sclerosis and related conditions over the coming days
611,"Dr Brenda Banwell of @ChildrensPhila delivering her #ECTRIMS2022 lecture on #paediatric #MS NOW @ECTRIMS @Iamsterdam Vit D independent risk driver of MS in kids, healthy levels protective https://t.co/b9bp4NTqHr",twitter,GBR,KlausSchmierer,,"dr brenda banwell of @childrensphila delivering her #ectrims2022 lecture on #paediatric #ms now @ectrims @iamsterdam vit d independent risk driver of ms in kids, healthy levels protective https://t.co/b9bp4ntqhr",male,"#ectrims2022, #paediatric, #ms",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}","dr brenda banwell of delivering her ec trims lecture on #paediatric ms now vit d independent risk driver of ms in kids, healthy levels protective"
612,"Honoured to hear Dr Brenda Banwell‚Äôs @ECTRIMS lecture on paediatric multiple sclerosis üß†

Incredibly insightful regarding the challenges associated with diagnosing early-onset MS.

#ECTRIMS #ECTRIMS2022 #PaediatricMS https://t.co/tU50i4TXBW",twitter,,LivedHealth,,honoured to hear dr brenda banwell‚Äôs @ectrims lecture on paediatric multiple sclerosis üß† incredibly insightful regarding the challenges associated with diagnosing early-onset ms. #ectrims #ectrims2022 #paediatricms https://t.co/tu50i4txbw,unknown,"#ectrims, #ectrims2022, #paediatricms","Beauty/Health & Fitness, Photo & Video",,honoured to hear dr brenda banwells lecture on paediatric multiple sclerosis incredibly insightful regarding the challenges associated with diagnosing early-onset ms. ec trims ec trims #paediatricms
613,"triMSonline: It's day 1 of the @ECTRIMS congress in #Amsterdam!

Are you interested in sharing your #MS research with international peers at the upcoming seventh #triMSonline conference? Come and see the team at booth B02 for information on how to submit‚Ä¶ https://t.co/28G7LeAu08",twitter,GBR,GavinGiovannoni,,trimsonline: it's day 1 of the @ectrims congress in #amsterdam! are you interested in sharing your #ms research with international peers at the upcoming seventh #trimsonline conference? come and see the team at booth b02 for information on how to submit‚Ä¶ https://t.co/28g7leau08,male,"#amsterdam, #ms, #trimsonline",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}",trimsonline: it's day 1 of the congress in #amsterdam! are you interested in sharing your ms research with international peers at the upcoming seventh #trimsonline conference? come and see the team at booth b02 for information on how to submit
615,"It's day 1 of the @ECTRIMS congress in #Amsterdam!

Are you interested in sharing your #MS research with international peers at the upcoming seventh #triMSonline conference? Come and see the team at booth B02 for information on how to submit and display your work. https://t.co/MW3rq5J9b9",twitter,,triMSonline,,it's day 1 of the @ectrims congress in #amsterdam! are you interested in sharing your #ms research with international peers at the upcoming seventh #trimsonline conference? come and see the team at booth b02 for information on how to submit and display your work. https://t.co/mw3rq5j9b9,,"#amsterdam, #ms, #trimsonline",,,it's day 1 of the congress in #amsterdam! are you interested in sharing your ms research with international peers at the upcoming seventh #trimsonline conference? come and see the team at booth b02 for information on how to submit and display your work.
617,New Data at ECTRIMS 2022 Highlight Biogen $BIIB ‚Äôs Commitment to Advancing Individualized Disease Management for People Living with MS https://t.co/ffwgcfkXJG,twitter,FRA,BertrandBio,,new data at ectrims 2022 highlight biogen $biib ‚Äôs commitment to advancing individualized disease management for people living with ms https://t.co/ffwgcfkxjg,male,,"Technology, Fine arts, Business",,new data at ectrims 2022 highlight biogen $biib s commitment to advancing individualized disease management for people living with ms
618,Biogen $BIIB Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS https://t.co/ZE9MLAVVEy,twitter,FRA,BertrandBio,,biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms https://t.co/ze9mlavvey,male,,"Technology, Fine arts, Business",,biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms
619,Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS $BIIB https://t.co/7oLgZidWXR,twitter,USA,newsfilterio,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib https://t.co/7olgzidwxr,unknown,,Business,,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib
620,"$BIIB Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS
https://t.co/qhjn885r32",twitter,,StockNewsBot2,,$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms https://t.co/qhjn885r32,unknown,,,,$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms
621,"$BIIB üì∞ Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS

https://t.co/fg8ar2L6g4

45 seconds delayed.",twitter,,quantisnow,,$biib üì∞ biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms https://t.co/fg8ar2l6g4 45 seconds delayed.,unknown,,Business,,$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.
622,New Data at ECTRIMS 2022 Highlight Biogen‚Äôs Commitment to Advancing Individualized Disease Management for People L https://t.co/RtEmbpDMqz,twitter,USA,CrweWorld,,new data at ectrims 2022 highlight biogen‚Äôs commitment to advancing individualized disease management for people l https://t.co/rtembpdmqz,unknown,,,,new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people l
623,New Data at ECTRIMS 2022 Highlight Biogen's Commitment to Advancing Individualized Disease Management for People Living with MS https://t.co/0StvUiZv78 https://t.co/h3of70jZFK,twitter,USA,SniffOutStocks,,new data at ectrims 2022 highlight biogen's commitment to advancing individualized disease management for people living with ms https://t.co/0stvuizv78 https://t.co/h3of70jzfk,unknown,,Business,,new data at ectrims 2022 highlight biogen's commitment to advancing individualized disease management for people living with ms
624,New Data at ECTRIMS 2022 Highlight Biogen‚Äôs Commitment to Advancing Individualized Disease Management for People Living with MS - https://t.co/qXbB9NcOGu safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tole... https://t.co/QZIBctKFWk,twitter,USA,Dw40031913,,new data at ectrims 2022 highlight biogen‚Äôs commitment to advancing individualized disease management for people living with ms - https://t.co/qxbb9ncogu safety and efficacy results from the phase 3 evolve-ms-1 trial demonstrate decreases in disease activity and favorable tole... https://t.co/qzibctkfwk,male,,Business,"{profession=Executive, jobTitle=CEO}",new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people living with ms - safety and efficacy results from the phase 3 evolve-ms-1 trial demonstrate decreases in disease activity and favorable tole...
625,"$BIIB üì∞ New Data at ECTRIMS 2022 Highlight Biogen's Commitment to Advancing Individualized Disease Management for People Living with MS

https://t.co/Z5BXIHQPhL

45 seconds delayed.",twitter,,quantisnow,,$biib üì∞ new data at ectrims 2022 highlight biogen's commitment to advancing individualized disease management for people living with ms https://t.co/z5bxihqphl 45 seconds delayed.,unknown,,Business,,$biib new data at ectrims 2022 highlight biogen's commitment to advancing individualized disease management for people living with ms 45 seconds delayed.
626,"$BIIB New Data at ECTRIMS 2022 Highlight Biogen‚Äôs Commitment to Advancing Individualized Disease Management for People Living with MS
https://t.co/dZmkLBlGeI",twitter,,StockNewsBot2,,$biib new data at ectrims 2022 highlight biogen‚Äôs commitment to advancing individualized disease management for people living with ms https://t.co/dzmklblgei,unknown,,,,$biib new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people living with ms
627,"#MultipleSclerosis is a network disease, and @ECTRIMS is a network organisation, says #ECTRIMS2022 Chair Bernard Uitdehaag, emphasising the importance of the hybrid nature the event to ensure people can attend from all over the world and many different stakeholder groups https://t.co/ILumKkKWcm",twitter,,TheEviBase,,"#multiplesclerosis is a network disease, and @ectrims is a network organisation, says #ectrims2022 chair bernard uitdehaag, emphasising the importance of the hybrid nature the event to ensure people can attend from all over the world and many different stakeholder groups https://t.co/ilumkkkwcm",,"#multiplesclerosis, #ectrims2022","Beauty/Health & Fitness, Business",,"multiple sclerosis is a network disease, and is a network organisation, says ec trims chair bernard uitdehaag, emphasising the importance of the hybrid nature the event to ensure people can attend from all over the world and many different stakeholder groups"
628,‚ÄúMS is a network disease‚Äù @ECTRIMS and we‚Äôre once again gathered @ Amsterdam to reflect on the advances & challenges in multiple sclerosis care. ‚ÄúWe need to stay connected‚Äù Prof. Uitdehaag.,twitter,MEX,irenetrefrenk,,‚Äúms is a network disease‚Äù @ectrims and we‚Äôre once again gathered @ amsterdam to reflect on the advances & challenges in multiple sclerosis care. ‚Äúwe need to stay connected‚Äù prof. uitdehaag.,female,,,"{profession=Executive, jobTitle=President}, {profession=Scientist & Researcher, jobTitle=Neurologist}",ms is a network disease and were once again gathered amsterdam to reflect on the advances & challenges in multiple sclerosis care. we need to stay connected prof. uitdehaag.
629,We are at #ECTRIMS2022 Come and say hello and discover the many ways you could work with us. Let‚Äôs make sense of MS @mssocietyuk @PopDataSci_SU #msresearch #MS https://t.co/zouEEAUEHk,twitter,,UKMSRegister,,we are at #ectrims2022 come and say hello and discover the many ways you could work with us. let‚Äôs make sense of ms @mssocietyuk @popdatasci_su #msresearch #ms https://t.co/zoueeauehk,,"#ectrims2022, #msresearch, #ms",,,we are at ec trims come and say hello and discover the many ways you could work with us. lets make sense of ms msresearch ms
630,"üì¢ #News: #ECTRIMS2022 is underway, and we are presenting key data on the role BTK inhibitors can play in fighting MS. 

Find out more here: https://t.co/kVqSAANOZ1

@ECTRIMS #MS #Neurology #MSInsideOut https://t.co/ucXQouSj6y",twitter,USA,EMDSerono,,"üì¢ #news: #ectrims2022 is underway, and we are presenting key data on the role btk inhibitors can play in fighting ms. find out more here: https://t.co/kvqsaanoz1 @ectrims #ms #neurology #msinsideout https://t.co/ucxqousj6y",unknown,"#news, #ectrims2022, #ms, #neurology, #msinsideout",Business,,"#news: ec trims is underway, and we are presenting key data on the role btk inhibitors can play in fighting ms. find out more here: ms #neurology msinsideout"
631,Prof Maria Pia Amato welcomes the 7000+ in person & 2000+ online participants to the 38th annual #ECTRIMS2022 conference. It‚Äôs time to embrace the evolution with @ECTRIMS 365 - a year long commitment to communication & improving outcomes for people living with #MultipleSclerosis. https://t.co/NUTtfoRRhJ,twitter,AUS,MStranslate,,prof maria pia amato welcomes the 7000+ in person & 2000+ online participants to the 38th annual #ectrims2022 conference. it‚Äôs time to embrace the evolution with @ectrims 365 - a year long commitment to communication & improving outcomes for people living with #multiplesclerosis. https://t.co/nuttforrhj,,"#ectrims2022, #multiplesclerosis",,,prof maria pia amato welcomes the 7000+ in person & 2000+ online participants to the 38th annual ec trims conference. its time to embrace the evolution with 365 - a year long commitment to communication & improving outcomes for people living with multiple sclerosis.
632,"We are here at @ECTRIMS! Come and find us at booth B02 in the exhibition hall at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis to find out more about #MSBH and the opportunities we have to offer!

#MS #ECTRIMS2022 https://t.co/VBcBcttk19",twitter,,MSBrainHealth,,we are here at @ectrims! come and find us at booth b02 in the exhibition hall at the 38th congress of the european committee for treatment and research in multiple sclerosis to find out more about #msbh and the opportunities we have to offer! #ms #ectrims2022 https://t.co/vbcbcttk19,female,"#msbh, #ms, #ectrims2022",,,we are here at ! come and find us at booth b02 in the exhibition hall at the 38th congress of the european committee for treatment and research in multiple sclerosis to find out more about msbh and the opportunities we have to offer! ms ec trims
633,"26 ‚Äì 28 October 2022
Amsterdam, the Netherlands
38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis #Amsterdam #ECTRIMS2022 https://t.co/QiQOHW7uPO",twitter,NLD,pavlosmichailid,,"26 ‚Äì 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam #ectrims2022 https://t.co/qiqohw7upo",male,"#amsterdam, #ectrims2022",,,"26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims"
634,ECTRIMS is there for you! Sign up to hear about the most interesting scientific developments presented at #ECTRIMS2022 ! #MS #MindSlab,twitter,NLD,MindSlab_LU,,ectrims is there for you! sign up to hear about the most interesting scientific developments presented at #ectrims2022 ! #ms #mindslab,unknown,"#ectrims2022, #ms, #mindslab",,,ectrims is there for you! sign up to hear about the most interesting scientific developments presented at ec trims ! ms #mindslab
635,Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022 https://t.co/hha14Jqo0F #BusinessWire,twitter,,Stock_Market_Pr,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 https://t.co/hha14jqo0f #businesswire,,#businesswire,Business,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire
637,"Found your poster @ECTRIMS 2022 @AilsaJanePodMed . (Apologies for my poor photography skills!).
#ECTRIMS2022 #MultipleSclerosis https://t.co/EJIo8XxX78",twitter,,sineadnieidhin,,found your poster @ectrims 2022 @ailsajanepodmed . (apologies for my poor photography skills!). #ectrims2022 #multiplesclerosis https://t.co/ejio8xxx78,female,"#ectrims2022, #multiplesclerosis",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Lecturer}",found your poster 2022 . (apologies for my poor photography skills!). ec trims multiple sclerosis
638,"Is there much biomarker variability over time in an individual with #MultipleSclerosis? If so, what are we missing when we measure these factors via a single snapshot in time? Thoughts @drbarrysinger, @bart_professor and other #ECTRIMS2022 attendees?",twitter,AUS,MStranslate,,"is there much biomarker variability over time in an individual with #multiplesclerosis? if so, what are we missing when we measure these factors via a single snapshot in time? thoughts @drbarrysinger, @bart_professor and other #ectrims2022 attendees?",,"#multiplesclerosis, #ectrims2022",,,"is there much biomarker variability over time in an individual with multiple sclerosis? if so, what are we missing when we measure these factors via a single snapshot in time? thoughts , and other ec trims attendees?"
639,"#ECTRIMS 2022. ‚ÄúFor multiple sclerosis, we need to emulate the concept of time is brain as is relevant in stroke care. The longer we delay use of high efficacy therapy the higher probability of rapid progression to disability‚Äù The case for saving brain and spine in MS",twitter,USA,OdagoDr,,"#ectrims 2022. ‚Äúfor multiple sclerosis, we need to emulate the concept of time is brain as is relevant in stroke care. the longer we delay use of high efficacy therapy the higher probability of rapid progression to disability‚Äù the case for saving brain and spine in ms",male,#ectrims,"Beauty/Health & Fitness, Family & Parenting, Sports","{profession=Scientist & Researcher, jobTitle=Neurologist}","ec trims 2022. for multiple sclerosis, we need to emulate the concept of time is brain as is relevant in stroke care. the longer we delay use of high efficacy therapy the higher probability of rapid progression to disability the case for saving brain and spine in ms"
640,@themsguide Dominic Shadbolt making the case for early discussion of long term prognosis in people with #MS @ECTRIMS @Iamsterdam  #ECTRIMS2022 @XMontalban @GavinGiovannoni https://t.co/UznvQV1Wfh,twitter,GBR,KlausSchmierer,,@themsguide dominic shadbolt making the case for early discussion of long term prognosis in people with #ms @ectrims @iamsterdam #ectrims2022 @xmontalban @gavingiovannoni https://t.co/uznvqv1wfh,male,"#ms, #ectrims2022",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",dominic shadbolt making the case for early discussion of long term prognosis in people with ms ec trims
641,"The @PromsInitiative has a governance model that is participatory, multistakeholder and ensures we are involving all the necessary expertise, especially people affected by #MultipleSclerosis

@MULTIACTProj #ECTRIMS2022 https://t.co/pEVHqXz1R1",twitter,GBR,AnneHelme,,"the @promsinitiative has a governance model that is participatory, multistakeholder and ensures we are involving all the necessary expertise, especially people affected by #multiplesclerosis @multiactproj #ectrims2022 https://t.co/pevhqxz1r1",female,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,"the has a governance model that is participatory, multistakeholder and ensures we are involving all the necessary expertise, especially people affected by multiple sclerosis ec trims"
642,"@ECTRIMS has organised an event for people living with MS which will take place on Saturday, 29th of October. More details can be found here https://t.co/YibTNWiQaJ",twitter,IRL,MSIRELAND,,"@ectrims has organised an event for people living with ms which will take place on saturday, 29th of october. more details can be found here https://t.co/yibtnwiqaj",female,,,,"has organised an event for people living with ms which will take place on saturday, 29th of october. more details can be found here"
643,"@ECTRIMS has also arranged an event for people living with MS on Saturday, find out more here https://t.co/YibTNWiQaJ https://t.co/Iyx7JSsyiH",twitter,IRL,MSIRELAND,,"@ectrims has also arranged an event for people living with ms on saturday, find out more here https://t.co/yibtnwiqaj https://t.co/iyx7jssyih",female,,,,"has also arranged an event for people living with ms on saturday, find out more here"
644,"During #ECTRIMS2022 learn about smoldering #neuroinflammation in #MultipleSclerosis. Join 3 sessions moderated by @C_OrejaGuevara in the theatre in the exhibition hall. 

‚û°Ô∏è https://t.co/LJAFi7c0jc

These sessions are generously supported by ECTRIMS Sponsor @sanofiscience https://t.co/IKkDTGupzl",twitter,CHE,ECTRIMS,,during #ectrims2022 learn about smoldering #neuroinflammation in #multiplesclerosis. join 3 sessions moderated by @c_orejaguevara in the theatre in the exhibition hall. ‚û°Ô∏è https://t.co/ljafi7c0jc these sessions are generously supported by ectrims sponsor @sanofiscience https://t.co/ikkdtgupzl,,"#ectrims2022, #neuroinflammation, #multiplesclerosis",,,during ec trims learn about smoldering #neuroinflammation in multiple sclerosis. join 3 sessions moderated by in the theatre in the exhibition hall. these sessions are generously supported by ectrims sponsor
645,"#ECTRIMS2022 | Engage with leading #MS researchers and practitioners in Industry Sessions. Today‚Äôs sessions are supported by @OctaveBio @sanofi @JanssenGlobal @Roche and @bmsnews 
 
View the full programme of Industry Sessions ‚û°Ô∏è https://t.co/9PLrja15rU",twitter,CHE,ECTRIMS,,#ectrims2022 | engage with leading #ms researchers and practitioners in industry sessions. today‚Äôs sessions are supported by @octavebio @sanofi @janssenglobal @roche and @bmsnews view the full programme of industry sessions ‚û°Ô∏è https://t.co/9plrja15ru,,"#ectrims2022, #ms",,,ec trims | engage with leading ms researchers and practitioners in industry sessions. todays sessions are supported by and view the full programme of industry sessions
646,"Prof. @rocca_mara discussing the role of non-conventional MRI in predicting the prognosis of MS patients in the earliest phases of the disease but also in those with definite MS
#ECTRIMS2022 #MRI #MS 
@ECTRIMS @MAGNIMS @NRU_SanRaffaele @SanRaffaeleMI @MyUniSR https://t.co/Tu7j9cPUlR",twitter,NLD,paolopreziosa,,prof. @rocca_mara discussing the role of non-conventional mri in predicting the prognosis of ms patients in the earliest phases of the disease but also in those with definite ms #ectrims2022 #mri #ms @ectrims @magnims @nru_sanraffaele @sanraffaelemi @myunisr https://t.co/tu7j9cpulr,male,"#ectrims2022, #mri, #ms",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",prof. discussing the role of non-conventional mri in predicting the prognosis of ms patients in the earliest phases of the disease but also in those with definite ms ec trims #mri ms
647,"Helga Weiland, co-Chair of the @PromsInitiative Engagement Coordination Team, introduces the session and explains the importance of involving people affected by #MultipleSclerosis in the study and development of #PROs

#ECTRIMS2022 https://t.co/x4CHaLtvAQ",twitter,GBR,AnneHelme,,"helga weiland, co-chair of the @promsinitiative engagement coordination team, introduces the session and explains the importance of involving people affected by #multiplesclerosis in the study and development of #pros #ectrims2022 https://t.co/x4chaltvaq",female,"#multiplesclerosis, #pros, #ectrims2022",Beauty/Health & Fitness,,"helga weiland, co-chair of the engagement coordination team, introduces the session and explains the importance of involving people affected by multiple sclerosis in the study and development of #pros ec trims"
648,"While we aren‚Äôt yet at a point where we can measure the effectiveness of #MultipleSclerosis treatments via a simple blood test, @CharlotteTeuni1 (@MScentrum020) tells #ECTRIMS2022 that technology is improving and progress is being made. https://t.co/UeXkJb3ud5",twitter,AUS,MStranslate,,"while we aren‚Äôt yet at a point where we can measure the effectiveness of #multiplesclerosis treatments via a simple blood test, @charlotteteuni1 (@mscentrum020) tells #ectrims2022 that technology is improving and progress is being made. https://t.co/uexkjb3ud5",,"#multiplesclerosis, #ectrims2022",,,"while we arent yet at a point where we can measure the effectiveness of multiple sclerosis treatments via a simple blood test, () tells ec trims that technology is improving and progress is being made."
649,"#ECTRIMS2022 Hot Topic 1: hugh efficacy therapies in MS. @XMontalban, Dalia Rotstein and @GavinGiovannoni review which baseline poor prognosis factors are also relevant for treatment response, the importance of timely switch and giving patients the choice of starting HET. https://t.co/uXI8eEerqR",twitter,ESP,GeoArrambide,,"#ectrims2022 hot topic 1: hugh efficacy therapies in ms. @xmontalban, dalia rotstein and @gavingiovannoni review which baseline poor prognosis factors are also relevant for treatment response, the importance of timely switch and giving patients the choice of starting het. https://t.co/uxi8eeerqr",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","ec trims hot topic 1: hugh efficacy therapies in ms. , dalia rotstein and review which baseline poor prognosis factors are also relevant for treatment response, the importance of timely switch and giving patients the choice of starting het."
650,PROMs is a great initiative. What surprises me is the insight that the voice of PwMS is so relevant. Really? In 2022y What do we talk about since years? Sorry I turn off the ironic mode now. #ECTRIMS2022 #ms #patientengagement #patientincluded,twitter,DEU,Birgitpower,,proms is a great initiative. what surprises me is the insight that the voice of pwms is so relevant. really? in 2022y what do we talk about since years? sorry i turn off the ironic mode now. #ectrims2022 #ms #patientengagement #patientincluded,female,"#ectrims2022, #ms, #patientengagement, #patientincluded",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",proms is a great initiative. what surprises me is the insight that the voice of pwms is so relevant. really? in 2022y what do we talk about since years? sorry i turn off the ironic mode now. ec trims ms #patientengagement #patientincluded
651,The PROMs project was announced in 2019 bringing PwMS with doctors together to discuss the involvement of PwMS by @EuropeanCharcot and @MSIntFederation . Goal: info must come directly from PwMS without being interpreted. https://t.co/rl2rV2MN4f #ECTRIMS2022 #ms https://t.co/UXsLbHceWV,twitter,DEU,Birgitpower,,the proms project was announced in 2019 bringing pwms with doctors together to discuss the involvement of pwms by @europeancharcot and @msintfederation . goal: info must come directly from pwms without being interpreted. https://t.co/rl2rv2mn4f #ectrims2022 #ms https://t.co/uxslbhcewv,female,"#ectrims2022, #ms",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",the proms project was announced in 2019 bringing pwms with doctors together to discuss the involvement of pwms by and . goal: info must come directly from pwms without being interpreted. ec trims ms
652,"Bielekova: PIRA prediction biomarkers. Inflammatory and fibrosis pathways prevail the most. (Spinal cord ‚Äòmore fibrosis‚Äô, Brain lesions more ‚Äòinflammatory‚Äô)
No inflammatory independent ‚ÄòPIRA‚Äô found & MS types are non predictive.
#ECTRIMS2022 https://t.co/eGdukQnSNT",twitter,BEL,bart_professor,,"bielekova: pira prediction biomarkers. inflammatory and fibrosis pathways prevail the most. (spinal cord ‚Äòmore fibrosis‚Äô, brain lesions more ‚Äòinflammatory‚Äô) no inflammatory independent ‚Äòpira‚Äô found & ms types are non predictive. #ectrims2022 https://t.co/egdukqnsnt",unknown,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}","bielekova: pira prediction biomarkers. inflammatory and fibrosis pathways prevail the most. (spinal cord more fibrosis, brain lesions more inflammatory) no inflammatory independent pira found & ms types are non predictive. ec trims"
653,Prof Bielekova starts a fascinating Hot Topics session at #ECTRIMS2022 by showing data indicating how important the identification of CSF #biomarkers are for predicting disease progression in people living with #MultipleSclerosis https://t.co/MKtJxgtmil,twitter,AUS,MStranslate,,prof bielekova starts a fascinating hot topics session at #ectrims2022 by showing data indicating how important the identification of csf #biomarkers are for predicting disease progression in people living with #multiplesclerosis https://t.co/mktjxgtmil,,"#ectrims2022, #biomarkers, #multiplesclerosis",,,prof bielekova starts a fascinating hot topics session at ec trims by showing data indicating how important the identification of csf #biomarkers are for predicting disease progression in people living with multiple sclerosis
654,"Prof. Nicola De Stefano summarizing the relevance of conventional MRI to provide reliable and accurate marker of MS progression
MRI can give several information about the prognosis of our patients
#ECTRIMS2022 #MRI #MS
@ECTRIMS @MAGNIMS https://t.co/d5Yh1pds5h",twitter,NLD,paolopreziosa,,prof. nicola de stefano summarizing the relevance of conventional mri to provide reliable and accurate marker of ms progression mri can give several information about the prognosis of our patients #ectrims2022 #mri #ms @ectrims @magnims https://t.co/d5yh1pds5h,male,"#ectrims2022, #mri, #ms",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",prof. nicola de stefano summarizing the relevance of conventional mri to provide reliable and accurate marker of ms progression mri can give several information about the prognosis of our patients ec trims #mri ms
655,"Wow, Helga Weiland , Woman living with #ms is live at #ECTRIMS2022 speaking about the needs an the PROMs initiative. The role to involve PwMS into patient reported outcomes. Agree. Great initiative! We need much more of this! üòÉ https://t.co/kgPXoPpYqu",twitter,DEU,Birgitpower,,"wow, helga weiland , woman living with #ms is live at #ectrims2022 speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this! üòÉ https://t.co/kgpxoppyqu",female,"#ms, #ectrims2022",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}","wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!"
656,These days there are two things keep me going: #Menopause and #ms. There is not enough info out and also we need more research for women living with #ms and going into the next life changing phase. I wrote about it on my blog: https://t.co/2ZPEntl6pE #ECTRIMS2022,twitter,DEU,Birgitpower,,these days there are two things keep me going: #menopause and #ms. there is not enough info out and also we need more research for women living with #ms and going into the next life changing phase. i wrote about it on my blog: https://t.co/2zpentl6pe #ectrims2022,female,"#menopause, #ms, #ms, #ectrims2022",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",these days there are two things keep me going: #menopause and ms. there is not enough info out and also we need more research for women living with ms and going into the next life changing phase. i wrote about it on my blog: ec trims
657,"Prof. Claudio Gasperini discussing the relevance of MRI in establishing prognosis in multiple sclerosis
#ECTRIMS2022 #MS #MRI 
@ECTRIMS @MAGNIMS @sinneurologia https://t.co/NKgKE5h31i",twitter,NLD,paolopreziosa,,prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis #ectrims2022 #ms #mri @ectrims @magnims @sinneurologia https://t.co/nkgke5h31i,male,"#ectrims2022, #ms, #mri",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri
658,"#ECTRIMS2022, Hot Topic 1: hugh efficacy therapies for MS: https://t.co/QQ9ycG0rOW",twitter,ESP,GeoArrambide,,"#ectrims2022, hot topic 1: hugh efficacy therapies for ms: https://t.co/qq9ycg0row",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","ec trims, hot topic 1: hugh efficacy therapies for ms:"
659,"Want to hear more about #PROMSinitiative topics and connected activities? Don‚Äôt miss the #ECTRIMS2022  Symposium by @EuropeanCharcot dedicated to the role of #PROs happening now in the Hall 12 (10-11am)! For more info https://t.co/KrxOetPyxt

#patientengagement #MultipleSclerosis https://t.co/P2HbV4Hc4Z",twitter,,PromsInitiative,,want to hear more about #promsinitiative topics and connected activities? don‚Äôt miss the #ectrims2022 symposium by @europeancharcot dedicated to the role of #pros happening now in the hall 12 (10-11am)! for more info https://t.co/krxoetpyxt #patientengagement #multiplesclerosis https://t.co/p2hbv4hc4z,unknown,"#promsinitiative, #ectrims2022, #pros, #patientengagement, #multiplesclerosis",,,want to hear more about #promsinitiative topics and connected activities? dont miss the ec trims symposium by dedicated to the role of #pros happening now in the hall 12 (10-11am)! for more info #patientengagement multiple sclerosis
660,"üì¢ #News: #ECTRIMS2022 is underway, and we are presenting key data on the role BTK inhibitors can play in fighting MS. @ECTRIMS #MS #Neurology #MSInsideOut https://t.co/pqkdNjxCxH",twitter,DEU,MerckHealthcare,,"üì¢ #news: #ectrims2022 is underway, and we are presenting key data on the role btk inhibitors can play in fighting ms. @ectrims #ms #neurology #msinsideout https://t.co/pqkdnjxcxh",,"#news, #ectrims2022, #ms, #neurology, #msinsideout",,,"#news: ec trims is underway, and we are presenting key data on the role btk inhibitors can play in fighting ms. ms #neurology msinsideout"
661,@EuropeanCharcot is my first session at #ECTRIMS2022 theme: European Charcot Foundation Symposium: The patient at the centre - role of patient reported outcomes. Room is still empty but I think people are on their way üòâ#ms https://t.co/oSgNL7aHjd,twitter,DEU,Birgitpower,,@europeancharcot is my first session at #ectrims2022 theme: european charcot foundation symposium: the patient at the centre - role of patient reported outcomes. room is still empty but i think people are on their way üòâ#ms https://t.co/osgnl7ahjd,female,"#ectrims2022, #ms",Business,"{profession=Sales/Marketing/PR, jobTitle=Social Media Consultant}",is my first session at ec trims theme: european charcot foundation symposium: the patient at the centre - role of patient reported outcomes. room is still empty but i think people are on their way ms
662,"Great RIMS session on updates in MS rehabilitation focusing on cognitive and physical functioning and fatigue management in Multiple Sclerosis by Roshan das Nair, Anders Guldhammer Skjerb√¶k and Daphne Kos #ECTRIMS2022 https://t.co/BnUfcMXnMz",twitter,GBR,NEuRoMSproject,,"great rims session on updates in ms rehabilitation focusing on cognitive and physical functioning and fatigue management in multiple sclerosis by roshan das nair, anders guldhammer skjerb√¶k and daphne kos #ectrims2022 https://t.co/bnufcmxnmz",unknown,#ectrims2022,Beauty/Health & Fitness,,"great rims session on updates in ms rehabilitation focusing on cognitive and physical functioning and fatigue management in multiple sclerosis by roshan das nair, anders guldhammer skjerbk and daphne kos ec trims"
663,"We're underway at #ECTRIMS2022 where we are sharing the latest data, researchüî¨ and breakthrough innovations that have the potential to improve outcomes for people living with #MS. https://t.co/3AwndIGxEi",twitter,DEU,MerckHealthcare,,"we're underway at #ectrims2022 where we are sharing the latest data, researchüî¨ and breakthrough innovations that have the potential to improve outcomes for people living with #ms. https://t.co/3awndigxei",,"#ectrims2022, #ms",,,"we're underway at ec trims where we are sharing the latest data, research and breakthrough innovations that have the potential to improve outcomes for people living with ms."
664,"Day 1 of #ECTRIMS2022 has started here in Amsterdam! Fantastic to be able to attend in person again. Stay tuned as we live tweet sessions highlighting the latest in #MultipleSclerosis research over the next 3 days. If you are here, say hi - we‚Äôd love to chat! https://t.co/Ixh67Fw1f5",twitter,AUS,MStranslate,,"day 1 of #ectrims2022 has started here in amsterdam! fantastic to be able to attend in person again. stay tuned as we live tweet sessions highlighting the latest in #multiplesclerosis research over the next 3 days. if you are here, say hi - we‚Äôd love to chat! https://t.co/ixh67fw1f5",,"#ectrims2022, #multiplesclerosis",,,"day 1 of ec trims has started here in amsterdam! fantastic to be able to attend in person again. stay tuned as we live tweet sessions highlighting the latest in multiple sclerosis research over the next 3 days. if you are here, say hi - wed love to chat!"
666,"@MAGNIMS educational session 6,  #ECTRIMS2022: MRI and the diagnosis of MS. @FBarkhof shows examples of MRI green and red flags in the diagnosis of MS. https://t.co/Qv5XLZUI68",twitter,ESP,GeoArrambide,,"@magnims educational session 6, #ectrims2022: mri and the diagnosis of ms. @fbarkhof shows examples of mri green and red flags in the diagnosis of ms. https://t.co/qv5xlzui68",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","educational session 6, ec trims: mri and the diagnosis of ms. shows examples of mri green and red flags in the diagnosis of ms."
667,"Today at #ECTRIMS2022 learn about managing patients with relapsing remitting #MS 

üìÖ 26 Oct 17:30 CEST
Satellite Symposium 4: Putting your everyday patient first: The here & now in RRMS
‚û°Ô∏è https://t.co/iIBEwfGZuC

This ECTRIMS symposium is proudly sponsored by @ViatrisInc https://t.co/o5YzujheeU",twitter,CHE,ECTRIMS,,today at #ectrims2022 learn about managing patients with relapsing remitting #ms üìÖ 26 oct 17:30 cest satellite symposium 4: putting your everyday patient first: the here & now in rrms ‚û°Ô∏è https://t.co/iibewfgzuc this ectrims symposium is proudly sponsored by @viatrisinc https://t.co/o5yzujheeu,,"#ectrims2022, #ms",,,today at ec trims learn about managing patients with relapsing remitting ms 26 oct 17:30 cest satellite symposium 4: putting your everyday patient first: the here & now in rrms this ectrims symposium is proudly sponsored by
668,"Prof. @FBarkhof discussing MRI mimics in the diagnostic work-up of #MS green (typical) and red (atypical) flags
Let‚Äôs reduce the risk of multiple sclerosis misdiagnosis
@ECTRIMS @MAGNIMS #ECTRIMS2022 #MRI https://t.co/zJDjijX2NF",twitter,NLD,paolopreziosa,,prof. @fbarkhof discussing mri mimics in the diagnostic work-up of #ms green (typical) and red (atypical) flags let‚Äôs reduce the risk of multiple sclerosis misdiagnosis @ectrims @magnims #ectrims2022 #mri https://t.co/zjdjijx2nf,male,"#ms, #ectrims2022, #mri",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",prof. discussing mri mimics in the diagnostic work-up of ms green (typical) and red (atypical) flags lets reduce the risk of multiple sclerosis misdiagnosis ec trims #mri
669,"@MAGNIMS educational session 6,  #ECTRIMS2022: MRI and the diagnosis of MS. @olgacicc reviews future MRI measures. Re: anterior visual pathway, work by @AVidalJordana and @DrWBRO suggests the added value of paraclinical tools is greatest in ON symptomatic cases. @cemcat_em https://t.co/9XSXgU8NHf",twitter,ESP,GeoArrambide,,"@magnims educational session 6, #ectrims2022: mri and the diagnosis of ms. @olgacicc reviews future mri measures. re: anterior visual pathway, work by @avidaljordana and @drwbro suggests the added value of paraclinical tools is greatest in on symptomatic cases. @cemcat_em https://t.co/9xsxgu8nhf",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","educational session 6, ec trims: mri and the diagnosis of ms. reviews future mri measures. re: anterior visual pathway, work by and suggests the added value of paraclinical tools is greatest in on symptomatic cases."
670,"Prof. @olgacicc discussing novel promising #MRI measures for #MS diagnosis #ECTRIMS2022
Moving towards an early and more accurate diagnosis of MS using MRI
@ECTRIMS @MAGNIMS #multiplesclerosis https://t.co/2bGETODpi1",twitter,NLD,paolopreziosa,,prof. @olgacicc discussing novel promising #mri measures for #ms diagnosis #ectrims2022 moving towards an early and more accurate diagnosis of ms using mri @ectrims @magnims #multiplesclerosis https://t.co/2bgetodpi1,male,"#mri, #ms, #ectrims2022, #multiplesclerosis",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis
671,"@MAGNIMS educational session 6,  #ECTRIMS2022: MRI and the diagnosis of MS. @J_SastreGarriga walks us through a critical reapprisal of the criteria, reminding us they should not be applied robotically. @cemcat_em https://t.co/3X48MvOMf9",twitter,ESP,GeoArrambide,,"@magnims educational session 6, #ectrims2022: mri and the diagnosis of ms. @j_sastregarriga walks us through a critical reapprisal of the criteria, reminding us they should not be applied robotically. @cemcat_em https://t.co/3x48mvomf9",female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","educational session 6, ec trims: mri and the diagnosis of ms. walks us through a critical reapprisal of the criteria, reminding us they should not be applied robotically."
672,Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022 - Neuro Central via BrainSights for iOS https://t.co/cSACrej0qd,twitter,,BrainSightsApp,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 - neuro central via brainsights for ios https://t.co/csacrej0qd,,,Technology,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 - neuro central via brainsights for ios
673,"The #ECTRIMS2022 has kicked off!
Please come for a 'brain break' to our booth
#Neurology #Sanofi #MS https://t.co/aH5TbXP4YP",twitter,NLD,SijntjeWidlak,,the #ectrims2022 has kicked off! please come for a 'brain break' to our booth #neurology #sanofi #ms https://t.co/ah5tbxp4yp,unknown,"#ectrims2022, #neurology, #sanofi, #ms",,,the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms
674,"$MRK.GY
üá©üá™
Merck KGaA

Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
>Merck will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

https://t.co/ho2R0Aj2VE",twitter,FIN,BullBearBres,,$mrk.gy üá©üá™ merck kgaa merck showcases depth of ms portfolio at ectrims supporting commitment to advancing ms care >merck will present 39 abstracts at the 38th congress of the european committee for treatment and research in multiple sclerosis (ectrims) https://t.co/ho2r0aj2ve,unknown,,,,$mrk.gy merck kgaa merck showcases depth of ms portfolio at ectrims supporting commitment to advancing ms care >merck will present 39 abstracts at the 38th congress of the european committee for treatment and research in multiple sclerosis (ectrims)
675,#ECTRIMS2022 first session. First Talk. Let‚Äôs go! #MS #RIS https://t.co/5DbdsiaXO7,twitter,,XtineLebrunF,,#ectrims2022 first session. first talk. let‚Äôs go! #ms #ris https://t.co/5dbdsiaxo7,female,"#ectrims2022, #ms, #ris",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Neurologist}",ec trims first session. first talk. lets go! ms #ris
677,#MEDIA: New data on COVID-19 outcomes and cognition in patients with relapsing forms of multiple sclerosis #ECTRIMS2022 https://t.co/tIUKCBcBzm https://t.co/uU60S7cDtc,twitter,USA,bmsnews,,#media: new data on covid-19 outcomes and cognition in patients with relapsing forms of multiple sclerosis #ectrims2022 https://t.co/tiukcbcbzm https://t.co/uu60s7cdtc,,"#media, #ectrims2022","Beauty/Health & Fitness, Science",,#media: new data on covid-19 outcomes and cognition in patients with relapsing forms of multiple sclerosis ec trims
678,"We're underway at #ECTRIMS2022 where we are sharing the latest data, researchüî¨ and breakthrough innovations that have the potential to improve outcomes for people living with #MS. Read more: https://t.co/McvDUOIwvV https://t.co/vVQO0kW4pB",twitter,DEU,MerckHealthcare,,"we're underway at #ectrims2022 where we are sharing the latest data, researchüî¨ and breakthrough innovations that have the potential to improve outcomes for people living with #ms. read more: https://t.co/mcvduoiwvv https://t.co/vvqo0kw4pb",,"#ectrims2022, #ms",,,"we're underway at ec trims where we are sharing the latest data, research and breakthrough innovations that have the potential to improve outcomes for people living with ms. read more:"
680,Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 20.. $ATRA https://t.co/sjPhiUGFg3,twitter,USA,newsfilterio,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 20.. $atra https://t.co/sjphiugfg3,unknown,,Business,,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 20.. $atra
681,"It‚Äôs the first day of the 38th Congress of the European Committee for Treatment and Research in #MultipleSclerosis 2022!

We can‚Äôt wait to be joined by over 9000 participants from over 100 countries here at #ECTRIMS2022

@ECTRIMS #MS #Neurology #NeuroTwitter https://t.co/yXtHX5EllV",twitter,,VJNeurology,,it‚Äôs the first day of the 38th congress of the european committee for treatment and research in #multiplesclerosis 2022! we can‚Äôt wait to be joined by over 9000 participants from over 100 countries here at #ectrims2022 @ectrims #ms #neurology #neurotwitter https://t.co/yxthx5ellv,,"#multiplesclerosis, #ectrims2022, #ms, #neurology, #neurotwitter",Photo & Video,,its the first day of the 38th congress of the european committee for treatment and research in multiple sclerosis 2022! we cant wait to be joined by over 9000 participants from over 100 countries here at ec trims ms #neurology #neurotwitter
683,$ATRA news Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022,twitter,,UsMarketNews,,$atra news atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022,unknown,,Business,,$atra news atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022
684,"Interested in connecting with fellow colleagues at #ECTRIMS2022 to discuss innovative technologies in #MSresearch?

Join us this evening for cocktails, hors d'oeuvres & networking w/ some of the brightest minds in #neurology! 

‚úâÔ∏è Request your invitation: https://t.co/6cEJHapc9H",twitter,USA,OctaveBio,,"interested in connecting with fellow colleagues at #ectrims2022 to discuss innovative technologies in #msresearch? join us this evening for cocktails, hors d'oeuvres & networking w/ some of the brightest minds in #neurology! ‚úâÔ∏è request your invitation: https://t.co/6cejhapc9h",male,"#ectrims2022, #msresearch, #neurology",Beauty/Health & Fitness,,"interested in connecting with fellow colleagues at ec trims to discuss innovative technologies in msresearch? join us this evening for cocktails, hors d'oeuvres & networking w/ some of the brightest minds in #neurology! request your invitation:"
685,Welcome to #ECTRIMS2022! Let's share our knowledge on #MS and together make a world free of MS. https://t.co/aI9HI4SfUH,twitter,NLD,MScentrum020,,welcome to #ectrims2022! let's share our knowledge on #ms and together make a world free of ms. https://t.co/ai9hi4sfuh,female,"#ectrims2022, #ms",,,welcome to ec trims! let's share our knowledge on ms and together make a world free of ms.
686,Browsing e-Posters at #ECTRIMS2022? Be sure to check out our late-breaking abstract - EP1269: Surrogates for SARS-CoV-2 vaccination response in multiple sclerosis identified in a real world scenario. Exciting new work by @Muriel85354596 and others!,twitter,DEU,NeurologyMainz,,browsing e-posters at #ectrims2022? be sure to check out our late-breaking abstract - ep1269: surrogates for sars-cov-2 vaccination response in multiple sclerosis identified in a real world scenario. exciting new work by @muriel85354596 and others!,,#ectrims2022,,,browsing e-posters at ec trims? be sure to check out our late-breaking abstract - ep1269: surrogates for sars-cov-2 vaccination response in multiple sclerosis identified in a real world scenario. exciting new work by and others!
687,Amazing to see a session on the latest research findings in MS specifically for MS patients! We absolutely need more patient involvement in research! #ECTRIMS2022,twitter,USA,MegiClarke,,amazing to see a session on the latest research findings in ms specifically for ms patients! we absolutely need more patient involvement in research! #ectrims2022,female,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Post-doc}, {profession=Scientist & Researcher, jobTitle=Neuroscientist}",amazing to see a session on the latest research findings in ms specifically for ms patients! we absolutely need more patient involvement in research! ec trims
688,"Everything is ready!!! 
#ECTRIMS2022 starts TOMORROW! 
More than 8,200 participants !!!
A lot of news about  #MultipleSclerosis !!!     
@ECTRIMS @drbarrysinger @AaronBosterMD @FabienneBrilot @IntNatlWiMS @KlausSchmierer 
@bart_professor 
@J_SastreGarriga https://t.co/zlSsFs8aOi",twitter,ESP,C_OrejaGuevara,,"everything is ready!!! #ectrims2022 starts tomorrow! more than 8,200 participants !!! a lot of news about #multiplesclerosis !!! @ectrims @drbarrysinger @aaronbostermd @fabiennebrilot @intnatlwims @klausschmierer @bart_professor @j_sastregarriga https://t.co/zlssfs8aoi",female,"#ectrims2022, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}","everything is ready!!! ec trims starts tomorrow! more than 8,200 participants !!! a lot of news about multiple sclerosis !!!"
689,The whole #icofamily is eager to welcome all visiting #ECTRIMS2022 as of tomorrow. We‚Äôll make sure to pop your brain with insights & meaningful discussions on #brainAI #digitalhealth #ms #icobrain #icompanion & #popcorn https://t.co/XfbBUeqEm9,twitter,BEL,icometrix,,the whole #icofamily is eager to welcome all visiting #ectrims2022 as of tomorrow. we‚Äôll make sure to pop your brain with insights & meaningful discussions on #brainai #digitalhealth #ms #icobrain #icompanion & #popcorn https://t.co/xfbbueqem9,unknown,"#icofamily, #ectrims2022, #brainai, #digitalhealth, #ms, #icobrain, #icompanion, #popcorn",Beauty/Health & Fitness,,the whole #icofamily is eager to welcome all visiting ec trims as of tomorrow. well make sure to pop your brain with insights & meaningful discussions on #brainai #digitalhealth ms #icobrain #icompanion & #popcorn
690,"üì£ An invitation for ALL people living with #MS

Join us this Sat 29 Oct for ""ECTRIMS 2022: The Patient Experience"" in Amsterdam at the RAI & online, where MS experts will breakdown the latest insight from #ECTRIMS2022

Register now for this free event ‚û°Ô∏è https://t.co/GHq9cP5Ctq https://t.co/AhxHLO0dSH",twitter,CHE,ECTRIMS,,"üì£ an invitation for all people living with #ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from #ectrims2022 register now for this free event ‚û°Ô∏è https://t.co/ghq9cp5ctq https://t.co/ahxhlo0dsh",,"#ms, #ectrims2022",,,"an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event"
691,"We are at #ECTRIMS2022 in Amsterdam to be updated about the latest research in MS!
‚ÄãLooking forward to meet you at our booth and at the congress. #ECTRIMS2022 #Neurology #MS https://t.co/0xTwCgZd3Z",twitter,NLD,SijntjeWidlak,,we are at #ectrims2022 in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. #ectrims2022 #neurology #ms https://t.co/0xtwcgzd3z,unknown,"#ectrims2022, #ectrims2022, #neurology, #ms",,,we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms
692,"We have arrived in Amsterdam ready for @ECTRIMS üåèüéâ We‚Äôre looking forward to hearing about the latest breakthroughs in MS treatment and bringing the info straight to you üé• 

Stay tuned ‚û°Ô∏è https://t.co/sEhOxRLoAG

#ECTRIMS #ECTRIMS2022 https://t.co/8M8EX2Hr12",twitter,,LivedHealth,,we have arrived in amsterdam ready for @ectrims üåèüéâ we‚Äôre looking forward to hearing about the latest breakthroughs in ms treatment and bringing the info straight to you üé• stay tuned ‚û°Ô∏è https://t.co/sehoxrloag #ectrims #ectrims2022 https://t.co/8m8ex2hr12,unknown,"#ectrims, #ectrims2022","Beauty/Health & Fitness, Photo & Video",,we have arrived in amsterdam ready for were looking forward to hearing about the latest breakthroughs in ms treatment and bringing the info straight to you stay tuned ec trims ec trims
693,"üì£ #ECTRIMS2022 starts TOMORROW! More than 8,200 participants from 109 countries üåé are already registered, and the numbers are climbing. Don‚Äôt miss this opportunity to join the conversation w/ leading #MS researchers & practitioners. 

Join today ‚û°Ô∏è https://t.co/GJGdaoyPlu https://t.co/fVGcQrVbdN",twitter,CHE,ECTRIMS,,"üì£ #ectrims2022 starts tomorrow! more than 8,200 participants from 109 countries üåé are already registered, and the numbers are climbing. don‚Äôt miss this opportunity to join the conversation w/ leading #ms researchers & practitioners. join today ‚û°Ô∏è https://t.co/gjgdaoyplu https://t.co/fvgcqrvbdn",,"#ectrims2022, #ms",,,"ec trims starts tomorrow! more than 8,200 participants from 109 countries are already registered, and the numbers are climbing. dont miss this opportunity to join the conversation w/ leading ms researchers & practitioners. join today"
694,"It is a really good sign that when asked about the most exciting #MultipleSclerosis research topics to be presented at #ECTRIMS2022, the panel at the official press conference lists more than 10 different themes!  A lot to look forward to over the coming days. @ECTRIMS https://t.co/sCXeBf0Nh1",twitter,AUS,MStranslate,,"it is a really good sign that when asked about the most exciting #multiplesclerosis research topics to be presented at #ectrims2022, the panel at the official press conference lists more than 10 different themes! a lot to look forward to over the coming days. @ectrims https://t.co/scxebf0nh1",,"#multiplesclerosis, #ectrims2022",,,"it is a really good sign that when asked about the most exciting multiple sclerosis research topics to be presented at ec trims, the panel at the official press conference lists more than 10 different themes! a lot to look forward to over the coming days."
695,"Professor @GavinGiovannoni on :""flipping the pyramid"" (early use of high-efficacy disease modifying therapy in multiple sclerosis) (for #ECTRIMS2022) https://t.co/pIVHHbPHQO",twitter,USA,Brandon_Beaber,,"professor @gavingiovannoni on :""flipping the pyramid"" (early use of high-efficacy disease modifying therapy in multiple sclerosis) (for #ectrims2022) https://t.co/pivhhbphqo",male,#ectrims2022,"Books, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neurologist}","professor on :""flipping the pyramid"" (early use of high-efficacy disease modifying therapy in multiple sclerosis) (for ec trims)"
696,"We are excited to attend @ECTRIMS 2022 and eager to meet participants involved in #MultipleSclerosis #research from all over the world.

Our e-poster: ""Heterogeneous Virtual Multiple Sclerosis Patients for analysis of personalized treatment responses""

‚ÑπÔ∏èhttps://t.co/5wuT9awQIl https://t.co/BSZFCn5HoH",twitter,,InSilicoTrials,,"we are excited to attend @ectrims 2022 and eager to meet participants involved in #multiplesclerosis #research from all over the world. our e-poster: ""heterogeneous virtual multiple sclerosis patients for analysis of personalized treatment responses"" ‚ÑπÔ∏èhttps://t.co/5wut9awqil https://t.co/bszfcn5hoh",unknown,"#multiplesclerosis, #research",Technology,,"we are excited to attend 2022 and eager to meet participants involved in multiple sclerosis #research from all over the world. our e-poster: ""heterogeneous virtual multiple sclerosis patients for analysis of personalized treatment responses"""
697,"Tomorrow at #ECTRIMS2022, learn more about our late-breaking data on an approved medicine for people with relapsing #multiplesclerosis.",twitter,USA,ScienceAtBMS,,"tomorrow at #ectrims2022, learn more about our late-breaking data on an approved medicine for people with relapsing #multiplesclerosis.",,"#ectrims2022, #multiplesclerosis",Science,,"tomorrow at ec trims, learn more about our late-breaking data on an approved medicine for people with relapsing multiple sclerosis."
698,On a train (Brussels to Amsterdam) for first international conference. Can‚Äôt wait to learn on new advances in multiple sclerosis. #ECTRIMS2022 https://t.co/Hq3e9MZT8z,twitter,USA,OdagoDr,,on a train (brussels to amsterdam) for first international conference. can‚Äôt wait to learn on new advances in multiple sclerosis. #ectrims2022 https://t.co/hq3e9mzt8z,male,#ectrims2022,"Beauty/Health & Fitness, Family & Parenting, Sports","{profession=Scientist & Researcher, jobTitle=Neurologist}",on a train (brussels to amsterdam) for first international conference. cant wait to learn on new advances in multiple sclerosis. ec trims
699,Don‚Äôt miss the opportunity to connect with Novartis Medical at ECTRIMS and learn what‚Äôs happening in #MS and neuroscience. #ECTRIMS2022 https://t.co/3v3wNy0ah8,twitter,USA,NovartisUSMed,,don‚Äôt miss the opportunity to connect with novartis medical at ectrims and learn what‚Äôs happening in #ms and neuroscience. #ectrims2022 https://t.co/3v3wny0ah8,,"#ms, #ectrims2022",Beauty/Health & Fitness,,dont miss the opportunity to connect with novartis medical at ectrims and learn whats happening in ms and neuroscience. ec trims
700,"If you're at #ECTRIMS2022 this week make sure you come and visit our poster which discusses remote web-based assessment of mood, fatigue and cognition in people with multiple sclerosis. https://t.co/jYjmh9OG0q",twitter,GBR,CANTABconnect,,"if you're at #ectrims2022 this week make sure you come and visit our poster which discusses remote web-based assessment of mood, fatigue and cognition in people with multiple sclerosis. https://t.co/jyjmh9og0q",,#ectrims2022,"Beauty/Health & Fitness, Technology, Business",,"if you're at ec trims this week make sure you come and visit our poster which discusses remote web-based assessment of mood, fatigue and cognition in people with multiple sclerosis."
701,"MOTOmed at ECTRIMS 2022
The 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis will take place from October 26 to 28 in Amsterdam. Three days with a diverse scientific program, MOTOmed will accompany the Congress with an exhibition booth. https://t.co/k6JxlGlKWZ",twitter,DEU,ReckMOTOmed,,"motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth. https://t.co/k6jxlglkwz",unknown,,,,"motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth."
702,"InSysBio team is going to present its ePoster ""Neurodegeneration quantitative systems pharmacology modelling for analysis of multiple sclerosis therapy"" at ECTRIMS 2022, October 26.
https://t.co/1tMpgc95O5
#ECTRIMS22 #neurodegeneration #multiplesclerosis #biopharma #biotechnology",twitter,CYP,insysbio,,"insysbio team is going to present its eposter ""neurodegeneration quantitative systems pharmacology modelling for analysis of multiple sclerosis therapy"" at ectrims 2022, october 26. https://t.co/1tmpgc95o5 #ectrims22 #neurodegeneration #multiplesclerosis #biopharma #biotechnology",,"#ectrims22, #neurodegeneration, #multiplesclerosis, #biopharma, #biotechnology",Fashion,,"insysbio team is going to present its eposter ""neurodegeneration quantitative systems pharmacology modelling for analysis of multiple sclerosis therapy"" at ectrims 2022, october 26. ec trims22 #neurodegeneration multiple sclerosis #biopharma #biotechnology"
703,"@drbarrysinger @ECTRIMS @C_OrejaGuevara @KlausSchmierer @AaronBosterMD @bart_professor @MSViewsandNews Amazing to be back in person for this meeting after so long! Can‚Äôt wait to see you all there and to share our collective insights with the #MultipleSclerosis community. Please get in touch if you‚Äôd like to meet up over the coming days, we‚Äôd love to hear from you.",twitter,AUS,MStranslate,,"@drbarrysinger @ectrims @c_orejaguevara @klausschmierer @aaronbostermd @bart_professor @msviewsandnews amazing to be back in person for this meeting after so long! can‚Äôt wait to see you all there and to share our collective insights with the #multiplesclerosis community. please get in touch if you‚Äôd like to meet up over the coming days, we‚Äôd love to hear from you.",,#multiplesclerosis,,,"amazing to be back in person for this meeting after so long! cant wait to see you all there and to share our collective insights with the multiple sclerosis community. please get in touch if youd like to meet up over the coming days, wed love to hear from you."
704,"ECTRIMS2022 draws near. What will it tell us? Yep don‚Äôt be an UmpaLumpa. If it is worth saying this once, it‚Äôs worth saying again. https://t.co/BYrHeKAc1q",twitter,GBR,the_MSBlog,,"ectrims2022 draws near. what will it tell us? yep don‚Äôt be an umpalumpa. if it is worth saying this once, it‚Äôs worth saying again. https://t.co/byrhekac1q",unknown,,,,"ectrims2022 draws near. what will it tell us? yep dont be an umpalumpa. if it is worth saying this once, its worth saying again."
705,üåéüî¨Ready to learn/share the latest #MS research at #ECTRIMS2022 @ECTRIMS in Amsterdam. Will be LIVE tweeting starting tomorrow. Looking forward to seeing colleagues! @C_OrejaGuevara @KlausSchmierer @AaronBosterMD @bart_professor @MStranslate @MSViewsandNews https://t.co/L3B5OzNK1e,twitter,USA,drbarrysinger,,üåéüî¨ready to learn/share the latest #ms research at #ectrims2022 @ectrims in amsterdam. will be live tweeting starting tomorrow. looking forward to seeing colleagues! @c_orejaguevara @klausschmierer @aaronbostermd @bart_professor @mstranslate @msviewsandnews https://t.co/l3b5oznk1e,male,"#ms, #ectrims2022",Science,,ready to learn/share the latest ms research at ec trims in amsterdam. will be live tweeting starting tomorrow. looking forward to seeing colleagues!
706,"How can we target the pathologic CNS immune cell response for people living with #MultipleSclerosis? To find out more, join us in Hall 12 for our GMA Symposium ‚ÄúConnecting the dots: immune cells and CNS inflammation‚Äù on October 26, 13:15-14:15 CEST. #ECTRIMS2022 #HCPsOnly https://t.co/TlNNpOhc90",twitter,DEU,MerckHealthcare,,"how can we target the pathologic cns immune cell response for people living with #multiplesclerosis? to find out more, join us in hall 12 for our gma symposium ‚Äúconnecting the dots: immune cells and cns inflammation‚Äù on october 26, 13:15-14:15 cest. #ectrims2022 #hcpsonly https://t.co/tlnnpohc90",,"#multiplesclerosis, #ectrims2022, #hcpsonly",,,"how can we target the pathologic cns immune cell response for people living with multiple sclerosis? to find out more, join us in hall 12 for our gma symposium connecting the dots: immune cells and cns inflammation on october 26, 13:15-14:15 cest. ec trims #hcpsonly"
707,"The wait is over! #ECTRIMS2022 begins tomorrow, and we can‚Äôt wait to hear from you and the experts üòç

You can stay up-to-date on all the latest news by visiting ‚ú®https://t.co/FB5htuqt0q‚ú®

@ECTRIMS #MS #MSresearch #Neurology https://t.co/khDk3Wg8Ql",twitter,,VJNeurology,,"the wait is over! #ectrims2022 begins tomorrow, and we can‚Äôt wait to hear from you and the experts üòç you can stay up-to-date on all the latest news by visiting ‚ú®https://t.co/fb5htuqt0q‚ú® @ectrims #ms #msresearch #neurology https://t.co/khdk3wg8ql",,"#ectrims2022, #ms, #msresearch, #neurology",Photo & Video,,"the wait is over! ec trims begins tomorrow, and we cant wait to hear from you and the experts you can stay up-to-date on all the latest news by visiting ms msresearch #neurology"
708,See you beyond the (treatment) barriers #GoDomGo #MS #AttackMS https://t.co/OeTjxE4He7 #ECTRIMS2022 @ECTRIMS,twitter,GBR,KlausSchmierer,,see you beyond the (treatment) barriers #godomgo #ms #attackms https://t.co/oetjxe4he7 #ectrims2022 @ectrims,male,"#godomgo, #ms, #attackms, #ectrims2022",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",see you beyond the (treatment) barriers #godomgo ms #attackms ec trims
709,@MSWarriorMJ @ECTRIMS @MSwebNL Travelled from Switzerland to the Netherlands to join the Ectrims congress as an MS Patient myself...and guess what? Covid+ since yesterday... Bad luck :(,twitter,,MSguncel,,@mswarriormj @ectrims @mswebnl travelled from switzerland to the netherlands to join the ectrims congress as an ms patient myself...and guess what? covid+ since yesterday... bad luck :(,female,,,,travelled from switzerland to the netherlands to join the ectrims congress as an ms patient myself...and guess what? covid+ since yesterday... bad luck
710,"The Karolinska Institutet‚Äôs Academic Specialist Center (ASC) to Present Results of GeNeuro‚Äôs ProTEct-MS Phase 2 Study of Temelimab at ECTRIMS 2022 - 
#MS #fightneurodegeneration #HERV $GNRO

https://t.co/SBIBaycKtl",twitter,CHE,GeneuroO,,the karolinska institutet‚Äôs academic specialist center (asc) to present results of geneuro‚Äôs protect-ms phase 2 study of temelimab at ectrims 2022 - #ms #fightneurodegeneration #herv $gnro https://t.co/sbibaycktl,unknown,"#ms, #fightneurodegeneration, #herv",,,the karolinska institutets academic specialist center (asc) to present results of geneuros protect-ms phase 2 study of temelimab at ectrims 2022 - ms #fightneurodegeneration #herv $gnro
711,Officially in Amsterdam for ECTRIMS 2022! Looking forward to a great week of exciting new data in the multiple sclerosis space. Would love to meet up with any colleagues and connections that have also traveled across the pond to attend! #ectrims2022 #MultipleSclerosis https://t.co/Q9729ySHay,twitter,NLD,patinc91,,officially in amsterdam for ectrims 2022! looking forward to a great week of exciting new data in the multiple sclerosis space. would love to meet up with any colleagues and connections that have also traveled across the pond to attend! #ectrims2022 #multiplesclerosis https://t.co/q9729yshay,female,"#ectrims2022, #multiplesclerosis","Science, Animals & Pets, Family & Parenting, Music","{profession=Scientist & Researcher, jobTitle=Neuroscientist}",officially in amsterdam for ectrims 2022! looking forward to a great week of exciting new data in the multiple sclerosis space. would love to meet up with any colleagues and connections that have also traveled across the pond to attend! ec trims multiple sclerosis
712,"The @MSIntFederation team is off to #ECTRIMS2022!

You can find us at B07 in the exhibition if you want to chat about #AtlasofMS, #fellowships or our work to improve global access to #MultipleSclerosis treatments üåéüíä https://t.co/R3WUJVrZJQ",twitter,GBR,AnneHelme,,"the @msintfederation team is off to #ectrims2022! you can find us at b07 in the exhibition if you want to chat about #atlasofms, #fellowships or our work to improve global access to #multiplesclerosis treatments üåéüíä https://t.co/r3wujvrzjq",female,"#ectrims2022, #atlasofms, #fellowships, #multiplesclerosis",Beauty/Health & Fitness,,"the team is off to ec trims! you can find us at b07 in the exhibition if you want to chat about #atlasofms, #fellowships or our work to improve global access to multiple sclerosis treatments"
713,Landing in Amsterdam. Let‚Äôs join #ECTRIMS2022! Exciting times ahead #MS #NMOSD #RIS https://t.co/X17IUP4AwL,twitter,,XtineLebrunF,,landing in amsterdam. let‚Äôs join #ectrims2022! exciting times ahead #ms #nmosd #ris https://t.co/x17iup4awl,female,"#ectrims2022, #ms, #nmosd, #ris",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Neurologist}",landing in amsterdam. lets join ec trims! exciting times ahead ms #nmosd #ris
714,"Thrilled our #multiplesclerosis Precision Care Solution featured in 13 #ECTRIMS2022 presentations in Amsterdam, Oct 26-28. Growing body of evidence on value for MS patients and their physicians. https://t.co/dMdapLqEn2",twitter,USA,OctaveBio,,"thrilled our #multiplesclerosis precision care solution featured in 13 #ectrims2022 presentations in amsterdam, oct 26-28. growing body of evidence on value for ms patients and their physicians. https://t.co/dmdaplqen2",male,"#multiplesclerosis, #ectrims2022",Beauty/Health & Fitness,,"thrilled our multiple sclerosis precision care solution featured in 13 ec trims presentations in amsterdam, oct 26-28. growing body of evidence on value for ms patients and their physicians."
715,"Looking forward to attending @ECTRIMS later this week. Come and visit us at booth B02 in the exhibition hall to find out about our ongoing health policy initiative @MSBrainHealth
 
#ECTRIMS2022  #MS #healthpolicy",twitter,GBR,OxHealthPolicy,,looking forward to attending @ectrims later this week. come and visit us at booth b02 in the exhibition hall to find out about our ongoing health policy initiative @msbrainhealth #ectrims2022 #ms #healthpolicy,,"#ectrims2022, #ms, #healthpolicy",Beauty/Health & Fitness,,looking forward to attending later this week. come and visit us at booth b02 in the exhibition hall to find out about our ongoing health policy initiative ec trims ms #healthpolicy
716,"Are you attending @ECTRIMS this year? Come and visit us at booth B02 in the exhibition hall to chat with our team about the latest MSBH news and insights.

#MS #ECTRIMS2022 https://t.co/h4mpLZcDSy",twitter,,MSBrainHealth,,are you attending @ectrims this year? come and visit us at booth b02 in the exhibition hall to chat with our team about the latest msbh news and insights. #ms #ectrims2022 https://t.co/h4mplzcdsy,female,"#ms, #ectrims2022",,,are you attending this year? come and visit us at booth b02 in the exhibition hall to chat with our team about the latest msbh news and insights. ms ec trims
717,"Join us at #ECTRIMS2022 to experience #MS slowly expanding lesions in 3D and via augmented reality! Through our MS-LINK initiative, we‚Äôll print 3D SELs created from the combination of two MRI timepoints that you can see, feel, and take home. 
#MultipleSclerosis #Neurology https://t.co/OfdWCGRi7T",twitter,USA,EMDSerono,,"join us at #ectrims2022 to experience #ms slowly expanding lesions in 3d and via augmented reality! through our ms-link initiative, we‚Äôll print 3d sels created from the combination of two mri timepoints that you can see, feel, and take home. #multiplesclerosis #neurology https://t.co/ofdwcgri7t",unknown,"#ectrims2022, #ms, #multiplesclerosis, #neurology",Business,,"join us at ec trims to experience ms slowly expanding lesions in 3d and via augmented reality! through our ms-link initiative, well print 3d sels created from the combination of two mri timepoints that you can see, feel, and take home. multiple sclerosis #neurology"
718,"More than 8,200 #MS professionals from over 108 countries around the world üåè have signed up for #ECTRIMS2022, and the numbers are climbing! Two days until ECTRIMS 2022, can you feel the excitement?

Join us in Amsterdam, or online, on 26-28 October: https://t.co/GJGdaoyPlu https://t.co/ID7jtQiUOe",twitter,CHE,ECTRIMS,,"more than 8,200 #ms professionals from over 108 countries around the world üåè have signed up for #ectrims2022, and the numbers are climbing! two days until ectrims 2022, can you feel the excitement? join us in amsterdam, or online, on 26-28 october: https://t.co/gjgdaoyplu https://t.co/id7jtqiuoe",,"#ms, #ectrims2022",,,"more than 8,200 ms professionals from over 108 countries around the world have signed up for ec trims, and the numbers are climbing! two days until ectrims 2022, can you feel the excitement? join us in amsterdam, or online, on 26-28 october:"
719,We look forward to sharing our latest #MultipleSclerosis (MS) research at the #ECTRIMS2022 Congress. HCPs: Join us virtually or in Amsterdam at booth #A30 in hall 10 to learn more about our new data and upcoming presentations. View the program:,twitter,USA,biogen,,we look forward to sharing our latest #multiplesclerosis (ms) research at the #ectrims2022 congress. hcps: join us virtually or in amsterdam at booth #a30 in hall 10 to learn more about our new data and upcoming presentations. view the program:,,"#multiplesclerosis, #ectrims2022, #a30","Beauty/Health & Fitness, Science",,we look forward to sharing our latest multiple sclerosis (ms) research at the ec trims congress. hcps: join us virtually or in amsterdam at booth #a30 in hall 10 to learn more about our new data and upcoming presentations. view the program:
720,"#ECTRIMS2022

The #Immunic team is already looking forward to meeting the #MS community this week. Let's get connected and learn from one another! 

$IMUX #MultipleSclerosis #ScientificResearch #Msresearch @ECTRIMS https://t.co/JUE0BLXcIG",twitter,USA,ImmunicInc,,#ectrims2022 the #immunic team is already looking forward to meeting the #ms community this week. let's get connected and learn from one another! $imux #multiplesclerosis #scientificresearch #msresearch @ectrims https://t.co/jue0blxcig,,"#ectrims2022, #immunic, #ms, #multiplesclerosis, #scientificresearch, #msresearch","Beauty/Health & Fitness, Business",,ec trims the #immunic team is already looking forward to meeting the ms community this week. let's get connected and learn from one another! $imux multiple sclerosis #scientificresearch msresearch
721,Super excited and on our way to Amsterdam for @ECTRIMS The largest #MultipleSclerosis meeting!! World experts in MS meet & once again face to face üëãüèªüëãüèª https://t.co/8XHL0y8miT,twitter,MEX,irenetrefrenk,,super excited and on our way to amsterdam for @ectrims the largest #multiplesclerosis meeting!! world experts in ms meet & once again face to face üëãüèªüëãüèª https://t.co/8xhl0y8mit,female,#multiplesclerosis,,"{profession=Executive, jobTitle=President}, {profession=Scientist & Researcher, jobTitle=Neurologist}",super excited and on our way to amsterdam for the largest multiple sclerosis meeting!! world experts in ms meet & once again face to face
722,"Looks like a promising #ECTRIMS2022 weather forecast. Safe travels, everyone - looking forward to many great sessions, talks as well as 1:1 catch ups in Amsterdam. #DTx #RCT #MS https://t.co/wWpfKuGiAQ",twitter,DEU,matthiaszenker,,"looks like a promising #ectrims2022 weather forecast. safe travels, everyone - looking forward to many great sessions, talks as well as 1:1 catch ups in amsterdam. #dtx #rct #ms https://t.co/wwpfkugiaq",male,"#ectrims2022, #dtx, #rct, #ms",Travel,,"looks like a promising ec trims weather forecast. safe travels, everyone - looking forward to many great sessions, talks as well as 1:1 catch ups in amsterdam. #dtx #rct ms"
723,"#ECTRIMS2022 | Hot Topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for #MS
 
üìÖ Fri 28 Oct 12:00‚Äì13:00 (Hot Topic 10: Emerging role of lipids in MS)
‚û°Ô∏è https://t.co/P8ogqLoCrx
 
Full programme ‚û°Ô∏è https://t.co/rYgbXPpEyZ https://t.co/gIgKHp1MQ6",twitter,CHE,ECTRIMS,,#ectrims2022 | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for #ms üìÖ fri 28 oct 12:00‚Äì13:00 (hot topic 10: emerging role of lipids in ms) ‚û°Ô∏è https://t.co/p8ogqlocrx full programme ‚û°Ô∏è https://t.co/rygbxppeyz https://t.co/gigkhp1mq6,,"#ectrims2022, #ms",,,ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme
725,"Heading to #ECTRIMS2022 & looking for something to listen to on your flight? Check out MS DIAGNOSIS JOURNEY podcast, where real people with MS tell their dx experience.  Over 30 curated episodes available where you get your podcasts or https://t.co/KRlUvxjM1F",twitter,USA,lkay54,,"heading to #ectrims2022 & looking for something to listen to on your flight? check out ms diagnosis journey podcast, where real people with ms tell their dx experience. over 30 curated episodes available where you get your podcasts or https://t.co/krluvxjm1f",female,#ectrims2022,Politics,,"heading to ec trims & looking for something to listen to on your flight? check out ms diagnosis journey podcast, where real people with ms tell their dx experience. over 30 curated episodes available where you get your podcasts or"
726,"The question on many of our minds leading up to @ECTRIMS: ùóúùòÄ ùó∂ùòÅ ùóΩùóºùòÄùòÄùó∂ùóØùóπùó≤ ùòÅùóº ùóøùó≤ùó¥ùó≤ùóªùó≤ùóøùóÆùòÅùó≤ ùó∫ùòÜùó≤ùóπùó∂ùóª?

We want to find out what the evidence is saying and get your questions answered üëá

#Remyelination #MultipleSclerosis https://t.co/vt7MdC4jXB",twitter,,LivedHealth,,the question on many of our minds leading up to @ectrims: ùóúùòÄ ùó∂ùòÅ ùóΩùóºùòÄùòÄùó∂ùóØùóπùó≤ ùòÅùóº ùóøùó≤ùó¥ùó≤ùóªùó≤ùóøùóÆùòÅùó≤ ùó∫ùòÜùó≤ùóπùó∂ùóª? we want to find out what the evidence is saying and get your questions answered üëá #remyelination #multiplesclerosis https://t.co/vt7mdc4jxb,unknown,"#remyelination, #multiplesclerosis","Beauty/Health & Fitness, Photo & Video",,the question on many of our minds leading up to : ? we want to find out what the evidence is saying and get your questions answered #remyelination multiple sclerosis
727,$TGTX upcoming event October 26: 2022 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting. Options expiring on November 18 that cover the event have an implied move of ¬±30.1% https://t.co/kuzxRMjR5e,twitter,USA,MarketChmln,,$tgtx upcoming event october 26: 2022 european committee for treatment and research in multiple sclerosis (ectrims) annual meeting. options expiring on november 18 that cover the event have an implied move of ¬±30.1% https://t.co/kuzxrmjr5e,,,,,$tgtx upcoming event october 26: 2022 european committee for treatment and research in multiple sclerosis (ectrims) annual meeting. options expiring on november 18 that cover the event have an implied move of 30.1%
728,$HZNP upcoming event October 26: 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022. Options expiring on November 18 that cover the event have an implied move of ¬±11.8% https://t.co/HTB4ZCXjW2,twitter,USA,MarketChmln,,$hznp upcoming event october 26: 38th congress of the european committee for treatment and research in multiple sclerosis (ectrims) 2022. options expiring on november 18 that cover the event have an implied move of ¬±11.8% https://t.co/htb4zcxjw2,,,,,$hznp upcoming event october 26: 38th congress of the european committee for treatment and research in multiple sclerosis (ectrims) 2022. options expiring on november 18 that cover the event have an implied move of 11.8%
729,Excited for collaboration and research updates in #MS #NMOSD #MOGAD Ready for #ECTRIMS2022 #Amsterdam https://t.co/Ni5CuNZQFD,twitter,USA,DrJNicholas,,excited for collaboration and research updates in #ms #nmosd #mogad ready for #ectrims2022 #amsterdam https://t.co/ni5cunzqfd,female,"#ms, #nmosd, #mogad, #ectrims2022, #amsterdam",Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",excited for collaboration and research updates in ms #nmosd #mogad ready for ec trims #amsterdam
730,"#ECTRIMS2022 | Meet the speakers: @JeromeHendriks talks about his session on the progression of #MS lesions.

üìÖ Fri, 28 Oct, 12:00‚Äì13:00 CEST (Hot Topic 10: Emerging role of lipids in MS)

‚û°Ô∏èhttps://t.co/P8ogqLGLFF 

Full Scientific Programme ‚û°Ô∏è https://t.co/rYgbXP8BwZ https://t.co/SnkyQ3BewQ",twitter,CHE,ECTRIMS,,"#ectrims2022 | meet the speakers: @jeromehendriks talks about his session on the progression of #ms lesions. üìÖ fri, 28 oct, 12:00‚Äì13:00 cest (hot topic 10: emerging role of lipids in ms) ‚û°Ô∏èhttps://t.co/p8ogqlglff full scientific programme ‚û°Ô∏è https://t.co/rygbxp8bwz https://t.co/snkyq3bewq",,"#ectrims2022, #ms",,,"ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme"
731,"We're packing up and hitting the road to #ECTRIMS2022! üß≥ 

Visit us at booth D26, Hall 11. ‚¨ÖÔ∏è 

Don't miss our panel discussion on 10/26 with leading #MSresearch experts, presentations, poster sessions & a cocktail reception!

https://t.co/QhcIdSPiZb https://t.co/cfooJHFCKy",twitter,USA,OctaveBio,,"we're packing up and hitting the road to #ectrims2022! üß≥ visit us at booth d26, hall 11. ‚¨ÖÔ∏è don't miss our panel discussion on 10/26 with leading #msresearch experts, presentations, poster sessions & a cocktail reception! https://t.co/qhcidspizb https://t.co/cfoojhfcky",male,"#ectrims2022, #msresearch",Beauty/Health & Fitness,,"we're packing up and hitting the road to ec trims! visit us at booth d26, hall 11. don't miss our panel discussion on 10/26 with leading msresearch experts, presentations, poster sessions & a cocktail reception!"
732,How do peripheral and central drivers of inflammation affect people living with #MS? We are making the connection. Learn more at our symposia: #multiplesclerosis #ECTRIMS2022 #HCPsOnly https://t.co/07lyN1oqUN,twitter,DEU,MerckHealthcare,,how do peripheral and central drivers of inflammation affect people living with #ms? we are making the connection. learn more at our symposia: #multiplesclerosis #ectrims2022 #hcpsonly https://t.co/07lyn1oqun,,"#ms, #multiplesclerosis, #ectrims2022, #hcpsonly",,,how do peripheral and central drivers of inflammation affect people living with ms? we are making the connection. learn more at our symposia: multiple sclerosis ec trims #hcpsonly
733,"Visit our booth, stand A20 in Hall 10 to learn about the unmet need of addressing silent progression in MS. #MS #multiplesclerosis #ECTRIMS2022 #HCPsOnly https://t.co/1rNInAEi1d",twitter,DEU,MerckHealthcare,,"visit our booth, stand a20 in hall 10 to learn about the unmet need of addressing silent progression in ms. #ms #multiplesclerosis #ectrims2022 #hcpsonly https://t.co/1rninaei1d",,"#ms, #multiplesclerosis, #ectrims2022, #hcpsonly",,,"visit our booth, stand a20 in hall 10 to learn about the unmet need of addressing silent progression in ms. ms multiple sclerosis ec trims #hcpsonly"
734,"There is still time to register for the Joint Pre-ECTRIMS 2022 Workshop! Attend in-person or online. Register NOW using the link below! #MultipleSclerosis #ECTRIMS #PreECTRIMS #CME 

https://t.co/lzvC3qsNvc",twitter,USA,academiccme,,there is still time to register for the joint pre-ectrims 2022 workshop! attend in-person or online. register now using the link below! #multiplesclerosis #ectrims #preectrims #cme https://t.co/lzvc3qsnvc,,"#multiplesclerosis, #ectrims, #preectrims, #cme",,,there is still time to register for the joint pre-ectrims 2022 workshop! attend in-person or online. register now using the link below! multiple sclerosis ec trims #preectrims #cme
736,"Only 5 days until #ECTRIMS2022 starts! If you haven‚Äôt already, please fill out this survey that will help us deliver the hangout the best way possible: https://t.co/YcQWW21JDH 
https://t.co/ejo1Ye9hKJ",twitter,GBR,the_MSBlog,,"only 5 days until #ectrims2022 starts! if you haven‚Äôt already, please fill out this survey that will help us deliver the hangout the best way possible: https://t.co/ycqww21jdh https://t.co/ejo1ye9hkj",unknown,#ectrims2022,,,"only 5 days until ec trims starts! if you havent already, please fill out this survey that will help us deliver the hangout the best way possible:"
737,"Don't miss Octave's #ECTRIMS2022 Precision Medicine: From Research to Clinical Practice panel discussion on Oct. 26!

Join @drbarrysinger, @SKriegerMD, @GravesNeuro & others for a chat on precision medicine in #MS & available tools. 

More info ‚¨áÔ∏è 
https://t.co/QhcIdT6m1b https://t.co/99CSNQfQtO",twitter,USA,OctaveBio,,"don't miss octave's #ectrims2022 precision medicine: from research to clinical practice panel discussion on oct. 26! join @drbarrysinger, @skriegermd, @gravesneuro & others for a chat on precision medicine in #ms & available tools. more info ‚¨áÔ∏è https://t.co/qhcidt6m1b https://t.co/99csnqfqto",male,"#ectrims2022, #ms",Beauty/Health & Fitness,,"don't miss octave's ec trims precision medicine: from research to clinical practice panel discussion on oct. 26! join , , & others for a chat on precision medicine in ms & available tools. more info"
738,"Less than ùü≠ ùòÑùó≤ùó≤ùó∏ to go until @ECTRIMS üï£üìÜ Make sure you're subscribed to be the first to hear the latest updates about the ùóµùóºùòÅ ùòÅùóºùóΩùó∂ùó∞ùòÄ in MS üëâ https://t.co/xTWrQDlFZy

#ChatMS #MultipleSclerosis #Remyelination https://t.co/gmHnRgjiMa",twitter,,LivedHealth,,less than ùü≠ ùòÑùó≤ùó≤ùó∏ to go until @ectrims üï£üìÜ make sure you're subscribed to be the first to hear the latest updates about the ùóµùóºùòÅ ùòÅùóºùóΩùó∂ùó∞ùòÄ in ms üëâ https://t.co/xtwrqdlfzy #chatms #multiplesclerosis #remyelination https://t.co/gmhnrgjima,unknown,"#chatms, #multiplesclerosis, #remyelination","Beauty/Health & Fitness, Photo & Video",,less than to go until make sure you're subscribed to be the first to hear the latest updates about the in ms #chatms multiple sclerosis #remyelination
739,"The countdown is on ‚è∞ In less than a week we‚Äôll be at #ECTRIMS2022 where you can expect featured presidential lectures, teaching courses, and much more!

@ECTRIMS has so much to offer everyone interested in #MultipleSclerosis, so don‚Äôt miss out!

#MSresearch #MS #Neurology https://t.co/fCJQgF26gW",twitter,,VJNeurology,,"the countdown is on ‚è∞ in less than a week we‚Äôll be at #ectrims2022 where you can expect featured presidential lectures, teaching courses, and much more! @ectrims has so much to offer everyone interested in #multiplesclerosis, so don‚Äôt miss out! #msresearch #ms #neurology https://t.co/fcjqgf26gw",,"#ectrims2022, #multiplesclerosis, #msresearch, #ms, #neurology",Photo & Video,,"the countdown is on in less than a week well be at ec trims where you can expect featured presidential lectures, teaching courses, and much more! has so much to offer everyone interested in multiple sclerosis, so dont miss out! msresearch ms #neurology"
740,Do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? ‚¨áÔ∏è Follow Nada‚Äôs journey as she discovers the differences between the two disorders #ECTRIMS2022 #NMOSD #multiplesclerosis,twitter,CHE,Roche,,do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? ‚¨áÔ∏è follow nada‚Äôs journey as she discovers the differences between the two disorders #ectrims2022 #nmosd #multiplesclerosis,,"#ectrims2022, #nmosd, #multiplesclerosis",,,do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis
741,"Attending #ECTRIMS2022? Check our abstracts on #AI-based characterization of #MS clinical symptomatology using lesion parenchymal fraction; and  
on X-Sectional & Long. Comparative Analyses of brain volumes in MOGAD, NMOSD & MS. See you at our booth D11! https://t.co/dQwQZMcWHu https://t.co/sK68NNR7OQ",twitter,BEL,icometrix,,"attending #ectrims2022? check our abstracts on #ai-based characterization of #ms clinical symptomatology using lesion parenchymal fraction; and on x-sectional & long. comparative analyses of brain volumes in mogad, nmosd & ms. see you at our booth d11! https://t.co/dqwqzmcwhu https://t.co/sk68nnr7oq",unknown,"#ectrims2022, #ai, #ms",Beauty/Health & Fitness,,"attending ec trims? check our abstracts on #ai-based characterization of ms clinical symptomatology using lesion parenchymal fraction; and on x-sectional & long. comparative analyses of brain volumes in mogad, nmosd & ms. see you at our booth d11!"
742,#BrainStorm #Cell #Therapeutics #Presents #NurOwn¬Æ #Phase 2 #Progressive #MS #Biomarker #Data at the 38th #ECTRIMS #Congress https://t.co/sOBGSnVEgv $BCLI @BrainstormCell https://t.co/2sbNiT6UXL,twitter,ISR,PRNewswireIL,,#brainstorm #cell #therapeutics #presents #nurown¬Æ #phase 2 #progressive #ms #biomarker #data at the 38th #ectrims #congress https://t.co/sobgsnvegv $bcli @brainstormcell https://t.co/2sbnit6uxl,male,"#brainstorm, #cell, #therapeutics, #presents, #nurown, #phase, #progressive, #ms, #biomarker, #data, #ectrims, #congress","Business, Technology",,#brainstorm #cell #therapeutics #presents #nurown #phase 2 #progressive ms #biomarker #data at the 38th ec trims #congress $bcli
743,"How can digital innovations improve the treatment of #MS? Join us in Amsterdam next week to find out. Our long-term research partner Dr. Stefan Gold will be at this year's #ECTRIMS2022 to share new results from an international, multicenter trial investigating GAIA‚Äôs new #DTx https://t.co/JpHhHSoNSl",twitter,DEU,GAIA_COM,,"how can digital innovations improve the treatment of #ms? join us in amsterdam next week to find out. our long-term research partner dr. stefan gold will be at this year's #ectrims2022 to share new results from an international, multicenter trial investigating gaia‚Äôs new #dtx https://t.co/jphhhsonsl",female,"#ms, #ectrims2022, #dtx",,,"how can digital innovations improve the treatment of ms? join us in amsterdam next week to find out. our long-term research partner dr. stefan gold will be at this year's ec trims to share new results from an international, multicenter trial investigating gaias new #dtx"
744,We discuss our evolving understanding of #MultipleSclerosis and tools to detect progression early in the disease course. We also explore the role of BTK pathway in MS. Join us in Hall 12 during our symposium on October 28 14:15-15:15 CEST. #ECTRIMS2022 #HCPSONLY https://t.co/NiqTyB9NIM,twitter,DEU,MerckHealthcare,,we discuss our evolving understanding of #multiplesclerosis and tools to detect progression early in the disease course. we also explore the role of btk pathway in ms. join us in hall 12 during our symposium on october 28 14:15-15:15 cest. #ectrims2022 #hcpsonly https://t.co/niqtyb9nim,,"#multiplesclerosis, #ectrims2022, #hcpsonly",,,we discuss our evolving understanding of multiple sclerosis and tools to detect progression early in the disease course. we also explore the role of btk pathway in ms. join us in hall 12 during our symposium on october 28 14:15-15:15 cest. ec trims #hcpsonly
745,"Mark your #ECTRIMS2022 calendar! üìÖ

Visit us on Thurs. Oct. 27 during Poster Session 2 to learn more on Octave's innovations around multivariate blood serum biomarkers for #MS.

‚û°Ô∏è Poster Session 2: Thurs. Oct. 27 | 5:00‚Äì7:00 p.m. CEST | Poster Hall 9 

https://t.co/QhcIdT6m1b https://t.co/Xy49lHkBgj",twitter,USA,OctaveBio,,mark your #ectrims2022 calendar! üìÖ visit us on thurs. oct. 27 during poster session 2 to learn more on octave's innovations around multivariate blood serum biomarkers for #ms. ‚û°Ô∏è poster session 2: thurs. oct. 27 | 5:00‚Äì7:00 p.m. cest | poster hall 9 https://t.co/qhcidt6m1b https://t.co/xy49lhkbgj,male,"#ectrims2022, #ms",Beauty/Health & Fitness,,mark your ec trims calendar! visit us on thurs. oct. 27 during poster session 2 to learn more on octave's innovations around multivariate blood serum biomarkers for ms. poster session 2: thurs. oct. 27 | 5:007:00 p.m. cest | poster hall 9
746,"Genentech to Present New Ocrevus (ocrelizumab) Data in Multiple Sclerosis and Continued Research Into #NeuromyelitisOpticaSpectrumDisorder at #ECTRIMS2022

https://t.co/t8uVw2Ay0G",twitter,USA,TheSumairaFDN,,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into #neuromyelitisopticaspectrumdisorder at #ectrims2022 https://t.co/t8uvw2ay0g,,"#neuromyelitisopticaspectrumdisorder, #ectrims2022",Beauty/Health & Fitness,,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into #neuromyelitisopticaspectrumdisorder at ec trims
747,"Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022 - Oct 19 2022

https://t.co/c5k8KE7nbm",twitter,IND,lswonline,,roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - oct 19 2022 https://t.co/c5k8ke7nbm,,,,,roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - oct 19 2022
748,"üì£ We are in the home stretch! ONE WEEK remains before #ECTRIMS2022 on 26‚Äì28 Oct in Amsterdam. Will we be seeing you there? Register today to join the conversation on the latest research & developments in #MS research, treatment and care

Sign up today ‚û°Ô∏è https://t.co/GJGdaohdWU https://t.co/TgtDMDDoPT",twitter,CHE,ECTRIMS,,"üì£ we are in the home stretch! one week remains before #ectrims2022 on 26‚Äì28 oct in amsterdam. will we be seeing you there? register today to join the conversation on the latest research & developments in #ms research, treatment and care sign up today ‚û°Ô∏è https://t.co/gjgdaohdwu https://t.co/tgtdmddopt",,"#ectrims2022, #ms",,,"we are in the home stretch! one week remains before ec trims on 2628 oct in amsterdam. will we be seeing you there? register today to join the conversation on the latest research & developments in ms research, treatment and care sign up today"
749,"We are proud to announce new data to be presented at #ECTRIMS2022 on disease activity and progression in patients with early-stage relapsing remitting #multiplesclerosis, and new research on misdiagnosis and delayed treatment in #NMOSD: https://t.co/XNJuO3WqDq $RHHBY $ROG https://t.co/iYpgNsE7R2",twitter,CHE,Roche,,"we are proud to announce new data to be presented at #ectrims2022 on disease activity and progression in patients with early-stage relapsing remitting #multiplesclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: https://t.co/xnjuo3wqdq $rhhby $rog https://t.co/iypgnse7r2",,"#ectrims2022, #multiplesclerosis, #nmosd",,,"we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog"
750,Genentech to Present New Ocrevus (ocrelizumab) Data in Multiple Sclerosis and Continued Research Into Neuromyelitis Optica Spectrum Disorder at ECTRIMS¬†2022 https://t.co/2y3XlRY5g9,twitter,,PharmacDaily,,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 https://t.co/2y3xlry5g9,,,,,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022
754,Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022 - https://t.co/OP4oSPw9gd data will show significant benefit on slowing disease activity and progression in patients with tr... https://t.co/VBSJMLGqYJ,twitter,USA,Dw40031913,,roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - https://t.co/op4ospw9gd data will show significant benefit on slowing disease activity and progression in patients with tr... https://t.co/vbsjmlgqyj,male,,Business,"{profession=Executive, jobTitle=CEO}",roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - data will show significant benefit on slowing disease activity and progression in patients with tr...
755,"$RO.SW | $ROG.SW | $RHHBY
üá®üá≠
Roche

Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022

https://t.co/SAelMWNHSU https://t.co/Is5v1e0L1D",twitter,FIN,BullBearBres,,$ro.sw | $rog.sw | $rhhby üá®üá≠ roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 https://t.co/saelmwnhsu https://t.co/is5v1e0l1d,unknown,,,,$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022
756,Genentech to Present New Ocrevus (ocrelizumab) Data in Multiple Sclerosis and Continued Research Into Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022 - https://t.co/YDwN863is9,twitter,USA,Dataemia,,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - https://t.co/ydwn863is9,male,,Business,,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -
757,#Breaking: We‚Äôre presenting new data at #ECTRIMS2022 that further advance the scientific understanding of #multiplesclerosis (MS) and neuromyelitis optica spectrum disorder (#NMOSD). Learn more: https://t.co/buuHCApJL5,twitter,USA,genentech,,#breaking: we‚Äôre presenting new data at #ectrims2022 that further advance the scientific understanding of #multiplesclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more: https://t.co/buuhcapjl5,,"#breaking, #ectrims2022, #multiplesclerosis, #nmosd",,,#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:
758,"$RHHBY Genentech to Present New Ocrevus (ocrelizumab) Data in Multiple Sclerosis and Continued Research Into Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022
https://t.co/T3vrbqjp0z",twitter,,StockNewsBot2,,$rhhby genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 https://t.co/t3vrbqjp0z,unknown,,,,$rhhby genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022
759,"$RHHBY Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022
https://t.co/gcVvNM3vrI",twitter,,StockNewsBot2,,$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 https://t.co/gcvvnm3vri,unknown,,,,$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022
760,"1 week until #ECTRIMS2022!

Visit three of Octave's posters on Wed. Oct. 26 to learn how we're transforming #MS care through innovations in biomarkers & advanced imaging analytics. 

‚û°Ô∏è Poster Session 1: Wed. Oct. 26 | 4:30‚Äì6:30 p.m. CEST | Poster Hall 9

https://t.co/QhcIdSOL9D https://t.co/E43JPRxFiA",twitter,USA,OctaveBio,,1 week until #ectrims2022! visit three of octave's posters on wed. oct. 26 to learn how we're transforming #ms care through innovations in biomarkers & advanced imaging analytics. ‚û°Ô∏è poster session 1: wed. oct. 26 | 4:30‚Äì6:30 p.m. cest | poster hall 9 https://t.co/qhcidsol9d https://t.co/e43jprxfia,male,"#ectrims2022, #ms",Beauty/Health & Fitness,,1 week until ec trims! visit three of octave's posters on wed. oct. 26 to learn how we're transforming ms care through innovations in biomarkers & advanced imaging analytics. poster session 1: wed. oct. 26 | 4:306:30 p.m. cest | poster hall 9
761,"There will be an MS patient-focused event at #ECTRIMS2022  on Saturday 29th October, both in-person and online (live streamed) Sign up here: https://t.co/3CSDYANOAy",twitter,GBR,TrishnaBharadia,,"there will be an ms patient-focused event at #ectrims2022 on saturday 29th october, both in-person and online (live streamed) sign up here: https://t.co/3csdyanoay",unknown,#ectrims2022,TV,,"there will be an ms patient-focused event at ec trims on saturday 29th october, both in-person and online (live streamed) sign up here:"
762,"NEW! Tune in next week for the debut of the official #ECTRIMSPodcast. Enjoy three back-to-back episodes of each day of #ECTRIMS2022 & stay up to date on all the key happenings unfolding at the world's largest international congress for #MSresearch 

üëâ https://t.co/OsrqyRksfy https://t.co/4DKcIt5ecm",twitter,CHE,ECTRIMS,,new! tune in next week for the debut of the official #ectrimspodcast. enjoy three back-to-back episodes of each day of #ectrims2022 & stay up to date on all the key happenings unfolding at the world's largest international congress for #msresearch üëâ https://t.co/osrqyrksfy https://t.co/4dkcit5ecm,,"#ectrimspodcast, #ectrims2022, #msresearch",,,new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch
763,"Have you heard? The new ECTRIMS Podcast is LIVE & ready for #ECTRIMS2022! Subscribe today on all your favourite podcast channels (Spotify, Apple etc) & listen to the latest insights unfolding at the world`s largest #MSresearch congress @MStranslate 

‚û°Ô∏è https://t.co/yWHlaVW7Jr https://t.co/thB2bewrdr",twitter,CHE,ECTRIMS,,"have you heard? the new ectrims podcast is live & ready for #ectrims2022! subscribe today on all your favourite podcast channels (spotify, apple etc) & listen to the latest insights unfolding at the world`s largest #msresearch congress @mstranslate ‚û°Ô∏è https://t.co/ywhlavw7jr https://t.co/thb2bewrdr",,"#ectrims2022, #msresearch",,,"have you heard? the new ectrims podcast is live & ready for ec trims! subscribe today on all your favourite podcast channels (spotify, apple etc) & listen to the latest insights unfolding at the world`s largest msresearch congress"
764,"#ECTRIMS2022 | Meet the speakers: Agustin Pappolla @vallhebrontalks about his session: Prediction of response in relapsing-remitting MS patients initiating oral DMTs

üìÖ Thu 27 Oct 15:00‚Äì16:00 CEST (Free Communications 5: Treatment) 

See the programme ‚û°Ô∏è https://t.co/rYgbXP8BwZ https://t.co/Xx4jTiNtv9",twitter,CHE,ECTRIMS,,#ectrims2022 | meet the speakers: agustin pappolla @vallhebrontalks about his session: prediction of response in relapsing-remitting ms patients initiating oral dmts üìÖ thu 27 oct 15:00‚Äì16:00 cest (free communications 5: treatment) see the programme ‚û°Ô∏è https://t.co/rygbxp8bwz https://t.co/xx4jtintv9,,#ectrims2022,,,ec trims | meet the speakers: agustin pappolla about his session: prediction of response in relapsing-remitting ms patients initiating oral dmts thu 27 oct 15:0016:00 cest (free communications 5: treatment) see the programme
765,What would you like to hear about from ECTRIMS 2022? https://t.co/6hYubq6nnF,twitter,GBR,the_MSBlog,,what would you like to hear about from ectrims 2022? https://t.co/6hyubq6nnf,unknown,,,,what would you like to hear about from ectrims 2022?
766,"@MStranslate @ECTRIMS When viewed strictly Incorrect criteria that Multiple Sclerosis theory is causative mysterious elusive
autoimmune response of unknown origin.MRI results show Plaques development which can be treated indefinitely w/ 
Neurology often harsh corrosive sometimes deadly drugs. #CCSVI",twitter,CAN,ms_matko,,@mstranslate @ectrims when viewed strictly incorrect criteria that multiple sclerosis theory is causative mysterious elusive autoimmune response of unknown origin.mri results show plaques development which can be treated indefinitely w/ neurology often harsh corrosive sometimes deadly drugs. #ccsvi,male,#ccsvi,Beauty/Health & Fitness,,when viewed strictly incorrect criteria that multiple sclerosis theory is causative mysterious elusive autoimmune response of unknown origin.mri results show plaques development which can be treated indefinitely w/ neurology often harsh corrosive sometimes deadly drugs. ccs vi
767,My initial thoughts on ECTRIMS 2022 and the return of the round up! https://t.co/EhRLS7oCRP,twitter,GBR,the_MSBlog,,my initial thoughts on ectrims 2022 and the return of the round up! https://t.co/ehrls7ocrp,unknown,,,,my initial thoughts on ectrims 2022 and the return of the round up!
768,"Join us at #ECTRIMS2022 on October 26-28 in Amsterdam, the Netherlands, to hear Mitzi Williams, Gavin Giovannoni, and Alexandra Goodyear present key OCREVUS data. Please see full Prescribing Information at https://t.co/k33kg31vLt. Intended for US healthcare professionals only. https://t.co/Z32uPaE87q",twitter,USA,OCREVUSHCP_USA,,"join us at #ectrims2022 on october 26-28 in amsterdam, the netherlands, to hear mitzi williams, gavin giovannoni, and alexandra goodyear present key ocrevus data. please see full prescribing information at https://t.co/k33kg31vlt. intended for us healthcare professionals only. https://t.co/z32upae87q",,#ectrims2022,,,"join us at ec trims on october 26-28 in amsterdam, the netherlands, to hear mitzi williams, gavin giovannoni, and alexandra goodyear present key ocrevus data. please see full prescribing information at . intended for us healthcare professionals only."
772,"Heading to @ECTRIMS?

We look forward to connecting with you, Oct 26-28! Visit us at booth D26 in Hall 11.

Learn more about Octave's ECTRIMS activities & mark your calendars: https://t.co/QhcIdSPiZb 

#ECTRIMS2022 #MSresearch #NeurodegenerativeDiseases",twitter,USA,OctaveBio,,"heading to @ectrims? we look forward to connecting with you, oct 26-28! visit us at booth d26 in hall 11. learn more about octave's ectrims activities & mark your calendars: https://t.co/qhcidspizb #ectrims2022 #msresearch #neurodegenerativediseases",male,"#ectrims2022, #msresearch, #neurodegenerativediseases",Beauty/Health & Fitness,,"heading to ? we look forward to connecting with you, oct 26-28! visit us at booth d26 in hall 11. learn more about octave's ectrims activities & mark your calendars: ec trims msresearch #neurodegenerativediseases"
773,"We're thrilled to share that OCREVUS data will be presented at the #ECTRIMS2022 conference in Amsterdam, the Netherlands, from October 26-28. Please see full Prescribing Info at https://t.co/k33kg323B1. Intended for US healthcare professionals only. How will you attend this year?",twitter,USA,OCREVUSHCP_USA,,"we're thrilled to share that ocrevus data will be presented at the #ectrims2022 conference in amsterdam, the netherlands, from october 26-28. please see full prescribing info at https://t.co/k33kg323b1. intended for us healthcare professionals only. how will you attend this year?",,#ectrims2022,,,"we're thrilled to share that ocrevus data will be presented at the ec trims conference in amsterdam, the netherlands, from october 26-28. please see full prescribing info at . intended for us healthcare professionals only. how will you attend this year?"
774,"Next week, we will be in #Amsterdam attending the 2022 @ECTRIMS Congress. We can't wait to bring you all of the latest updates on #MultipleSclerosis research. Stay tuned to all of our channels for a number of special features we will be releasing from the meeting. #ECTRIMS2022 https://t.co/NPpE3cnwHq",twitter,AUS,MStranslate,,"next week, we will be in #amsterdam attending the 2022 @ectrims congress. we can't wait to bring you all of the latest updates on #multiplesclerosis research. stay tuned to all of our channels for a number of special features we will be releasing from the meeting. #ectrims2022 https://t.co/nppe3cnwhq",,"#amsterdam, #multiplesclerosis, #ectrims2022",,,"next week, we will be in #amsterdam attending the 2022 congress. we can't wait to bring you all of the latest updates on multiple sclerosis research. stay tuned to all of our channels for a number of special features we will be releasing from the meeting. ec trims"
775,"The #ECTRIMS2022 38th annual congress will be hosted in Amsterdam for the first time in 11 years!

üìÖ26th-28th October

@VJNeurology will join live to learn all about the exciting new discoveries in #MSresearch from leading professionals üë©‚Äç‚öïÔ∏è

@ECTRIMS #MS #Neurology #NeuroTwitter https://t.co/rONlFbtTIx",twitter,,VJNeurology,,the #ectrims2022 38th annual congress will be hosted in amsterdam for the first time in 11 years! üìÖ26th-28th october @vjneurology will join live to learn all about the exciting new discoveries in #msresearch from leading professionals üë©‚Äç‚öïÔ∏è @ectrims #ms #neurology #neurotwitter https://t.co/ronlfbttix,,"#ectrims2022, #msresearch, #ms, #neurology, #neurotwitter",Photo & Video,,the ec trims 38th annual congress will be hosted in amsterdam for the first time in 11 years! 26th-28th october will join live to learn all about the exciting new discoveries in msresearch from leading professionals ms #neurology #neurotwitter
776,Don‚Äôt be an UmpaLumpa when it comes to S1P‚Äôs ECTRIMS 2022. https://t.co/6jMcjjERek,twitter,GBR,the_MSBlog,,don‚Äôt be an umpalumpa when it comes to s1p‚Äôs ectrims 2022. https://t.co/6jmcjjerek,unknown,,,,dont be an umpalumpa when it comes to s1ps ectrims 2022.
777,How can we target the pathologic CNS immune cell response for people living with #MultipleSclerosis? To find out more visit Hall 12 for our GMA Symposium ‚ÄúConnecting the dots: immune cells and CNS inflammation‚Äù on October 26 13:15-14:15 CEST. #ECTRIMS2022 #HCPSONLY https://t.co/PqNCtdNU6G,twitter,DEU,MerckHealthcare,,how can we target the pathologic cns immune cell response for people living with #multiplesclerosis? to find out more visit hall 12 for our gma symposium ‚Äúconnecting the dots: immune cells and cns inflammation‚Äù on october 26 13:15-14:15 cest. #ectrims2022 #hcpsonly https://t.co/pqnctdnu6g,,"#multiplesclerosis, #ectrims2022, #hcpsonly",,,how can we target the pathologic cns immune cell response for people living with multiple sclerosis? to find out more visit hall 12 for our gma symposium connecting the dots: immune cells and cns inflammation on october 26 13:15-14:15 cest. ec trims #hcpsonly
778,"Less than 10 days to go - looking forward to joining #ECTRIMS2022 in person in Amsterdam, hearing and discussing latest news and scientific results in #MS. Feel free to DM me for 1:1 on #digitaltherapeutics in MS, research ideas - or simply a coffee chat. #RCT #DTx #DiGA https://t.co/nP9eTovcpH",twitter,DEU,matthiaszenker,,"less than 10 days to go - looking forward to joining #ectrims2022 in person in amsterdam, hearing and discussing latest news and scientific results in #ms. feel free to dm me for 1:1 on #digitaltherapeutics in ms, research ideas - or simply a coffee chat. #rct #dtx #diga https://t.co/np9etovcph",male,"#ectrims2022, #ms, #digitaltherapeutics, #rct, #dtx, #diga",Travel,,"less than 10 days to go - looking forward to joining ec trims in person in amsterdam, hearing and discussing latest news and scientific results in ms. feel free to dm me for 1:1 on #digitaltherapeutics in ms, research ideas - or simply a coffee chat. #rct #dtx #diga"
779,"We are attending @ECTRIMS conference 2022 üéâ We'll be bringing ùó±ùóÆùó∂ùóπùòÜ ùòÇùóΩùó±ùóÆùòÅùó≤ùòÄ about the research that will ùó∫ùóÆùó∏ùó≤ ùóÆ ùó±ùó∂ùó≥ùó≥ùó≤ùóøùó≤ùóªùó∞ùó≤ to your life with MS.
Make sure you're subscribed so you don't miss anything üëâ https://t.co/xTWrQDlFZy

#MultipleSclerosis https://t.co/hKmcenV3FY",twitter,,LivedHealth,,we are attending @ectrims conference 2022 üéâ we'll be bringing ùó±ùóÆùó∂ùóπùòÜ ùòÇùóΩùó±ùóÆùòÅùó≤ùòÄ about the research that will ùó∫ùóÆùó∏ùó≤ ùóÆ ùó±ùó∂ùó≥ùó≥ùó≤ùóøùó≤ùóªùó∞ùó≤ to your life with ms. make sure you're subscribed so you don't miss anything üëâ https://t.co/xtwrqdlfzy #multiplesclerosis https://t.co/hkmcenv3fy,unknown,#multiplesclerosis,"Beauty/Health & Fitness, Photo & Video",,we are attending conference 2022 we'll be bringing about the research that will to your life with ms. make sure you're subscribed so you don't miss anything multiple sclerosis
780,#ECTRIMS2022 is showcasing the work of talented #MS researchers in a series of three Young Scientific Investigators‚Äô Sessions. Make sure to add these to your ECTRIMS 2022 personal programme: https://t.co/2yhkh4BolS https://t.co/yn26BAKngs,twitter,CHE,ECTRIMS,,#ectrims2022 is showcasing the work of talented #ms researchers in a series of three young scientific investigators‚Äô sessions. make sure to add these to your ectrims 2022 personal programme: https://t.co/2yhkh4bols https://t.co/yn26bakngs,,"#ectrims2022, #ms",,,ec trims is showcasing the work of talented ms researchers in a series of three young scientific investigators sessions. make sure to add these to your ectrims 2022 personal programme:
781,VOTE NOW: I'm looking forward to following coverage of the upcoming #ECTRIMS2022 Congress (October 26-28) and hearing all of the latest developments in #MultipleSclerosis research.,twitter,AUS,MStranslate,,vote now: i'm looking forward to following coverage of the upcoming #ectrims2022 congress (october 26-28) and hearing all of the latest developments in #multiplesclerosis research.,,"#ectrims2022, #multiplesclerosis",,,vote now: i'm looking forward to following coverage of the upcoming ec trims congress (october 26-28) and hearing all of the latest developments in multiple sclerosis research.
782,"#ECTRIMS2022 | Hot Topic 5 is about the escalation and de-escalation of #MS treatments in specific situations
 
üìÖ Thur 27 Oct 10:00‚Äì11:00 (Hot Topic 5: Escalating & de-escalating DMTs) 
‚û°Ô∏è https://t.co/ZC0k3x2A1x
 
Review the full Scientific Programme ‚û°Ô∏è https://t.co/rYgbXP8BwZ https://t.co/7ejOaGToMl",twitter,CHE,ECTRIMS,,#ectrims2022 | hot topic 5 is about the escalation and de-escalation of #ms treatments in specific situations üìÖ thur 27 oct 10:00‚Äì11:00 (hot topic 5: escalating & de-escalating dmts) ‚û°Ô∏è https://t.co/zc0k3x2a1x review the full scientific programme ‚û°Ô∏è https://t.co/rygbxp8bwz https://t.co/7ejoagtoml,,"#ectrims2022, #ms",,,ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme
783,"We are supporting an #MS researcher to visit the @ECTRIMS  conference in Amsterdam this month! 
If you need financial help to attend MS-specific conferences, our #bursary can help. 

üëâGet in touch today: https://t.co/JcqloC77i5
#multiplesclerosis  #msresearch",twitter,GBR,msresearch,,"we are supporting an #ms researcher to visit the @ectrims conference in amsterdam this month! if you need financial help to attend ms-specific conferences, our #bursary can help. üëâget in touch today: https://t.co/jcqloc77i5 #multiplesclerosis #msresearch",female,"#ms, #bursary, #multiplesclerosis, #msresearch",,,"we are supporting an ms researcher to visit the conference in amsterdam this month! if you need financial help to attend ms-specific conferences, our #bursary can help. get in touch today: multiple sclerosis msresearch"
784,"Neuromyelitis Optica spectrum disorder is often compared with multiple sclerosis. Whilst there are similarities, there are important differences. 
Watch the animations here: https://t.co/xFcDobnKaD 
 
#ECTRIMS2022 #NMOSD #multiplesclerosis https://t.co/fjklmvxcNQ",twitter,CHE,Roche,,"neuromyelitis optica spectrum disorder is often compared with multiple sclerosis. whilst there are similarities, there are important differences. watch the animations here: https://t.co/xfcdobnkad #ectrims2022 #nmosd #multiplesclerosis https://t.co/fjklmvxcnq",,"#ectrims2022, #nmosd, #multiplesclerosis",,,"neuromyelitis optica spectrum disorder is often compared with multiple sclerosis. whilst there are similarities, there are important differences. watch the animations here: ec trims #nmosd multiple sclerosis"
785,"Octave is excited to sponsor #PrecisionMedicine: From Research to Clinical Practice panel discussion at #ECTRIMS2022! 

You won't want to miss this event with @drbarrysinger, @SKriegerMD, & @GravesNeuro on the future of #MSresearch & care. 

More info ‚¨áÔ∏è 
https://t.co/QhcIdSPiZb https://t.co/6a8IawnwpV",twitter,USA,OctaveBio,,"octave is excited to sponsor #precisionmedicine: from research to clinical practice panel discussion at #ectrims2022! you won't want to miss this event with @drbarrysinger, @skriegermd, & @gravesneuro on the future of #msresearch & care. more info ‚¨áÔ∏è https://t.co/qhcidspizb https://t.co/6a8iawnwpv",male,"#precisionmedicine, #ectrims2022, #msresearch",Beauty/Health & Fitness,,"octave is excited to sponsor #precisionmedicine: from research to clinical practice panel discussion at ec trims! you won't want to miss this event with , , & on the future of msresearch & care. more info"
786,"Good news! The wait for the #ECTRIMS2022 abstract book is finally over. From oral presentations to posters, enjoy a peak into all the publications this year's congress has to offer ‚û°Ô∏è https://t.co/9QxIz47eRC

#MSresearch #MSJournal #MS https://t.co/fjk63Cirmh",twitter,CHE,ECTRIMS,,"good news! the wait for the #ectrims2022 abstract book is finally over. from oral presentations to posters, enjoy a peak into all the publications this year's congress has to offer ‚û°Ô∏è https://t.co/9qxiz47erc #msresearch #msjournal #ms https://t.co/fjk63cirmh",,"#ectrims2022, #msresearch, #msjournal, #ms",,,"good news! the wait for the ec trims abstract book is finally over. from oral presentations to posters, enjoy a peak into all the publications this year's congress has to offer msresearch msjournal ms"
787,New article:  ECTRIMS 2022 Committees https://t.co/FAI4o8QmCQ #MS #multiplesclerosis #neurology https://t.co/3up5wuzgvk,twitter,,PaperbirdsN,,new article: ectrims 2022 committees https://t.co/fai4o8qmcq #ms #multiplesclerosis #neurology https://t.co/3up5wuzgvk,,"#ms, #multiplesclerosis, #neurology","Beauty/Health & Fitness, Books",,new article: ectrims 2022 committees ms multiple sclerosis #neurology
788,"#Ultomiris for #NMOSD - #AstraZeneca announced that the results were exceptional; after a median treatment duration of 73 weeks, there were zero relapses
https://t.co/aFkt5S0285
#pharma #pharmaceutical #globalhealth #ECTRIMS22 #ECTRIMS #MultipleSclerosis #news #media",twitter,IND,ipharmacenter,,"#ultomiris for #nmosd - #astrazeneca announced that the results were exceptional; after a median treatment duration of 73 weeks, there were zero relapses https://t.co/afkt5s0285 #pharma #pharmaceutical #globalhealth #ectrims22 #ectrims #multiplesclerosis #news #media",unknown,"#ultomiris, #nmosd, #astrazeneca, #pharma, #pharmaceutical, #globalhealth, #ectrims22, #ectrims, #multiplesclerosis, #news, #media",Beauty/Health & Fitness,,"#ultomiris for #nmosd - #astrazeneca announced that the results were exceptional; after a median treatment duration of 73 weeks, there were zero relapses #pharma #pharmaceutical #globalhealth ec trims22 ec trims multiple sclerosis #news #media"
789,"#ECTRIMS: B-cell depletion and return in participant subgroups of the phase 3 ULTIMATE I and II studies of #ublituximab versus teriflunomide in participants with relapsing multiple sclerosis
$TGTX https://t.co/0UxzG5ow1p",twitter,CHE,Franca_ole,,#ectrims: b-cell depletion and return in participant subgroups of the phase 3 ultimate i and ii studies of #ublituximab versus teriflunomide in participants with relapsing multiple sclerosis $tgtx https://t.co/0uxzg5ow1p,female,"#ectrims, #ublituximab",,,ec trims: b-cell depletion and return in participant subgroups of the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis $tgtx
790,"ECTRIMS: Disability changes in the absence of relapse in the phase 3 ULTIMATE I and II studies of #ublituximab versus teriflunomide in participants with relapsing multiple sclerosis
""...with significant improvement versus teriflunomide""
$TGTX https://t.co/bTgkr31Jmm",twitter,CHE,Franca_ole,,"ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of #ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx https://t.co/btgkr31jmm",female,#ublituximab,,,"ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx"
791,"#MultipleSclerosis is an irreversible, neurological condition that may deteriorate the nerves in both the grey and white matter of the brain. Join us at #ECTRIMS2022 to see how we‚Äôre exploring potential solutions for people living with MS.",twitter,USA,ScienceAtBMS,,"#multiplesclerosis is an irreversible, neurological condition that may deteriorate the nerves in both the grey and white matter of the brain. join us at #ectrims2022 to see how we‚Äôre exploring potential solutions for people living with ms.",,"#multiplesclerosis, #ectrims2022",Science,,"multiple sclerosis is an irreversible, neurological condition that may deteriorate the nerves in both the grey and white matter of the brain. join us at ec trims to see how were exploring potential solutions for people living with ms."
792,"Damage caused by #MultipleSclerosis can disrupt communication between the brain and the rest of the body. At #ECTRIMS2022, we‚Äôll discuss our work to address the needs of people living with MS.",twitter,USA,ScienceAtBMS,,"damage caused by #multiplesclerosis can disrupt communication between the brain and the rest of the body. at #ectrims2022, we‚Äôll discuss our work to address the needs of people living with ms.",,"#multiplesclerosis, #ectrims2022",Science,,"damage caused by multiple sclerosis can disrupt communication between the brain and the rest of the body. at ec trims, well discuss our work to address the needs of people living with ms."
793,"Like Matt, people living with #MultipleSclerosis can face daily challenges. We aim to empower individuals with MS to take back control of their lives. #ECTRIMS2022",twitter,USA,ScienceAtBMS,,"like matt, people living with #multiplesclerosis can face daily challenges. we aim to empower individuals with ms to take back control of their lives. #ectrims2022",,"#multiplesclerosis, #ectrims2022",Science,,"like matt, people living with multiple sclerosis can face daily challenges. we aim to empower individuals with ms to take back control of their lives. ec trims"
794,"During #ECTRIMS2022, learn how we‚Äôre committed to delivering meaningful, scientific innovations to address unmet needs for patients living with #MultipleSclerosis.",twitter,USA,ScienceAtBMS,,"during #ectrims2022, learn how we‚Äôre committed to delivering meaningful, scientific innovations to address unmet needs for patients living with #multiplesclerosis.",,"#ectrims2022, #multiplesclerosis",Science,,"during ec trims, learn how were committed to delivering meaningful, scientific innovations to address unmet needs for patients living with multiple sclerosis."
795,"#ECTRIMS: Functional systems scores and expanded disability status scale score evaluations in the ultimate I and II studies of #ublituximab versus teriflunomide in participants with relapsing multiple sclerosis
""... significant improvements in EDSS score and multiple FSS"" $TGTX https://t.co/Wg1WJfWrv3",twitter,CHE,Franca_ole,,"#ectrims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of #ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx https://t.co/wg1wjfwrv3",female,"#ectrims, #ublituximab",,,"ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx"
796,"ECTRIMS: Disease outcomes with #ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis
Conclusions: ""... with significant treatment benefit...""
$TGTX https://t.co/2W6CjWeoWa",twitter,CHE,Franca_ole,,"ectrims: disease outcomes with #ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx https://t.co/2w6cjweowa",female,#ublituximab,,,"ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx"
798,"We are thrilled to announce that #ECTRIMS2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME¬Æ) with 18 European #CMEcredits.

Join us this October 26-28 for the world's largest #MSresearch congress: https://t.co/0ZJKVKGHTU https://t.co/3r4dCFbmJb",twitter,CHE,ECTRIMS,,we are thrilled to announce that #ectrims2022 has been accredited by the european accreditation council for continuing medical education (eaccme¬Æ) with 18 european #cmecredits. join us this october 26-28 for the world's largest #msresearch congress: https://t.co/0zjkvkghtu https://t.co/3r4dcfbmjb,,"#ectrims2022, #cmecredits, #msresearch",,,we are thrilled to announce that ec trims has been accredited by the european accreditation council for continuing medical education (eaccme) with 18 european #cmecredits. join us this october 26-28 for the world's largest msresearch congress:
799,"#ECTRIMS2022: Abstracts are live! $TGTX will have five poster presentations, highlighting data from the Phase 3 ULTIMATE I & II clinical trials. Read more: https://t.co/WABuOHEmwV Visit our Booth-D30 #MultipleSclerosis @ECTRIMSCongress #FearlessForPatients https://t.co/tUUtoiZR9q",twitter,USA,TGTherapeutics,,"#ectrims2022: abstracts are live! $tgtx will have five poster presentations, highlighting data from the phase 3 ultimate i & ii clinical trials. read more: https://t.co/wabuohemwv visit our booth-d30 #multiplesclerosis @ectrimscongress #fearlessforpatients https://t.co/tuutoizr9q",,"#ectrims2022, #multiplesclerosis, #fearlessforpatients","Beauty/Health & Fitness, Business",,"ec trims: abstracts are live! $tgtx will have five poster presentations, highlighting data from the phase 3 ultimate i & ii clinical trials. read more: visit our booth-d30 multiple sclerosis #fearlessforpatients"
800,"‚åõ The countdown is on! Two weeks to go before #ECTRIMS2022 on 26‚Äì28 Oct in Amsterdam. Will we be seeing you there? Register today to join the conversation on the latest research & developments in #MSresearch, treatment & care ‚û°Ô∏è https://t.co/GJGdaoznb2

#MSConnections #MS https://t.co/FS32HH0Xx1",twitter,CHE,ECTRIMS,,"‚åõ the countdown is on! two weeks to go before #ectrims2022 on 26‚Äì28 oct in amsterdam. will we be seeing you there? register today to join the conversation on the latest research & developments in #msresearch, treatment & care ‚û°Ô∏è https://t.co/gjgdaoznb2 #msconnections #ms https://t.co/fs32hh0xx1",,"#ectrims2022, #msresearch, #msconnections, #ms",,,"the countdown is on! two weeks to go before ec trims on 2628 oct in amsterdam. will we be seeing you there? register today to join the conversation on the latest research & developments in msresearch, treatment & care msconnections ms"
801,"With nearly one million people in the U.S. living with #MultipleSclerosis, we‚Äôre proud to be attending #ECTRIMS2022 on 26-28 October in Amsterdam, where we will have the opportunity to discuss the latest innovations in MS diagnosis and treatment options: https://t.co/xWEXhO0dqt https://t.co/ksva73NwlY",twitter,USA,QuanterixSimoa,,"with nearly one million people in the u.s. living with #multiplesclerosis, we‚Äôre proud to be attending #ectrims2022 on 26-28 october in amsterdam, where we will have the opportunity to discuss the latest innovations in ms diagnosis and treatment options: https://t.co/xwexho0dqt https://t.co/ksva73nwly",unknown,"#multiplesclerosis, #ectrims2022",,,"with nearly one million people in the u.s. living with multiple sclerosis, were proud to be attending ec trims on 26-28 october in amsterdam, where we will have the opportunity to discuss the latest innovations in ms diagnosis and treatment options:"
802,NEWS: New data for our neuromyelitis optica spectrum disorder (#NMOSD) medicine will be presented at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (@ECTRIMS): Learn more: https://t.co/gMR3n6rmBI. #ECTRIMS2022 https://t.co/0c38UIbvBH,twitter,IRL,HorizonNews,,news: new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 38th congress of the european committee for treatment and research in multiple sclerosis (@ectrims): learn more: https://t.co/gmr3n6rmbi. #ectrims2022 https://t.co/0c38uibvbh,unknown,"#nmosd, #ectrims2022",Science,,news: new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 38th congress of the european committee for treatment and research in multiple sclerosis (): learn more: . ec trims
803,"It‚Äôs only 3 weeks until #ECTRIMS2022 üß†

Did you know it is the world‚Äôs largest conference devoted to basic and clinical research & care in #MS?!

@VJNeurology can‚Äôt wait to catch up with the presenters & share all of their latest work on https://t.co/FB5htur0PY

@ECTRIMS https://t.co/TLGKdEEz0h",twitter,,VJNeurology,,it‚Äôs only 3 weeks until #ectrims2022 üß† did you know it is the world‚Äôs largest conference devoted to basic and clinical research & care in #ms?! @vjneurology can‚Äôt wait to catch up with the presenters & share all of their latest work on https://t.co/fb5htur0py @ectrims https://t.co/tlgkdeez0h,,"#ectrims2022, #ms",Photo & Video,,its only 3 weeks until ec trims did you know it is the worlds largest conference devoted to basic and clinical research & care in ms?! cant wait to catch up with the presenters & share all of their latest work on
804,How is our evolving understanding of centrally driven #MultipleSclerosis pathology shaping patient management? We explore this question with our sponsored activities at the 38th annual ECTRIMS hosted in Amsterdam from 26-28 October 2022. #ECTRIMS2022 #HCPsOnly https://t.co/U7vpivtmlw,twitter,DEU,MerckHealthcare,,how is our evolving understanding of centrally driven #multiplesclerosis pathology shaping patient management? we explore this question with our sponsored activities at the 38th annual ectrims hosted in amsterdam from 26-28 october 2022. #ectrims2022 #hcpsonly https://t.co/u7vpivtmlw,,"#multiplesclerosis, #ectrims2022, #hcpsonly",,,how is our evolving understanding of centrally driven multiple sclerosis pathology shaping patient management? we explore this question with our sponsored activities at the 38th annual ectrims hosted in amsterdam from 26-28 october 2022. ec trims #hcpsonly
805,"üì£ BREAKING NEWS: #ECTRIMS2022 has been accredited with 18 European #CMEcredits by the European Accreditation Council for Continuing Medical Education! Register now for three exciting days in the latest updates in #MS research, treatment and care: https://t.co/0ZJKVKGHTU https://t.co/Vti1jVBB0A",twitter,CHE,ECTRIMS,,"üì£ breaking news: #ectrims2022 has been accredited with 18 european #cmecredits by the european accreditation council for continuing medical education! register now for three exciting days in the latest updates in #ms research, treatment and care: https://t.co/0zjkvkghtu https://t.co/vti1jvbb0a",,"#ectrims2022, #cmecredits, #ms",,,"breaking news: ec trims has been accredited with 18 european #cmecredits by the european accreditation council for continuing medical education! register now for three exciting days in the latest updates in ms research, treatment and care:"
806,Forest bathing for Multiple Sclerosis patients. Best practice from Denmark ‚Å¶@ECTRIMS‚Å© #ECTRIMS2022 #sclerosehospital #multiplesclerosis ‚Å¶@Sclerose_dk‚Å©  https://t.co/OHNU9OSKbD,twitter,DNK,innov8_dk,,forest bathing for multiple sclerosis patients. best practice from denmark ‚Å¶@ectrims‚Å© #ectrims2022 #sclerosehospital #multiplesclerosis ‚Å¶@sclerose_dk‚Å© https://t.co/ohnu9oskbd,unknown,"#ectrims2022, #sclerosehospital, #multiplesclerosis","Beauty/Health & Fitness, Technology, Business","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Entrepreneur}, {profession=Executive, jobTitle=Founder}",forest bathing for multiple sclerosis patients. best practice from denmark ec trims #sclerosehospital multiple sclerosis
807,"And don't miss out on Wednesday, 12 October 2022 from 5 to 6 p.m. the virtual 60 minutes presentation of our international and English-speaking master's programme
""Charcot Multiple Sclerosis Management Master of Science"" https://t.co/Opz9Exlf6g @msif #ECTRIMS2022 @ean @emsp https://t.co/XAKIWULAQU",twitter,DEU,TZiemssen,,"and don't miss out on wednesday, 12 october 2022 from 5 to 6 p.m. the virtual 60 minutes presentation of our international and english-speaking master's programme ""charcot multiple sclerosis management master of science"" https://t.co/opz9exlf6g @msif #ectrims2022 @ean @emsp https://t.co/xakiwulaqu",unknown,#ectrims2022,,"{profession=Scientist & Researcher, jobTitle=Neurologist}","and don't miss out on wednesday, 12 october 2022 from 5 to 6 p.m. the virtual 60 minutes presentation of our international and english-speaking master's programme ""charcot multiple sclerosis management master of science"" ec trims"
808,"#ECTRIMS2022 | Meet the speakers: @TZiemssen from @SINTEF talks about electronic health interventions in #MS

üìÖ Fri 28 Oct 10:00‚Äì11:30 CEST (Scientific Session 14: e-Health)
‚û°Ô∏è https://t.co/OYdp99gc9R
View the full Scientific Programme ‚û°Ô∏è https://t.co/BS7MGHMHLJ https://t.co/Nlx4X1QzEC",twitter,CHE,ECTRIMS,,#ectrims2022 | meet the speakers: @tziemssen from @sintef talks about electronic health interventions in #ms üìÖ fri 28 oct 10:00‚Äì11:30 cest (scientific session 14: e-health) ‚û°Ô∏è https://t.co/oydp99gc9r view the full scientific programme ‚û°Ô∏è https://t.co/bs7mghmhlj https://t.co/nlx4x1qzec,,"#ectrims2022, #ms",,,ec trims | meet the speakers: from talks about electronic health interventions in ms fri 28 oct 10:0011:30 cest (scientific session 14: e-health) view the full scientific programme
809,"It is only three weeks until our team travel to Amsterdam to attend the 38th @ECTRIMS congress üá≥üá±. Book a time with us to learn how SyMRI is useful in the management of MS patients. https://t.co/mkXP84U1SX

#MRI #symri #quantitativemri #patientexperience #ms #multiplesclerosis https://t.co/JrylVBPVP7",twitter,SWE,Synthetic_MR,,it is only three weeks until our team travel to amsterdam to attend the 38th @ectrims congress üá≥üá±. book a time with us to learn how symri is useful in the management of ms patients. https://t.co/mkxp84u1sx #mri #symri #quantitativemri #patientexperience #ms #multiplesclerosis https://t.co/jrylvbpvp7,unknown,"#mri, #symri, #quantitativemri, #patientexperience, #ms, #multiplesclerosis",Technology,,it is only three weeks until our team travel to amsterdam to attend the 38th congress . book a time with us to learn how symri is useful in the management of ms patients. #mri #symri #quantitativemri #patientexperience ms multiple sclerosis
810,#MS is a disease that often occurs in women of childbearing age. Join us at #ECTRIMS2022 on 26-28 Oct in Amsterdam to hear about and discuss the latest research on treatment options. See the fully searchable programme for more ‚û°Ô∏è https://t.co/VqaDbppVY1 https://t.co/nM3iROcILA,twitter,CHE,ECTRIMS,,#ms is a disease that often occurs in women of childbearing age. join us at #ectrims2022 on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more ‚û°Ô∏è https://t.co/vqadbppvy1 https://t.co/nm3irocila,,"#ms, #ectrims2022",,,ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more
